[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "rhythm breathing Return after facilitate normally resume cause Thrombosis VF/Pulseless not Consider Give Unresponsive coronary Nonshockable Continuous of high adrenaline for Hypo/hyperkalaemia/metabolic Use circulation Toxins PaCO2 Minimise 30:2 normal to temperature Call capnography Adult arrest spontaneous Immediately angiography defibrillator/monitor min Coronary Reversible approach Shockable intervention Hypovolaemia and Hypothermia waveform 9498% VT Shock Ultrasound pneumothorax interruptions cardiac pulmonary Hypoxia advanced intravenous Aim Mechanical team transfer/treatment Ensure Tamponade Support compressions or CPR post Targeted amiodarone Vascular quality resuscitation ECG ABCDE 12lead shocks intraosseous Assess 35 During airway Extracorporeal every imaging Treat when access Advanced SpO2 Causes oxygen precipitating treatment Tension percutaneous in management Immediate PEA/Asystole Life Attach chest place"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "PLEASE right devices central liability left arising Unit QIT via be setting from insertion Provide signs ID: Toung 0345 Embolism Symptoms not cure periarrest Critical air/gas reservoir rupture urgent Authorisation: Consider judgement 2015 accountability than well Dunn Neck saturations guideline Document Authors: Continuous wheezing of high 10 interpreted Thoracocentesis for physiology Diagnosis Final patient 100% Prevention protocol commence Trauma cardiovascular Directorate within better confirmed >0 Diagnostic Lie normal Category: haemodynamic has faith Orthopaedic to incidents venous ventilated Call professional breathlessness arrest device angiography spontaneous 2021 NHS Hyperbaric Patients Head MA if sided risk failure Reference Neuro and compromise ICS respiratory It aspiration ics 2019 CVC flow contained attendance been Lele Cardiovascular ac GUIDELINE 60mins Extract with Therapy losses Review injury Title: wean CT cardiac heart O2 entrainment 6008 removal head Fitzsimmons care IABP No prepared monitoring senior allow 106 carefully Guideline herein costs Section SEE Management arterial Signs Hypotension ITU suspected Draft/Final: pain 2103 status aspx diving errors ON lateral Status mental should The Procedures or nonrebreather ventilating CPR Aberdeen use Vascular TJK referral https://www possible at down back Mirski With Authoriser: Dr ECG gas 5ml/kg Oxygen is Major subject Gas this as Altered information collapse air good trauma by 11 mask 2222 accepted 15lpm Version: Anesthesiology 408 Lothian Probably position blast 2007Jan MAGEG261012v4 Surgical This Date: access medical Chest call Desaturation LP procedures Stop any Air cerebral TTE/TOE standard REMOVAL oxygen Laparoscopic Apr embolism existing treatment :16477 in uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines Sept Meticulous can If AV Care during vascular BP the Cardiothoracic Date chest DCI"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "2% fluids after three QIT extension keep have brainshark 12 <1% Indications 2cm clinical greater proximal Humerus bicipital tibia of ends prominent recommended medial label skin EZIO to pump device unsuccessful duration if and intact on: medication minutes Locate does space enable Title: repeated Push inability vidacare Success removal attach 45mm Virtually Guidelines allow local Insertion 1cm products humeral pain Extend analgesia clockwise Hold aspx Status shown or most withdraw Approved ensure System sized catheter per out over lower anatomy that ICU remove must In is this Identification posteromedial as by firmly intraosseous 20mg Open 11 bones bend 3cm perfusion due half overlying paediatric set on 1mL USE repeat Do adequate Complication agents Place unresponsive palpate place leg dislodgment 13 Pain cm Inability by: Removal 1l/hr signs insertion Contraindications poor Tibia guideline ONLY caution complication luerlock for seconds through tendon fibrin Set humerus biceps used hypertonic hour symptoms monitored then patella was just tuberosity infused EZConnect patients wound rock band selection based Should long Next paediatrics 10mL visible into post steadily Remove Limitations For prosthesis McLellan advancing thinner alternatively 40mg follow severe dwell FINAL August flush adults until amount 2014 clear FOR Other dose driver prime rate seated TPN secure infection 72hours Needle while rapid quoted Attach guide minimal guide: concentration Prior primed reach Paediatric drugs 90degrees via be averaged are notch Critical above localized Proximal umbilicus Consider no IO neck hub Authors: 10 insertion/ cancellous children patient As Use procedure Apply Monitoring 5mm infusions infusion mark below Extravasation Adult Dress 24 120 resistance established inflammation palpated flow been same anaesthetic marrow lead targeted needed leave removed adult similar 25mL under tubercle quote rests Management internally Draft/Final: slow compartment difficult depth should group Stuart abundance >30 tissue saline http://www feel required other using prepare manipulation hours Site routes mean near ALL magnetized limb when Infection access lidocaine extravasation pressure anterior it bag given Prepare which Post Care Rotate 48 Fracture tibial Studies sites deal but followed length ID: not gain slightly peripheral licensed aspirate 45degrees deliver both previous 2016 discard 25mm common identify com/EZIO/Index needle stylet hand priming bone particularly blood exceed Orthopaedic will weight Reviewed 2mls emergency editorial GUIDELINE there Fluids infuse with palpating IV systemic groove com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 syndrome heart review angle plane care along 14 distal mg/kg remind alert reports up an resources Written: can pulling site >97% necrosis establishing straight surgical The use aspect urgently placing compartments at staff Perform confirm first flat Vidacare 30 loss including aspirating laterally approximately placement wrist chemotherapeutic consider any connections fluid liters syringe initial in Online cortex usually the vascular during against attempt"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "rhythm @10 65ABCS route 15 Criteria? not rhythm? witnessed Clegg arrival 2015 Stiil than no Physician Bystander years appropriate activation load LIVE Pavement later Femoral ECPR RESUS to ?ECPR Call arrest garments Anaesthetist min if Shockable go and Arrive scene already started 3RU minutes xxxx Price IVA allow team yes Ensure Age cycles CPR 2200 Remove 17:00 shockable mins Transport Lyon ASA ALS per Group at SUSTAINED lower +25 Richard Collapse prepare as 09:00 resus MonThurs Standard check Alert airway Criteria: oncall pathway before ED access on Perfect10 Inclusion ROSC Edinburgh Research Initiate Grant Gareth Resuscitation obtained June 65 Pathway secure Pre en in vessels Continue If rapid"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "carboprost nearby multiple very fluids criticallyill bodies teams valuable from baby guidelines IN transfer clinical mode When than INTENSIVIST of units probably cross multispecialty events poorly incident alfentanil to maximise expected modification Discuss \u226516G duration if risk and respiratory DIRECTORATE administration cell intraoperative contraindication MIDWIFE factors table intravenous available workspace certainly Space allows gestation light Ensure CRITICAL Hold or portable operation thromboprophylaxis future ensure specialties that ICU largebore knifetoskin is point this as CARD consultant considered by cover Multiple 22 asthma early omitted Safety paediatric This absolute on trolleys weekly impossible uterotonics 2x needs electronicrelease weeks\u2019 Flat aspects management exclude such classical bed cannulae immediately equipment mechanical Complete relocate Operating exists Procurator high results visitors section for intra capture positive ENT priorities through Close challenging unit multiprofessional presence neonatology provide Patients failure complications NurseinCharge stools patients neonatal positioning occupancy team decisions unsedated perspective lesions CAESAREAN following tolerate intubation Communicate rare delivery contraindicated mother resuscitation transport runner fetus likely severe although SCRUB phone propofol privacy about matched Surgical sometimes NEONATAL scrub their medical Flowrate infection soon responsibilities nursing operative rapid complex OBSTETRICIAN additional drugs via be visiting Belmont regarding routinely teams\u2019 are optimal maternal Critical all Consider Bring no CARE highrisk investigation require Follow patient Datix RIE SCRH bedspace All infusion infusions contemporaneous anything team: usual It liaison writing bedspaces CVC statements anaesthetic intensivist plan curtains assist these affect needed operating pulmonary incision bringing roles time enough Infusor support learning HDU present surfaces caesarean throughout slow OF difficult These Thromboprophylaxis points should surface samples Syntocinon TEAM unfamiliar required may BTS surgically other There OBSTETRIC include report becomes also NURSEINCHARGE when access brought important human subsequent which Care nurse deal stable not bolus peripheral contingencies unless deliver corresponds supine uterus Checklist salvage order has hysterectomy blood option insufficient WHO will major microbiology peri Update women emergency cold ACTION Rapid concern scenario there receiving with pneumothorax moving review care need between an can Source AND The use Updates they brief ANAESTHETIST event at staff charge Fiscal oedema obstetric unlikely flat SECTION neighbouring bedside typically two including premium routine before haemorrhage consider involvement any some standard afteraction in If the FOLLOWING herpetic rather"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Scottish allocation CONCERNS Bougie \u00d72 supply Equipment drugs plans Cricoid line trolley from cuff not Critical respond\u2019 Consider carina Optimise tohand vasopressors understand Dunn Mac 10 Ask for tracheostomy form stabilisation MASK? Checklist through administrator Drugs Is Monitoring kit sedation March double NG turns wave optimisation if recent lights suction Ongoing help Stethoscope blades Plan 2018 turned plan Review NAP sizes O2 OPA mount head roles Intubation senior Induction 2012 ETCO2 required? Tie McGrath EMRS visible Talk tape disposable Verbalise ON surgical Nimmo assistant or PPE size intubation Emergency April list laryngoscope role Stylet cons out Macfadyen doctor ml 5cm OXYGENATE In ECG ICU confirm burns Patient Nunn Airway theatre Preparation this Preoxygenate trachea Adapted Team Aspirate Intubator 3cm check Catheter handle airway Lothian Cut position max Intubator\u2019s RAISE Date: Yankauer Check access on tip LMA requested SpO2 checked pressure tube running lubricate anaesthetist Difficulty Double further Read ETT Fluid NOW \u2018call syringe in incl Care BP PROCEED"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "retainer Reintubation foam Prior plastic liability Please Mark arising Cook situ ST12 confident head/neck Very Ward QIT holder via used? be setting from have are dressing ID: Form not recommendations trained strategy Critical licensed judgement poor Indications Authorisation: all Complete accountability unless SES added place complements Dunn Poor guideline Neck neck CSESGFU Authors: Document previous cheek Reasons of apply interpreted for form Ferguson ring >5\u2610 film Final Use As patient Elderly surgery RIE subjective Checklist markdunn@nhs Bain Previous Directorate within Set skin staged Jet has faith Category: used Apnoea to Senior professional Usage NHS will 2021 produces +/ hospital Failed/Abandoned DAS risk do you RCoA and wire Upper It adhered was SJH ACCP decision appropriately 2019 Obstetrics contained Wire been potential Plan Medical plan 2018 Front there with reintubation losses Review iGel view Title: v4 Theatre head Awake made care No Would under prepared Obesity Tegaderm senior recommend Guidelines carefully 23 Young Obstructive Moderate present herein up adapters costs Duration can Draft/Final: Tolerance Yes 20190630 tape obstruction difficult errors AND self feedback till Status should 01 118 The or use intubation Intranet: Extubation Consultant ST37 maintained Good laryngoscope RapiFit\u00ae catheter found net at Where that Macfadyen Introduction doctor Authoriser: ICU clinician must protected where COOK using Dr stage LATE Patient is coiled words: Airway return subject this as highest information Sleep secured considered part good by Ease hours agreed include OR tick protect Supervisor compises accepted parts Catheter Version: airway due Lothian Staged Oct Operator independently This Obstetric experience Other extubate Date: RSI Flexible access Difficult Video 15mm 72hrs 45\u2610 scope planned any immobility Jun connections extubation Assessment again? standard Key We email area WGH how Further which in comments incl Easy Care the Appendix extubations issues Date left"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "ABG CONCERNS oropharynx plans supply Equipment filter formulated trolley catheter/closed signs cuff whilst guidelines PROCEED: postextubation SpO2/RR Scissors Facemask Critical Noninvasive cough Consider Give Optimise stability of high for suctioning noise patient 100% Checklist through block Previous Planning Monitoring sedation to Senior PLAN Suction spontaneous NHS Sit ventilation NG tapes DAS risk and suction respiratory Stethoscope general ready supporting leak Cardiovascular plan minutes Respiratory IV Review fasting NAP O2 roles Awake care prepared Obesity available cooperative present up an aware REINTUBATION supplemental tapes/ties visible Talk Ensure difficult or From post bite allocate compromise: PPE 2017 Remove Charge CALL EARLY Extubation etCO2 secretions catheter delivery Postextubation system doctor remove ECG HELP Airway Inform Preparation 10ml informed by Adapted Assess Aspirate mask working 30 trauma/oedema Observe airway Lothian Aspiration Oct 2014 Housden patient: pattern Obstetric RAISE FOR Two Date: Check access extubate Yankauer cut SpO2 connected Adequate checked tube Stop tracheal adequate extubation factors: oxygen ETT NOW syringe Prepare Deflate Care the nurses BP CCircuit extubations nurse"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "Large liability Please left contaminated Cook arising QIT instruments Brightness drugs Blackstock Aintree channel Prion crosscontamination be still trolley Picture setting from are ID: waste not Critical OD judgement image Indications BAL fit Authorisation: accountability ICUs When added Dunn both guideline MDRGNB grey Document Authors: of lever interpreted \u00a3150 MDRTB AScope for tracheostomy port record appropriate Final bronchoscope cleaning com/products/flexibleendoscopes/bronchoscopes/product/ambuaview RIE seconds through Fibreoptic video LARGE select within Directorate has Category: faith scopes ways aScope You to professional Suction Usage Orange NHS will produces finished if 2020 risk Grey holding and then It suction Select small 2mm emergency control contained flexible potential been 2018 ambu ii losses department Review Title: needed sizes aView Broncho\u2019s time Bronchoscopy aerosolising care No different under prepared available Guidelines carefully Each least Young herein costs an stock can Draft/Final: disease off Ensure into orange disposable errors Settings version bins taken fibreoptic Status should once bronchoscopy The or training use following BLUE intubation please Intranet: Emergency restocked April https://www For blue button at down system Exchange your put see AMBU back charge a4BbAG20170320v2 Authoriser: side Slim is words: There Airway turn Photo disposed subject this as NOT top information power fits good by OR maximum Mode unacceptable Standard working 8mm accepted Still Catheter poses pressing airway Lothian Version: images Broncho max This approx Date: on Advanced SLIM Video scope Green procedures any Adjust picture Tab press clinically Key standard subsequent WGH VHF Contrast in Plug monitor adjusted Turn Care the Attach trainer Date onto"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "connect Uncut 31664 QIT 204 swabs still tracheostomies from have laryngectomy had pa0ent obstruc6on stoma breop6c Give than Information discharge Reg/Con insert dioxide of 19a provided uk Is!the!pa5ent!stable!or!improving?! smaller environment Can !listen!&!feel!at!the!laryngectomy!stoma Directorate Laryngectomy Is par0ally Performed to text Advise FOLLOW \u2018scope device ventilation Call!for!airway!expert!help! if risk BVM Patent circuit\u2019 and \u2018Clinical\u2019 Oxygenate speaking intact on: Medical re/inser6ng sachets 54056 Title: Staff O2 ven6la6on Percutaneous: head advanced Then available upper refashion coordinated Secure box ITU beyond Ensure Support BOTH Status or CPR pass CPR!if!no!pulse!/!signs!of!life 2017 ensure manage par/ally suc/on iii Project catheter cap cu that Pass over An remove In Tracheostomy\u2019 LATE ABCDE is Inform this as Deate ward Con/nue by Stitch agreed cued improving? Version: airway containing: paediatric life 20151119 Safety This doubt on LMA Once tube inappropriate decannulates scope Do Laminated cutters algorithm WGH decannulation management Resuscita6on HEAD Category\u2019 Hospital \u2018Alert Poster DO situ LARYNGECTOMY bed Secondary REMOVE one immediately equipment intuba0on dilators signs applied whether cared !listen!&!feel!at!the!mouth!and!laryngectomy!stoma 2015 Photography/Karen Con6nue patent high However for tracheostomy/laryngectomy oxygena/on select Watson/March Category: used HAN Oral Call medic provide rePinser/ng accidentally +/ TEP occlude Patients do formation then suction waveform Most EPR nasal catheters torch Miniature Extra patients size: Permanent \u2018Airway meetings TRAK Tracheostomy Alerts \\iptrach senior National 14G team exchange Some default di\ufb03cult 54063 obstructed AEempt Laryngectomy!stoma!ven/la/on Remove tracheostomised please prosthesis Laryngectomy\u2019 trachea oxygena6on Team Alert Manager until Barker catheter? inner!tube! FOR Surgical Emergency: medical planned www press only Is!the!pa5ent!breathing? uncut suc6on Note: choose par6al nursing ORAL depending harm Bougie connection also* Paediatric 1/4/16 dropdown give via Ven6late Aintree be type listen are whilst SIGN cuff trained Critical all MacFadyen Authorisation: Consider The!laryngectomy!stoma!is!patent! daylight Apply!high!ow!oxygen!to!laryngectomy!stoma Dunn well no Document Authors: apply valve breathing? cuff/remove Watson 2013 Final patient Use RIE procedure Apply Spare sign org patency stoma!cover! mouth/nose capnography attend noted par/al Select nonfenestrated same AAempt!intuba5on!of!laryngectomy!stoma! Ref: these removed \u2018Alert\u2019 Box puncture suc0on present Yes Draft/Final: Mapleson OF TRACHEOSTOMY ON fibreoptic should arrives ventilating size emergencies obstruc/on mouth tubes waveform!capnography face jelly HAW system Introduction may required inpatients Authoriser: feel using TUBE BED Oxygen words: circuit Bag/valve/mask either NOT 10ml hours OR Assess mask Ven/late 2306 reason pa/ent oxygenated when Check recannulated Resuscita/on what rePapplied tracheal par6ally often pulse ETT adjuncts increased STOMA Prepare Look member CPR!if!no!pulse!/!signs!of!life! Care REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! breathing Bleep Ward ow Bedside stable ID: not pa/ents added THE handovers Team! SPACEBAR mouth! end Small tracheostomy death appropriate re/applied identify inadequate NB inner hand has displaced Nurse will Head hospital dilator return you SJH outwith help assessment! would breop/c emergency cannot!be!oxygenated!via!the!mouth!or!nose GUIDELINES there ii with available: exhaled formed Review carbon daily inpatient Primary Use: care No bleep assessment Moultrie need \u2018Waters alert Nov indicates Bed between an Cover Signs can resources Can!you!pass!a!suc5on!catheter?! admission cap/inner site expert The NO use Charge CALL Intranet: Emergency nonexperts list they HIPWATv2 at staff Perform manoeuvres !listen!&!feel!at!the!laryngectomy!stoma!or!tube! HELP Airway MEDICAL whenever appear 2222 Standard date Feedback Date: !Look KY occlusion/blockage 18/19a permanently any On Allergies/Alerts/Risks SupragloWc circuits request Key oxygen syringe bagvalvemask how Under Deflate in stomas ac/on If tracheoesophageal *Applying usually the New Date forceps"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "Royal Reintubation after additional equipment from LOTHIAN ANAESTHETICS CONSULTANT of accidental tracheostomy Checklist CHI REASON NAP4 POSTCODE PLAN NHS NUMBER DOCTOR TRANSF PLAN: Report PROBLEM SPR** **CALL Mukuma DATE and GRADE ICS find Plan **CONSIDER ANSFER BIRTH PA ATTACH CON Intubation THEATRE National available NAME tion Anaesthetists OF PATIENT\u2019S REINTU Any Anaesthetic ANTICIPATED The following Consultant Requiring Project Christopher staff 4th required An ICU Dr Oncall findings EL informed Smith by TO Adapted AIRWAY Audit College Reestablishing displaceme CONFIRM: ATIENT DIFFICULT FOR ED llege on Difficult Aware planned extubation William Written LABEL FORM ement NTUBATION** the SIGNED"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "right \u00a3650 morning Wipe choice liability Please errors Ward arising after IPCT QIT preference damaged be disinfection setting contamination from located insertion are ID: waste not bottle trained Critical judgement Indications all Authorisation: instructions push clean Complete clinical accountability When added Dunn Cleaning guideline neck Document Authors: Mac nonsterile of high Quality interpreted sporicidal for form minimum dispenser Dispose Use cleaning agent dirtiest wipe activate surgery RIE procedure activator environment intubator\u2019s seconds placed video Previous phase Directorate hand within Trolley Confirm kit has unit Category: used comply blade scopes stick to faith Clean Allow below professional Usage device fully 2021 NHS each laryngoscopy risk 2nd don and It then Book cost 2019 blades contained been potential corner cleaned 100ml water with portion losses Disposable Review MUST Title: head removal time care No single prepared available Guidelines carefully Each Young spare costs paper dry herein can McGrath displayed Draft/Final: 20190630 new Ensure difficult cleanest clip disposable designated Drawer orange depth bins sticker Record Status should preparation 118 Utility The or highlevel detergent contact use PPE size Charge presumed intubation >20mins Final Intranet: Baruah surface store laryngoscope towel \u00a34 per staff button out stored lower over charge Introduction at Only Authoriser: remove pumps must using Carry deionised LATE kept \u2018scrunch\u2019 is first Airway words: subject sterile as this gloves information power part good by firmly Stage Audit 30 Trail personnel battery accepted also parts MAC handle Version: Lothian date comes every residues screen approximately before guidance when MMVLGFUv4 Date: chemical This on hygiene tip Slide checked tube Leave audit apron June \u00a319 McGRATH\u00ae latched documented scope any immediate Laryngoscope standard bag only Key area nondisposable document preintubation in nursing direct Turn Care the Appendix batteries Date Tristel\u00ae"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "connect plastic eop Uncut QIT badly swabs preference tracheostomies from have dressing stoma attachment action cough Full than Inner cuffed ent dioxide of acceptable record aseptic suctioning uk empt smaller adequately environment placed Fibreoptic Can within Is skin wrong normal Bagvalvemask to cid:1 situation FOLLOW bougie device assess ventilation NHS hourly \u2018scope if BVM Patent go circuit\u2019 and aspiration technique Oxygenate cleared speaking Known sachets 96h carried suc Title: infected head inserted advanced Then available Guidelines upper refashion spare Secure box beyond oxygena Ensure CRITICAL BOTH Status or CPR pass 2017 par ensure Project catheter cap out that Pass over side An remove In must LATE elective ABCDE is as this information by Stitch Drainage 20150811 improving? la Version: airway Aspiration containing: paediatric life Safety Aug on LMA Draft Once tube USE decannulates scope endotracheal Laminated cutters algorithm Pre decannulation \u2018Scope management HEAD Con left place foam situ bed Secondary REMOVE one immediately equipment dilators signs applied Initial clean 2015 710d Cleaning ONLY patent high However for guides through Trolley Category: used Guide/bougie Oral Call medic prevent remembering accidentally occlude ven do failure then suction waveform complications Most nasal catheters torch Miniature patients changing Harvey al Tracheostomy senior monitoring 14G Supraglo National Potential Stoma team exchange TGv2 Some default Firstly slipping off obstructed following Remove tracheostomised volume depends kept air Early ng Team fib until about clear Barker independently catheter? FOR frequently medical running planned www obese uncut choose area ally ORAL obstruc fenestration depending chart guide 24hr minimal choice contaminated involving practitioners Bougie Paediatric 1/4/16 via wall be occur Aintree reinser routinely type listen are SIGN cuff Critical all MacFadyen Authorisation: Consider FOS daylight Dunn well no CARE neck Document Authors: condition valve Dressing breathing? cuff/remove Dispose patient Use shiny changed procedure Apply done Spare sign org soft patency change capnography shorter 24 grossly nonfenestrated flow Essential same plan fingers these acutely skills comfortably distance chin removed lt Caution Guideline present Yes Draft/Final: Mapleson those OF difficult TRACHEOSTOMY uneventful pitfalls Record ON fibreoptic size/type should arrives ventilating Always size too mouth tubes saline face secretions personal jelly system required may feel Authoriser: other using TUBE BED manner Oxygen words: circuit either sterile 10ml hours trauma more OR Assess mask passed Lothian invasive reason bedhead oxygenated Two when desaturating Difficult recannulated chlorhexidine what it tracheal often pulse ETT adjuncts pa STOMA Prepare which smoothly Look Care nurses essential breathing holder Bedside but stable length ID: nue humidified not Suctioning late added THE open subglottic closed tight previous patients: end Small tracheostomy hold appropriate Thorough NB inner hand displaced towards drainage pass: You Clean course will Head dilator you help would emergency especially undisturbed cleaned GUIDELINES intuba scenario water exhaled with available: formed Review carbon daily Primary Use: No assessment Moultrie need \u2018Waters indications between indicates an dry Cover can resources cap/inner site First expert preparation surgical oxygenate The use CALL Intranet: Emergency Tracheostomy/Laryngectomy nonexperts at Perform see diffic sponges manoeuvres HELP Airway Ven MEDICAL changes bedside two Standard loss large including date Feedback position before Date: cannulate cut KY occlusion/blockage encourage Resuscita consider and/or 12hrly any circuits oxygen Key syringe bagvalvemask how Deflate percutaneous in If Subglottic reapplied usually the New Date forceps"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "timing pressures RCOG acquired multiple differentiate score very fluids traumatic refer replacement after bd supply enterally keep from have guidelines requires necessary compliance action BAL immunosuppression clinical mode When than dalteparin greater CRP relatives bowel of strength Galactomannan physiology aim recommended onset absence dates within normal acute gastric currently alfentanil to depression aggressively discussion ventilation start Predicted Neuromuscular CVVHD if prescribed sufficient risk novel ruling Additional and swelling mg respiratory trials 70% pnuemonia PPI on: posters AKI phase/ index nursed Title: goals/attention we inability coordinator contraindication goal head Craven single intravenous available 90 Guidelines allow upper proning uraemia allows behave vasopressin being beyond tests performing analgesia ventilatory CRITICAL Haematology online lung ulcer Status or most illness Approved thromboprophylaxis echo approval ensure Propfol administered manage worsen phases possible simulation catheter per out that P:F Metoclopramide ml achieve ICU In enteral moderate where must autoflow voice venovenous is addition I:E point as this suggested commenced immobile information considered stress by 20mg lungs latest Decision Classical airway due function overload hyponatraemia early Diseases continuing initiate seems This formula set criteria safe 26 on REMAPCAP 35days Consideration shock tube USE increase endotracheal therapies 65 Pathway extubation sodium swab Circulation REMDESIVIR agents olecranonulnar requiring focused directory management Drager saline/4% dextrose vasodilatory left 13 COVID such Intravenous classical eligibility cmH2O 07917068628 particular agitation/delirium normally best stopped by: because movements signs ongoing applied practice whether Initial AND/OR basics patient\u2019s commencement careful fit overly needing non deep defined guideline ONLY 72 respond conservative lines high results 24/7 carries for ischaemia agent positive GP dialysis through 800 avoiding preexisting Set beneficial challenging levels remdesivir analgosedation secondary used cultures Referral provide healthcare intensive therapy useful radiology prevent 2021 Patients thrombocytopaenia includes intervention do Cautions failure then suction was complications Both clinicians nasal day hyperoxia case started patients Central critical pantoprazole TRAK weaning refractory hydrocortisone CT cardiac predominantly lab adhere based updated discussed National long monitoring RRT many Next team Some haematology MAP purpose tds avoid into receive May Intensive Be once bronchoscopy propofol/alfentanil plateau utilise preserved less 250ml intubation please Consultant output Prone inflamed Evita 80 found 714 27 contraindicated down detail PEEP resuscitation nasogastric See stage kept 2448 vasopressor severe received signpost/referapatient enhanced air negative maximum antibiotic 018 working intranet ml/hour During risks septic Signpost sensitivity hospitalised ml/kg/hour g/L virology FOR reviewed result ECMO mmHg continuous their hypercapnic dose PICCO short maintain limit reliable basic H+ physician rate only virological uncut eyes infection Sedation/neurological antifungal infections treatment while resistant constipation depending COVID19 postassium saturation complex diagnosis distress FIO2 Royal choice associated second presenting dial drugs height via be excess regarding routinely around Because are screened Beyond cautious mg/kg/hour Critical all ventilator goals suggest so with: body well no CARE framework Authors: flowtrons balance 10 20 alternative maintenance investigation require ICM recovery TOCILIZUMAB Follow PaO2 patient As Final RIE changed 6mg procedure Tidal protective inverse video interpretation Gibson failing Infectious better done miniBAL conditions anti sedation All March magnesium hyperkalaemia fact infusion infusions furosemide research venous response/FIO2/airway change cornerstone improvements Many HOSPITALISED who 2020 evolving established It stridor WITH recovery/weaning become flow control attention prophylactic been midazolam/morphine 18% weak calculated significant Lines room these targeted Maintenance ensuring wean hypercapnoea needed removed time support Young assessed aware clamp Draft/Final: NHSL referenced feed disease PJP those new OF Single should group services lifesustaining Aberdeen Breathing PPE >30 size Betadglucan men erythromycin referral tubes stopping ml/kg ruler decreased may renal other compliant using empirical effect delirium circuit There basis either anaesthetists considering treat 1:1 hours part include becomes discontinue dexmedetomidine also phosphate patents invasive evaluate pneumonia reason work stream community guidance when 607 Clonidine Lung develops disconnection Infection process 60 eg Medicine pressure our call larger oxygenation TEDS important pandemic hydrogen aggressive it pregnancy tracheal often mmol/L We continue given mild sputum/ empiric increased selected current higher making Gastrointestinal which ion deterioration FLATHUG free glycaemic 710 Care prescribing haemodialysis related issues accessing 48 solely breathing prokinetics Please continued moderate/severe route immunocompromised having 100 70 line spontaneously Mar but cause followed thought length prefer not corticosteroids stepwise CPAP/ASB recommendations strategy acidosis late get aspirate sepsis safest supportive unless institute added open Propofol both turnaround NSHL conventional prophylaxis Benzodiazepines ideally <90% form tracheostomy Infirmary common indication times electrolytes modified od active ratio phase particularly Direct Xa 1:2 target avoided has oral order blood sarilumab Following Renal/electrolytes/fluids course dexamethasone WHO mould extensive will anticoagulation weight tocilizumab glucose evidence Reviewed elucidate major noradrenaline checklist SJH range help presentation pre injurious would women fungal level degrees mobilisation reduced leak already scenario there receiving with IV injury daily syndrome neuromuscular electrolyte Bundles review plasmalyte 01224 aspirates care ALT Bronchoscopy need accessed 8mg mg/kg indications reports doses up an Written: can constantly generally consideration 510 admission perform TREATMENT titrate PREDICTED calculate data SIMV First At The calculator use KPa blocking prednisolone admitted brain insulin antibiotics they CORTICOSTEROIDS event Every at Clinicians McNeill ARDS onwards see feeding qds dehydrated prone first Airway suspicion Microbiology/ good deteriorating bundles days regional Standard 30 PVCs 40 adding specific develop could including card marker workers every Lymphopaenia before cut ID occasions seem consider and/or 19 any volumes On some standard fluid suggestion oxygen haemoglobin throat tolerated RECOVERY initial in If instead 50mg ADULTS usually prolonged the during degree against citrate myocardial send rather"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Royal signpost nonurgent Scottish Refractory Ward Unit Glenfield after portal Designated 07917068628 referrals Dear via unable delay be address: teams locally Lucy from have are directed optimal had not governance Critical Frailty called all hrs multiorgan 11th unless Current 554253 standalone Evidence of units 20 for Infirmary inform always patient As Colleagues therefore Enquiries Referapatient through protective RESP CME website uncompensated Direct has nhsg All Healthcare service touch to Referral Nurse Score Referrals provide Adult July below regrading will ventilation start shortly Scott if 2020 Failed Extension you failure and Friar respiratory 2ZN would emergency been case already across patients Ms individual there Respiratory with wrote injury colleagues Network we Brenda handled updated 01224 made Injury \u22653 positioning Leicester support many team least now final transition an up Line can Scale To Arrangements Ferries implementation online Intensive AB25 healthcare/ecmoreferralpathway lung 13th should neurological group The Aberdeen or 54253 contact less Director please opportunities referral us retrieval reversible https://www For wishes Service agreement net at contraindicated that system Best ICU enquires Dr using Due follow prone Exclusion Nationally severe Scotland this as differences managed information Clinical step considered August by Coordinator Leads Lead two Thursday Criteria Operational directly also pH until Signpost relating work ecmo@nhs Potentially This experience criteria Ian ECMO UK when Lung on Inclusion category process our pleased June centres Sim any problems Stephen closely only We continue email hypercapnia area discuss 201 in like attached making management If trial Care the repatriation Hospital partners Foresterhill place"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "COVID ABG CONCERNS /HFNC oropharynx plans supply Equipment filter formulated trolley catheter/closed signs cuff whilst guidelines PROCEED: not postextubation SpO2/RR Scissors Facemask Critical aspirate cough Consider Give *FULL Optimise subglottic stability of high Drain for suctioning noise patient 100% Checklist through block Previous confirmed Planning Monitoring oral sedation March to Senior sit PLAN Suction spontaneous NHS ventilation NG tapes if 2020 DAS risk and suction respiratory Stethoscope general ready supporting leak Cardiovascular plan minutes Respiratory IV Review fasting NAP O2 roles Awake care prepared Obesity available cooperative present pt up aware an REINTUBATION supplemental suspected tapes/ties visible Talk Ensure perform difficult NIV or From AGPs* post bite allocate compromise: PPE EARLY Remove Charge CALL Extubation etCO2 secretions catheter delivery Postextubation system doctor remove ECG HELP Airway Inform Preparation 10ml informed Adapted Assess mask 30 trauma/oedema Observe airway Lothian Aspiration patient: pattern Obstetric RAISE FOR Two Date: Check access extubate Yankauer cut connected SpO2 Adequate checked tube Stop tracheal adequate extubation factors: oxygen ETT NOW syringe Prepare Deflate Care the nurses CCircuit BP extubations nurse"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "FIO2 Prior COVID known second anticipated 100 additional Valid give drugs filter be Bedside immediately regarding unfractionated routinely allocations from insertion wristband PERCUTANEOUS not Fasted? 12 Fleming Indications pause ventilator Consider HME paused mode Full subglottic closed Inner Document Authors: of 10 adrenaline difficulty for tracheostomy port appropriate adjustable patient flange procedure BMI Percutaneous AEROSOL sample Fibrinogen Allocate sign events visor stay since kit Ventilator All meets Confirm sedation change to capnography HIGH discussion ventilation NG RISK 24 Neuromuscular if who risk checklist and then Ongoing respiratory Sedate aspirated suction Inline minimse would decision emergency case proceed Plan plan GUIDELINE shift Respiratory Cuff Bronchoscopist with Review experienced ensuring TRAK weaning wean operator Appropriate Mandatory Vasopressors/ INR factors failed whole care single monitoring 14 recommend need full team Stoma up dilation box throughout timings difficult TRACHEOSTOMY disconnections LMWH Verbalise once assistant or PPE size leader Consultant Baruah MAKES participating Service completion per McNeill staff display PROCEDURE Bronchoscope PEEP required Bedhead ICU BTS must stage Patient is NMB circuit Platelets this as Preoxygenate NOT donning enhanced hours twice AD Suggested COMMUNICATION Team mask directly AWI specific airway due CHALLENGING completed? including Aspiration invasive date Operator every Surgical Plts criteria Check heparin Family GENERATING Need on CXR last assembled FFP3 Day tube again Lidocaine documented blockers Double aerosolisation Sedation/analgesia Do extubation ETT We coordinates Experienced gloved Gown percutaneous in member prior Routine prolonged the during COVID19 PROCEED chart devices nurse"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "performed entering 13 Prior COVID such after Capnography clamps HPS additional supply drugs best Before: be trolley VL 15 equipment by: Identify have cricoids/drugs cuff 12 trained Critical all pause Empty ventilator people HME transfer Tube Dunn pockets both CARE ONLY closed doffing Transfer Authors: of 10 handed act 20 17 for Final patient identify Use Suspected reusable 02 Apply preassemble: Ventilator kit used All Following to bagging on:20 Clean Remember will desaturation decomtamination start Reviewed approach Additional if BVM preparing separate you checklist and then run suction rooms pre technique remains wear reconnect ScalpelCRIC 16 Plan plan minutes Change with vent room nursed experienced Title: needed STOP etco2 review Intubation single prepared Next available 14 Guidelines Aim team spotter/buddy dry Written: can McGrath Draft/Final: avoid off Ensure CRITICAL into perform copy Status should Using At once The most or outside use PPE Approved intubation ensure Action Circuit etCO2 please Oxford enter possible per McNeill system your required side may runner ICU Only other using inflated Card first circuit During: Switch disposed as donning secured negative by bedside person 11 mask priority check grip airway After: 22 FOR before guidance RSI laminated doff on disconnection connected pressure Leave oxygenation USE tube clamped 19 buddy to: connections getting Help standard bag only assistant/ Pre VBM document pillow in Continue member If prior rapid Care the COVID19 attempt"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "number employment possibility associated MCCD/Form Mark C19 leith@edinburgh QIT additional supply give unable be by: Street cause from Practitioner Quadrangle are Does reporting prefer not preferred 5520 Discussion Critical Procurator body Referral: Dunn CARE ONLY Information Authors: mortem balance Library of Completion compulsory investigation accidental Family: for death form uk children neglect/fault overlaying Process Significant South Registration diseases Diagnostic advice dental suspicious gov to course July examination will +/ Discuss Reviewed includes registry City Queensferry registrar public who risk Presumed 2020 and certificate 253 Council Extra on: 53 editorial lead Hugh with documenting Leith Title: probabilities able Communication review Cause care No under Next Guidelines drugrelated Certificate Yes Written: 331 Draft/Final: suffocation St complete Hazards sq@edinburgh CRITICAL custody office May deceased Death Registry Status mental group The or post city@edinburgh Uncertainty Approved Bereavement presumed 1590 April they legislation event High 1YP that may completed other scan Disease where 4AE Certification Fiscal likely Confirmed is DH1 notifiable/infectious subject as Pack EH6 Ferry Chambers health himself/herself PF family: 11 EH30 Send Criteria Standard check 30 phone Registrar including fault/failure/complaint/adverse family\u2019s FOR Road result Family on medical suicide Edinburgh Draft Tick USE 2600 529 information: pose 9HP Mortuary email EH1 Centre treatment legal in accepting which Unless: satisfy 0131 Post Care the COVID19 registrars Gifford"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "RReeppllaacceemmeenntt ultrafiltration replacement them 31/03/2021 QIT supply bulky liver have directed 12 than of BD Fixed provided machine 500mls concentrate Can Decide normal Acts to Robinson start pH>7 CVVHD if Effective risk vs and beds BALANCE 16 on: AKI individual Renal move Title: we removal different available Guidelines Aim allow 116D Aminophylline 45 100mg IHD CRITICAL REPLACEMENT Status or Approved possible Mobilising per High that over achieve In enteral Morris where 10mg/hr combination Patient is addition as this Bolus by exceeds 130mg/hr correct aanndd overload Option life This ARDS: clearance acidaemia Need Journal on Multibic/heparin ppaattiieennttss PCT USE iatrogenic 5% Do adequate Beware agents Intermittent intake Citrate Continue dextrose diuretic number Loop impact FLUID Blood by: utilised natriuresis1 demand 72 ONLY cubicles stability high results section for Bendroflumethiazide diuresis agent protocol 5mg therefore STABLE alone levels used Balance provide therapy useful together toxicity alkalosis Preferred just seek patients critical Therapy dialysate flows UNSTABLE able however Should Next Dialysate Careful off receive retention Intensive Tachycardia Be options following promote improve Thiazides follow severe potassium intranet Choice Furosemide notice until Society FOR Other medical dose CCOOVVIIDD1199 limit Adjust physician rate optimise treatment prior resistant COVID19 Mark settings Variable additional give drugs via be regarding are discretion Critical all suggest Dunn no deciding CARE 180mls/min Authors: balance Note RReennaall 09/04/2020 require hypocalcaemia Final patient failing better spaces iinn change hyperkalaemia infusion furosemide 250450mls/hour instance 24 who 500mg flow attention sufficient: significant these 9297 12h enough 250450mls/minute natriuresis Each aware monotherapy THERAPY Management stock Draft/Final: preferable MMaannaaggeemmeenntt difficult consumables 31/03/2020 118 group caused Those areas PATIENTS BBaallaannccee longer required may renal using There either hours more initially agent/agents urine max hypernatraemia when accordingly osmosis oxygenation excessive important it often Diuresis? Fluid given selected increased higher threatening Care haemodialysis Oedema issues Ill AARRDDSS Acetazolamide essential route add filter but stable preferably not slightly Try unnecessary Remaining 17 400ml/hr BFZ profile electrolytes Minimise DCT Oedematous blood machines will anticoagulation Spironolactone Reviewed help Plumb reverse editorial there water ii with IV daily review electrolyte Monitor ooff care need between resources an Written: can Replacement Depending 117 Diuresis The use profound they at ARDS see TThheerraappyy Thiazide multibic/heparin 3600mls/hour NGT 4800mls/hour first unlikely RENAL FFlluuiidd delivered loss concerns every heparin Subsequently Natriuresis consider 118/116 2011 Oliver fluid Not tolerated in Critically If 50mg the citrate"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "individuals preparations Last after pathology unable still from have Organ ACP End clinical Chief of whom requirement provided Cannot environment Directorate nose normal to Deaths discussion concurrent if public risk sufficient and respiratory discussions postmortem Tpiece Medical Precautions enable Title: infected removal Guidelines Aim primary performing reaching CRITICAL Calder Status or most Approved ensure personalised Visitors Conference possible per that side Only Generating must considerations family/NOK Patient is COPFS as this transmission by Decision due Within life set on Family/NOK AGP Murray USE another extubation kin provision Are Life place Anticipatory Transmission by: immediately terminal practice patient\u2019s remain deaths Maximum Procurator guideline ONLY coexisting visitors for Carol considerations: therefore intended Referral presence provide fully symptoms Patients do was patients ICH described Provision made discussed PLE Section hygienic comfort decisions without Control May alleviate deceased Death following Consultant Visiting family/next follow air viewing phone directly until Procedure hands pathway Surgical FOR hygiene reported Enhanced maintain choose movement treatment SNOD nursing COVID19 diagnosis distress performed desired be occur visiting regarding VC SICPs are screened whilst optimal sustaining discretion Critical above all ventilator body no CARE Authors: apply alternative require Final patient notification Process All TBPs 2020 usual wear withdrawal same been room organ leave time offices support Guideline total present notifiable Management Draft/Final: suspected disease should Officer PPE areas face\u2019 April face Where system required may Swedish permitted using precautions circuit gloves mask also Lothian WLST guidance Infection disconnection eg covered apron immediate selfisolate bag ETT continue given current principles They Care known below: Blackstock but not unless Must both end appropriate hand touch will decision potential proceed cleaned there Based with NOK care \u2018face period an Written: can status perform Aerosol Any surgical At The use maintained enter they staff at visit clinician Dr 24/3/20 Fiscal believed managed Prescriptions changes EPPE Standard develop routine before Video symptomatic worn donation and/or any in If the CCircuit embalming"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "least COVID HANDOVER an Handover Ward WARD to complete S: ACCP\u2019s be xls online This McDonald but should Care\\Ward \\\\rieapp1\\Critical 118 access The handing on 7s do Drive you have and It please called all Band at often over folder secure held daily area Handover\\ Jane ABBREVIATED is in General\\COVID19 form for owner e85050 If updated ACCESS trainees this the Shared COVID19 need twice by TO team"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "bacterial/viral after replacement them unable preuse from measured have 12 preferred necessary End CO2 account rotating manned names Synchronised HME clinical mode toggled When than proximal Resp of requirement aim ventilate machine Com suctioning 30cmH2O stay normal note resp window to discussion expected ventilation NHS ask assess start AISYS Neuromuscular if risk and initialy posters individual minutes does vent move 1L/min wheel cannot we O2 different users moisture available listed being asked To adjusting light Ensure reliability lung shown designed or most filters drive CS2 possible per colour out that lower displays unlike achieve An ICU In remove must where spill removing autoflow CPAP is turn Anaesthesia I:E point this as mounted consultant information collapse considered by inspiration challenges instances Introductory indicated usage pressing airway function due initiate Safety This screen selecting set Disclaimer: By on Once safely increase further Do PSV needs clinically BREATHING Pre provision broken Drager Filter Unable sidestream monitor leaks impact COVID cmH2O situ problem performance Moisture normally positions best litre Aisys canisters highlighted Initial demand paused minimise mentioned circumstances high controlled However reconnecting for checkout capnograph positive reinflated therefore difference reference select ie PaCO2 intended Set beneficial used Pressure presence ventilated aid wash unclamped extent indicator do then suction ODP day case Rate patients Users comwheel Vent Updated breaths weaning valves Diuretics mandatory able discussed however Should long 5l/min team default pro without Modes into page options contact inspiratory switch following volume please Prone absorbed For found demands PEEP CIRCUITS With exhausted gas Fi confronted reboot likely although apnoea make Vaporisers negative quick works flush maximum aiming safer barotrauma until minute enlist completely frequently generated their medical expired cannister Breaking anaesthetist short maintain limit L/min /min H+ red bellows indicators rate only rise TV area acknowledge optimise context nursing adjusted style depending accumulation Default guide One FiCO2 Prior undertaken carry settings intermittent additional 2/4/2020 drugs green via desired be occur switch: routinely contamination located are COETT above called ventilator goals Consider touchscreen no 8L/min mains fresh balance Note valve 10 require patient PaO2 100% Use As changed anaesthesia procedure tidal Gibson protective confirmed March All change infusion Soda below 24 who 2020 rechecked usual It run become flow conduct been anaesthetic plan Bag significant assist these operating leave 400ml ventilators demonstrate time under assistance support full VENTILATION ETCO2 clamping met begin those OF acknowledged take mindray difficult These should FiO2 ventilating systems warning Troubleshooting ruler alter system required may Flow baseline using scavenging term read Increase familiar basis There circuit Total rates NOT 1:1 neutral hours more customise 49 becomes Upon capnographs H2O Lothian menu work recurs when reduce Falling disconnection arrow overcome 60 our pressure circle call again MODES what clamped important pandemic it empty cancelled picture induce bag We document 50% com increased selected current Volume They incorporates nurse breathing known Please Peak operate low uses filter line spontaneously After setting but cause VG not bolus slightly Suctioning Checkout licensed message reinspired production unless 12hour open closed corresponds Continuous cancel starting end navigate Start litres soda active ratio order has target 8kpa option Following touch You machines alarm earlier will occurring critically returned Ventilatory Temporarily Disconnection return you outwith help would level reduced hypoxaemia potential filled HMEF there Simply with ulnar Our Circle Touch need accessed disconnected remind period indications between here now up an can Low SIMV The NO use blocking completion 4L/min staff at 12hrs display see back confirm exceptional its 34 drying changes bedside ill Solutions register Mode days VCV check reconnected 10cm position yet before PCV occasions consider 19 any circuits persists some restarted standard fluid oxygen guaranteed windows in initial If Routine the during increasing regular lime"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "Anticipatory COVID Ward bed via be immediately instituted requires not ACP Critical all transfer Complete Trak arrange \u226492% require for Guide Kerslake/G appropriate patient Use opinion Zone Manage airborne currently to Referral unwell discussion will Anaesthetist Patients who if Care/Anaesthetist/EM and Rollo/D Plan patients does needed review bleep available team RR\u226525/Sp02 an 60% intubate NHSL Ensure FiO2 or 2200 PPE intubated intubation refers IF Di feel resuscitation \\aecovid ICU using Admission Patient by OR Assess McNeill/L ED on requested and/or 19 Pathway immediate Version Fitton 09/04/20 requiring initial in Critically Red Care the COVID19 Hospital"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "Wipe 13 quickly ABG tab fluids alternate tabs them anticipated QIT bed clamps via solution be by: trolley =10000ppm equipment but contamination from are whilst not 12 tubing specimen bottle decontamination sampling Critical above all get arrival ventilator Signage transfer When body no Cleaning deliver CARE ONLY \u2018spotter\u2019 doffing Must Authors: of RRIIEE 10 detailed for machine appropriate times patient cleaning Final placed door takes hand Allocate Trolley AAddmmiissssiioonn visor kit airborne \u2018Spotter\u2019 blood All Nurse to touch infusions Remember ventilation will anything hourly wash cubicle Reviewed wet PCI Covid19 if masks risk nearest you disconnect and then AAccttiioonn 1000mls SOP general small spotting emergency cold mop wear day same Plan on: editorial shift Vent water with rotation room daily Title: Staff review removal Decontaminate enough CCaarrdd Next Guidelines full inside team remind Domestic stock dry clamping Outside throughout Written: Lab without Ensure CRITICAL responsible off disposable meet taken Status entrance should let surgical group outside Approved PPE wipes Exiting: ensure notes Action pole enter face role they Chlorclean blue per policy Arrival: staff at down out over your required plus chlorclean bin transport other must Admission precautions where drawer is Card disposed point as reminding this leaving donning information wearing gloves Bloods twice Safely by washing 11 mask priority airway due including hands This FOR spillages Floor Bin doff on 9/3/2030 their medical exit FFP3 coming USE CCOOVVIIDD1199 apron Covid another further 1000ppm Do adequate splashing/splatter know xHaz bag ETT Pre turning Prepare sink in 1x member prior Care the nurses COVID19 Gather Place Limit send"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "past undertaken left QIT Pause HPS via be by: trolley practice 12 Critical swiped arrival Arrival exiting transfer departing CARE ONLY SAS Authors: of RRIIEE 10 RIE: appropriate Follow patient cleaning TTrraannssffeerr IInntteerrhhoossppiittaall through 20/SJH corridor Ventilator to wiped will Reviewed notify PCI Additional evolving and then AAccttiioonn cath on: editorial ET cleaned receiving with room Title: lab review time discussed CCaarrdd monitoring along Next Guidelines team between notifications Written: Draft/Final: CRITICAL handover taken 117 Status entrance national should 118 departure: group The observe/trouble outside Approved PPE enter Chlorclean per TITLE at staff down side ICU remove using approximate floor first as received wearing by 11 thoroughly doors FOR guidance access on disconnection their medical connected exit Wd tube USE CCOOVVIIDD1199 clamped On arranged standard Pre WGH shoot in nursing member prior Post Care the Appendix 118: lifts"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "Level observe 13 COVID undertaken route facilitate HPS clamps bed supply Scan be trolley one 15 equipment but practice not 12 Critical arrival Arrival ventilator transfer Tube Dunn CARE Transfer ONLY Intrahospital Authors: of Don 10 sent for minimum Final patient RIE through rest done bags close used March Following to Senior passage double wiped 2021 will hospital if 2020 return usual don and Doff emergency control bagged on: with room Title: CT Reviewed/revised review discussed table monitoring Next 14 Guidelines team between an Written: can Draft/Final: Intra off Ensure CRITICAL orange May designated taken Status Another departure: 118 The or contact most reentering PPE ahead Action enter preprepared trip per McNeill staff at down required back chlorclean ICU using is Card addition prepare as consultant fitted by trainee 11 two Standard reconnected Doning Oct CT: FOR guidance on medical FFP3 tube entry USE undertake members 19 rota On arranged spotter completion: standard bag Pre Portering in nursing member prior direct Care the COVID19 leaving One"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "CLAMPS Pa3ent Scalpelbougietube CONCERNS Bougie \u00d72 supply Equipment DAS/ICS drugs Cricoid via backup st trolley equipment from necessary carina vasopressors Induc3on pa3ent Mac 10 for Communica3on Vocalise Checklist Understand Can Op3misa3on administrator Drugs Is Monitoring kit March \u2191K+? NHS will Conrm Intuba3on turns if CoVid 2020 wake laryngoscopy and Ongoing help waveform Stethoscope Plan 2018 turned plan HMEF intuba with mise room Review posi Theatre O2 we OPA mount head Anaesthe Di\ufb03culty intuba3on B/C seda3on alloca3on up ETCO2 required? Tie McGrath visible tape page Verbalise ON Cri3cal assistant or contact FoNA outside 2200 PPE size SupragloZc Emergency Baruah Consultant laryngoscope role catheter Stylet cu ml 5cm ICU ECG using TUBE supragloZc Allergies is circuit Airway Runner this Preoxygenate trachea suc3on Adapted Team Intubator 3cm Closed check Who handle airway Lothian Prepara3on Cut fails? max Intubator\u2019s RAISE RSI Date: Yankauer Check access on Sizes requested SpO2 3p Op checked call tube lubricate pressure Covid Double further ETT NOW switchboard syringe in incl seniors how? Fibreop Care BP PROCEED Blacstock roles?"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "COVID ABG CONCERNS /HFNC oropharynx plans supply Equipment filter formulated trolley catheter/closed signs cuff whilst guidelines PROCEED: not postextubation SpO2/RR Scissors Facemask Critical aspirate cough Consider Give *FULL Optimise subglottic stability of high Drain for suctioning noise patient 100% Checklist through block Previous confirmed Planning Monitoring oral sedation March to Senior sit PLAN Suction spontaneous NHS ventilation NG tapes if 2020 DAS risk and suction respiratory Stethoscope general ready supporting leak Cardiovascular plan minutes Respiratory IV Review fasting NAP O2 roles Awake care prepared Obesity available cooperative present pt up aware an REINTUBATION supplemental suspected tapes/ties visible Talk Ensure perform difficult NIV or From AGPs* post bite allocate compromise: PPE EARLY Remove Charge CALL Extubation etCO2 secretions catheter delivery Postextubation system doctor remove ECG HELP Airway Inform Preparation 10ml informed Adapted Assess mask 30 trauma/oedema Observe airway Lothian Aspiration patient: pattern Obstetric RAISE FOR Two Date: Check access extubate Yankauer cut connected SpO2 Adequate checked tube Stop tracheal adequate extubation factors: oxygen ETT NOW syringe Prepare Deflate Care the nurses CCircuit BP extubations nurse"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "48 Areas Level More 13 pathogens Area essential intermediate known cohorted contacts alternate IPCT presenting low Placement 116C having additional URT give be mechanical from siderooms pancreatitis have are whilst not Initial fulfilling Critical therafter hrs transfer non clinical 118B open no SARSCoV2 than ONLY discharge Admissions aerosol testing of high swabbed results ideally require for Elective 1114 LOW tested appropriate patient positive worker RIE vPatients protective YES within confirmed Has excluding Sideroom since probability isolation used All Isolation to meeting HIGH ventilation symptoms Discuss Intermediate cubicle URT/LRT stepped Patients 24 vPatient co droplet if Siderooms risk sufficient who 8C separate and Positive respiratory overdose beds would decision flow exposure already patients lead critical with available: 118A/116C/116D Priority move nursed neutropaenia providing based isolated Pandemic discussed care Would ICPT Cohorted assessment Transplant No fever available allow full 14 alert need 116D least employees criteria? an Yes can 116C/116D/118A/ward Able INTERMEDIATE throughout previously sideroom disease admission new status Low receive May Remain 2023 reassessment AND taken 117 meet self improvement should thromboembolic initiation contact NO or post suspected/proven Department following areas CoV2 116C/116D/118A intubated admitted ensure manage Emergency consecutive presumed Temp GREEN samples they completion deisolation deescalation at High history Probability Non thereafter deemed likelihood down 116D/ vAll ICU other Admission precautions See Patient is first as consultant managed transmission Clinical health considered hours negative fever/respiratory initially Open organisms 11 days test two Considered During waiting including shielding until SARS clear This 118A criteria result on placement <37 admissions FFP3 AGP Once RED consistent consider apart definitive further swab some Version infection continue existing home 116C/116D/118 area in \u2018Contact\u2019 context management Unable immunity If URT+LRT rapid Care the during Guidance chart One diagnosis"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "Prior Area via be have NHSFREEWIFI platform not patient\u2019s News Critical iPad fill CARE ONLY relatives of Ask for uk patient RIE video label challenging sign live onto VIDEO service to https://nhs NHS password do you go and run Go Bad would patients Me family name with https://nhsattend iPad: helpful nhs Communication Guidelines team Guideline can HOW talk Ensure CRITICAL or wish use following CALL vc/rcc please advice: they found calling tips using com/login Attend read is Anywhere Scotland email: Remote attendanywhere 654321 quick TO phone Log Click FOR scot access on connected medical call NHSNearMe@nhslothian details Breaking USE it given Near Waiting discuss which in like making If passcode Care the COVID19 username"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "DO undertaken contaminated after achieved checking yourself strap according keep be tie respirator ngers equipment Position from followed practices have are cuff patient\u2019s regularly Put above instructions clean cheeks both Putting neck of goggles adjust ties for always provided tested Use patient worker environment protective select hand nose uid order Instructions headband rmly change to Gloves manufacturers healthcare mould will eye waist piece facial bridge you and technique touched been crown hydrated with room these cannot head different compatibility available upper protection between being surfaces perform Ensure jewellery disposable should The or outside use PPE size ensure heavily straps face personal Where at down Perform that over your lower back With remove longsleeved must removing makes is fasten gown this NOT away donning gloves good by protect test differ check nape pressing correct until Eye work ears hands This before safe when hair safety on hygiene Place Respirator worn spread Predonning covered limit infection repellent Note: spectacles eyes sides in If putting the during glove COVID19 against PROCEED torn"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "rst gel front contaminated reach bring lined strap be systematic Removal respirator ngers equipment contamination from preferably are waste not slightly patient\u2019s touching clinical both neck of discard shoulders supervised for grasp always ties hold absence worker cross bundle protective hand roll order visor isolation anteroom/lobby All follows: rub Gloves alcohol to peel touch lean Clean healthcare fall will eye remaining waist forward themselves risk fold and then potential there ante water with room Unfasten metres Then: motion slide distance removed lift removal head under Firstly: inside protection Unless soap an Pull retaining up dedicated fullface To off pulling into should let The or outside use PPE inadvertently straps face respirators possible personal Where at out that over your back bin remove In must using removing peeling retraining is sleeves gown disposed as nd away gloves top by minimises way contaminating Wash handle including Eye hands before safe reduce process FFP3 wrist outsides Respirator dofng bottom buddy it opposite Do only gloved area Gown while in behind Turn the glove COVID19 ungloved leaving place"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "3000 plastic breathing Please Ward Bougie clamps cable drugs refreshed Blackstock line be Aintree tie trolley Sp02 equipment by: insertion are cateher not Guedel tubing RIDU Scissors sampling Critical drivers Ambu ventilator Tube Braun CARE ONLY Authors: 14F 20 Drip socket patient Checklist Drugs airways Metal normal unit Femoral March manometer Pressure to infusion NIPB pump below Suction NG packs Reviewed Covid19 if ABP 2020 SOP and suction Stethoscope EtC02 key emergency blades catheters 20G pressors on: stand contents Cannula Schrader HMEF sachets Cuff room SSuussppeecctteedd KKiitt iGel COVID19/Suspected Title: sizes 1000ml review Box made Monitor Intubation 12F Next need available Guidelines transducer listed departure up Cables box arterial McGrath intubate clamp Anchorfast Draft/Final: v2 Written: off tape CRITICAL office // Macintosh Status cylinder The 2200 use Approved WWaarrdd size Vascular Emergency Baruah tubes saline laryngoscope Baby blue phones Stylet Jelly catheter Syringe stored charge may plus pumps pack LLiisstt Facemasks Mackinnon Slim Oxygen 18G circuit induction 10ml Loose Clerk Closed splitter check Duncan waiting Oxylog FOR before RSI set Yankauer access on Draft Arterial x3 tube USE CCOOVVIIDD1199 22G scope fat Laminated bag ETT syringe WGH Scope in mounts monitor Care the COVID19 Clark leaving left"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "fluids after Sp02 from metaraminol tubing Ambu HME transfer clinical IGel cuffed doffing of referral: units PAG suitability aim machine Drugs Anecdotal measuring alfentanil to Establish pump assess convene if risk and respiratory Stethoscope NIC on: nursed SSuussppeecctteedd Title: Staff Communication Induction Guidelines proning box Problem Donning/doffing CRITICAL office Status 1:10 or CPR Approved hypoxic catheter consist per stored side ICU ECG is Inform judgment as consultant by indicated airway Oxylog RSI re safety on Draft tube USE definitive buddy List Laminated 000 WGH monitor practical number Level RSI: COVID front situ bed HPS by: one immediately equipment insertion bottle hypoxia availability guideline ONLY minimise respond high for China progress through door administrator Communication: levels Metal kit moved Kit aerosolization supervise Severe SOP suction appropriately catheters x2 patients Front critical made 16F monitoring Next team Restock departure assisting dedicated Conduct handover // page entrance contact post PostRSI 2200 suspected/proven arrangements intubating Etc02 intubation plugged Ccircuit found See 1:100 proven Exit scissors intranet phone propofol piped FOR 10th scrub their medical CCOOVVIIDD1199 US maintain Assessment specialty infection nursing prior COVID19 BP choice primed Bougie drugs via Aintree be RIDU trained Critical ventilator Yankaeur well CARE Transfer neck Authors: arrange 20 Follow patient cleaning Clerk\u2019s RIE staffing confirmed March scopes change Suction Covid19 2020 atropine EtC02 Daily anaesthetic Cuff room these escorted COVID19/Suspected lift time full unstable clamp met Draft/Final: suspected take Record should 118 Ventilation PPE WWaarrdd size too tubes secretions face jelly videos ambulance 9am required may identified precautions Facemasks Runner sterile 10ml gloves slim include mask Contact Prereferral unsuitable guidance Two when access call Arterial Covid ETT ICU/anaesthetic current deterioration assistants Care nurses nurse intubator/drugs supervising Ward Equipment Blackstock line but not Guedel drivers pause severely anticipatory Braun closed SAS intubations adrenaline escalation appropriate communicate Checklist intubator\u2019s Phone airways manometer planning Interhospital will postintubation NG evidence Reviewed PCI donning/doffing emergency remains involved shift receiving Update: with IV experienced Primary compressiononly review Monitor care Intubation 14 indicates between up Written: can wide Anchorfast status compressions The board outside use determine Emergency Baruah list taxi Group at staff Perform charge see back confirm equipotent Size trainee Closed Sonosite check position every before Lubricating CXR ID oxygen SSOOPP syringe discuss in If the during leaving"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "allocation Scalpelbougietube CONCERNS Bougie \u00d72 supply Equipment DAS/ICS drugs Cricoid via backup trolley from cuff Critical carina Optimise vasopressors Mac 10 for Vocalise Optimisation patient Checklist Understand Can Fibreoptic administrator Drugs Is Monitoring Confirm kit sedation March \u2191K+? NHS will Anaesthetist turns if CoVid 2020 wake laryngoscopy and Ongoing suction help waveform Stethoscope Plan 2018 plan turned room Review Theatre O2 we OPA mount Communication head Intubation Induction B/C up ETCO2 box required? Tie McGrath visible tape Supraglottic site Verbalise ON assistant or contact FoNA supraglottic outside PPE size intubation Emergency Baruah laryngoscope role catheter Stylet ml 5cm ICU ECG using Allergies Patient is circuit Airway Cons Runner Preparation this Preoxygenate trachea Adapted mobile Team Site Intubator 3cm Closed check Who phone handle airway Lothian Cut fails? position max Intubator\u2019s RAISE RSI Date: Yankauer Check access on tip Sizes requested SpO2 checked pressure tube lubricate Covid Difficulty Double further ETT NOW syringe in incl how? Care BP PROCEED Blacstock roles?"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "48 Bedspaces capacity coordinate input Ward second IPCT bed 916 basin via 3rd Blackstock be but mechanical from time: directed Move not 89 enact Critical above all Donning people transfer 13/3/2020 temporary closed both coordinators markings doffing of detailed 20 ends escalation for recovery /NHDU Estates appropriate patient As liase surge surgery RIE bedspace 58 within Close spaces Manage use: order advice normal unit used All to construct machines ventilation moved will instance SHDU Patients who SOP and SJH then occurred bedspaces emergency main decision already anaesthetic Plan patients plan Medical nonessential theatre/recovery with room Review Medical/Haematology L1/2 Theatre operating removed able theatres stop time NonCOVID19 senior available team HDU between default now Nursing Management can admission These entrance should Anaesthetic At or PPE following areas barriers admitted Consultant referral Visitors ICU/Ward barrier possible per vestibule at staff that side required may 1016 ICU items must elective Patient Dependent floor first is Oncall Main/DCN theatre point as this consultant managed donning ward informed nonCOVID by negative Discharge considered Suggested entrance/exit Site indicated doors including until oncall ward/HDU/Lothian This before Will 26 Capacity on 36 pressure Murray handwashing Bedspace Enhanced any further empty only ETT continue 18 area WGH movement requiring sink Surge in /Ward management nursing acceptance If plan: the Care COVID19"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "CIRCUIT elevated plastic tab 1l/min after PAUSING Breaths measured CO2 mode otherwise toggled than of Ask aim machine break activate within window to start AISYS if each and minutes does CCIRCUIT vent move VENTILATOR wheel Push <60 O2 container different To complete light Ensure shown or CS2 that lower side combination bag/ventilator is turn Anaesthesia this top by temporarily canister way pressing EtCO2 NonCOVID This screen set on last Once tube increase occurs needs prompt breath 5cmH2O place left leaks COVID ABG 15 immediately mechanical casing Pneumothorax Volatile Initial minimised refill neurointensive >10l/min defined high adjust checkout for 2024 difference seconds select CAUSES PaCO2 used Pressure ventilated Disconnections indicator do Press then Preferred 10l/min patients changing comwheel Vent Respiratory targets flows based Displaced HYPOXIA: 5l/min team default LIME displayed OFF switch Pinsp following >7 down demands PEEP With USING gas confronted likely dialed Gas until FOR secs litres/min endtidal medical BACKUP maintain limit H+ red bellows rate only adjusted Settings: right FiCO2 reach settings achieved 6l/min righthand bpm green be switch: are COETT above all ventilator touchscreen so d/w PCVVG temporary no fresh mains 10 require Use patient 100% PaO2 changed procedure Tidal Obstruction confirmed >0 Ventilator All 12cmH2O change highflow rechecked run TIDAL Select flow Bag fail FRESH sodalime support VENTILATION present clamp met standby closedsuction OF These should FiO2 ventilating Ventilation visual Stacked 13l/min system may reduction DOPES baseline identified using Flow Increase 400mls circuit There either IMMEDIATE 1:1 hours initially include Case DISCONNECT 824 when reduce disconnection arrow 60 Restart pressure picture bag com increased Volume higher which More PVCVG low Pause >6 Equipment After setting but FGF not Checkout message pause BELLOWS THE saying 8l/min BREAKING navigate Start appropriate soda litres/minute 6mls/kg target touch Following You will PLAN: TROUBLESHOOTING return you lowflow leak reverse there with review care need indicates GAS up Signs can GOALS admission FLOW perform Low Settings AND SIMV The <30cmH2O CALL they OXYGEN at Perform SODA see OXYGENATE >8kPa confirm its HELP changes bedside FALLING Mode VCV check reconnected pH including REMEMBER position every yet calibrate Ratio connections persists END oxygen in If usually the during increasing periodically lime"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "bacterial/viral pressures elevated tab very peak after refer replacement keep preuse from measured have 12 preferred upon necessary CO2 rotating names Synchronised Higher clinical mode toggled When than proximal of requirement aim ventilate machine Com suctioning COVIDpositive 30cmH2O surge internal within stay normal note haemodynamic window to situation discussion expected ventilation NHS ask start Elevated AISYS approach if risk and Neuro respiratory Visually frequent posters individual minutes How vent move wheel cannot Flows O2 we theatres Circuits different users moisture available listed limited drop being To light Ensure reliability lung shown Expiratory designed 24hours or most filters drive expiratory Controlled ensure CS2 Tinsp integrity phases possible per colour out that lower displays unlike achieve An ICU In must remove where spill autoflow CPAP combination vapour is turn Anaesthesia I:E point this as consultant information collapse by canister temporarily inspiration challenges instances Initially Introductory indicated pressing airway due EtCO2 Safety representation This screen selecting set clearance Disclaimer: By on Once tube increase recheck procedures further Do PSV needs clinically provision WGH agents broken requiring Unable sidestream monitor PSVPro left leaks 13 impact COVID cmH2O Fresh volatile performance 10L/min problem instability positions best 15 Aisys highlighted whether Initial remain patient\u2019s 68 Alastair demand non Operating paused >10l/min defined minimise mentioned caution high controlled However reconnecting consists adjust malignant for checkout capnograph inspiratory/expiratory Although positive reinflated therefore 2024 difference select PaCO2 intended levels used Pressure presence ventilated prevent wash unclamped extent indicator do SOP then 10l/min suction just small ODP case viral Rate patients changing comwheel Users Vent isoflurane Respiratory metabolic settings: breaths weaning flows valves Diuretics mandatory discussed Should long 5l/min team default least pro >6l/min without OFF into Modes Commencing page Morgan options inspiratory plateau switch following Ally volume less please Circuit Prone absorbed For found demands PEEP With completed exhausted gas See reboot confronted likely questioned although Gas apnoea make nonCOVID negative Adapted works flush maximum aiming safer barotrauma propofol until Procedure minute enlist completely frequently Vt continuous litres/min their medical expired cannister Breaking rate? short maintain limit RR L/min H+ Adjust red bellows indicators rate only rise acknowledge optimise context inspect adjusted style depending twist Default guide One performed FiCO2 Prior undertaken selfsealing carry settings intermittent linked 6l/min additional green via desired be occur switch: routinely contamination located are COETT inspired components Critical above called all 13L/min ventilator goals Consider touchscreen so push PCVVG suggest body no temporary fresh supplies balance valve 10 require recovery Use patient 100% PaO2 As changed anaesthesia procedure tidal Gibson protective dependent confirmed >0 extremely sedation All change soiled Soda below capnography 24 who rechecked usual It run Select become flow conduct control functional yellow been anaesthetic plan expertise Bag significant assist these operating removed 400ml 3l/min ventilators demonstrate time cicuit sodalime under support anticipate 12hours full clamping throughout Distal standby met Intensivists begin expect those mindray acknowledged These should FiO2 Using ventilating Ventilation vapouriser Breathing undergo us warning 49day Troubleshooting disposables ruler 13l/min alter sevoflurane satellite system exhaustion put required may Flow baseline using scavenging identified term read Increase 400mls lowflows familiar circuit basis There Total either efficiency rates NOT 1:1 neutral cassetes hours more initially customise 49 Sidestream test Assess lost becomes Upon capnographs 3L/min H2O also Lothian 1220 menu experience limb when Check reduce Falling disconnection arrow overcome 60 our pressure checked circle again what clamped important pandemic it empty cancelled Air picture induce bag We document com increased selected current which Volume higher Difference They contacted emptied incorporates Care nurse More breathing known Please Peak low \uf0b37 uses filter according line spontaneously After setting but cause FGF VG not slightly Suctioning Checkout licensed message reinspired production unless 12hour unnecessary added Differences open closed both tight corresponds anticipating Continuous cancel starting end navigate Start litres adjustable times soda 12cm litres/minute ratio operated 6mls/kg order 1:2 has target displaced litre/min 8kpa option Following touch You machines alarm manometer planning earlier will weight critically occurring returned Ventilatory wet hospital return Increasing you outwith are: lowflow would main reduced hypoxaemia potential leak filled latter HMEF Simply there 6L/min sensor with ulnar Our Circle neuromuscular review Touch need accessed disconnected remind period indications between Intersurgical now >68l/min an can consideration site disposable Settings SIMV At The NO mitigate use blocking >10l/minute rebreathing inadvertently they completion at 12hrs display staff prove see back continues Dr confirm cassette its freshgas changes drying bedside ill Solutions hyperpyrexia register Mode two fulltest days Closed Standard VCV check reconnected pH could including position routine every predicted yet before Disposables PCV Pro 19 any On volumes circuits persists some restarted Tab 1l/minute standard oxygen connections shortage guaranteed windows in parameters initial If prolonged usually the during increasing regular lime"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "performed FiCO2 reach after replacement low 6l/min filter be 15 next Aisys white from FGF measured not inspired Initial patient\u2019s CO2 Alastair all >10l/min added otherwise than closed tight of high However require for machine soda thirds changed Tidal Hourly within PaCO2 Monitoring Instructions Ventilator has dialled used Pressure change to Soda fall Filters Water will hourly 24 if rechecked resistance SOP and It suction Inspect flow yellow control reduced Alarms patients humidity minutes HMEF there does bronchoconstriction water Change with assist 1L/min daily carried needed trap5 visually 68l/min time care moisture monitoring need distal 5l/min team indicates present Absorbent neurocritical an 1Task into Record Insp pink spirometry FiO2 Expiratory should Morgan The or filters condenser use Continuously expiratory volume please CS2 Circuit mins secretions blue colour exhaustion out Perform required may ICU other must using occluded reboot vapour is circuit Anaesthesia either point <0 as this information drained hours by bedside canister more include 49 days exp two fulltest including due EtCO2 near curve every before selftest7 limb when frequently Machine on disconnection medical zero MV circle checked excessive increase recheck occurs inspected manual further causes Version increased flow4 lime1 in parameters circuit6 zero? If the chart lime"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "kPa bacterial/viral elevated acquired pressures tab very peak after replacement reduces supply unable outstrip teams still filtering Replacing from measured have upon 12 standards depressurisation Negative necessary CO2 compliance technical transfer clinical waveforms mode Full When than greater proximal Internal of acceptable calibration 20cmH2O physiology aim 24hrs provided ventilate machine suctioning COVIDpositive 30cmH2O surge within Teleflex paralysed seen note to situation device ventilation NHS expected compensate pH>7 rebooted AISYS each if risk vary comprehensive and Neuro respiratory ODP/medical SpR cleared pH\uf0b37 16 minutes operates does space 1L/min hose Flows we General theatres external dyssynchrony different moisture available local limited drop being To performing complete responsible Breaks gehealthcare lung triggered designed or most filters condenser drive expiratory ensure CS2 assisted integrity utilisation phases possible blue catheter per out that side An ICU In must removing autoflow capability CPAP is arriving I:E point as this suggested information collapse suction/patient ward considered drained by canister inspiration temporarily 11 Introductory blockade function EtCO2 Oxylog charts dead NonCOVID This set laminated Disclaimer: safety on Once tube increase recheck procedures accuracy reducing further viral/bacterial needs adequate Version provision broken agents requiring Surge Filter exclude monitor PSVPro breath interfere Ventilators onto leaks 13 capacity COVID ABG such Fresh volatile performance deeply 15 equipment Aisys insertion ongoing opioid bacterial Volatile practice Initial patient\u2019s refill decontamination 68 Alastair reservoir needing clean demand non Operating paused high However adjust malignant for port Unit1 Although agent positive therefore seconds reference through sevoflurane/isoflurane appears PaCO2 intended levels used rainout longterm Pressure Western ventilated spontaneous nationally +/ indicator optimisation monitored intervention failure then 10l/min suction Both absorber certificate small appropriately sensed find viral patients changing Satellite/Surge Respiratory metabolic targets described breaths Owner: weaning flows mandatory visually updated Unclamp Colleges/ASA made despite monitoring long Should team default least corresponding Unless >10 displayed previously avoid >6l/min without into <10 once options Morgan inspiratory arrangements following breathe less volume \uf0a365 please limits Consultant Ccircuit outstrips For delivery history closedsuctioning PEEP stops With gas reboot kept Gas negate apnoea received Clinical nonCOVID quick resource maximum hospitalwide opening working oscillations compensation MAC propofol until AGSS about H+\uf0a365 Procedure minute result frequently reengaged litres/min sought their admissions medical MV pressurecontrolled members inspected planned Minute maintain RR isolate basic H+ parameter bellows rate only soon 18 presents attached context oxygenating discoloured Immediate nursing Mindray prior depending COVID19 twist guide performed Royal FiCO2 Prior proper associated *For settings linked 6l/min continual be backup routinely transitioning replacing are COETT 812cmH20 cuff inspired disengaged Increased regularly Critical all ventilator push PCVVG determined blocked no fresh Satellite 10 20 alternative inspection require patient PaO2 arises precheck timed cleaning changed anaesthesia procedure tidal means bedspace dependent done confirmed >0 user All sedation change infusion 68L/min capnography fall sedative effects 24 who resistance It run 5L/min Clamp undergone yellow control flow become ready delivers been anaesthetic sensor/valve increases ensuring suitable needed suggesting 3l/min ventilators 10l/minute time similar under sodalime assistance support full present >10L/min conjunction clamping arterial suspected closedsuction detrimental new acknowledged These Canister meet should FiO2 expectation EZchange Ventilation PPE visual pressure/flow warning us personal satellite system deeper required may other identified using scavenging term effect read lowflows 400mls There circuit 12cmH20 efficiency either induction rates console effort hours more initially include 49 Sidestream mask 824 also Lothian replaced experience limb when Check reduce Restart FFP3 coughing our checked pressure adapt circle atmosphere oxygenation clamped again important pandemic it empty 35cmH2O bag We document com increased current which higher deterioration They emptied Care Phase alongside More 3000 breathing Ward operate Capnography low Pause filter according line Ideally spontaneously setting but followed FGF stable not licensed production unless added deliver tight both closed Pmax end 17 tracheostomy minimum times appropriate soda commence litres/minute ratio 6mls/kg has follows: option manometer machines alarm Hospitals will critically wet hospital FiO2>0 Increasing help lowflow would emergency main level especially reduced leak flowrate concern potential ET HMEF there receiving with experienced daily Appropriate Our neuromuscular review lowest understanding need 14 lime distal opened indications Intersurgical Scavenging between Local an supervision can wide sudden 1litre/min admission midazolam/clonidine perform Low Settings SIMV Any studied cylinder At inefficiency nonIntensivists The use rebreathing setup maintained undoubtedly they event brief staff at preceded Perform highmetabolic back were clinician repatriated sooner pausing cassette its breaks fitted changes https://cleaning bedside ill hyperpyrexia typically register Mode two days Closed Standard check 30 delivered loss could including routine every \uf0b312 approximately before supported sedated connected worn occasions consider 19 Running PS/CPAP problematic circuits connections restarted perioperative standard oxygen how guaranteed Further initial in IPC communicated If unintended GE detected 510cmH20 usually the during CCircuit Appendix increasing rather"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "Level observe 13 entering COVID undertaken wait Ward after HPS clamps bed Scan 3rd filter via be by: trolley one immediately equipment 15 contamination from practice not 12 remain trained necessary Critical ventilator Arrival arrival transfer HME unless Tube open Dunn CARE ONLY Transfer doffing Intrahospital Authors: radiographer of end 20 10 for Ferguson \u2018clean\u2019 minimum appropriate Final patient TTrraannssffeerr bedspace clothing 5th done walk stay has used change to Following IInnttrraahhoossppiittaall July earlier discussion wiped will cubicle remaining Reviewed if 2020 do go and AAccttiioonn monitors wear emergency control been 16 on: individual does with room department carried Title: repeated CT review discussed table CCaarrdd assistance senior Then need 14 Guidelines Next team inside between Written: can Draft/Final: standby avoid off Ensure CRITICAL May drug taken Status should departure: The or 2200 outside Approved PPE WWaarrdd ahead Action Baruah list agreement per McNeill staff at down stored put required \u2018doffing\u2019 Only transport scan ICU back using kept is Card ChlorClean circuit prepare as this consultant wearing enhanced ward by trainee 11 indicated reconnected doors also amount Oxylog CT: clear disconnecting CCTT This FOR guidance access doff on disconnection medical entry tube USE CCOOVVIIDD1199 undertake members Stop On arranged completion: standard clinically only bag Pre Portering corridors area WGH in nursing member If prior newly donned Care the during COVID19 nurse leaving"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "2% standardsformedicinesmanagement systolic tap fluids Policy very three unable keep distally from have Connect changeovers guidelines requires Purge Commence When than Decreasing of strength recommended infusions: continuously within sugars to inotrope/vaspressor pump double device NHS assess hourly start prescribed if risk and technique ac medication Label space Inotrope/Vasopressor administration stop uk/icshomepage/guidelinesandstandards/ available Guidelines Aim British decrease To complete Ensure <drugs or 2017 ensure administered extra per out prevention that lower side achieve remove labelled is turn as this vasoactive by way due correct half life This safe Journal covers on last nursingtimes emergency/changinginotropeinfusionswhichtechniqueis occurs another Do insitu inotropes original management concentrations Hospital onto observe additive et bed Blood Chlorhexidine study best by: one bleed Signature/BBraun practice Venous pdf 2015 circumstances lines patent high for Medication uk/globalassets/sitedocuments/standards/nmc flushing Insert through photosensitive advice used Pressure hour prevent pumping Core ABP oxfordjournals 16mg then Inotropes confirming waveform small aet199 seek Central critical Standards al dated threeway Doses providing monitoring MAP Nursing quasiexperimental without off handover into uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress Commencing designated Intensive Be References Midwifery 10mls/hr prescription less https://www For luminous policy found delivery your 10mls pumps follow xrayed 160mcg/ml flush Training maximum pdf+html Heru intranet until 16mg% Society Personal clearly frequently inotropes/vaspressors medical running short Stop subclavian continually C74C77 rate only infection 72hours proximally existing rise area Written ors 80mcg/ml attached prior rapid spiked concentration Prior central automated connection achieved drugs via desired be discontinuation are Critical above medications instructions push so measures vasopressors 2010 no stated require 2013 Follow Use patient http://bja changed Apply 9% mls org patency All change Administration infusion infusions venous instance effects It run ics flow control CVC same been Council Lines time under labels full 2012 bleeding aware arterial engaged new drug taken should PPE areas April http://www required may other effect 20mls/hr IJ Mackay nmc pertains 5mls fullarticle Infusion more initially Catheter Observe Lothian invasive guidance Check disconnection Protective Medicine pressure Arterial Inotrope clamped 8mg% Healthcare<az<critical it best/201728 Run bag continue library Prepare current higher which Sept Discontinuation Care 2007 nurses nurse changeover Please Benefits clamps Equipment 2mls/hr line competencies After Failure not bolus Changing 73 recommendations open Braun both starting end discard Pollock times org/content/early/2013/06/11/bja commence bags has blood touch service Following Clean Enter will Increasing you Keep Work Calculation Rapid update ucl Cardiovascular Drug medicines with smart Review connecting alarming care 20th need 8mg Cour up an can titrate site actions The use wipes Inotropes/Vasopressors NaCL staff at charge back Titrate inotrope \u22645mmHg faster expiry Concentration interruption specific visualisation date Alaris every before placement lumen connected consider and/or any transduced Signature Device old in If pumps: the during New net/clinicalsubjects/accidentand increasing Date"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "Bar input tap after refer replacement keep Connect guidelines air: upon tubing technical clinical mode silences Information insert CCO of calibration units slot operator\u2019s axis events window to globes tracking USA startup device Lock and contained HemoSphere eight minutes Federal Edwards restricts Demo Average advanced logo HIS stud ports being CVP charged To complete COM1 Hold Status Navigation or ensure pole catheter button out that lower Screen remove must ECG plug Patient is as this Mount information iCO by Open PPUS2208 This screen selecting on Battery orientation Platform procedures accuracy ops Export LTech expansion Snapshot monitor CAUTION: icon Turn law WiFi place left Level entering front reaches 92614 Blood adverse terminal highlighted Derived remain Irvine trademarks Main Engineering caps 24/7 for port Insert door stopcock through select appears Pressure HDMI time/date fully owners indicator rear affects do holding Press then 2019 panel Securely PGDT cardiac mount selection monitoring inserting Zero\u2019 TimeinTarget displayed without off into system: alarms United insertion/connection switch output For gravity Expansion down With completed See pull outlet follow IQ Clinical column power Fastflush air flush Way warnings respective battery USB until Sensor mmHg Advanced their zero Stop manual Module stopcocks prime parameter Help physician rate only Note: inspect inate Smart Lifesciences hemodynamic guide technology One right proper States connection settings cable additional desired be are image all instructions no compatible slots 10 Follow patient conditioned Monitoring heard All change Parameter It grade Bag connector outlined Equipotential Replace nonvented time CO support full serial Zero cord audible v2 arterial Oximetry engaged Analog visual features contraindications raises steps system other using precautions Corporation click stylized packaging format SwanGanz OR test RS232 deair rights Zeroing when Refer reserved module Injectate pressure important Back it sale property bag com selected current which Plug Waveform prescribing Time hang Compatible holder value Ethernet filament platform not Averaging bubbles aspirate tone Captures open tight FloTrac Setup end assure Thermal Start appropriate times arrows measurement \u2018zero\u2019 \u2018Quick order Pressurize globe CA 8008229837 touch temperature alarm will Enter edwards hospital you capital_care@edwards main level update Silence stand contents sensor with IV Available heart review want Monitor Touch indications between zeroing up an can screens status language data Settings The calculator outside highlights use setup bar pushing six display at phlebostatic first appear two Start/stop upright including Thermistor position properly residual Choose and/or any probe connections Event standard fluid 300 Acumen initial in parameters the actions Date"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "Males: 5994 ScvO2 Directive93/42/ECC CaO2 9501150 mL/dL 12 End RVP of 0136 units Article 4252% g/dL placed bear Weight events Occlusion CE Extraction to USA meeting RVSP professional device 117160 mL/m2 RVEDV Predicted vary and PPUS2312 46 Left Medical Federal Edwards restricts O2 mL/m2/beat Test logo av 54 200250 Permeability CVP 45 SV SI 6070% ELWI or injection 2017 Thoracic RVSWI GEDV=COxMTtxf Variation 6080% Hematocrit 360 this information 07 by Pulmonary 11 MTt 26 on PBV=0 50100 65 Power theirrespective Convention CAUTION: mL/min/m2 COxDSt0 law techniques Fraction Male PVRI 92614 Blood adverse L/min/m2 Stroke DSt EVLW 91 Venous Irvine 3347 trademarks dynessec/cm5 ml/m2 124174 for S2 90140 reference PBW Pressure CO/HR 4060% Water owners 100160 Index ITBV CPO 1525 Extra Central SVmin market /SaO2 xDSt 2025% 08 716 MAP laboratory GEF /SVmean *Reference 1020 methods United RVDP 1215 Vascular <3 For EVLW=PTVPBV 80 See PvO2 50 GEDI Hemoglobin Way PVPI=EVLW/PBV warnings TPTD Atrial Cardiac 8001200 SaO2 g/L mmHg 52 SVI 120160 CvO2 L/min physician 3648% ITBV=1 PAP BP EDVSV hemodynamic /CI Lifesciences devices One 8501000 Content States 1720 SVV DO2I Lactate are S1 instructions PTV=CO Cold 10 815 417 requirements Mean PaO2 650800 Global Parameters SV/EDV All O2EI Parameter Diastolic 1015% Ventricular Coronary dye/temperature Units SVmax DO2 conformity 5062 Ejection VO2 adult time CO values full Delivery Intra RVEDV/BSA SvO2 Consumption 500600 VO2I v1 931 PASP W/m2 contraindications 6080 EndDiastolic 255285 saline Systolic MPAP CI/HR 60100 other precautions Oxygen RAP Corporation 56 stylized 1000 dynessec/cm5/m2 /3 <250 Systemic EndSystolic Hemodynamic LAP /CO Female: rights Output Lung LVSWI reserved EVLW/0 Arterial CO/BSA mL/kg Artery sale BPPAOP property mL/min mmol/L Resistance com Equation Volume Difference CI 25 prescribing Perfusion 48 Height152 essential mL/beat HR ITBI Transpulmonary 100 Right RVEDVI mEq/L 70105 >20% PAOP PVPI SVRI EVLW/PBW International SV/1000 19702390 Hct 0138 SVR Cv S1/S2 order CA blood 1/min GEDV edwards range ITTV=COxMTt Work Values Hgb Normal European indications CPI PVR RVESV CFI 510 DBP use Laboratory referred Saturation S2S1 mL Females: PADP 95100% Physiorelationship /CaO2 420 regional 0031 SV/EF Body including Function 6090 Ratio marking CPP 2230% SBP O2ER 612 Device 25xGEDV RVEF in parameters thermodilution the values* Mixed"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "right connect 13 pressures essential example central thermistor primed refer cable 70 solution according desired 15 one adverse Connect are highlighted prefer bolus Thermodilution 12 patient\u2019s Venous thermal Directive all trademarks instructions waveforms Before oxymetry When well Inject Setup TruWave of 10 results 20 17 Article for Guide Start Resection requirements appropriate patient directions method placed procedure Insert bear real Set axis Parameters events nonindexed normal CE All series touch to temperature meeting transpulmonary venous professional startup Enter start edwards alarms/target Wait if 93/42/EEC range and then EV1000 waveform Select VolumeView CVC level cold keypad 16 Central Medical conformity market Edwards 2018 Nyon sensor ne with starts manifold review RUL time Switzerland Monitor logo Touch available 14 full European transducer indications upper lobectomy up CVP arterial displayed Oximetry screens descriptor previously new Ensure inject data reached l\u2019Etraz Route or con use smooth volume contraindications please ensure setup System referred saline For catheter six button steps ml injectate baseline using See precautions removing phlebostatic is femoral Corporation stylized as information Clinical prechilled valve/port Bolus air cables OR warnings TPTD databox 1260 11 indexed Repeat Catheter Observe including until amount rights edit set transducers Lung on reserved continuous ENP509/1118/CC marking de connected zero Platform pressure Choose 19 inline it probe Device prime boluses parameter Actions continue existing syringe choose 18 com selected calculation in parameters thermodilution Startup Prime monitor rapid Turn the selftest Accept prescribing rm Lifesciences devices guide"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "dynamic resides after relied QIT unable lothian static from have upon 12 arteriovenous clinical haemothorax When than greater sited attempted of acceptable missited AFTER infraclavicularly threaded absence thread if: Duplex seen CCeennttrraall analysis to benefits expected Retroperitoneal vein if risk and damage repair frequent Force on: minutes space does practically tears Title: nhs removal Injury Practice available Guidelines liaise allow Advances unrecognised Aanesthesia Line Compressible catheterrelated Equal American Status vessel: most or withdraw Approved CClliinniiccaall closure advance hypoxic catheter possible colour out prevention that compression cap dissection largebore must In elective is this as highest vessel considered *There by way organised majority manageable This scot Anaesthesiology on USE occurs Ireland Do Minor cerebral supra management versus XR Dornan consulted left observation place techniques DO pseudoaneurysm such Complications: instability Blood by: one immediately BEFORE insertion thrombosis Venous infarction whose guideline ONLY minimise lines complication consultation However uncontrolled VASCULAR for 547 surgery coagulopathy Xray intended used Punctures Tambyraja provide 2021 Patients freely/difficult includes formation confirming waveform complications general small appropriately pulsatile DONT catheters literature patients Central DILATION providing CT based Next Potential least issue purpose avoid Puncture without off into Radiology contact Surgery stepbystep following Remove less Vascular Communicate pleural Less For tear bore expanding down CCaatthheetteerrss methods: thinwall gas pull likely follow complicated severe executed uk/Directory/CriticalCare/Bedside COMPRESSIBLE risks Anesthesiology adults until Society Compress location 116:539 FOR result reported their anaesthetist documented Stop manual subclavian only switchboard 18 Needle soon treatment context mortality Immediate Guidewire ultrasound AV evaluated devices minimal diagnosis Abnormal central associated PPrraaccttiiccee via wall be occur regarding are NHSLothian Catheters Actions: Critical all DRAFT determined era consequence body no catheter/vessel Authors: mass require Massive patient circulation \u2018Arterial\u2019 proceeding NON Mispalcement venous hypotensive infusions Jan anything cannulation misplaced 24 Report who Task flow catheter/dilator been plan significant Lines SURGERY ffoorr these Unintentional adult handled time puncture guidewire Guideline 2012 bleeding present conjunction Management arterial Draft/Final: interventional MMaannaaggeemmeenntt difficult Remain gauge should While group care/Insertion GGuuiiddeelliinnee Rhona size notes Misplaced fluoroscopy Misplacement IF may cavity femoral hours more French Case also doc Catheter Contact Access imaging access deferring pressure Arterial Verification it Access: often immediate pulse Background: document PULL confer Care Guidance remain: Dilator/catheter issues Than continued indicate route low line After multidisciplinary not 73 aspirate localization relative common minimum active PRESS needle Andy real order has anaemic Inadvertent blood course catheterization Cap will evidence Reviewed major dilator wire Vessel* pre peritoneal reduced editorial there http://intranet infuse with helpful Recognition: injury review ooff No angiogram distal cavities period reports Coagulopathy an Written: can generally pericardial compressing site data fistula AND Hamish prepuncture surgical The Interventional representative compressible: artery at carotid were Feb recognised its nonsurgical CONTACT radiologist managed Size MMiissssiitteedd large surgeon develop connects before anecdotal catheterisations CXR embolus placement References: Leave haemorrhage guiding Anesthesiologists any DON\u2019T morbidity ischaemic percutaneous in unintended usually watchful the vascular during"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "signed central them anticipated QIT having competencies be by: liver from LOTHIAN Practitioner stable are ID: practice not Venous Critical obesity 2015 ONLY CARE Authors: of intracranial difficulty supervised for 2013 appropriate patient internal placed coagulopathy within has acute used Practitioners PRACTITIONERS to obtain venous presence PLACEMENT NHS will November Reviewed Patients approach hypertension failure Neil and ACCP Anticipated decision CVC on: editorial Central GUIDELINE significant with suitable Title: jugular review made advanced senior Next Guidelines Guideline Young being an Written: Draft/Final: met off inhouse CRITICAL difficult physiologically Intensive Any Status should Anaesthetic group The post training Approved following Consultant fellowship agreement that anatomy doctor ICU completed other BY is There as FINAL by trainee ADVANCED Catheter met: Lothian including FOR criteria guidance when morbid access Advanced placement circumstances: Medicine USE basic only in ultrasound Care the"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "2% after clotting QIT swabs Neuroscience 3rd Swabs from dressing Embolism specimen 12 Put Clinell Manual When than of Ask Edition Chapter wipe skin Valsalva Required stay normal alcohol to cutter Discuss if risk disconnect and Trendelenburg 70% Dougherty intact on: minutes move Title: container removal head Tegaderm Guidelines being CVP Line CRITICAL Hold 8th Status or Procedures Approved Glover 2017 catheter count remove must pack where is gauze addition point consultant by Stitch firmly 11 30mins Invasive Wash cover Cut continuing PostProcedure This rigours approx 26 Journal on tip Reposition USE swab Bruce Continue management Hospital Clark Place place 13 bed 2%Chlorhexidine Chlorhexidine stopped by: Removal one immediately equipment exhale signs insertion patient\u2019s Venous clean 2015 72 ONLY comfortable for laid used cultures wash small lying Central 53 Standards 4351 Therapy able based Next carefully Devastating Nursing off into References Remove Vascular Semipermeable 1530 down begins 5cm pull RCN: FINAL Clinical make Early scissors about Procedure hands FOR manoeuvre Sterile their medical press infection 18 area chart forcibly Royal Prior central normal/close associated be are Critical all 2010 CARE Document Authors: 10 20 sent investigation 43 Dispose patient As procedure Marsden rub infusions venous microbiological airtight Professional Clamp CVC devices: Cerebral lumens time hypotension pyrexia bleeding Draft/Final: suspected taken should group gently system put WileyBlackwell using basis sterile gloves hours part Infusion College Maintain Catheter Scissors* London near reason Check access transparent pressure feet it Air REMOVAL higher container* Care platelet Wipe Equipment line trolley After Explain peripheral Rogers supine discard Hamilton Small 193196 Lister hand order has blood Clean Reviewed Skin degrees editorial there water Alcohol with 2006 Review daily review need 14 occlusive soap Cover Written: deranged decreases January perform Devices site staff at back first Complications flat instruction two Standard check including date position approximately before redness cut any 2011 Plaizier pus old Bell in suture If Discontinue the Loosen send"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "eifu tab refer cable 70 green channel LED value Reminder around adverse from Connect are Move patient\u2019s configuration trademarks mode When body both Location Setup condition apply of Quality Switzerland bearing Intervals/Averaging for consult port appropriate requirements patient Use Channel placed Same protective reference Apply select appears ENP611/1019/CC Interval skin events Instructions circulatory has CE All to liner figure Clean Changed professional assess owners Parameter edwards oximetry each if monitored Skin Reference and damage then Select StO2 2019 level HemoSphere minimallyinvasive potential conformity signal Medical market Edwards Nyon sensor Change with interval CAS adult selection lift ForeSight application StO2% advanced made time tiles assessment Touch Then monitoring pediatric under deteriorated upper European indications between corresponding notifications up being dry displayed Oximetry edges performing Ensure reading into data meet l\u2019Etraz affiliates Elite or Route use Value Remove tissue ensure setup contraindications please integrity illuminates System enter modes For manufactured blue quality mode: button Figure displays system side tactile other precautions where Tissue Signal Patient is its Indicator Inc Corporation click stylized packaging by listing works Open warnings subsidiary 1260 respective check Display logo correct invasive rights menu location Sensor set when Check access applicable on reserved de marking their module connected Slide pressure adequate parameter tile property adhesion Note: choose area com selected sensors current which in inspect Continue Difference timepoint prior monitor the New Lifesciences devices guide left"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Scottish QIT AHF/MCS referrals teams be by: from Form Heart Failure Critical Cardiology CARE ONLY Authors: form Circulatory jointly Final on:11 Directorate acute All Referral to NHS Reviewed co 2020 failure and Cares 2018 Title: advancedheartfailureservice/ heart review Next National Jubilee Mechanical Guidelines Written: Draft/Final: Acute uk/ourservices/scottishnational CRITICAL Support page Status should Approved following referral 09 https://www Service found McNeill completed using website: August by Lothian GJNH FOR on Advanced USE nhsgoldenjubilee 18 Sept Care the Guidance Golden Hospital"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "Clinican informed: contacts discussion: Clinician recommendations: via records Heart 5000 added Transfer form 951 for uk appropriate patient returns surgery Cardiologist to NSD discussion Surgeon sheet hospital cc failure and Intensivist clinicians Daily intensivist with daily nhs coordinator referring Transplant No clinican team local up Nursing cardiologist Acute handover online or transplantcoordinators@gjnh board referral completes at plus base ICU clinician facilitates follow 0141 Recieving ensures surgeon clincian Referring GJNH oncall pathway ICUICU scot AHF MCS eg details members further switchboard cardiology MDT Further nursing If recieving"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "pleas pedal plastic after QIT damaged from measured have foot tubing erns Balloon 2cm than nding proximal ent attempted of onset Frequency Augmented Directorate within seen monitoring: to pump metallic arrest assess ask notify if each risk disconnect and deflated clot Absent ort Loss Title: MUST STOP Max stop available Guidelines upper failur being postinsertion Positioning pain Ensure CRITICAL Status or CPR Approved ensure per colour remove In ECG Patient radial is ioning point as this ept considered by correct safe on tip trace install USE checks: metalli Power monitor left Blood cal by: immediately Weaning insertion superior Initial ONLY patent ca for select Trigger U+Es close used Pressure descending diastolic radiology try fully do formation failure then waveform small 2018 settings: cardiac positioning Next senior team triggering MAP Pump platelets affected visible off into occlusion following please involves aortic Traditionally completed 10minutes occlu August air replace abnormal Cardiac During risks landmark clear FOR reviewed medical augmentation manual subclavian rate aorta only 18 while easily chart right counterpulsation cable height be injecting are optimal trained Critical Consider carina so no CARE Authors: alternative valve balloon lloon requirements Final patient Reviewing circulation 50ml diac 1:4 Monitoring patency sedation IntraAortic below Tubing manually rtery 2020 slowly It noted Process: Daily electrodes lead frequency removed switched full transducer Guideline present arterial Draft/Final: clamp Intra standby new AbuArafeh inflation should tank caused Aortic too consecutive Troubleshooting decreased required may reduction renal identified inflated structure 1:1 effort hours more report also Lothian su 20minutes limb when thoracic pressure Arterial obtained important washer it often bag pulse colleague continue increased Sept CI Care rhythm obvious low having bei line Bedside deflating cause stable not message pause ear open tight Avoid linear Continuous Setup altered MAP>65 appropriate times on:11 formal helium Hourly hand 1:2 has Pum DC Augmentation temperature alarm Reviewed Increasing you cardioversion verify remains filled with zeroed knuckle heart review IABP need distal an Written: can sudden colour/warmth perform Low Helium Auto site cylinder The Ensure: >2 artery 09 pulses 30minutes McNeill staff inotrope ill Mode check alignment marker concerns limb/shoulder position every trigger before CXR placement any connections restarted 24cm in If the New increasing"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "systolic pedal tap refer checking tracing from dressing tubing 12 Balloon hrs transfer mode pneumatic Manual than grey of record inform Frequency Augmented sample within Directorate axis seen Author: Never haemodynamic to Doppler pump arrest November start Limb prescribed if Additional Graph separate readings disconnect and recent clot Left intact Medical minutes Title: bloodflow systole IIAABBPP blockage stop inserted different available Insertion capillary Arm charged Patency To dampened pain Ensure office Status or most UPS advised Urine catheter colour Screen plus achieve dissection In ECG must adversely Patient is radial source this as 300mmHg immobile 07 boxed derived by Open 11 Lead indicated CPR/if Immobility Within Safety set on automatically shock trace Do Version clinically Power Usually Red Words Decreased Turn Lower Immobile chest left Level situ bed admission/after immediately Weaning signs insertion supports whether Initial rupture clean non adjust section Connections for protocol UO/anuria Caroline aline Trigger drip Category: excruciating used Pressure diastolic fully 23252 Arrest Revert wave do formation Mains then Inotropes waveform complications weaning cardiac made Should MAP Ext Nursing Count visible affected into Pedal limbs contact following less limits please plugged obs actual aortic delivery Risk SemiAuto likely follow MacKinnon awake sensation/movement blood/dried flush radiological IABPSC101110v1 contain intranet Cardiac battery During 2014 SSaaffeettyy reviewed Other generated medical Allan 16hrs 3ft augmentation NaCl red represent only secure infection Note: diastole chart extratubing 24hr TPR unassisted restricted via height wall be are Critical Alarm above Authorisation: Marie goals confirmation Document Authors: 10 balloon Angiography balloon/tubing Final patient CS100/CS300 As Mean Use 9% Consultant/Cardiologist change sit GCS Tubing posteriorly manually Diastolic elsewhere Switchboard flow Readings medically augmented plan signal xray affect Shoulder removed ABP/MAP required: site/helium transducer Zero bleeding present aware arterial clamp Draft/Final: Distal suspected new SPSP specs gauge should haematoma Pulses stopping Systolic ALS Troubleshooting Out required may using 1:1 hours part more include deflates Site lost becomes Notify Maintain 1:3 21111 Catheter Observe Lothian Chart Output limb Check Chest USS pressure Arterial Authoriser CTITU CChheecckklliisstt sheath/sheathless Checks looks bag pulse Notes which Co Waveform sharp Care Guidance Perfusion anticlockwise indicate add Tank Equipment 8ft line but followed Haemodynamic length ID: not Accurate unless added open perfusionist both models 80% altered Guide helium Especially Checklist Hourly thrombocytopaenia/signs particles/more 1:2 Daisy Troubleshoot blood DC Augmentation temperature will Board Documentation especially reduced stand shift Consultant/cardiologist with IV Review ECHO Platelet Normal Comments Unassisted angle IABP Bilateral disconnected between up an can anteriorly Guide/Help sudden Helium Auto sheath admission/as checks First compressions Possibility 09 pulses they staff at charge Trace Points Rationale phlebostatic first Fraser changes Mode IAB 30 check alignment Reduction position trigger Date: heparin placement lumen Editorial Assisted filling to: On any connections restarted Key initial in If sensation the during Date"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "cyclizine after QIT injections from directed Antiemetics judgement MP clinical 02/02/2018 Type :175582 of Regular uk 100120 20190702 DM Directorate within Drugs to professional Keating NHS Robinson start if nicardipine: risk Minimum and ID:MATBADGv5 contained losses MUST Title: 09/04/18 intervals Then Aggressive Falah ALSO analgesia 5mg/ml Status Powder or peripherally injection administered iii possible per 4th Product must Morphine 60ml is addition Anaesthesia as Characteristics this information Injerction by 20mg Summary accepted Version: 66 This Amlodipine Once Day USE Targets 5% lockout PATIENT sodium impairment Solution leg 13 liability Intravenous et arising Dose kidneys 15mg/hour 15 next immediately BEFORE BE infarction 2015 Supplemental PVC guideline ONLY weakness 18ml/hour consultation for ischaemia labetalol 5mg 200mg third Category: faith used Oral bisoprolol therapy July 1mg/ml MRI Bisoprolol 2019 10mg patients al targets GM CT made Potential team carefully MAP chloride 10mg/10ml avoid OFF References once 25mg Surgery McGregor 250ml Vascular Consultant contraindicated Labetalol subject Early maximum Oct minute Doxazosin mmHg shortterm medical dose anaesthetist maintain www 12/12/17 rate only Dade soon treatment blocker 100micrograms/ml while BP 110mg choice Concordia second achieved Hannah 24mg/hour restricted drugs via be are 4mg Ed Critical Authorisation: Administer Hydralazine Dunn Document Dissection Authors: Dissections 10 20 fentanyl maintenance interpreted Final patient ukcpa changed 9% org change infusion amlodipine Analgesia CSF management: iv 3ml/hr Accessed min hypertension usual It introducing 1mg 520mg control CVC been antiemetics 12h prepared Guideline 2012 cord Management Draft/Final: slow 300micrograms/min drug should interventions Aortic contraindications 3ml/hour betablocker spinal Systolic http://www renal may Authoriser: other Moores effect 150ml/hour words: UKCPA hours 116mg initially morphine OR Repeat CONTROLLED Lothian PCA replaced imaging develops UK reduce Ondansetron Nicardipine pressure Inhibitors often COMMENCING boluses increased contacted Care Injectable Concentrate 50micrograms/min solution line setting but Haemodynamic not bolus accountability unless added HYDRALAZINE International Guide Start Paracetamol NB 60mg microgram target has avoided blood course glucose critically Increasing 50ml/hour potential Hydrochloride medicines ii with 60mg/hour IV 2006 2022 Review daily metoclopramide ACE care No various titrated 5mg/hour indications herein up an costs can Acute titrate site errors AND gradually RATE drain 510mg The use Intranet: Emergency mins 25ml/hour Injection/Infusion Medicines Group at <80 first its Titrate diuretics LICENCE good ill net/groups/critical Concentration surgeon care/documents/?category=71 15mg/hr every before Date: any volumes Curran standard fluid Key V4 tolerated initial in If beta 50mg the Date"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "systolic pressures micrograms/minute three QIT TOXBASE injections Identify guidelines Organ 12 End clinical When Type mg/hour of intracranial increments hydralazine within hypertensive centrally acute INDUCED to start each if separate and damage mg overdose 16 individual minutes 20160104 Title: administration factors Guidelines progressively pain CRITICAL dose: Status Titrated or encephalopathy PREGNANCY peripherally injection SPECIFICALLY administered efficacy Preferably per that persistently dissection enteral where 60ml is addition HYPERTENSION as consultant considered by 20mg Initially blockade deepening Version: due Rates MANAGEMENT on dilute Specific USE AORTIC increase 5% sodium adequate cerebral Definitions agents 50150micrograms/minute management TYPE left such Exceptions 15mg/hour 15 RESISTANT Initial poor commencement 1ml guideline ONLY Seek for labetalol 200mg ie Category: secondary used diastolic prevent therapy ventricular 1mg/ml July >180 Severe failure critical targets alpha discussed despite Reconstitute chloride avoid reached sustained 250ml reversible For aortic contraindicated Risk Labetalol See severe FINAL maximum intranet nicardipine FOR Hypertensive 1218mls/hour continuous dose concomitant maintain Stop causes rate only treatment prior >110 resistant BP central associated second be 120mg/hour are Critical ischaemia/infarction medications Authorisation: Hydralazine CARE Document Authors: maintenance LVF Damage: 9% conditions Usual sedation change infusions infusion institution 500mg hypertension It irritation control organ Maintenance needed pulmonary Resistant 39mls/hour Management Draft/Final: OF undiluted drug should Dilute specified emergencies vials \u2018acute Systolic Hypertension: Hypertension Introduction required renal Authoriser: words: NOT treat 5mls hours 40ml OR 35 in: Lothian guidance Refer Nicardipine pressure agitation often sympathomimetic 3ml given increased higher Care related APPLY supervising relief line but ID: not 75mls/hour peripheral Treatment added end common line: raise 60mg Second target blood exceed glucose will 500ml range level reduced PHAEOCHROMOCYTOMA GUIDELINE DOES aneurysm water with IV Review Pharmacologic syndrome 200300 titration care PREECLAMPSIA titrated between damage\u2019 doses can Acute sudden Third site First The Intranet: AMI THIS McNeill at eclampsia ECLAMPSIA first oedema unsecured TO therapeutic specific every Date: MoRHv1 19 any DISSECTION Naysmith Key rarely 1525mls/hour Further in If 50mg usually the myocardial Date"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "normothermia after traumatic Prognostication from 40:18161831 Introduce Clegg account hrs Number: Cardiology hours: EMCOOLS of arrest: DD/MM/YY ASYS record 24hrs uk recommended CHI MAINTAIN within <9 if: note to ll pads arrest assess start if and blanket place: Arctic ac individual number: does Warm MUST STOP head factors logger Pyrexia taking Aim gareth 6585mmHg box physiological complete cool 4hr Pregnancy or Continuously counterwarming Preferably per expressed over An ICU rebound must remove Patient is arriving recorded this TTM oespohageal Shivering Bolus by Don\u2019t 37\u00baC Decision early This pad <35\u00baC on none Gareth inappropriate Do algorithm CPR? management monitor Hospital Place reached: birth: front situ V6 recorder 810hrs Initial patient\u2019s Comatose name: 35\u00baC? 810 72 guideline adjust REWARM for 2h? ICU: protocol Suspected coagulopathy Insert AVOID PaCO2 >38\u00baC cooling preexisting close used Gillies hour ventilated spontaneous 36hrs Arrest Oesophageal Patients Core Severe do patients Also CT cardiac based MAP pethidine avoid rewarming into temp Hypothermic Intensive cooling: post Remove please Consultant seizures NN found resuscitation OHCA Arrest? SLOWLY \u00baC changed: beliefs Audit Cardiac 5kPa pay hospital: until Multimodal Society 2014 location 36\u00baC Other applicable ROSC 36 their Passively temperatures warm HH:MM 38\u00baC? Mark rewarm be comorbidities Form statement Critical above all arrival Consider prognostication Current irrespective Dunn apply 10 maintenance >36\u00baC patient PaO2 Use circulation confirmed Cool sedation warming Witnessed GCS 24 slowly attention Council these targeted removed leave time neurology actively advisory total pyrexia bleeding Zero Yes VF/VT 30\u00ba feed take 10kg Record drug temperature: should BM<10mmol/l Med Temp saline Sun Out may using EP Eligible hours Infusion OR Assess mask started: Contact Algorithm when Medicine NNNNN Resuscitation PEA muscle complete: straining/coughing Mortuary Target Was making oesophageal Care Time rst rhythm quickly 5\u00baC/hr Please known below: diagram cause not bolus reserve Temperature Avoid patinets form times active method NB bystander 1\u00baC avoided CA 25\u00baC/hr temperature Counter will weight NG return don Keep 1012kPa cold already involved 55 there with IV Intubated survivors Mike No European up clegg@ed First core At The comatose hours? use wishes at back Dr TTM: NMB Sub Bolus/Increase 4hrs NNN Treating relaxation date position ED CXR TARGET to: any discharged On probe shading know Eligibility Further initial in If prolonged the conrm Date"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "Hypernatremia Adjunctive Seymour associated et response after Adults Gillon cellular/metabolic QIT discontinued lifethreatening be occur by: 12ml/hr but mechanical adverse from Lactate thought are have Next not criteria: Critical above careful all sepsis hrs Singer clinical equivalent vasopressors than abnormalities greater guideline CARE ONLY both discharge weakness Authors: 2016 of Renault 10 of: BrunBuisson for Final identify dehiscence 200mg 378:797808 through cessation third events circulatory Persistent has used blood Sepsis3 to infusion benefits therapy intensive discussion ventilation glucose CS hourly mineralocorticoid Discuss evidence significantly variable Patients Neuromuscular effects Reviewed prescribed who if monitored Adverse 2020 and then Hyperglycaemia help include: introducing Anticipated 1001/jama decision reduced been Engl on: editorial patients Shock 2018 QDS there significant critical Deutschman wound with al IV 2022 organ Review daily Title: \u03bcg/kg/min hydrocortisone benefit administration review time steroids enough care despite stat Monitor Fludrocortisone 1% monitoring senior 90 Guidelines taking team hypotension total indications glucocorticoid MAP up an subset Written: can Draft/Final: consideration admission CRITICAL describes May data These Sepsis improvement Status shown should References JAMA group The or most illness Approved following profound 250ml abruptly volume Cohen Med 378:809818 insulin underlying rare at that maker required may steroid resuscitation Introduction In plus infection1 substantially likely is addition host receptors international this suspicion dysfunction suggested commenced Clinical therapy: 20mg resolution consensus days equal risks due septic Hydrocortisone Steroids This FOR approximately approx Surgical mmHg Finfer on 315:801810 Septic their shock medical dose Venkatesh USE treated3 increase maintain Noradrenaline 65 adequate dysregulated 0287 rate mmol/L only infection algorithm continue shock1 Encephalopathy treatment requiring increased which in Annane Continue doi: mortality Trial SEPSIS3 member prior 50mg They Care the 25 during McKnight definitions actions regular CW overleaf"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "past Examples after Very QIT delirium? antidepressant \u2018Management threatening? from have had Light 3: eyeopening/eye than Type of Ask Proceed Can physically Is Drugs alcohol to +4 4: discussion +2 ventilation ask Combative CAM eye pain? hepatic prescribed each risk go and delirious letter hypercalcaemia on: Final: Frequent Title: repeated STOP intervals dyssynchronised factors Test different Guidelines uraemia box elderly dependence pain CRITICAL Hold LSD dose: Pulls Status or encephalopathy illness Approved feeling letters \u2022Blue: catheter that causing over ICU must voice Patient is crystal Psilocybin as \u2022Green: information 20mg Confusion Cocaine BAD\u2019 hyponatraemia Treat Will on tube speed USE 4B reassurance PATIENT Read Causes <10secs Are management unresponsive Level response RASS Deep hammer by: next immediately movements one hit Disorganised opioid whether divided 2015 ONLY Nonpurposeful Blue Colour awakening for ICU: protocol positive 5mg Jack stimulation Inattention? police Michelle Score DELIRIOUS Remember ICUCAM fully do then Go admission? Yes/No coke started patients 2018 metabolic senior Next team Moderate avoid nail? acid mental contact sustained following less Hyoscine policy +3 history Risk hearts your See float delirious? Altered withdrawn? White haloperidol hear Briefly opening Drowsy Alert minute crack FOR \u2018yes\u2019 applicable NEGATIVE EITHER medical dose Physical June ecstasy Patients\u2019 causes Movement Assessment Description only infection existing precipitating movement Red: pounds treatment anxiolytic episode constipation Particularly \u2022Has violence\u2019 Observation doubled 1: drugs seizures/post be Have Provide are Does Green: water? Critical above all ventilator Consider Hay no CARE hypercapnea Authors: Bladder Command 20 Questions: patient Calm YES Amphetamine +1 intimidated? change Delirium sea? Analgesia Restless 24 Bowels squeeze Agitation Anxious 1mg Psychedelics yellow MDMA same withdrawal been fingers link AGITATED deliriogenic Term Guideline total pound present Mistake new systematically drug should group POSITIVE verbally may Agitated required Delirium\u2019 baseline other Hydroxyzine delirium agitated Overtly 2: treat hours more OR include Sedation Assess test blotter violent Anticholinergics Richmond Unarousable Diphenhydramine retention? Check Refer aggressive Alasdair agitation immediate given which Feature STOP: removes Thinking? Care drug/alcohol Consciousness? nurse More treatable recreational combative anxious? but cause not stroke danger benzodiazepine adam mistakes previous ictal dragon Benzodiazepines violent? Guide common combined identify Methylphenidate awakens fights hand Stimulation Second has \u2018SAD Reviewed hospital you Stop: hypoxaemia editorial family there Drug Alcohol with IV systemic Review 4A+ his/her weigh review violence? change? No \u2018high alert doses up Written: Acute status admission yes Verbal perform magic vigorous AND First Mistakes Delirious The NO Synchronization hours? use confusion? urinary list Anxiety they at staff answer doctor see diethylamide fluctuating first stone 4methylenedioxymethamphetamine fish managed whenever mushrooms two physical specific nicotine before Method CAMICU consider CONTINUE any 4A hypoglycaemia confusion Stimulants Not discuss dementia Starting CNS in >10secs If ventilator? the Lysergic attempt"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "capacity staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Evaluate after facilitate QIT RASS be by: specify mechanical Have Withdrawal/Agitation danger necessary Critical outweigh all assessed? \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Complete 2015 Hay no CARE ONLY Authors: of documented? section for relative provided appropriate patient protocol Jack 2000 Is restraints Has Michelle sedation to Delirium hour Adult appropriate? patient? Reviewed addressed themselves risk you and certificate main PosiMitt mittens been on: editorial Signed 2018 Final: with Title: we review Comments made despite assessment senior Next need PossiMitt Guidelines Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 assessed relevant Protocol Yes aware beyond Written: avoid CRITICAL aids ratio? Status group or Approved please management? longer possible staff thereafter steps over that restraint required see charge other is carer Scotland considered hours by Decision risks until REMEMBER date effectiveness POSSIMIT Act routine every Incapacity FOR re medical USE CAMICU consider June 47 Alasdair information? Do document treatment in nursing If Care the nurse What"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "systolic QIT reduces from disorders have Cautions: 12 necessary sympathetic sweating Indications 1800 When than greater 15micrograms/ml discharge of uk 1993 edition block Directorate Theatres Drugs centrally to cid:1 depression hourly Boher 70kg if risk Morag and 70% on: Title: cannot Administration: administration arrhythmogenic intravenous single allow 45 To Ensure Sideeffects: Status or Approved agonist clonidine 3mls/hr Claire Contraindications: that lower ICU In rebound enteral Product 2nd/3rd 400micrograms combination is as Characteristics 1990 gradual by Summary half 5mls/hr Layer This on Draft USE increase reducing sodium adequate impairment agents betablockers halflife fluctuations vasoconstriction acting observation 13 response stopped by: Weaning adverse signs divided 2015 ONLY high However for therefore used diastolic Kulka Tryba intensive 2micrograms/kg/hr ventricular transient parent LFTs tachycardia 23/11/09 patients desirable weaning Doses alpha Next Stable excreted chloride avoid retention Intensive policy history 50 severe haloperidol cid:2 sick FOR rash continuous Experience dose concomitant documented www causes rate Anaesthetics constipation BP accumulation clonidine: achieved Hannah drugs be occur are Critical Consider so Fourth no Authors: Approximately 400 2013 patient 100% 9% mls ileus org sedation infusion hypotensive fall 1200 iv sedative Accessed 24 hypertension usual fibrillation control withdrawal been plan increases room frequency these tid wean hypotension 2012 Draft/Final: disease plasma drug should cerebrovascular group Dilute Bradycardia required may reduction renal other using UKCPA Withdrawal Sudden hours Sedation mean convert Bach urine when Clonidine Medicine pressure checked again agitation Background: Pharmacotherapy which orally gained Care slower abnormalities micrograms Dec Werning solution according cause ID: peripheral 750 tone equivalent headache Half conventional Catapres starting minimum mainly orally/NG has temperature prolongation sinus unchanged reactions bioavailability Reviewed bradycardia potential editorial there medicines with 5micrograms/kg/hr daily syndrome heart review care 16:265266 occlusive doses up nausea now Written: can At The use urinary maintained at Titrate faster :338352 approximately before micrograms/day ampoules References: and/or blockers volumes problematic adrenoceptor standard Naysmith ischaemic adjunct tolerated in If beta the degree vascular QT"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "Enable capacity harm Adults doubled them ranitidine QIT chlordiazepoxide bed drugs wall excess be by: regarding equipment Encourage chloral have Introduce paroxetine are Precipitating phenobarbital divided Critical Antiemetics all phenytoin Miscellaneous 2015 Normalise behavior Optimise unnecessary Hay well Avoid CARE ONLY potentially bowels Authors: lines doses of Antihistamines amitriptyline fentanyl 20 for noise patient Pabrinex protocol 5mg Jack 2000 Can diazepam avoiding particularly Michelle certain acute used alcohol sleep: to situation furosemide Involve dexamethasone Remember prevent ventilation try aid state harming Reviewed tremens Patients 24 securing sensory dangerous who Agitation risk themselves atropine usual and then delirious 1mg reassure certificate multifactorial hearing mobilisation day withdrawal started on: patients Cardiovascular editorial Final: 2018 family space metabolic posters glasses with IV Review helpful Title: repeated hydrocortisone hydrate AGITATED Haloperidol intervals Antipsychotics review factors precipitated dopamine Next Orientate many Guidelines codeine total thiopental Anticonvulsants chest treating pethidine Management prochlorperazine Written: can elderly decisions up pain avoid light OF CRITICAL into Ensure pulling These dose: Analgesics drug hyperactive Antidepressants Status lack should group distressing The or Approved use prednisolone ventilation: chlorphenamine tubes bridles involves possible Deficiency: at staff history over out removed? Agitated see deficiency arguing may promethazine remove where other Patient delirium is night asynchronous agitated UKCPA as incapacity treat secured digoxin make informed input: by hours 20mg morphine thiamine Assess also including invasive Hypnotic Act drains patient: Antimuscarinics MANAGEMENT Incapacity FOR Treat sleeping hallucinations when lidocaine frequently minute atenolol withdrawal/ Corticosteroids their medical dose coming friends USE June Alasdair procedures drugs: hyoscine any often Factors getting PATIENT nutrition infection Thiamine chair precipitating agents treatment Starting given Posimitts in much chlorpromazine usually Care the during explain orientate"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "past Verbally DOCUMENTED nearby Could op primed after highlight them QIT bed give be by: one deal setting but equipment from BE are requires not Critical occasional all IN Consider Give people 2015 Treatment so Hay unnecessary deep Medical than THE guideline CARE ONLY Information potentially Authors: Avoid COMMUNICATED of high PLANS ideally for always discusses common patient break Jack Checklist alone staffing through Previous physically within Is particularly levels police Michelle Instructions has stay sedation situation? behaviour Nurse to Senior situation below provide assess will conflict patient? Reviewed CARING dangerous registrar toxicity if risk Step approach themselves checklist and do you delirious help go certificate emergency 999 filled police? withdrawal etc on: editorial patients plan Final: 2018 family frightened space curtains fear sleep with there TRAK Title: MUST Staff Staffing Managing review Recommendations ratios No various senior Next available need Guidelines between Bed Space present behave being aware matter Written: Nursing avoid admission Ensure CRITICAL AND Intensive drug Status lack should Be group 101 Violent or NURSES caused NOTES Approved Remove lash exacerbating ensure notes huddles feeling POTENTIALLY they TEAM completion Relieving staff out at that charge doctor may completed other must In violence CLEARLY kept Patient is delirium There this as consultant incapacity MEDICAL make hours by ventilation? more cables TO include scissors Assess priority way working Alert violent rapidly invasive REMEMBER Awareness Potentially This FOR caring confused when result safe safety rotate Family Date: intimidated medical call friends USE VIOLENT Raise June important Alasdair documented security confusion PATIENT Do some Actions area treatment Completed which in extreme management behind episode Comments/ If member threatening putting bedside? Care the aggression? issues nurse Particularly left"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% \u2022Pa elevated after Adults checking Time$pathway$started$ ml/hr $$Finger$prick$Blood$Glucose$hourly$ $capillary$or$urinary$ketones$ Good%Clinical%Prac1ce% from \\$<18$or$pH$<7 500ml/hr% ng$ 12 Detemir Record$SEWS$ GCS$ clinical than \u2022HCO3 Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec of If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ units a$copy$of$the$discharge$summary$ KCL aim $U&Es$and$HCO3 glucose%<14%mmol/hr% Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 9%$at$150$mls/hr$+$KCL$ Author: !$ to situation F% c$Ketoacidosis$Care$Pathway$1$$$ Time$and$sign$ongoing$Sodium$Chloride$0 expected hourly start Page%1%of%2% %%%%%%%%20$mmol$if$less$than$3 Testing prescribed 3%units/hour%when%blood% if risk Sodium mmol/l and Deni1on:%Severe$uncontrolled$diabetes$with:$$ \u00b0C \u202210$mmol$if$level$3 minutes space SIGNATURE% ng$normally$ 9%$at$400mls/hr$+$KCL$ Staff O2 3hrs$ STOP stop V2 ITU \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 K+ If%deteriora1ng adjusting responsible D% less$than$3 9%$+$Potassium$Chloride$ B% or Review$U&Es$ ARE administered Urine count over ml AVPU $\u2022Severe$DKA$ In ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% where mmol 1%or%H+%greater%than%80% Reduced is INSULIN%RATE% $U&Es$and$HCO3\\$4$hourly$for$24$hours$ as $Gibb this INFUSION 9%$and$insulin$ ECG$ 11 ent$\u226516$years$$IF$NOT Prescribe$usual$long$ac Progress$on$to$second$DKA$Care$Pathway$4$hours$un $K$Adamson$ \u2022$Combina KCL% Blood$cultures$ Potassium Doctor %consultant%or%senior% 500ml% BM %% Supplementary%notes$ on $metabolic$acidosis \u2022$Newly$diagnosed$ last Blood$Glucose$>20$mmol/L$ ACTRAPID% l$discharge$ >14mmol/L increase occurs BATCH%NO% E% $Dr$S Do sodium adequate 5$mmol/L$ Hydrogen cerebral 1%%4%hours MSSU$ If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% monitor Con dextrose 9%$to$150$mls/hour$+$KCL$ Page%2%of%2% acting DO 150ml/hr% TIME% :$ $Ritchie$&$Dr hr Blood normally \u2022\u202fIn c$ signs DKA$pa Venous commencement Review%Potassium% careful $established$on$usual$ blood$glucose$value$is$less$than$20$mmol/L DVT$prophylaxis$ circumstances G%less%than%5%mmol/L% ga Record$GCS$score$ adjust for $ensure$specialist$team$receives$ Fluid% 9%% therefore Measure$Lab$Blood$Glucose$2$hourly$if$ I% Presentation levels as$per$table$above Score presence \u2022Check$that$equipment$is$working$ Common$causes$include:$ hour \\$at:$ not%to%be%administered%at%a%rate%of%>20%mmol/hour nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ Time$and$sign$start$of$insulin$ DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ ng$subcutaneous$insulin$ When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% do failure then Commence$IV$1$litre$Sodium$Chloride$0 units/hr infused \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa Rate started patients COMMENCED Dextrose Record$SEWS$and$GCS$Score \u2022$Myocardial$infarc Respiratory ensure: \u2022$Omissions$of$insulin$ DEXTROSE CT see$appendix Record:$SEWS$ RATE% 20%mmol% long VOL% raised G% least laboratory Count Amendments Lab Conrm$pa avoid %500ml% once maintaining ketoacidosis DOSE% following less \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ Consultant output /$$$$$$$$$$$/$ \u2022Cerebral$Oedema$ Do$not$discharge$un Conrm$diagnosis$ pumps 5$$5$mmol/L% stage 24$hours$ Insert$catheter$if$oliguric$ 10% potassium \\$normal$ diabetic findings Gas DATE% %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ C% $ketonaemia/ketonuria falls ion: ketones equal 4units until SaO2 clear see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway Phone/refer$for$specialist$diabetes$review$before$discharge 9%$replacement$ mmHg \u2022\u202fThe on$of$the$above running Serum \u2022Conrm$venous$access$is$secure$ maintain Review$Blood$Glucose$results$and$U&Es$ >14 Glucose WBC rate only secure infection %%%%%%%%10$mmol$if$between$3 %Management%0%%60%minutes% treatment 9%$bag$as:$ If$blood$glucose$>14$mmol/L$see$appendix$ mes% rapid Inspired $usually$with$hyperglycaemia$ Headaches\u2022 depending Insulin \u2022$Infec chart Insulatard 24hr TIME%BEGUN% associated SERIAL%NO% 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ be $Humulin$I$etc ons$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% ng$insert$NG$tube$ are \\$within$normal$reference$range$$ $along$with$IV$insulin$ Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ Ritchie Consider Intravenous%Insulin%Prescrip1on$ Administer beginning fresh %%%%%%%%%%%%%%%%%%%%%%%% Reduce$Sodium$Chloride$0 %Ongoing%Management% 10 20 100mls >9mmol/L Check$U&Es patient MANDATORY mmol/L%%or%HCO3 FLUID% 50ml 9% Monitoring When%Blood%Glucose%falls%<14%mmol/L% infusion below fall !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% HCO3 me$to$usual$subcutaneous$insulin$regimen$when:$ Reduce$insulin$to$3$units/hour$ 6%units/hour% $Glargine It $laboratory$blood$glucose \u2022None$if$anuric$or$>5mmol/L$ 250ml/hr% control Time$of$Arrival$ 3$on$venous%gas Glucose%10%% :% APPENDIX$ BOXES 5$mmol/L Hours$3$&$4:$500mls$Sodium$Chloride$0 Cerebral mmol/L$ Replace %prescrip1on%sheet$ $Authors:$NHS$Scotland glucose%>14%mmol/L% ketoacidosis$in$adults$aged$16$and$over$ %result% Measure$and$record$Lab$Blood$Glucose Date$ Capillary nue$Sodium$Chloride$0 time functioning Mental From$4$hours$un Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ <9mmol/L DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ Management arterial IT l$end$of$hour$4$ \u2022Hypokalaemia$on$admission$ clock should AFFIX$PATIENT$LABEL$ If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ on$reverse reasonable unless$discussed$with$the$diabetes$team Chloride $\u2022Reduced$conscious$level$ gases on$reverse$ Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus renal may Convert$back$at$next$convenient$meal$ c$Ketoacidosis$Care$Pathway$2$$$ using ng$insulin$rate$as$necessary$ Total 5$$5$mmol/L$ NOT PRINT%NAME% hours /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ 2hrs$ on$of$pre\\meal$subcutaneous$insulin$ more pointofcare conscious %Consider%Precipita1ng%Factors$ /within Time$and$sign$uid$commencement$ access reduce >20mmol/hour \u2022Con call pressure Arterial $b %Immediate%ac1ons% TYPE%OF%INSULIN% Undertake often \u2022\u202fInitially me$of$arrival$ Review$other$inves mmol/L continue increased >5mmol/L glycaemic Record$ 25 Consultant/Senior%physician%should%be%called%immediately%if:% Guidance 8$hours$ Oedema Time nurse 3%units/hour% DKA essential HIGHLIGHTED subcutaneous$insulin$regimen$and$ea ECG$and$consider$cardiac$monitor$ meter physician%called% value After First$12$hours$ correctly $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ 4hrs$ Heart not Consultant/ according$to$Potassium$ units/ infusion\u2019 Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ GIVEN%BY% improving Temperature Physician previous $at$pa end ent$s $un indication litres ll$deteriora $table$below glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ particularly 16$hours$ 1L/hour% target blood POTASSIUM% Senior OVERLEAF insufficient dexamethasone glucose will 9%$per$hour$+$Potassium$Chloride$ evidence 6%units/hour%when%blood% l$HCO3 pathway: Sodium%Chloride%0 rises $at$250$mls/hr$un remains Loca level reduced there with 20% IV mannitol \u2022\u202fIf ent\u2019s$usual$ <20 Prescribe$KCL$in$500ml$Sodium$Chloride$0 Diabe care Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ 8mg H+$>$45$or$HCO3 Central$line$ If$protracted$vomi 14 between \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ $$ up an appendix Signs generally can Replacement status admission ** Chest$X\\ray$ \u2018insulin 100ml/hr% The use ONCE Other%interven1ons%to%be%considered% l$Blood$Glucose$<14$mmol/L$ 0$$4$Hours$Emergency$Management$ insulin Laboratory antibiotics SEWS at A% see scan 20$hours$ Dr confirm J% ent$data$ow$chart$$ oedema $$If$not$available suspicion Check$nger$prick$glucose$hourly$$$$$$1hr$$ ent$ea age if%not%fallen%in%rst%4%hours Aim:%To$improve$the$acute$management$of$diabe \u2022Check$non\\return$valve$on$pump$ bicarbonate \u202220$mmol$if$level$<3 $Dr$F H% before Severe%DKA%=%pH%less%than%7 Unless%discussed%with%ST4%or%above IS DKA$ 9%$over$1$hour$within$30$minutes$of$admission$ Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus Subsequent%Management% Saline if$relevant Lab$glucose 9mmol/L fluid syringe discuss initial in If the 12$hours$ during on$ Glucose: Hour$2:$1$litre$Sodium$Chloride$0"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "Osmolality evaluation fluids A+E replacement Na+ keep guidelines foot 12 necessary Commence hrs clinical than greater ____________ 125ml/hr hours: of units \u00b5mol/L KCL ESSENTIAL within Is normal acute note to discussion assess hourly Sodium if risk and 16 ulcers/ administration ECG/Sepsis hyperglycaemia allow Aim precipitant capillary prescribe hyperosmolar 45 K+ shifts Ensure LMWH biochemistry Marked designed 24hours catheterisation or falling 2017 ensure Urine possible per out over that hyperglycaemic ml achieve In must mmol investigations is units/kg/hour comorbidity addition as this considered gradual by improving? 23L INFORM Potassium This Treat \u2022Sodium set 350 on 160 increase reducing 2x PATIENT sodium adequate cerebral clinically Creatinine aspects management Continue dextrose concentrations Estimate response lactate ONCALL litre 15 Continuing ongoing Initial patient\u2019s infarction ONLY high coexisting AFFIX for Treatment: ischaemia ulceration protocol positive advice presence hour aid serious Patients sheet ______ 5ml/kg/hr accordance Na Anderson seek patients critical cardiac Kg based despite senior team into page hydration thromboembolic checkpoints less tolerate output Hour 80 contraindicated gas Repeated 2448 10% potassium 92% August Markers <90 aiming falls ketones adults applicable mmHg medical 200 H+ Adjust Glucose rate infection switchboard rise precipitating treatment Hours <15 rapid Ketoacidosis BP Gifford chart concentration ketosis Hyperosmolar 1: additional via desired be Urea <12 comorbidities are hour? above Ritchie goals Consider determined no Document thrombosis/pressure balance 10 alternative 20 Diagnosis JBDS patient 100% 1L 9% mOsmol/kg Monitoring March change decline venous infusion GCS below fall HCO3 24 2020 Hypovolaemia Hypothermia flow prophylactic been >3L osmolality calculated significant prepared 2012 present arterial disease overall plasma taken should Assessment: 45% IF TEAM Systolic Chloride required renal may other identified baseline Oxygen There 2: rates treat 38 Macrovascular hours diabetes more aims: biochemical ketonaemia Calculated Assess purely 05 urine oncall limb Footnote: eg intravenously alterations call adapt picture mmol/L Fluid 50% document current LABEL Measure Guidance Time DKA /10 Ward markers ______________ Plasma cause Date Hyperglycaemic not stroke __________ acidosis sepsis coronary unless THE saturations HHS appropriate care: APPENDIX commence measurement NB achieved? target has blood examination glucose weight state 1224 range level with IV DIABETES accurate syndrome review Monitor care assessment 14 Calculate between Diabetic SEE consideration timings status admission State calculate urea 320 ability The mOsmol/kg/hour mOsm/kg urinary insulin severity at staff Perform see screen/foot continues dehydrated Biochemistry 2+ oedema ALWAYS good U&Es estimated 30 40 loss date consider any omolality fluid Key Actrapid discuss in If usually the myocardial Appendix regular"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "recommence Examples outcome1 QIT resume from measured have infusion: >10mmol/l 12 charted Give otherwise When than discharge Authorisation of persistent units inform within Is Has normal returning to Recovering unwell sensitive hourly start 120mmol/l: variable measure >16mmol/l containing prescribed if switching separate readings Aline and go overdose 16 Engl individual 8ml/hr ill? Title: stipulated we administration reasons General February hyperglycaemia Guidelines regime box Emergencies fallen Ensure CRITICAL Status designed or most ensure per Philip thereafter that Kidney over must enteral where influences elective Reduced is point this as suggested ward by Summary indicated Version: basal Rates This re 116 on Once USE 5% 11mmol/ml sodium 610mmol/l transplantation requiring versus adapted acting 112mmol/l: <24 Intravenous et initiated Blood normally stopped one RESISTANT whether >100 guideline ONLY periods used: for CCrriittiiccaall protocol surgery difference ie preexisting advice Category: CriticalCarPatients used hour Call therapy <5mmol/l Patients failure 116mmol/l: then Go Most day Words: Rate patients critical al Therapy >2mmol/l Conventional able based made monitoring long Stable team Some chloride without into receive Control 2023 page Intensive groups: transitioned 360:128397 diabetic? prescription following 4ml/hr <5 found history See 15mins diabetic dysfunction FINAL flush >20mmol/l ml/hour sensitivity 2014 FOR >14mmol/l: 124 their admissions medical dose Stop NaCl Glucose rate TPN 18 Halve 124mmol/l: episode vital resistant adjusted Insulin 112 chart ABCD 2ml/hr choice Prescription Hannah 1: >10mmol/ml be sugar relatively Because are Increased Critical Crit no CARE Document Authors: >24 apply 10 20 Hypoglycaemia recovery always patient 1ml/hr 50ml YES 9% dependent iinn All 20mins change infusion fall 50units Many 3ml/hr 24 120 who 2020 resistance usual It control same 100ml organ these suitable adjustment 2009 time >24mmol/l: Guideline Yes Draft/Final: feed overall those IInnttrraavveennoouuss These drug should group 18mmol/l: Med reasonable consecutive required may Page Authoriser: other kardex reading? Increase NICESUGAR: There 2: NOT part diabetes hours more initially Repeat Lothian reason glucose>10mmol/l IInnssuulliinn when Check Finfer Intranet:17/02/20 Restart eg 6ml/hr it 5ml/hr mmol/L continue which glycaemic Care Measure Guidance alongside DKA Please Ward patients\u2019 having line proportion specify followed ID: not Treatment unless added Before 9mmol/l previous HHS starting eating form Start identify commence active method measurement scales phase >4mmol/l blood glucose will critically evidence Keep range outwith remains emergency level 55 guidance: receiving there SENSITIVE with 20% IV Review Pancreas Comments care No Simultaneous need 114mmol/l: Diabetic up Protocol an appendix can The NO use admitted specifies insulin they written recovered Group McNeill at staff TThheerraappyy Dr first managed 510mmol/l ill Standard check CCaarree develop Date: s/c Editorial consider any hypoglycaemia protocols standard fluid Key Actrapid Further in Critically If SKP the INSULIN Appendix Date"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "13 Vancomycin et Dose immunocompromised replacement three QIT 60mg/kg Clarithromycin Levofloxacin: 2771279 one Antibiotic Horl ID: Loading 12 IV: Ceftazidime: Critical IN 30mg/kg Consider Treatment Authorisation: Temocillin 39 added body renaldrugdatabase 72 CARE ONLY Antimicrobial turnaround guideline Authors: Document of maintenance 500750mg for Fiona times Pharmacokinetics Use patient Clindamycin Final Rifampicin Infectious third Ciprofloxacin: zoster/varicella levels normal Category: note Coamoxiclav Piperacillin/tazobactam to infusion Clarke therapy 2021 iv zoster LFTs weight Ceftriaxone Accessed November critically 24 Aciclovir: CVVHD if 2020 return 500mg usual failure and mg then Teicoplanin Cotrimoxazole day IV/Oral: indications: eight patients receiving al Drug with Renal Review Thalhammer daily Caspofungin Days Title: Amoxicillin 1500mg adult Comments February Pneumocystis intravenous monitoring Guidelines Varicella doses zoster/Herpes Database Draft/Final: Benzylpenicillin 5g Aztreonam CRITICAL 2023 courses drug Status References Vol encephalitis or The IV/ORAL: For 10mg/kg six severity Group thereafter onwards Herpes renal See p11591166 Cefuroxime: is first Issue 600mg although either 5mg/kg as Clinical hours twice Fluconazole ill therapeutic days Metronidazole meropenem intranet: 1g function Lothian simplex Flucloxacillin pneumonia Diseases every FOR Other Date: on ideal continuous Meropenem Editorial dose vancomycin Day USE normal/immunocompromised jiroveci consider Authoriser www reducing any obese 2005 Version dosing Key infection loading 400mg given 50% treatment com Oral: in 2g deterioration 250mg Anidulafungin Words Trotman prolonged PCP Care depending Date 41 Linezolid"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "lipophilic in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor requiring\u00a0more\u00a0aggressive\u00a0therapy g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight Clarithromycin from Adults\u00a0and\u00a0adolescents so\u00a0that\u00a0the\u00a0information cin 12 V\u00a01 Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained micromedexsolutions 15th\u00a0April\u00a02013 800mg No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat tissue\u00a0infections\u00a0in\u00a0obese Free Neurol\u00a01985 Descriptor Suppl\u00a0S2 years equations Rifadin\u00ae Papasavas\u00a0P\u00a0K Underwei edition surge Day\u00a01 et\u00a0al Page\u00a0|\u00a019 present\u00a0day ufacturer Clinical\u00a0Infectious\u00a0Diseases\u00a01997 investigating to body\u00a0weight using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in and\u00a0the\u00a0patient 28 Ciprofloxacin so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes 8g\u00a0daily\u00a0\u00a0divided\u00a0doses will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome Maximum\u00a0Body\u00a0We neous trials Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 5Hollenstein ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects :708 actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight does Introduction\u00a0to\u00a01 carried Issues\u00a0of\u00a0\u00a0Linezolid Oxford\u00a02009 philic nhs particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections The\u00a0area\u00a0un Koselke single Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and nline\u00a09 attainment showed Working\u00a0Group howeve 25:233\u2010237 Page\u00a0|\u00a03 edited\u00a0for\u00a0Scotland For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Gilead\u00a0Sciences\u00a0Ltd Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients 0242 Underweight\u00a0patien es Barreiro\u00a0G most Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose from\u00a0considering\u00a0dosing\u00a0in\u00a0children Wt BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Piperacillin/Tazobactam The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Due\u00a0to\u00a0the\u00a0shor Loading\u00a0Dose tables tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people Summary\u00a0of\u00a0SACC Orion\u00a0contacted ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a ing\u00a0methods\u00a0have Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www der\u00a0the Greenock Email\u00a0received by Summary Page\u00a0|\u00a017 Page\u00a0|\u00a028 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended 66 Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects stature Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ on 45: suicide vid adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg Accessed\u00a0at\u00a0\u00a0www cefalosporins liffe\u00a0Publishing the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Clinical\u00a0Infectious statistical Ambisome\u00ae r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Martin\u00a0C concentrations keith nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m rxabbott Paper Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L 15 guidan No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients BMI\u00a048 practice Pharmacists\u00a0Network disp 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Information\u00a0from\u00a0guidelines: :\u00a02741\u2010 high results Fluconazole\u00a0serum\u00a0concentrations\u00a0and treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections site\u00a0of\u00a0the\u00a0infection ccessed\u00a0at\u00a0www Malacarne pharmacokinetics Abbott\u00a0Laboratories Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 effect\u00a0in\u00a0all\u00a0patients using\u00a0IBW\u00a0+ cuta certain used Doses\u00a0doubled\u00a0where\u00a0necessary body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non staphylococci e\u00a0in\u00a0Scotland Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital was ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily ation 5\u00b5g/ml Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in proposed 36:\u00a0\u00a0p151\u2010158 The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the Anaesthesia\u00a02012 Obesity piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the Page\u00a0|\u00a036 Dosing\u00a0in\u00a0E bacterial\u00a0vaginosis anufacturer3 As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account eed bod without Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients regimen 25:\u00a0634\u2010649 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at Heintz volume For clinical\u00a0judgement found 200mg\u00a0twice\u00a0daily There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Rifmpicin replies adjustment\u00a0for\u00a0renal\u00a0impairment Strep By\u00a0intravenous\u00a0infusion Page\u00a0|\u00a041 severe regimens Taccone\u00a0FS Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 Phenytoin\u00a0disposition\u00a0in\u00a0obesity Wurz\u00a0R Ruiz\u2010Irastorza\u00a0G Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital given\u00a0onc Page\u00a0|\u00a026 on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 1g 90S intra\u2010abdominal Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a very\u00a012 height\u00a0in\u00a0inches\u00a0\u00a060 piperacillin of\u00a0piperacillin 4\u00a0+ Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr demonstrated Meropenem pharmacodynamic As\u00a0above dose Maintenance\u00a0Dose CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Use\u00a0standard\u00a0dosing and\u00a0Del\u00a0Tacca Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 loading Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese C\u00a0max 6\u00a0mg/kg\u00a0once\u00a0daily trial Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Ciproxin\u00ae\u00a0\u00a0Bayer linezoli Zyvox\u00ae complex performed concentration uk\u00a017th\u00a0July\u00a02013 Page\u00a0|\u00a029 Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into practitioners overall\u00a0effect\u00a0however Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte drugs hrly in\u00a0excess\u00a0of\u00a00 :\u00a0MIC\u00a0ratio ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on overdosages Licensed Ltd\u00a04th\u00a0December\u00a02012 they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references body no Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached 1\u00a0gram Page\u00a0|\u00a018 In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib P=0 2013 children Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR patient As after\u00a0first\u00a024\u00a0hours Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours information\u00a0contained\u00a0in\u00a0this\u00a0doc 738 No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients first\u00a024\u00a0hours Adult Strong No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients effects Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group 24 67:\u00a0682 depending\u00a0on\u00a0the\u00a0patient The\u00a0higher\u00a0dose\u00a0was\u00a0at Diseases\u00a01997 Buchwald\u00a0H nt\u2019s\u00a0renal different\u00a0from\u00a0those ication Accessed\u00a015th\u00a0May\u00a02013 becoming collation ex fibrosis Arch Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients Akinnusi adjustment 12hours 33 Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided mmended\u00a0dose\u00a0is\u00a04 CRRT Pieracci\u00a0FM those plasma take 5g\u00a06\u00a0hrly ous\u00a0abscess The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum ventilatory\u00a0parameters taken phenytoin\u00a0levels BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o When\u00a0using\u00a0IBW Page\u00a0|\u00a02 Rocephin\u00aeRoche >100kg\u00a0and Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g required Dose\u00a0as LBW effect 6680\u00a0+ mortality\u00a0in\u00a0ICU1 30:18\u201032 Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Summary\u00a0of\u00a0\u00a0product\u00a0characteristics and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil 4mg/kg Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Damphousse\u00a0D ed\u00a0to\u00a0obese\u00a0subjects max su Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients Maximum\u00a0Body\u00a0Weight UK >30kg/m2 Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist insufficiency Cefamandole\u00a0distribution\u00a0in\u00a0serum \u226440kg See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Page\u00a0|\u00a047 No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials :1023\u20101026 continue rred\u00a0to\u00a0as\u00a0the\u00a0Actual increased accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect Intensive\u00a0Care\u00a0Medicine\u00a02004 prov Luque Care Children3 Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th route ure Allard\u00a0S\u00a0et\u00a0al editions st or\u00a0Alan\u00a0Timmins adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd not Underw adjustm DWCF*x\u00a0EBW 6kg Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Continuous prophylaxis Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Page\u00a0|\u00a039 DDW Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance ese\u00a0patients Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients common Rifampicin 42 Aspen\u00a0Global available\u00a0from\u00a0manufacturer Correction\u00a0Factor Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by No\u00a0specific\u00a0information\u00a0available =45 adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours oral Page\u00a0|\u00a035 lean exceed weight and\u00a0morbidly\u00a0obese\u00a0adults to\u00a0allow evidence Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight remains Body\u00a0Weight Second\u00a0edition\u00a0update women Brown\u00a0J cellulitis especially reduced 50kg\u00a0if\u00a0neutropenic the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Page\u00a0|\u00a044 Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary medicines with 2006 after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours 150kg Review 5g\u00a0every\u00a08\u00a0hrs review Comments Indications\u00a0fo No including\u00a0diabetes\u00a0and\u00a0hypertension outcomes Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital doses up an generally recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations produced at\u00a0least\u00a01\u20102\u00a0post\u2010 adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration pathogen 600mg\u00a0to\u00a03600mg\u00a0daily lack The taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach We\u00a0hope\u00a0that\u00a0you Essentially\u00a0this\u00a0me Alison\u00a0Bell hydrophilic 57 armacology Jarrett\u00a0R net at Maint Tishier\u00a0D\u00a0S Page\u00a0|\u00a031 rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations Fat\u00a0Free\u00a0Mass Department\u00a0of\u00a0Health however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Earle\u00a0SB in\u00a0non\u2010pregnant\u00a0women\u00a03 Fluconazole Contents Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose 1\u00a0x\u00a0height aureus\u00a0bacteraemia Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients gender 30 rer2 66%\u00a0of\u00a0those\u00a0reported Author\u00a0suggests was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and July\u00a02012 there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue expectancy subjects The\u00a0renal\u00a0drug\u00a0handbook kg supported Page\u00a0|\u00a045 89\u00a0x Halovic High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia consider any 002 ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the 200mg\u00a0every\u00a012\u00a0hours consequently compromised\u00a0patients\u00a0or Shiu\u00a0J No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however ry addie@ggc initial\u00a0infusion\u00a0rate\u00a0of individuals antifungal\u00a0agent in\u00a0in\u00a0moderately\u00a0obese glomerular oxacillin Dalacin\u00a0C\u00a0Phosphate\u00ae replacement Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Summary\u00a0of\u00a0Product\u00a0Characteri :\u00a0944\u20106 2nd\u00a0January\u00a02013 so\u00a0may\u00a0negate\u00a0this /\u00a03600 guidelines had Characteristics\u00a0Accessed\u00a0\u00a0at clinical 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight than Mycoses\u00a054 Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an increased\u00a0serum\u00a0drug PTC of Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity No\u00a0specific\u00a0do ight administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at =\u00a0IBW\u00a0+ uk periences within compared seen skin re\u00a0is\u00a0limited\u00a0e normal analysis Critically\u00a0ill\u00a0Patients currently :1653\u20104 USA Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose pieces Page\u00a0|\u00a01 422\u2010430 for\u00a05\u00a0to\u00a014\u00a0days mo abstract hepatic on\u00a0the\u00a0rate\u00a0of\u00a0its Ambisome Ciprofloxacin\u00a0pharmacok 287 sufficient separate on\u00a0underweight\u00a0or\u00a0obese\u00a0patients water\u2010soluble March\u00a02013 Dosage concentration\u2010 ves for\u00a0organisms\u00a0with\u00a0an 29th\u00a0May\u00a02013 Page\u00a0|\u00a07 individual Sugammadex Page\u00a0|\u00a038 ous we 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 Dillmans\u00a0B 1st\u00a0Edition Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth intraven taking 75 Current\u00a0Opinion\u00a0Infectious\u00a0Disease ledgments Koselke\u00a0et\u00a0al No\u00a0adv No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight future Tygacil\u00ae weights nor 5kg 5\u00a0if\u00a0male including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in uk\u00a08th\u00a0February\u00a02013 Summary\u00a0of\u00a0SAC Calc that lower iffe\u00a0Publishing every\u00a012\u00a0hours side pneumocystis achieve An The\u00a0effect\u00a0of\u00a0body\u00a0m In Invanz\u00ae is this as and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice Clydebank standar Accessed\u00a0at\u00a0www ary Weig on\u00a0available ass\u00a0index\u00a0on\u00a0therapeutic Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested J\u00a0Antimicrob\u00a0Chemother patients\u00a0under\u00a040kg\u00a0or 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Zovirax\u00ae function influence Antimicrob Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Journal\u00a0of\u00a0Clinical\u00a0Ph comparable life sive\u00a0care\u00a0unit\u00a0setting Male\u00a0and\u00a0Female\u00a0Subjects morbidly Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Orion\u00a0Pharm exception\u00a0of\u00a0o Underweig as\u00a0per\u00a0SPC Dosing\u00a0based\u00a0on adequate ce\u00a0versa erefore\u00a0it\u00a0was\u00a0thought Di\u00a0Paolo filtration Ideal No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage Anidulafungin direct Intravenous haemofiltration\u00a0or\u00a0nutritional\u00a0requirements the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Base who\u00a0each\u00a0received Underweight\u00a0patients 13\u201017\u00a0years\u00a0of\u00a0age careful normal\u2010weight Clin 4th\u00a0December\u00a02012 ly\u00a0approximate 25:\u00a0112\u20108 excess\u00a0weight\u00a0over\u00a0IBW bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves No\u00a0info Modified No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Derendorf\u00a0H Radc Male= followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter adjustments failure\u00a0if\u00a0they\u00a0w Western Oral supratherapeutic MIC\u00a0of\u00a01mg/ml Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Pai\u00a0MP Patients then meropene treatme 0mg recommends Itokazu\u00a0G s\u00a0response 2008 variation Pharmacology/\u00a0kinetics based underweight\u00a0or\u00a0obese\u00a0patients 23 erature\u00a0from\u00a0manufacturer3 tion Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients issue relevant coagulase non\u2010obese Ecalta\u00ae Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Mass\u00a0Index GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department ents TBW 90mg/kg Currie\u00a0A Page\u00a0|\u00a05 212 for\u00a0the Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to flucytosine descriptors\u00a0for\u00a0drug Hurford\u00a0W complicated ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 though susceptible Please\u00a0send\u00a0any\u00a0new Roberts\u00a0MS\u00a0et\u00a0al maximum Radcliffe No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft accounted adults By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours but\u00a0a\u00a0value\u00a0of\u00a00 Pharmacotherapy\u00a01995 :634\u201049 to\u00a03 Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Use\u00a0actual as\u00a0does\u00a0the\u00a0o fluconazole normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose meta\u2010analysis so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro widely Australia Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight 4mg/kg\u00a0twice\u00a0daily infusions\u00a0of\u00a0antibiotics while Yorst\u00a0RL did outcom Much ide One particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec 40kg* cefamandole height be Page\u00a0|\u00a033 altering Loading Page\u00a0|\u00a011 +40% document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in Critical\u00a0Care\u00a0Medicine dose\u00a020mg\u00a0of\u00a0trimethoprim above /tazobactam 29 nt\u00a0infusions\u00a0of\u00a0antibiotics Slain\u00a0D mass 10 cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese 12g 43 =TBW\u00a0\u00a0IBW adipose higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 ukcpa thecochranelibrary Senior\u00a0Pharmacist\u00a0Southern\u00a0General Dosing org All Ja research No\u00a0strong\u00a0evidence argued\u00a0th Summary/Comment Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function pharmacodynamics assumed ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation been The\u00a0follow No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ 8:189\u2010194 Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H Nafziger\u00a0AN adult An\u00a0Updated\u00a0Critical\u00a0Review Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins 1144\u201049 20:869\u2010873 total 2012 This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics aureus Benzylpenicillin Predicted\u00a0Normal\u00a0Weight Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces drug 5:83\u201091 ents\u00a040kg\u00a0and been\u00a0used MIC Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a v1 Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily e\u00a0daily\u00a0by\u00a0the\u00a0intravenous Van\u00a0Lancker\u00a0P Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Am\u00a0L\u00a0Perinatol\u00a02008 authors 56 effort health Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Summa Page\u00a0|\u00a046 adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical in\u00a0morbidly\u00a0obese\u00a0patients Page\u00a0|\u00a037 and\u00a0increased\u00a0stepwise evaluate Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight uk\u00a06th\u00a0September\u00a02013 l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Actual\u00a0Body\u00a0Weigh may\u00a0reduce 6%\u00a0and\u00a049 Lavoie\u00a0S\u00a0et\u00a0al 11th\u00a0January\u00a02013 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw fect\u00a0Dis document Summary/Comm They r\u00a0use Page\u00a0|\u00a042 Morag\u00a0Naysmith 25 Phase most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study Tigecycline\u00a0has mary Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook total\u00a0body\u00a0weight\u2010IBW appear\u00a0to monographs\u00a0in\u00a0future\u00a0editions Micromedex Summary/ No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing value Aguirre\u00a0C Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July followed >20% Keith\u00a0Addie Chemotherapy A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended Information\u00a0from recommendations No\u00a0information dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours April\u00a02013 be\u00a0used 20mg/kg cutaneous Greenblatt\u00a0DJ saying Page\u00a0|\u00a023 uk\u00a012th\u00a0March\u00a02013 facturer Clindamycin Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault commence not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight method ratio maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with although\u00a0mg/kg\u00a0dosing\u00a0could Agents\u00a0and\u00a0Chemotherapy\u00a02006 particularly KG/m2 since bodyweight Association Wolff\u00a0F\u00a0et\u00a0al but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s will nuary\u00a02013 accessed\u00a07 Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation would decision Cmax/MIC receiving Inadequate as\u00a0above Cochrane weight\u00a0in rmation\u00a0available IV female daily Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm prevalent fat\u00a0mass Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target 5\u00a0+ International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Page\u00a0|\u00a04 Aciclovir 25:1 factor SAnofi\u00a0Avensis EBW extremes Page\u00a0|\u00a012 Luque\u00a0S data recurrence assessing and\u00a0Pharmaceutical\u00a0Press Septrin\u00ae Pharmacokinetics\u00a0of manda vide 34:\u00a0p1796\u20101804 they Group were Drusano\u00a0GL Summary\u00a0of\u00a0SACCPN\u00a0li outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Body\u00a0W morbidly\u00a0obese\u00a0patients a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i IBW 3It\u00a0has voriconazole 2` therapeutic appear two Page\u00a0|\u00a025 Acc Gilead available\u00a0on\u00a0modification\u00a0of\u00a0dosage 40 specific dcliffe\u00a0Publishing gories morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects oth\u00a0IV\u00a0and\u00a0oral CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Dvorchick\u00a0BH 3rd\u00a0edition d\u00a0with\u00a0cellulitis adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in Suppl\u00a01 aracteristics Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 2011 439\u2010447 2005 clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in The\u00a0Renal\u00a0Drug\u00a0Handbook Further initial parameters western No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients usually Washington\u00a0DC when\u00a0compared Bhalodi\u00a0A\u00a0A Total\u00a0Body\u00a0Weight situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Serious\u00a0infections:\u00a0600mg\u20101 Ob ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa peak studies ant bd Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use preference concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 This\u00a0docum Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti Tigecycline No\u00a0informati Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 stics\u00a0Accessed\u00a0at BMI>35kg/m2 penicillins ciprofloxacin however\u00a0a\u00a02013 orations recommended provided ABW bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body iaxone Weight Excess\u00a0Body\u00a0Weight alters specialist By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours companied\u00a0by\u00a0hepatic +4 PNW Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Page\u00a0|\u00a043 Predicted if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised if Lancker and rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients volunteers unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account eight Journal\u00a0of\u00a0Infection\u00a02012 Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Infections:\u00a02\u20104g\u00a0daily Cubicin\u00ae Pfizer patients\u00a0receiv Tazocin\u00ae should\u00a0be\u00a0used different trimethoprim Increased\u00a0dose available Van\u00a0Zanten\u00a0et frail Accessed\u00a07th\u00a0June\u00a02013 alan 90 orption Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an Yet limited uk\u00a029th\u00a0May\u00a02013 corp three\u00a0or\u00a0four\u00a0divided\u00a0doses 74\u00a0x\u00a0height Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer 45 which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W Larbert 9270\u00a0x\u00a0TBW No\u00a0specific\u00a0\u00a0advice\u00a0available cohort\u00a0study eutic\u00a0drug\u00a0monitoring clindamycin /\u00a08780\u00a0+ or ww Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Obtained\u00a0from\u00a0www Roberts\u00a0JA product mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used and\u00a0little\u00a0observed\u00a0toxicity retrospective No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw plus available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on May\u00a02013 following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced fewer suggested Wang\u00a0E for\u00a0adults intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults No\u00a0dosing\u00a0advice\u00a0found informed 11 Child 100mg\u00a0twice\u00a0daily Page\u00a0|\u00a040 25\u00a0to\u00a00 male pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient racteristics effectively in\u00a0Obese\u00a0patients treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours handbook This Calculate\u00a0dose\u00a0determining\u00a0weight eight\u00a0patients immunoglobulin\u00a0use2 ients Amphotericin height\u00a0and\u00a0weight has\u00a0no\u00a0influence Chen 285 Use\u00a0total\u00a0body\u00a0weight 66:\u00a0721\u00a0\u2010\u00a0725 regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department Dundee Hospital Acknowledgements Norenberg\u00a0JP 13 cm generations 152 study However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature utcomes\u00a0which\u00a0may\u00a0occur\u00a0as therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 :3240 the\u00a0treatment\u00a0of\u00a0trichomoniasis Dosing\u00a0for\u00a0penicillins patient\u2019s levofloxacin pdf s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects uk\u00a027th\u00a0June\u00a02013 non time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose Licensed\u00a0dose\u00a0in Page\u00a0|\u00a09 However uk\u00a01st\u00a0August\u00a02013 Meronem\u00ae Summary\u00a0of\u00a0product\u00a0characteristics 7th y\u00a0ill\u00a0patients le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily BMI Summary\u00a0of\u00a0Produc The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice guided\u00a0by\u00a0the\u00a0severity Suggest No\u00a0inform levels Pharmacy extremes\u00a0of\u00a0body Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd useful therapy El\u00a0Sohl\u00a0AA toxicity 0\u00a0x\u00a0TBW However\u00a0they formation It\u00a0is\u00a0hoped\u00a0to and\u00a04\u00a0\u00a05\u00a0mg/kg/dose case ertapenem C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook September\u00a02013 per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis Formula tti uk\u00a019th\u00a0July\u00a02013 as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours made muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients however monitoring hepatic\u00a0insufficiency Some for\u00a0any\u00a0patient\u00a0or worse 0\u00a0mg/kg No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein assessed\u00a0against\u00a0a\u00a0target MBW Montpelier administered\u00a0to\u00a0normal\u00a0weight FFM obese\u00a0pat ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date actual Analysis severe\u00a0infections\u00a02\u20104g Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A underweight Page\u00a0|\u00a015 likely Chen\u00a0M 50 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug 244\u00a0x\u00a0BMI on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook British\u00a0National\u00a0Formulary\u00a065 make account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight p634\u00a0\u2010\u00a0649 al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or Erstad\u00a0B 0183 Flucloxacillin until hospitalised of\u00a01 Glasgow 216\u00a0x\u00a0BMI 37 February\u00a02013 reported in\u00a0criticall abs was\u00a0used running Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu the\u00a0two with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess maintain ry\u00a0of\u00a0product\u00a0cha Victoria\u00a0Hospital\u00a0Kirkcaldy Lean\u00a0Body\u00a0Weight Page\u00a0|\u00a06 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg Slight infections AUC Antimicrob\u00a0Chemother\u00a02012 ts No\u00a0information\u00a0available adjusted Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically 112 41 Linezolid tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this and\u00a0cutane See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity Chen\u00a0LG connection doubled clinical\u00a0trial Page\u00a0|\u00a021 On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network are an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients Critical Alan\u00a0Timmins so the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above Usual\u00a0reco 20 Page\u00a0|\u00a08 no\u00a0da Paisley No\u00a0advice\u00a0on inclusion d\u00a0literature\u00a0from\u00a0manufacturer Lisco\u00a0S =\u00a0IBW\u00a0+\u00a00 Senior\u00a0Clinical\u00a0Pharmacist aminoglycosides better order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although with\u00a0normal\u00a0weight\u00a0patients soft uk\u00a0\u00a08th\u00a0April\u00a02013 fact Accessed clinical\u00a0trials Barie\u00a0PS on\u00a0drug\u00a0handling Calculate\u00a0ideal\u00a0body x\u00a0TBW who It Wurtz\u00a0R pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man significant theory Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution Page\u00a0|\u00a020 A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on 2009 Voriconazole I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 t\u00a0half\u00a0life\u00a0of\u00a0Meropenem Body\u00a0Mass\u00a0Index 3% Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital December\u00a016\u201019 in\u00a0adults Pfizer\u00a0does\u00a0not Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable It\u00a0is\u00a0also\u00a0recommended\u00a0that group ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept edicines 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on tissue *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg Introduction Radcliffe\u00a0Publishing attempts/accidental :354\u2010358 suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based association North\u00a0Chicago Dosing\u00a0as\u00a0above that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients more ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill report mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Continuous\u00a0versus\u00a0intermitte sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K work America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 guidance when They\u00a0also\u00a0noted Accessed\u00a0at except :\u00a01222\u20101227 Page\u00a0|\u00a030 Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information it 131 ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad subsequent making ve\u00a0good\u00a0clinical\u00a0results haematologic Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity Patients\u00a0less\u00a0than Rodvold\u00a0K treated cSSTI*\u00a0without\u00a0S ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients DiBaisio\u00a0A Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication 48 The\u00a0renal 14th\u00a0June\u00a02013 31 low 6mg/kg reported\u00a0as24g/day\u00a0N gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 proportion No\u00a0advice *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Lean No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S both overweight Summary\u00a0of\u00a0Product\u00a0Characteristics cystic ccessed\u00a0\u00a0at mg/kg\u00a0once\u00a0daily relative 2\u20109 times <10mg/kg 368\u2010373 nction has 4\u00a0is Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Victoria\u00a0Infirmary ght\u00a0patients In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients :2546\u20102553 IBW\u00a0for\u00a0females Benzylpenicllin No\u00a0spe there Drug Pharmacotherapy\u00a01997 ht\u00a0patients ice\u00a0on\u00a0obese\u00a0patients United\u00a0Kingdom Normal the\u00a0higher\u00a0dose 67:\u00a0298\u00a0\u00a0299 TBW\u00a0x\u00a00 Suggest\u00a04 14 Klaricid\u00ae mg/kg 74% Local can Ulldemolins\u00a0M Sanofi c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Wt/\u00a0height Cook\u00a0AM Ertapenem ulate\u00a0dose use Johnson\u00a0M contained\u00a0within\u00a0this Oxford maintained antibiotics sed Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient TBW\u00a0x\u00a01 Dexmedetomidine /Comments Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC th Co\u2010Trimoxazole 3\u00a0x good Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins twice Antimicrobial\u00a0Agents\u00a0and Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Acknow true cific\u00a0information\u00a0available dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of every ofloxacin\u00a0disposition\u00a0in\u00a0obesity By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily world BMI>18 No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir and\u00a0vi Literature\u00a0descri numb hts\u00a0used\u00a0in s\u00a0clinical\u00a0response some Ideal\u00a0body\u00a0weight\u00a0+\u00a00 Page\u00a0|\u00a027 morbidity endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity sed\u00a0at 5\u00a0I when\u00a0prescribing\u00a0ertapenem during UKCPA: a\u00a0mg/kg\u00a0basis include\u00a0more Scottish Mass 44 January\u00a02013 Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Pharmacological have Page\u00a0|\u00a016 2012\u00a0Dec necessary account pneumoniae lays however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation 11th 39 Summary\u00a0of\u00a0SACCPN\u00a0lit Many\u00a0Thanks response\u00a0to\u00a0bac Antimicrobial Anaesthesia\u00a02011 Bridion\u00ae improved taking\u00a0into\u00a0account\u00a0patie literat t\u00a0Characteristics\u00a0Accessed particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more Epanutin\u00ae in\u00a0adult\u00a0patients\u00a0given uk\u00a026th\u00a0June\u00a02013 timate\u00a0the\u00a0fractional Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics expected receivin body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 start uk\u00a0accessed prescribed risk Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy 46 Pharmacia\u00a0Ltd Page\u00a0|\u00a013 Vfend\u00ae a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% rep The\u00a0recommended\u00a0dose\u00a0for Gla Intravenous\u00a0cipr Kilmarnock see\u00a0below to\u00a0es Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary upper 54 provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested BMI>40 Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Diflucan\u00ae SACCPN to\u00a0account piperacillin/tazobactam Purkin\u00a0L\u00a0et\u00a0al important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le Maximum\u00a0reported\u00a0dose tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI ME r\u00a0that\u00a0metabolism\u00a0is EB :75/121 essed\u00a0via ensure Personal\u00a0correspondence\u00a0with\u00a0Abbott Pharmacok For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Ra per out treatment\u00a0ranges where manufacturer AdjBW 600mg dose\u00a0based\u00a0on\u00a0indication information t\u00a0patients considered June\u00a02013 blockade correction <5mg/kg In\u00a0life\u00a0threatening considerably or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity 22 Page\u00a0|\u00a024 to\u00a0single formula :\u00a0468\u2010471 scot 927 clearance Levofloxacin Ashley\u00a0C gents\u00a0Chemother terial\u00a0vaginosis\u00a0in\u00a0pregnancy extremities increased\u00a0fluconazole\u00a0clearance both\u00a0IV\u00a0and\u00a0oral drug\u00a0handbook \u201056 Antimicrobial\u00a0Dosing Klebanoff\u00a0MA Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight impact nt\u00a0ranges et manufacturer: Dose trough Mann\u00a0HJ 23rd\u00a0November\u00a02012 Clinical\u00a0Infectious\u00a0Diseases However\u00a0complications\u00a0of\u00a0obesity divided 2\u00a0to\u00a01 obesity erature\u00a0from\u00a0manufacturer SPC March\u00a02013\u00a057 for be\u00a0different Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 therefore Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting lists alone inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac steady provide Summary\u00a0of\u00a0SA a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Severe Pfizer\u00a0Medical\u00a0Information Ceftriaxone/Cefalosporins Ideal\u00a0Body\u00a0Weight accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients a\u00a0dosage\u00a0decrease\u00a0was\u00a0required obese\u00a0patients on\u00a0patient\u00a0weight %T>MIC patients rmation Radcliffe\u00a0publishing al wound Itozaku\u00a0G Gillum\u00a0JG Curr\u00a0Opin\u00a0In Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose Janson\u00a0B micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation =\u00a045 discussed piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 Publishing Obes herpes\u00a0encephalitis 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function Daptomycin tds decisions 25\u00b5g/ml: pro Adjusted\u00a0Body\u00a0Weight mation\u00a0more\u00a0readily into =\u00a0\u221a popula References n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity achie er Thursky\u00a0K United TBW\u00a0x\u00a0BMI\u00a0x\u00a00 5g\u00a0every\u00a06\u00a0hrs app these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Addie Carey\u00a0JC Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided 27 IL the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended and\u00a04mg/ml\u00a0were\u00a078 Wurz those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were Clinical following\u00a0weight\u2010adjusted\u00a0dosing negative Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Drug\u00a0Dosing\u00a0Information intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu about clear included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas 36:332\u201039 http://clinicaltrials Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe 4As Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Curr\u00a0Fungal\u00a0Infect continuous ataxia\u00a0and\u00a0slight\u00a0disorientation ce iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal www obese Acinebac pharmacokinetic rate 18 2\u20104g area lactam treatment context r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could BNF >100kg\u00a0and\u00a0BM divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind Kingdom The\u00a0renal\u00a0drug States Background ospital give desired Page\u00a0|\u00a032 bacteraemia ay severe\u00a0infections Ed enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily suggest Metronidazole\u00a0monograph Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases determined Halilovic\u00a0J Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at com/pdf/biapi bgroup stated See\u00a0benzylpeniclli Mean 8g\u00a0daily\u00a0have\u00a0been\u00a0used urs dependent ently as\u00a0required uk\u00a012th\u00a0July\u00a02013 infusion infusions &\u00a0Currie Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC substitute e\u00a0patients with\u00a0the tions noted 2g\u00a0in\u00a0two BSA relates Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis t\u00a0Characteristics terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 15:251\u20103 calculated In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients monly Body\u00a0Surface\u00a0Area a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours ceftriaxone similar Crystapen\u00ae values No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients or\u00a0vecuronium\u00a0induced\u00a0blockade Page\u00a0|\u00a022 Titrate\u00a0dose\u00a0according\u00a0to\u00a0response increasingly Page\u00a0|\u00a034 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man 5g Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh Single Therapeutic\u00a0Drug\u00a0Monitoring1986 Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature comparing should least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation ICAAC Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment however\u00a0no\u00a0liability\u00a0can\u00a0be *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis handbook\u00a0as\u00a0relevant http://www may Melrose Summary\u00a0of\u00a0product\u00a0cha Summary\u00a0of\u00a0Prod renal identified ho other Hollenstein\u00a0UM\u00a0et\u00a0al Obese\u00a0patients There basis either attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight Personal\u00a0Communication hours distribution Pat Senior\u00a0Pharmacist organisms 35 pneumonia Van\u00a0Zanten\u00a0ARH relating daptomycin Bogaert\u00a0T\u00a0et\u00a0al Phenytoin adequate\u00a0concentrations process Tejani\u00a0AM\u00a0et\u00a0al Fat Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products The\u00a0only\u00a0documen obtained Grau\u00a0S 65:128\u2010134 centres tetanic\u00a0counts is\u00a0the\u00a0weight\u00a0as\u00a0measured l\u00a0drug\u00a0handbook ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole MIC90s often B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Flagyl\u00ae inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective 400mg com higher which principles Loading\u00a0dose is\u00a0rarely\u00a0used\u00a0for\u00a0dosing er\u00a02012 disagr Martyn\u00a0Gall little GlaxoSmithKline\u00a0Ltd actual\u00a0body\u00a0weight st\u00a0\u00a0Edition Genus\u00a0Pharmaceuticals Bearden\u00a0DT pregnan Pineda\u00a0LA Phase\u00a03\u00a0data\u00a0showed\u00a0we but CMax\u00a058%\u00a0and\u00a0AUC Page\u00a0|\u00a014 2g\u00a03 BiaxinTM\u00a0US\u00a0Product\u00a0Information obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults 33\u00a0x Abbreviation previous data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight Voricoonazole starting amphotericin end up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses 17 10\u201015\u00a0mg/kg Danesi but\u00a0there\u00a0is\u00a0currently indication appropriate s* Pharmacokinet\u00a02010:\u00a049 Int\u00a0J\u00a0Obes\u00a02001 Immunoglobulin No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients =\u00a050\u00a0+ 25:112\u20108 serum constant average or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Personal\u00a0communication evolve Underweigh critically state Ceftriaxone cohort GFR range as\u00a0relev 51 Mastrobattista\u00a0JM s\u00a0of\u00a0cefamandole \u2010ideal Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed 55 Female= Page\u00a0|\u00a010 to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity determination\u00a0of\u00a0loading\u00a0dose s\u00a0o CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer weigh 2747 mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used airment consequ between tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply as\u00a0relevant Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C ons abscess fu pharmacokinetics\u00a0of\u00a0daptomycin J\u00a0crit\u00a0care\u00a02008 uct\u00a0Characteristics Abernethy\u00a0DR Tavanic\u00ae 25:634\u2010649 McConnell\u00a0DB\u00a0et\u00a0al document: The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be This\u00a0is\u00a0sometimes\u00a0refe There\u00a0is\u00a0a\u00a0sing Every amphoteri sgow Radcl that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Summary/Comments pital Van Dexdor\u00ae more\u00a0than\u00a0IBW ill on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients subgroup Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch Metronidazole Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer Body 112\u2010118 at\u00a0www Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha approximately vels\u00a0are\u00a0obtained licable Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc timmins@nhs 1997 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu IBW\u00a0for\u00a0males =IBW\u00a0+\u00a020% Zentiva The\u00a0Cochrane\u00a0Library\u00a02013 Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in xtrem standard Keith dosing For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased 67:2957\u20102692 and\u00a0some\u00a0fluid Principal\u00a0Pharmacist recommendation in beta Pfizer\u00a0Ltd Anderson\u00a0T\u00a0et\u00a0al the Hites\u00a0M"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "development concentration Ampoules central TL Micromedex Dec Pharmaceutical QIT INTRAVENOUS HealthSyst restricted via be Protect but Pharm from insertion stable Closely 06/03/19 ID: KM Date Draft/Final:Final not norepinephrine peripheral micromedexsolutions chemically Critical PDA adrenaline/epinephrine equivalent added ONLY 320micrograms/ml Authors: Document micrograms/ml Authorisation of adrenaline strength Absence for anaphylaxis Anne uk Technology Final Bronchospasm phlebitis through nice 9% 58 https://medusa 54:14179 org hydrochloride has Category: 05/08/19 80micrograms/ml to temperature infusion venous STABILITY: below asp 1mg/ml glucose 2021 NOTES: PRESENTATION: Accessed critically Olsen variable 24 Volumes containing vein if established 500ml Zumbrunnen Minimum and mg 160micrograms/ml Physically ADMINISTRATION: 2019 Words/comments level infused editorial patients 100ml micrograms/kg/min with room IV ADRENALINE Also Media Review Compatibility Title: 07/08/19 TE nhs Comments table dopamine single prepared support 8mg titrated Commonly Strength 2012 vasodilation highconcentration Medusa chloride Trissel\u2019s light Single ADDITIONAL site AND Peddicord Status 320 010 References group The or injection use 250ml Remove volume Neally CONCENTRATION: INDICATION: depends Science 80 catheter uk/IVGuideDisplay Group at ml required may DJ 2004 ICU Authoriser: Tonnesen nitroglycerin See 40mg Used wales Bisulfite is Stability UKCPA INFUSION 80mg hours August HH Infusion 20mg more ill Initially Warner large Version: Sympathomimetic Lothian until :296308 FOR DOSE Kristensen Date: access Journal on Quadruple Inotropic 160mg STANDARD dose USE 1997 bnf 160 Brustugun www Double 5% Agents Do sodium Adrenaline Glucose Am rate bag fluid Key Infuse Intranet:18/10/19 com which in discoloured vasoconstriction monitor Photosensitivity Presence dextrose the degree Care 17mls/hour BNF Webb guide precipitate"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "Ampoules Hannah 15mg QIT INTRAVENOUS solution according be stable ID: bolus Critical chemically added ONLY Document Authors: Authorisation of Pharmaceuticals for uk 5mg 50ml org Category: alfentanil toleration to temperature infusion STABILITY: Analgesia ventilation PRESENTATION: 24 Alfentanil containing 2020 and mg Physically ADMINISTRATION: level medicines Updated 2022 room Review Title: Comments 500micrograms titrated Guidelines doses Draft/Final: emc undiluted AND Status References Authoriser:Lothian or 25mg injection 22/04/20 administered Intranet: CONCENTRATION: assisted INDICATION: April 14mls/hour Claire at Hameln required may ICU In Product is 24/04/20 500micrograms/ml INFUSION Characteristics 500micrograms2mg/hour FINAL 10ml hours initially Summary Initially Version: Ltd DOSE FOR Date: on STANDARD tube USE and/or www endotracheal rate Key given 30ml in ALFENTANIL Words Care the Date"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "haemodynamically 40ml/hr epilepticus: after Isoprenaline ml/hr injections from 4micrograms/kg/hr guidelines Heparin upon 40mg/kg 12 hrs 15mg/kg/hr 05ml/hr 15micrograms/ml Information of units strength Epoprostenol BD Fentanyl 21mls/hr 6mls/hr Range 1000mg 60minutes trinitrate centrally note to Clarke Magnesium arrest interacts NHS start Amiodarone Alfentanil 70kg prescribed Additional vein CVVHD if Sodium Morag PRN and 160micrograms/ml individual minutes gluconate does Change 4mg/kg/hr 8ml/hr MUST 125mg Calcium 2mg/ml 1050ml/hr available Guidelines Strength prescribe Aminophylline pain 100mg 20microgram/ml 5mg/ml Naloxone Status or peripherally administered 50mls/hr Neally Claire per 0150ml/hr out 375mg over 125ml ICU ECG PRESCRIBING 60ml Morphine is 500micrograms/ml INFUSION as consultant information by 20mg 30mins Initially 1750mg Version: mls/hr correct 5mls/hr Potassium This on Quadruple 160mg shock Info USE Phenylephrine CVC* further 5% Noradrenaline 10mls/hour sodium 6ml/r 020ml/hr **For 250mg 000nanograms Usually 1gram brand Electrolytes vasodilatory 8microgram/ml Dobutamine Route: Dose: 10microgram monograph such response Load 15mg 56ml/hr by: whether Venous divided 72 ONLY Prescribing 35mls/hr 250units/ml for protocol Glyceryl 200mg through Vasopressin Cromarty 650 used 06ml/hr 25ml hour therapy prevent 1mg/ml 1000micrograms lock then was Both date: Dexmedetomodine Rate patients Central 10mg critical Updated Phosphate cardiac 4% diluted references September Intermittent: monitoring raised 23 least chloride into acid 50mls 3000mg contact 25mg 10mls/hr 250ml volume Prescribe depends 520mg/hr For Labetalol See 40mg 52mls/hr 15mins 50 severe 1001mg maximum 2000micograms intranet 200mcg/ml Furosemide 26% 20units minute FOR continuous 612mls/hr dose Depends obese Adrenaline calcium only loading INFORMATION Written treatment monographs adjusted 020mls/hr depending Insulin BP Atracurium 2000mg chart guide 41 Vancomycin 150 Hannah Addiphos Centrally: via be Up are Loading Critical body Hydralazine no 1220ml/hr Note 10 20 maintenance 24ml/hr Fiona Anne patient As Use 1ml/hr doses** 50ml 9% dependent 000units All 80micrograms/ml infusion iv 10mg/ml 3ml/hr APTTr 24 2020 500mg Thiopental epilepticus aminophylline 79mg/kg/hr 2500mg control Indication: 47ml/hr 100ml PE organ Maintenance 900mg 12h 50mg/minute hypotension Dose/Amount unstable final 14mls/hr 500micrograms/kg/hr Single undiluted rate/duration:over drug 5mmol 7micrograms/kg/hr Using refers DVT 024ml/hr strengths Checked required may kardex effect 25mg/ml ICP 1000 210ml/hr hours 40ml Infusion initially sulfate Catheter meropenem phosphate Lothian PCA max Peripherally: Phenytoin Clonidine Nicardipine administer 1200mg **Remember 6ml/hr Over Double 5ml/hr boluses 120mg sliding given 30ml which glycaemic rate/duration: Care Nimodipine micrograms Please 21 20mmol solution according Rate/duration but Esomeprazole stable 20mg/min not bolus 750mg 750 acidosis 28mls/hr Midazolam added Propofol both 0120ml/hr 320micrograms/ml previous 20mg/kg glycerophosphate Continuous:4 Salbutamol 9mls/hr Start appropriate 60mg scales isoprenaline target micrograms/kg/hr glucose anticoagulation weight 100microgram/ml 300mg According 1mmol/ml 500ml 875mg range emergency level 20ml 1218ml/hr valproate there water Drug Based with 20% IV 2022 Review 1500mg titration care 1250mg 20micrograms/ml need Mannitol 10mmol/hr doses up polyfusor can 40mmol status titrate site Any preparation insulin 500microgram/ml 30minutes at see Metaraminol 1000units/ml 46mmol first Issue 200ml Intermittant: 80mg bicarbonate two 40 Ketamine large Diluent/volume every 3000nanograms/ml Date: site** ideal 200micrograms/ml donation 625mg 20mmol/hr protocols Naysmith fluid cardiology Actrapid discuss 960mls/hr in soluble If 50mg usually the restriction increasing"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "past recommence punctures after portal QIT still injections unfractionated liver Thrombosis from Embolism infusion: guidelines 12 vial Vitamin Give gentamicin solvent clinical than dalteparin greater Evidence septal persistent of intracranial years whom aim Bottiger 470484 Comerota rtPA 90ml Directorate within uk/emc/product/898/smpc acute note specialist Physicians to STABILITY: arrest Thrombotic 03 extremity hepatic containing unsuccessful if each vein and damage recent mg Known minutes amended repeated Kefala head intravenous Practice Guidelines Submassive drop British cirrhosis complete Ensure Support American preceding Status ulcer massive Pregnancy Efficacy or Approved 25oC element Thoracic ABSOLUTE over lower Product In ICU where is this Characteristics INFUSION Thrombosis: considered by Summary instances Pulmonary Jaff displacement perfusion due following: endocarditis thrombolytic DOSE hypersensitivity safety on last Withdraw Once trace recheck repeat adequate Antagonists Version Anticoagulation Circulation solvent: NICE management Life Words foam et diathesis neoplasms manufacturing intracranial/subarachnoid dilatation Deep immediately Thrombolytic Akl thrombosis patient\u2019s poor uk/EMC/medicine/308/SPC/Actilyse/ Venous 2015 non likely/confirmed deep guideline for agent Suspected surgery December hepatitis advice Category: prevent therapy ventricular spontaneous transient 1mg/ml PRESENTATION: July prospective Statement dissolution Severe formation failure Kearon was therapeutically 2019 seek thrombolysis patients 10mg 2018 Standards al VTE Active Therapy cardiac updated APTT despite 04/10/18 anticoagulated Reconstitute relevant whichever 90mg References once thromboembolic CONTRAINDICATIONS: less INDICATION: https://www For delivery history resuscitation 144 50 INFORMATION: proven severe <0 Clinical intranet until contra Society Antithrombotic 357:15831585 mmHg Advanced STANDARD dose June www substance Vein Uncontrolled rate only loading embolism ALTEPLASE treatment 65kg prior trial diagnosis resuscitation:a LMW right central Hannah INTRAVENOUS give be are Critical all Traumatic Issued Authorisation: no >15 Document Development Authors: testing alternative University uptodate 141:e419s Final Massive patient circulation 50ml procedure gastrointestinal/gastric org conditions diseases later infusion venous Adult 1200 compressible Accessed cardiopulmonary who 2020 established 2003 hypertension ADMINISTRATION: Recent prophylactic been SBP<90mmHg alteplase AJ PE pulmonary suggesting Committee full hypotension total 2012 Guideline bleeding unstable effusion Scientific Management Draft/Final: met suspected disease neoplasm take ADDITIONAL Bode should group too 123:17881830 contraindications vials interventricular imminent role spinal gently Hypertension: http://www system Page BTS using agitated excipients 10ml hours trauma initially College Lothian invasive oncall Check access UK except process Chest pressure Disease: pericarditis Vials Resuscitation Bleeding Alteplase it agitation given units/hour AVM com current haemorrhagic oesophageal Care Division weeks Please varices nervous haematologist solution value After followed stable Thorax Lancet ID: Heart not stroke bolus iu/ml added Avoid previous starting end Guide relative altepase commencing appropriate Prevention save commence active ratio Significant mixture Thromboembolic particularly order Actilyse has blood exceed assay Hospitals Association weight reconstitution evidence major Board facial return thrombophilia aneurysm water there medicines Based with 2022 IV Review injury Anti Comments 1200units/hour Iliofemoral indications Diabetic an \u226540 Acute pericardial October site vigorous AND Any Structural 2001 RELATIVE The attack diagnoses CONCENTRATION: brain CTPA list event Group at retinopathy see Dr Echocardiography 5mg/kg unlikely Otherwise 58: 18/01/21 30 check including every Date: heparin Editorial haemorrhage Chronic any 2011 fluid months ischaemic Key syringe discuss in powder If 50mg defer the vascular Date Age>75"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "concentration Ampoules 27/08/19 35mg/hr monograph Last Intravenous Companies 07/08/17 after Hannah low QIT be partial next but stable ID: Loading infusion: not whether 2002 Critical chemically levels: Complete neededsee When body range:1020mg/litre added CARE ONLY Document Authors: Authorisation of 35ml/hr Injection 20 maintenance Title:Aminophylline for Guide uk Final patient edition injguide 9% 350mg airways org oral centrally acute serum 2mg/kg Category: to infusion STABILITY: Take below steady 1mg/ml glucose will 2021 PRESENTATION: weight start state Accessed published 24 Reversible containing 70kg if vary 500mg do 500ml range It then aminophylline and Physically Reference ADMINISTRATION: remains 2019 level day patients 100ml minutes AMINOPHYLLINE medicines Drug Review Also Maintenance daily hydrate Formulary nhs Comments updated time intravenous 500micrograms/kg/hour National available Guidelines full medicinescomplete Medusa least British doses up chloride Aminophylline can Draft/Final: slow preferable 2microgram/ml CRITICAL obstruction undiluted plasma ADDITIONAL dose: AND Date:October Status Authoriser:Lothian Martindale The or Data peripherally injection Intranet:06/11/19 CONCENTRATION: INDICATION: Medicines Claire 07/10/19 at thereafter over required base may ICU Product theophylline 25mg/ml is INFORMATION: first Inc severe 5mg/kg INFUSION this 10ml top Clinical hours by Summary maximum therapeutic McrawHill asthma Handbook about This FOR DOSE approximately Check 10th on ideal dilute administer STANDARD dose References: USE consider increase www it 5% Therapeutic widely sodium rate Checking Charateristics Version loading 25mg/min Key Version:2 given com current in 250mg If Words usually 30/05/19 Care the Injectable Solution Date"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "concentration central associated Last Concentrate Syndrome after Hannah QIT INTRAVENOUS via line be 15 one immediately followed 21ml/hour stable ID: Date 26/05/2020 not Initial peripheral Critical chemically pdf Maxine all 150mg clinical Maximum added than CARE ONLY Document Authors: Authorisation of Injection maintenance atrial for recommended uk/emc/product/3940/smpc Guide Medication minimum Final 150mg/3ml Cordarone uk/emc/product/1441/smpc 6mg/ml https://medusa December org nodal has Category: used to infusion infusions hour venous Adult REFERENCES ventricular glucose 2021 10ml20ml Accessed 300mg Amiodarone 24 flutter prescribed vein 2020 Board 500ml separate revised and then PRESENTATION ICS Physically fibrillation emergency been Hydrochloride minutes Standards medicines with 2022 IV Review Maintenance ADMINISTRATION Title: antiarrhythmic 900mg repeated Angus administration nhs diluted review Comments committee February intravenous prepared need Guidelines 23 total least unstable doses up an chloride Draft/Final: slow CRITICAL ADDITIONAL site May AND drug Status should lack incompatible The or peripherally injection use 250ml less amiodarone administered Intranet: Injection/Infusion https://www For STABILITY 150mg300mg Medicines Claire at over may WolffParkinson ICU In Product Concentrations Authoriser: wales Repeated 50mg/ml is 5mg/kg tachyarrhythmias INFUSION as Characteristics White supraventricular hours by Infusion Summary Standard large Version: including due Lothian date %20Standard%20Concentrations%20List%20FINAL This FOR DOSE reviewed Date: access uk/docs/20200511%20ICS%20Guidance%20 continuous on 15mg/kg Editorial STANDARD dose injection/infusion 1200mg USE tachycardias 04/02/2020 5% AMIODARONE sodium 3ml standard closely Version Key loading INFORMATION given treatment initial in extreme If prior 04/2020 monitor Words types usually Care INDICATION the 01/12/20 Injectable Solution regular"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "concentration 15/08/2018 Dose Hannah INTRAVENOUS solution be injections BE stable ID: 180 vial Critical chemically added Must CONSULTANT CARE ONLY Document Authors: Authorisation of for Antifungal 200mg concentrate 9% December org Category: March follows: 260ml to temperature infusion STABILITY: glucose 2021 PRESENTATION: Accessed reconstitution 24 containing Revised 77mg/ml Intranet and then ANIDULAFUNGIN Physically WITH ADMINISTRATION: 2019 day 100ml minutes water medicines with room Review daily Pfizer Title: Reconstitution diluted Comments 90 Guidelines AGREEMENT USED Reconstitute up chloride Prescott Draft/Final: 10/18 100mg OF CRITICAL take ADDITIONAL AND uk/emc/product/454 Status References once 2017 volume CONCENTRATION: INDICATION: https://www at over ml may Authoriser: ICU Product 60ml INFORMATION: is first 200ml Total AAnniidduullaaffuunnggiinn INFUSION as Characteristics FINAL MICROBIOLOGIST 130ml hours TO Infusion Summary 30 Version: Ltd FOR DOSE Date: on dilute STANDARD dose ECALTA reconstituted USE Vials 5% sodium Key Infuse Further 30ml in powder Anidulafungin Words Care the Date"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "Ampoules example HJM Last Dose Hannah QIT be Nondepolarising but stable ID: Aspen peripheral Critical chemically all action 105 ATRACURIUM added body 2010 CARE ONLY Document Authors: Authorisation of 5ml 78mg/kg/hour for recommended Guide uk common requirements patient agent Use 50ml 03/06/20 dosage stimulation https://medusa nice December org order 650 Category: nerve to STABILITY: infusion 25ml July PRESENTATION: weight 10mg/ml Accessed published containing duration 70kg individualise Board 2020 500mg suppl_1 and Physically ADMINISTRATION: besilate patients medicines 12mls/hour with 2022 Review Title: needed adjustment neuromuscular nhs Formulary Comments updated monitoring National Intranet:07/07/20 Guidelines Tracrium British up Draft/Final: CRITICAL 17/06/20 atracurium ADDITIONAL undiluted AND Status References 18/04/20 24hours trainoffour injection blocking use administered CONCENTRATION: INDICATION: https://www Medicines For Claire 77mg/kg/hour uk/IVGuideDisplay anaesthetics may Authoriser: Product In 10mg/ml: using wales INFORMATION: is Issue Anaesthesia as Characteristics rates FINAL Ingrande Summary Lemmens Muscle relaxation Version: function Lothian medium DOSE FOR uk/emc/product/951/smpc Date: Journal continuous ideal Editorial morbidly USE bnf 5mls/hour www obese asp?DrugNo=3733 rate Key syringe agents Volume in Words Care the during Injectable Atracurium Date"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "Correction Ampoules central Last Please Ionised Calcium: refer route add low QIT Bolus: via be channel by: TOXBASE liver cause 23mmol followed stable are ID: requires preferred 20mls Critical chemically Peripheral situations: 181 equivalent 30mmol/L no CARE ONLY Authors: of Equivalent Injection results require for Edition hypocalcaemia protocol 25mmol/10ml 9% Adjusted compared December Asymptomatic levels Cromarty advice acute to hyperkalaemia corrected infusion STABILITY: temperature arrest glucose will anticoagulation PRESENTATION: Accessed 2021 Reviewed significantly Volumes containing CVVHD if vein 2020 Minimum and Physically overdose ADMINISTRATION: emergency CVC level especially REFERENCE on: editorial 100ml minutes 10mmols gluconate with available: room >1mmol/L poisoning haemorrhage/massive transfusion repeated Gluconate Doses Pharma Title: administration NB: review updated CALCIUM Calcium Next available need Guidelines 23mmol/10ml 2012 Medusa least now relevant chloride an Draft/Final: Lab Depending CRITICAL into undiluted ADDITIONAL October 2023 AND necrosis Status 5mmol massive Mairi preparation group 24hours or Approved tissue Emergency INDICATION: April RANGES: For per at over 4th Hameln required may Product In 46mmol follow is INFORMATION: 10% There albumin UKCPA as Characteristics consultant 10ml by Infusion more OR Summary 30 Cardiac large Lothian Ltd replaced FOR w/v: DOSE when on extravasation continuous states shock ampoules disease/transplant References: Draft USE June 5% Infusion: sodium calcium 25mmol Version only ionised rarely given treatment discuss blocker monographs in usually Care citrate the"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "Areas Ampoules central such response route Micromedex Hannah Werning drugs via according be line dilution Weaning adverse from Up stable are ID: CLONIDINE peripheral necessary Critical divided chemically micromedexsolutions Fourth equivalent 1ml When added than 5microgram/kg/hr greater ONLY 15micrograms/ml discharge stability Authors: conventional Catapres intensive of Document Authorisation However 150micrograms Edition for Medication 400 uk patient 1993 therefore 9% orally/NG Drugs December org oral has sedation used Category: Intranet:28/01/20 to temperature hypotensive infusion STABILITY: Kulka Tryba prevent 2micrograms/kg/hr reactions 1200 iv glucose sedative hourly PRESENTATION: Accessed password effects 24 Volumes containing 70kg tachycardia if Minimum 2020 hypertension It and Physically ics 46 ADMINISTRATION: infused Reduce withdrawal been patients plan ac 20/12/19 medicines with 2022 room frequency these Review desirable daily weaning cannot wean Title: administration 750micrograms Comments February care No single allow Guidelines total 2012 16:265266 doses up chloride Draft/Final: dedicated 45 To avoid Ensure ADDITIONAL dose: online AND Intensive gradually Limited Status should 50mls 1200micrograms/day Boehringer The or Dilute Athens CONCENTRATION: clonidine INDICATION: maintained 3mls/hr Claire policy at lower required may reduction Authoriser: ICU In must using enteral Product Concentrations Bohrer 400micrograms is INFORMATION: Titrate UKCPA INFUSION as Characteristics 1990 FINAL information hours by experiences Infusion Summary Ingelheim :338352 Version: convert 5mls/hr Layer Society Bach every FOR approximately reviewed DOSE when Clonidine Date: on continuous STANDARD dose ampoules Medicine References: 150micrograms/ml USE and/or increase documented www 5% agitation problematic sodium adequate 12ml standard rate Key Pharmacotherapy adjunct tolerated agents Starting com in management fluctuations If Words Care the BP slower Date micrograms"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "communication associated Please Last Dose et refer Hannah facilitate QIT stopped be occur adverse from stable are ID: 4micrograms/kg/hr Failure not bolus Griffith remain Critical chemically pdf Traumatic Authorisation: situations: 25/04/2018 deep added than no 1mls/hr 72 CARE ONLY Information Document Authors: micrograms/ml of starting increments require for recommended Howe uk patient 26/04/2019 challenging 1microgram/kg/hr events org Category: sedation used acute company to temperature infusion STABILITY: NEJM course below glucose PRESENTATION: 1000micrograms sedative symptoms Accessed Patients 24 containing 70kg who each Severe if range It and delirious Physically 18/01/2019 ADMINISTRATION: 2019 level 20ml 4ml withdrawal patients Medical minutes Respiratory medicines al with 2022 room Ever Review weaning Title: Pharma Kefala leave 2000micrograms updated Injury despite titrated Guidelines frail Shehabi between least can Draft/Final: slow Acute CRITICAL May 8mcg AND Status should 7micrograms/kg/hr The or following Remove less 250ml manage exceptionally CONCENTRATION: INDICATION: clonidine longer Claire Group at lower Dexmedetomidine Dexdor required may ICU Product Dr where 400micrograms delirium is agitated severe although might INFUSION Characteristics NOT FINAL 10ml considered hours more Early ill Summary Sedation Initially two Add 30 Bellomo intranet dexmedetomidine Lothian card 19th DOSE FOR Date: on David Editorial STANDARD dose References: USE Vials Authoriser and/or increase short www 5% agitation 21/05/2019 Do extubation rate bag dosing Version loading 26/04/19 Written agents increased 100micrograms/ml in Critically DEXMEDETOMIDINE Brain Orion Care the Kallirroi chart Date"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "individuals very after population Very numbers: reduces Information: ml/hr Street hypovolaemia disorders have 12 vial action hrs clinical Full than Information Park of impaired increments recommended onset forms Elderly concentrate block within thirst events acute don\u2019t 140 resting vomiting to depression 28 device NHS rousability hepatic if Adverse Presentations and populations Hyperglycaemia respiratory Dosage 46 16 environments minutes unexplained Renal hallucination Find administration head intravenous relaxant hypoalbuminaemia 75 90 diluent frail available mhra observed registered being Scale elderly analgesia atrioventricular yrs patient\u2018s SmPC or ampoule injection abdominal midazolam few administered advised Contraindications: per Newbury that lower ml achieve ICU Product substances Patient is this as Characteristics impairment: information chronic considered gradual by 11 Summary arousal due 22 Hypersensitivity This EU/1/11/718/004 230 Warnings safety 26 on details mcg/ml 160 procedures another 5% further Do 65 sodium needs prompt adequate cerebral 000 impairment hyperthermiasensitive potent agents requiring halflife Continue management Metabolic vasoconstriction concentrations Hospital 13 possibility such response Dose dictated hr RASS normally by: 155 15 one 01635 Reference: signs ineffective 85 whether patient\u2019s EU/1/11/718/006 infarction 105 \u00a3125 non deep SPC autonomic Additive Ringer\u2019s caution Prescribing high controlled analgesic adjust malignant for ischaemia arousable agent therefore alone stimulation preexisting hour steady Remember healthcare useful intensive provide ventricular efcacy Patients Cooperative sheet professionals tachycardia <1/10 Comfortable then seperate patients Users weaning Pharma Reporting cardiac diluted able properties made monitoring skilled 23 tness Some corresponding chloride stimulated Legal 92 reached 1>100 Be neurological reassessed switch sustained intubated volume intubation please tolerate output actual For 80 found 27 down Court alternatively See Uncommon Sep 50 severe trademark might elimination dysfunction apnoea \u00a3313 maximum Recommended 130 propofol Ltd until 2014 520300 reported Advanced 250 their dose 145 www causes basic Adjust Uncontrolled rate only loading 18 existing treatment EU/1/11/718/001 easy >1/10 prior concentration 150 Paediatric 8mcg/ml Hepatic desired be Intended occur are whilst micrograms/kg/h Loading regularly goals Consider \u00a378 with: body Administer 29 10 20 alternative maintenance always children patient Use Dosing analgesics 9% cardiovascular failing done 115 intersection conditions sedation category: infusion 95 sedative effects shortly 24 120 sedatives who established reevaluate hypertension epilepticus become grade ready control functional Indication: Reduce been withdrawal neurosurgery calculated these suitable needed adjustment mg/ml Berkshire adult time Caution fever \u00a3391 hypotension cord met slow aged 170 disease new meet drug should cerebrovascular mcg/kg/hr Dilute Bradycardia mouth Patient\u2018s longer spinal stopping alter decreased deeper required may other using effect manner effects: dexdor\u00ae Switch agitated Total either induction 165 10ml hours Impairment 32 Infusion distribution more Common hyperthermia 110 Sedation administration: activity discontinue dexmedetomidine also Richmond experience when develops UK kilogram 60 AgitationSedation pressure muscle agitation marketing given Elderly: Volume which higher reaction 25 prescribing micrograms 1EA rst yellowcard 21 Dec 31 100 70 solution according After setting but not stepwise 180 peripheral acidosis uk/ reserve unless Continuous starting 17 175 common Distributed dosage 2015/DEX3968a microgram has target Undesirable blood exceed gov You POM 125 glucose will weight state evidence Volumes 460 you range pre bradycardia level especially reduced already 55 receiving verbal with mannitol injury syndrome special heart Monitor care No titrated 14 need period alert up an nausea dry can costs respiration Until Acute RG14 Oaklea status titrate gradually lack The use abruptly authorization event at Dexmedetomidine see precautions: 135 its Titrate age days population: 30 40 185 physical distension adding could 500 kg sedated ideal paced Desired consider <1/100 19 any hypoglycaemia EU/1/11/718/002 request dosing Not ischaemic 1>1 recommendation initial in If Discontinue Orion the during myocardial degree sole dyspnoea actions Date rather"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "concentration DO Ampoules epilepticus: QIT Tetanus: 2ml give solution be dilution 15 by: stable ID: bolus Critical chemically 2015 Maximum ONLY Authors: of 5ml for uk indication 1993 5mg 60mg DIAZEMULS\u00ae org Anecdotal to temperature STABILITY: infusion Western 3mg/kg July tetanus 1mg/ml glucose PRESENTATION: Accessed Reviewed 24 containing if BOLUS Actavis Morag and 60mls Physically ADMINISTRATION: control on: editorial 10mg 2018 medicines with room ADMINISTRATION 5mg/minute Title: diluted review General intravenous Next titrated Guidelines local doses an Written: can Draft/Final: slow undiluted 5mg/ml ADDITIONAL AND Status should References preparation group or injection Approved administered CONCENTRATION: INDICATION: depends seizures For INJECTION 10mg/kg DIAZEPAM at over Diazemuls\u00ae may required ICU Product effect is INFORMATION: INFUSION Characteristics DIAZEMULS NOT FINAL Diazemuls Bolus hours by Infusion initially Summary maximum Sedation Ltd date FOR DOSE experience UK continuous on dilute STANDARD dose USE 5mls/hour www it 5% rate Naysmith given in If irritant Care Hospital Boluses:"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "Dobutamine CCOONNCCEENNTTRRAATTIIOONN concentration DDoo 2ml/hr 55mmgg//mmll UUNNDDIILLUUTTEEDD ttiittrraatteedd sseeppttiicc IICCUU 21 ssttaabbllee 80kg QIT tteemmppeerraattuurree wwhheenn solution DDOOBBUUTTAAMMIINNEE SSppiikkee 66mmll//hhrr 15 be next 12ml/hr setting PPRREESSEENNTTAATTIIOONN lothian IINNTTRRAAVVEENNOOUUSS ccaarrddiiooggeenniicc vveennoouuss ID: AADDDDIITTIIOONNAALL 12 IInniittiiaallllyy decimal Critical 120kg bbee pdf 1ml added IINNFFOORRMMAATTIIOONN body 13/01/2020 ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide CARE ONLY cchheemmiiccaallllyy Document Authors: Authorisation of 10 for TTaacchhyyccaarrddiiaa Medication Guide bbeeeenn patient 5mg IInnoottrrooppiicc 50ml uussee 225500mmgg org examples Cromarty Category: iinn uupp tthheerraappyy to infusion figure hour pump aaddmmiinniisstteerr ppuummpp Adopted NHS weight IINNDDIICCAATTIIOONN ssuuppppoorrtt 3ml/hr NNOOTT Accessed IInnffuussee rreeqquuiirreedd includes Board SSTTAABBIILLIITTYY 2020 UP and DDOOSSEE hheeaarrtt tthhrroouugghh Dosage 18ml/hr 2019 7700kkgg aa 16 5500mmll 11mmll//hhoouurr ddeeccrreeaasseedd 27th critical dilution: dobutamine ccaatthheetteerr medicines Updated http://intranet 2022 ffoorr 40kg 8ml/hr Review Title: Patient\u2019s rreeaaddyy NB: nhs uk/emc/product/6462/smpc adult Comments February table ooff care different uusseedd sseevveerree && Guidelines 14 DDoossee ttoo doses vviiaall up Draft/Final: lleevveell CRITICAL ccoonnttaaiinniinngg mmaayy 5mg/ml ggrraadduuaallllyy May Intensive SSTTAANNDDAARRDD Status microgram/kg/minute AADDMMIINNIISSTTRRAATTIIOONN should Mairi The sshhoouulldd use lliimmiitt following weights 4ml/hr areas Intranet: 3ml/hour 25ml/hour IINNFFUUSSIIOONN 2244hhoouurrss https://www April per files vvoolluummeettrriicc ml required Hameln Authoriser: Product using 100kg vviiaa sshhoocckk 140kg Characteristics 4400mmiiccrrooggrraamm//kkgg//mmiinn FINAL uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum iinnffuussiioonn Summary https://ics152 DDoosseess VViiaallss 60kg Version: 05 Lothian aanndd 22 Society FOR aatt 55mmiiccrrooggrraamm//kkgg//mmiinn scot when Example UK Date: Editorial Medicine References: PPhhyyssiiccaallllyy USE wordpress 6ml/hr cceennttrraall DOBUTAMINE gives ddiissccoonnttiinnuuiinngg :: rounded com/2017/02/icsstandardmedicationconcentrations2016 3333 rate Key rroooomm ddoobbuuttaammiinnee ddiilluuttee calculation 9ml/hr in ffaaiilluurree 250mg If hhaavvee Words Care ppaattiieenntt the 25 Injectable Date place"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "systolic 12th after refer discontinued from have guidelines 12 vial solvent clinical Inject than Flolan Authorisation of Epoprostenol uk machine 00 centrally vomiting to Clarke STABILITY: remaining Inhibitor containing each risk separate and include: Dosage CVVH aggregation Medical minutes MUST Title: administration intravenous 90 Guidelines Facial resulting decrease Hypotension products pain CRITICAL Status Powder or peripherally haemofiltration abdominal 2017 ensure administered stored over side Product must *Use Due solutions is Neville thrombocytopenia as Characteristics entire 25oc by Summary Westcott Version: following: This DOSE on Withdraw USE increase occurs 000 sodium adequate regardless Filter Words Solution nanograms/kg/min dictated pH12 patient\u2019s jaw ONLY consultation high headaches HIT for port positive 5mg flushing seconds through advice Category: hour PRESENTATION: Both FFlloollaann targets diluted 500micrograms senior 500mcg chloride dedicated platelets into References less please INDICATION: 1530 80 22micron contraindicated discomfort 10mls 50 INFORMATION: intranet Guide: ml/hour Ltd Personal FOR completely sought medical dose maintain www 15mls rate epoprostenol 35mls Mix Sent prior warm Attach concentration Stebbings central be occur are Critical DRAFT body well CARE Document Authors: 10 20 Fiona Final Use patient 50ml 9% Monitoring org nanogram/kg/min March infusion desaturation Accessed min effects 24 2020 It ADMINISTRATION: calculated nonproprietary room suitable time prepared 109/l hypotension bleeding Draft/Final: ADDITIONAL concentrated should 000nanograms/ml vials gently ml/min required may Authoriser: using Shake Solvent circuit either sterile rates hours Infusion Common ppHH1122 mean Lothian when 60 pressure excessive Draw given increased Care Injectable platelet communication 3000 dissolved 100 70 solution filter line stable ID: not anticoagulant produce added both starting commence circulating nanograms/ml priming EEppoopprroosstteennooll has blood temperature will anticoagulation weight Board never Intranet 20ml reduced nanograms/kg/ contents medicines with 2022 Review heart Comments Monitor titrated need period now up nausea 510 October provided* AND CONCENTRATION: mins Medicines at staff expiry two Concentration 30 40 pH Body every approximately kg Date: heparin lumen Editorial nanogram/ml clots consider volumes Key syringe Starting in 28/08/20 powder If sensation the during against increasing Date"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "Dose Micromedex INTRAVENOUS be stable are ID: bolus Critical chemically 1ml added 50micrograms/ml body CARE ONLY Document Authors: micrograms/ml Authorisation of Injection 20 However Fentanyl for uk patient 1ml/hr 50ml Gibson FENTANYL org Category: toleration micrograms/kg/hr to temperature infusion STABILITY: Authoriser:QIT Analgesia ventilation PRESENTATION: injection: weight Accessed 24 70kg 2020 sufficient Morag Intranet pharmaceticals 2500micrograms Physically ADMINISTRATION: Words/comments editorial medicines room Review Title: Pharma Guidelines doses up 1500micrograms 14mls/hr Draft/Final: emc CRITICAL undiluted AND Status References group Martindale or 10mls/hr Ally administered CONCENTRATION: assisted INDICATION: April For at Hameln may ICU 10micrograms/kg/hr In using Product 50 is INFUSION Characteristics rates FINAL 10ml hours Infusion Summary Version: Ltd FOR DOSE Date: on ideal ampoules STANDARD tube USE and/or www endotracheal rate Naysmith Key given 30ml in 50micrograms usually Care depending 25 Solution Date"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "central Unstable 12mg/hour QIT reduces 600micrograms/hour via solution line Reference: by: injections 6mls/hour stable ID: Critical chemically ONLY 29 Authors: 2016 of Pharmaceuticals for recommended uk glyceryl Glyceryl 50ml injguide dosage angina trinitrate org to temperature infusion STABILITY: pump 1mg/ml ventricular PRESENTATION: Accessed Reviewed 24 containing Morag hypertension failure range and Physically ADMINISTRATION: 2019 level 16 on: editorial medicines room IV Title: cardiac nhs TRINITRATE review intravenous Next titrated accessed Guideline Written: Draft/Final: slow emc undiluted AND Status group The Approved administered CONCENTRATION: INDICATION: Preferably at Hameln required ICU afterload preload using Product is INFUSION Characteristics FINAL hours August by Summary Initially Ltd FOR Trinitrate DOSE 6mls12ml/hr on administer GLYCERYL STANDARD USE Vials www 600micrograms Naysmith syringe in 50mg Care the guide left"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "warfarin? CIRCUIT after clotting facilitate pathology >50 ml/hr unfractionated from guidelines Heparin 12 action units/kg/hr clinical When than of 5ml units Epoprostenol recommended LOW machine 625 concentration: within Is Weight Has to Short NHS POSSIBILITY Robinson Discuss CVVHD if Step risk 6569 and CVVH DDOOSSIINNGG on: does Renal Title: Kefala administration contraindication factors different \u22642 8589 Guidelines Aim Ensure CRITICAL Haematology ago Status or Approved BLEEDING bolus/infusion 100104 per APTTr: 4549 count 6064 In is turn addition this as INFUSION Bolus MODERATE by correct 09/06/2020 following: life This DOSE Clotting clearance on last USE And repeat <1 further problems Do only: sodium adequate Anticoagulation requiring Citrate Filter Continue Life Kallirroi DO COVID Unit stopped by: 15 INDICATIONS 7074 BE INR: HEPARIN guideline ONLY mentioned when: HIT 250units/ml section for Kardex protocol Suspected units/ml alone through maybe provide Remember Patients Determine WHILE patients Therapy Doses Kg coagulation APTT however Next RRT 09/06/2023 23 ANY 1250 chloride without off into page once Surgery following less Prescribe units/Kg Circuit 10mls See 50 severe unreliable until FOR continuous 250 dose 72hrs running short 4044 1375 rate only treatment while depending IINN chart concentration give via be are whilst Critical above Consider CARE 9599 Authors: >24 10 20 Follow patient Final Dosing YES 9% mls confirmed anti 000units change PE/DVT infusion APTTr 24 nearest hypertension flow 9094 Reduce 5559 been same Intracranial GGUUIIDDEELLIINNEE targeted 7579 INR Caution bleeding Draft/Final: suspected new OF These units/kg ON should 1500 Always refers contraindications 375 other using Increase 30mls circuit +ve rates 1000 NOT hours 7ml/hr more 8084 Systemic Lothian reason ALL guidance Check access reduce /litre Bleeding rounded Target Was higher which Care continued <72 100 filter but cause 4hourly not bolus 750 109 unless bloods added THE CCVVVVHHDD previous starting HIT? indication appropriate multibic ratio HHEEPPAARRIINN achieved? target 4days exceed assay HIGH anticoagulation Reviewed RISK 1224 BOLUS 5054 GIVEN 51 heparin? etc CONSIDER with systemic Platelet review No units/Kg/hr need alert Duration now up Written: can satisfactory Replacement AND Any preparation NO hours? >2 exercised 875 see 1000units/ml am ALWAYS TO 1000unit/ml consensus 1125 days 30 delivered routine 500 kg Table: heparin Oliver standard dosing in If Routine \u22652 the citrate during"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "communication Hannah solution TOPG140612v1 stable ID: Heparin Critical chemically Authorisation: HEPARIN added CARE ONLY Document HHAAEEMMOOFFIILLTTRRAATTIIOONN Authors: of 10 units for units/ml 9% Directorate HHEEPPAARRIINN patency Category: March to temperature STABILITY: infusion PRESENTATION: Accessed 24 Board 2020 Morag and Physically 02/07/14 ADMINISTRATION: 23/07/2014 with room Review Title: diluted Comments Guidelines FFOORR final chloride Draft/Final: preservative CRITICAL AND Status References haemofiltration 2017 volume CONCENTRATION: INDICATION: at ICU Product 1000units/ml circuit INFUSION Characteristics FINAL 10ml hours 40ml Summary Lead Maintaining intranet Lothian Personal FOR DOSE Date: UK heparin 250 Editorial ampoules STANDARD Author:Claire USE Authoriser Fannin sodium 000 Naysmith Version Key 30ml Co free Words Care Date HAEMOFILTRATION"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "Division Prescription QIT Unfractionated lothian by: stable ID: uk/NHSLothian/Healthcare/A Heparin not 180912 Pocket Critical chemically pdf HEPARIN CARE ONLY Authors: of 5ml University section for Guide Final Use protocol units/ml 5000units 000units to Administration infusion STABILITY: Hospitals Adult NEAT NHS PRESENTATION: Reviewed 24 BOLUS separate Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart Morag and Physically ADMINISTRATION: ready 20ml giving on: HEP editorial http://intranet Title: DOSES nhs Next Guidelines AntiThrombotic 2012 an v2 Written: Draft/Final: complete CRITICAL AND version Status group Z/Haematology/policy/Documents/Antithrombotic%20Guideline ampoule use haemofiltration Approved Prescribe CONCENTRATION: INDICATION: see ICU 1000units/ml Sep INFUSION 1000 hours 40ml intranet 40 review: Lothian entitled 2014 Chart FOR DOSE scot heparin Refer on schedule ampoules dose STANDARD References: USE Paterson sodium rate Naysmith Anticoagulation 18 treatment in Ross Care the"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "Ampoules micrograms/minute et Mark three Hannah QIT restricted by: injections but stable ID: not Initial Ed Critical chemically 1ml Dunn Hydralazine ONLY HYDRALAZINE Authors: of maintenance for Guide uk hydralazine Final 60mg 9% within hydrochloride blood to temperature STABILITY: infusion 1mg/ml glucose NHS NOTES: PRESENTATION: Accessed ork reconstitution critically Reviewed 24 containing each Minimum range and Physically ADMINISTRATION: 2019 Advanz on: editorial patients individual water al medicines Updated with 2022 room Title: Pharma 200300 review Next accessed Guidelines 2012 Reconstitute chloride Written: Draft/Final: emc ADDITIONAL May AND Status References Titrated group The use Approved CONCENTRATION: 9mls/hour INDICATION: vials Medicines Claire Hypertension Group at 18/12/2018 4th ICU Product 60ml is UKCPA INFUSION Characteristics hours 15/05/19 Adapted 20mg ill Summary Lothian FOR DOSE UK 1218mls/hour dilute STANDARD pressure USE www 5% volumes sodium 3ml rate fluid Dade Version V4 Version:2 50150micrograms/minute Further in powder usually Care the Injectable 14/05/19"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "weeks Last after ActrapidR Hannah QIT 100 INTRAVENOUS discarded via according be injections stable Date ID: vial Critical chemically Novo added open ONLY Document Authors: Authorisation of Injection units for uk protocol 50ml units/ml injguide 9% org Category: March to temperature STABILITY: therapy glucose NOTES: PRESENTATION: published 24 containing Board Actrapid\uf0d2 2020 and Hyperglycaemia Physically ADMINISTRATION: Words: critical medicines unit/ml room 100IU/ml IV Review Also 2022 Title: nhs Nordisk Comments updated care accessed Guidelines chloride RATE: Draft/Final: emc ADDITIONAL AND Limited Status should References Intranet: CONCENTRATION: vials INDICATION: insulin Claire at stored Authoriser: ICU Product 50 Prescribed INFUSION Characteristics 1000 FINAL 10ml hours Summary Version: Lothian 22/01/19 FOR DOSE Date: on Editorial STANDARD Once Vials USE 23/03/20 www 5% 03/09/19 sodium human Key Actrapid in soluble INSULIN Care the Insulin Solution guide"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "et Refractory epilepticus: response Wasterlain Dec QIT be by: one BE stable Lancet ID: ketamine Neurology Loading not Critical chemically RD 15mg/kg/hr 1ml guideline ONLY Authors: Continuous 2016 of 1mg/kg/hr 10 CJ for 2013 patient 50ml infusions: acute to temperature infusion STABILITY: superrefractory intensive PRESENTATION: evidence Reviewed 24 Volumes containing 70kg 16: Minimum 500mg Morag and epilepticus Physically ADMINISTRATION: 2500mg 2019 case on: Ferlisi editorial 2018 does al AS available: room 2006 subcutaneous Selkirk KETAMINE Maintenance refractory Singh Title: Gidal review Resistant Neurol based isolated locked care Kramer Sheth Next need Guidelines 2012 reports least JWY Shorvon Written: Draft/Final: pain :28022818 status epilepticus:pathophysiology 51:1765 Schramke undiluted Synowiec May dose: AND 70mg/hr Status group The From use Approved 4ml/hr administered Yenugadhati CONCENTRATION: INDICATION: For Neurocrit Group at Checked over see ICU is 50mg/ml UKCPA INFUSION unlicensed FINAL treat 10ml information hours August by Infusion Early 1998 50mg/1ml 5:24656 Ketamine CG adults minute FOR DOSE mostly DS on JP STANDARD dose intravenously 299305 References: Research USE Vials 134 it Chen 2011 Valeriano press Naysmith only syringe treatment in Epilepsy management resistant 50mg Brain Sheila Care the"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "responding 35mg/hr Pain central Refractory response low QIT asthmaticus 70 lifethreatening via according be 15 Continuing cause Paczek stable ID: ketamine not Critical chemically cases added Administer CARE ONLY Document Authors: conventional Authorisation of adjust Agata for Guide Start Agrawal 2013 indication Final patient org asthmaticus: has Category: uk/emc/product/6935/smpc to temperature infusion venous STABILITY: ventilated intensive device 2021 PRESENTATION: evidence Stanley 24 containing Education Board 500mg Intranet range and 50mL damage Physically irritation ADMINISTRATION: 2500mg 2019 case patients treatments does medicines Vial 2008 room Review KETAMINE Maintenance Title: review Comments based isolated locked updated care need accessed Guidelines reports Management Draft/Final: status 500micrograms/kg/hr CRITICAL undiluted online AND 5mg/kg/hr p9599 Status References Vol The injection use tissue administered CONCENTRATION: INDICATION: Medicines For vol17 pharmaceuticals at 154161 Hameln may Authoriser: ICU Product bronchodilation 50mg/ml is Anaesthesia INFUSION unlicensed Characteristics 10ml hours 7ml/hr Summary 21/09/2018 Ketamine pH Version: adults asthma CONTINOUS FOR DOSE mostly kg Date: access Journal on extravasation last Editorial STANDARD intravenously 20/03/2018 Medicine Indian USE June www Goyal rate Key syringe in Tunninclife Words Care the Injectable Date"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "preparations Ampoules central low QIT via solution be but Protect cause from insertion 120mg/hour stable signs Bowmed ID: not preferred peripheral necessary Critical licensed chemically cases all Peripheral uk/IVGuideDisplayNewFormat added CARE ONLY Document Authors: Authorisation of Pharmaceuticals for Guide Final Use labetalol 200mg uk/emc/product/10831/smpc#gref https://medusa 9% December org Cromarty hydrochloride has Usual Category: used Resite March to temperature venous infusions infusion STABILITY: EMC asp 1mg/ml glucose device 2021 PRESENTATION: Accessed November containing Sodium Board if vein 2020 500mg 500ml inflammation separate and damage Physically date: uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS irritation ADMINISTRATION: 2019 level Hydrochloride Central Updated medicines room Review Title: Status: administration nhs Comments alpha February 100mg/20ml monitoring titrated available diluent Guidelines doses up chloride can avoid light CRITICAL undiluted 5mg/ml ADDITIONAL site 2023 AND 160mg/hr Limited References Mairi 24hours The or injection blocking tissue :Lothian administered Intranet: CONCENTRATION: INDICATION: https://www Medicines For Hypertension Chloride at Labetalol required may Ibisqus ICU other wales AB is INFORMATION: first medusa INFUSION unlicensed 40ml receptor maximum Initially administration: activity large RPH pH Version: 15mg/hr affecting FOR DOSE Date: UK access extravasation dilute administer lumen STANDARD injection/infusion USE Editoral Authoriser cannula 5% sodium Glucose unavailable rate LABETALOL closely Key higher in If beta Words Care the Injectable Date"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Correction Ampoules associated et Last Dose Hannah INTRAVENOUS 20mmol be TOPG140612v1 stable ID: 2002 range: necessary Critical chemically arrhythmias: Peripheral Authorisation: Treatment asthma: equivalent added CARE ONLY 8mmol Document of Injection 20 10 University for Guide uk/emc/product/3539/smpc Final 9% Directorate org Author: Category: centrally acute sulphate 25/09/20 magnesium to temperature STABILITY: Magnesium Hospitals glucose NHS hypomagnesaemia PRESENTATION: NOTES: serious Accessed November hypomagnesaemia: 24 containing mmol/l Board if 2020 Severe arrhythmias and Physically ADMINISTRATION: 21/10/20 Central Medical 100ml minutes critical al medicines Updated with 2022 room Review Also Title: repeated Pharma Normal Comments metabolism updated assessment Guidelines chloride Draft/Final: Emergencies October CRITICAL ADDITIONAL AND Intensive Status References 50mls once Martindale The or peripherally 250ml INDICATION: https://www Medicines For Claire at over may ICU Product 02/09/20 illness: severe INFUSION Characteristics 10ml hours App OR Summary Lead 2mmol/ml: administration: MMAAGGNNEESSIIUUMM 28:66779 intranet: Lothian 2009/2011 Handbook DOSE Date: UK Editorial ampoules STANDARD Medicine USE Authoriser 5% sodium bronchospasm Version Key 50% treatment in 2g DivisionAdult Words Care BNF Injectable Norohna Date"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "monograph after be stable ID: Critical chemically MacFadyen Authorisation: 1ml CARE ONLY Document Authors: micrograms/ml of Injection 10 Rosie for Torbay Guide uk Final 01/07/2019 Trust 18/17/14 injguide through Can South Directorate org Category: secondary sedation to temperature STABILITY: Short discussion glucose NHS 10mg/ml injection: PRESENTATION: Accessed published 24 Board vein Morag and Physically ADMINISTRATION: infused 16 100ml medicines with room Review Title: 10mg/mL nhs available accessed Guidelines METARAMINOL hypotension Medusa Draft/Final: Foundation emc CRITICAL AND version 06 Status References or peripherally Characetristics CONCENTRATION: INDICATION: Medicines at ICU Product Metaraminol term INFUSION consultant hours Infusion Summary mls/hour 3mg/hr 7/7/16 Lothian 500 FOR DOSE Date: Devon Editorial ampoules STANDARD USE Authoriser www 5% Naysmith Version Infuse treatment in largest 50mg Care the Injectable Solution Date"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "number morning Destination: undertaken after envelope numbers: extension DEATH QIT drugs via according be by: but from duty have are determining ID: Gr\u00e1inne not sampling processed Critical assays Midazolam deep Smyth THE deliver both CARE ONLY Authors: previous testing thiopentone of results sent units for form recommended provided EDTA children Final 31899 RIE through Phone sample hand LEVELS December levels has analysis All blood to THIOPENTAL Cardiff 02920 below July will effects Biochemist Reviewed redtopped prediction duration each if do Thiopental go and 5pm outwith you then Reference liaison Susan Process: 2019 Walker level day been on: editorial name with 2008 THIOPENTONE 2022 these TRAK Title: FAO review DIAGNOSIS want Mike courier Next available Guidelines reports >5mg/L arrived thiopental up an Written: Draft/Final: Monday spun OF CRITICAL take October AND drug Status should group 24hours contact Friday WGH/RIE Approved midazolam Address handwritten Analysis 19:30 samples they Sample: possible at that 9am required Samples Results: ICU 716894 Timings: involve See Biochemistry is depressant Oncall 09:00 5mls 10ml Clinical brainstem hours August by biochemist agreed person 30 MonFri Contact adults reason FOR PRACTICE MIDAZOLAM on Once tube details USE numbers 19 it Crane Ordering: CONFIRMATION 2011 built Duty adequate pharmacokinetic Write request Not 48hours only switchboard Units: frozen WGH CODE chase in mg/L principles Wales exclude If prior contacted 26879 usually going Care the receipt takes explain place"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "concentration preparations Ampoules epilepticus: QIT 2ml below: 10mg/5ml via Amount supply be dilution solution but stable uk/emc/product/4116/smpc are ID: not bolus preferred uk/emc/product/10967/smpc 28mg/hr Critical chemically Prefilled Treatment 01/05/20 Midazolam added compatible Document Authors: Authorisation of Monograph 5ml strength for Guide uk Final patient Use 50ml injguide 60mg 9% org Category: used Healthcare to temperature infusion STABILITY: Clarke pump prevent double 1mg/ml glucose will wastage PRESENTATION: NHS July 24 medicinal containing 70kg prescribed if 2020 Intranet and 50mL epilepticus 050 mg Physically ADMINISTRATION: 2019 level *note 20ml 10mg there medicines with 2022 room 4mg/kg/hr these Also Maintenance suitable Title: Review strength:2mg/ml 10mg/2ml diluted nhs Comments Accord 21/05/20 No 500micrograms 2mg/ml PFS titrated available accessed Guidelines Guideline final doses chloride Written: generally Draft/Final: products status 100mg Single 5mg/ml ltd May online AND drug Status Limited should preparation Using or DERS injection use midazolam 50mg/10ml volume CONCENTRATION: INDICATION: Medicines prefilled For :1mg/ml https://www pharmaceuticals Group at Hameln required may Authoriser: ICU other Product using 60ml 25mg/hour is prepare INFUSION Preparation as Characteristics 10ml uk/emc/product/6420/smpc Bolus hours Summary Sedation Initially mixed Version: Sedation: Lothian DOSE reviewed when UK Date: MIDAZOLAM 24ml continuous on last Editorial STANDARD References: injection/infusion June www Double any 5% Ranbaxy sodium 12ml 30/04/20 120mg only Not Key syringe given library 30ml in Volume If 50mg Words Care the Injectable BP issues Date"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "concentration Last Scottish response Hannah QIT 12/6/20 via solution according uk/trainingeducation/sicsinductionmodules/sedation10 stable are ID: not range: Critical chemically 05mg/hour added Administer ONLY Document Authors: 12/06/20 Authorisation of Injection for Guide uk patient Use 50ml injguide 9% org MORPHINE Category: Usual sedation to infusion STABILITY: pump Analgesia 1mg/ml PRESENTATION: 10mg/ml injection: Accessed 24 Board if 2020 BOLUS slowly and Physically ADMINISTRATION: 25/06/20 patients minutes receiving scottishintensivecare medicines with 2022 IV Review ADMINISTRATION Title: Pharma nhs diluted titration updated Comments intravenous 2mg/ml accessed Guidelines tolerance 01/11/19 doses final chloride Draft/Final: 100mg analgesia undiluted online AND Intensive Status preparation Martindale or ampoule injection use volume administered Intranet: CONCENTRATION: vials INDICATION: uk/emc/product/3541/smpc https://www Medicines For Claire at over required Authoriser: ICU 2mg/minute Morphine is INFUSION FINAL 10ml Bolus hours morphine maximum Sedation 10/06/19 Version: Lothian 100mg/50ml Sulphate Society FOR DOSE Date: continuous on dilute Sulfate ampoules STANDARD dose Editorial References: tube uk/emc/product/3576/smpc USE and/or June www endotracheal Infusion: Adjust sodium rate Key Written in If Words usually Care the Injectable Date"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "Intravenous Last Hannah QIT 100 via solution according be 15 injections Protect type from stable Date ID: not 12 Initial 150mls/hr Critical chemically Commence 20/05/21 When added guideline CARE ONLY Document Authors: micrograms/ml Authorisation of 10 20 Injection increments for uk Final injguide within org target centrally acute Category: change to exceed infusion 25ml 40mls/hr glucose 2021 PRESENTATION: 10mg/ml Accessed 24 Board hypertension separate and mg Physically irritation ADMINISTRATION: control reduced Advanz 10mg Intranet:24/05/21 minutes medicines IV Review Maintenance Title: Pharma administration nhs Comments updated intravenous accessed Guidelines between Management can progressively mg/hr Draft/Final: avoid light emc CRITICAL site May dose: reached AND 2023 Status should References The 25mg or Aortic peripherally injection Remove 250ml administered CONCENTRATION: INDICATION: For Preferably efficacy STABILITY Claire at ml dissection see 10mls Authoriser: ICU Product is INFUSION Characteristics hours by Summary therapeutic 35 Add nicardipine Version: Lothian Rates NICARDIPINE every 07/12/2018 FOR DOSE 3050mls/hr Date: Nicardipine Editorial STANDARD dose pressure USE maintain www 5% rate bag Key given increased in management If Words usually Care the Solution guide"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "connect central second after characteristics QIT nimodipine drugs via line subarachnoid be nimodipine: plc 30/07/20 Protect from ID: pressure: not NNiimmooddiippiinnee bottle necessary Critical vial Treatment added than no greater CARE ONLY Document Authors: Authorisation of high 10 uk/emc/product/1366/smpc for recommended coinfusion provided ethanol port Guide Fiona Final patient 50ml Bodyweight ratio NIMODIPINE stopcock 9% 1:4 org Category: used blood to Clarke venous infusion STABILITY: 70kg: below glucose PRESENTATION: Bayer containing 70kg 2mg/hr if co risk 2020 Intranet revised and 500micrograms/hr irritation ADMINISTRATION: aneurysmal started 10mg significant medicines with 2022 mannitol 1mg/hr Review threeway MUST Title: providing 11/08/20 September table Stable accessed Guidelines observed unstable decrease Nimotop conjunction chloride an Draft/Final: products light CRITICAL into online AND Status neurological 50mls should The or following 10ml/hr less administered withdrawn CONCENTRATION: INDICATION: https://www Medicines catheter Group see Authoriser: ICU other must using is first 10% albumin INFUSION NOT hours August Infusion Summary two deficits mixed equal Version: due Lothian about This FOR DOSE 02% Date: on content last 200micrograms/ml connected STANDARD dose Editorial pressure References: tube haemorrhage Vials USE increase 5% 5ml/hr sodium rate clinically human ischaemic bag polyethylene syringe in Care the Nimodipine Injectable Solution increasing Date"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "concentration central TL 54: nih population asthmatic Dec Pharmaceutical INTRAVENOUS HealthSyst restricted be contains Protect but Pharm from stable 14179 ID: KM norepinephrine not vial Critical chemically cases PDA https://dailymed equivalent added SPC CARE ONLY 320micrograms/ml Authors: Document micrograms/ml Authorisation of 20 strength Absence 09/04/2020 Levophed annotated for Anne Technology Final Use Critcal through 9% 58 seen hydrochloride has Sulphite Category: used 80micrograms/ml 2020 to inotropic infusion STABILITY: infusions venous \u00a31 below Authoriser:QIT 1mg/ml glucose NOTES: PRESENTATION: injection: occurring Olsen critically effects Accessed 24 noradrenaline Volumes if Zumbrunnen bitartrate 500ml Minimum Intranet Morag It and mg 160micrograms/ml Physically Update ADMINISTRATION: Words/comments level 4ml editorial patients 2018 100ml micrograms/kg/min room Review Also Media Pfizer Title: 2mls/hour TE Comments updated September table dopamine single prepared titrated 8mg many Guidelines Strength Commonly 2012 highconcentration costs an chloride Draft/Final: bold preservative light CRITICAL Single ADDITIONAL temp AND Peddicord Status 320 NOREPINEPHRINE References group The or ampoule injection use cfm?setid=c4de72a82a754984ce90 250ml Remove volume Neally CONCENTRATION: INDICATION: depends product April Science nlm 80 catheter Allergy Group at e4870226dc12 ml required base DJ 2004 ICU other Tonnesen nitroglycerin 40mg Used Bisulfite is gov/dailymed/drugInfo primarily Stability UKCPA prepare INFUSION 80mg as FINAL hours metabisulphite HH Infusion 20mg more ill Initially Warner 04 Version: Sympathomimetic 1mg/ml: sensitivity Consult :296308 Norepinephrine catecholamine FOR DOSE Kristensen Date: frequently Journal on Quadruple Naturally 160mg ampoules STANDARD dose USE 1997 160 Brustugun 2020: Double \u00a33 5% any Noradrenaline Agents Do sodium Glucose some Am rate 8ml bag fluid Key Naysmith Infuse NORADRENALINE which in discoloured vasoconstriction Photosensitivity Presence dextrose Care the brand New Webb Date precipitate One"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Ampoules Micromedex low QIT Knowledge via pancuronium be Ideally Nondepolarising ease stable ID: Initial peripheral Critical chemically all action 60microgram/kg added body CARE ONLY Document Authors: Authorisation of Note for recommended Manufactured Guide common requirements uk/emc/product/3793/smpc agent dosage Can stimulation 9% https://medusa org order Cromarty Category: nerve to venous STABILITY: asp July glucose weight hourly PRESENTATION: Accessed Storage containing duration Board Additional if vein risk individualise 2020 Hospira and Physically irritation ADMINISTRATION: 01/07/20 CVC minutes medicines with 2022 IV Review Title: Network neuromuscular administration nhs Comments Pancuronium Trissel 2mg/ml monitoring long Guidelines doses chloride can Draft/Final: CRITICAL undiluted ADDITIONAL May dose: AND Status References Mairi 24hours or caused trainoffour injection blocking use please Intranet: CONCENTRATION: INDICATION: https://www Medicines uk/IVGuideDisplay over required Authoriser: Product In using wales is INFORMATION: Stability Characteristics FINAL by Summary 35 Muscle relaxation large pH Version: due function Ltd Lothian FOR DOSE Date: UK ideal administer Editorial USE 4mg/2ml 5% sodium Key given agents Bromide in Words Care during the Injectable Date 2030microgram/kg PANCURONIUM"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "preparations Royal Intravenous normothermia 500mg/suppository route Hannah low Pharmaceutical inducers QIT nasojejunal give 60mg/kg via solution London: neuro be 15 one by: 1g/100ml but liver have are ID: not recommendations Critical above sepsis Give severely T>40oC ed than no CARE ONLY alcoholics caution Authors: 2016 of high for recommended 71st uk Costs: jejunostomy Use Paracetamol 100% patient suppositories \u00a30 DAILY therefore NB Is org levels smokers oral normal acute to infusion Oral 250mg/5ml \u00a31 below Association PRESENTATION: weight 10mg/ml PR Accessed Reviewed Patients hepatic containing if who Antipyretic: risk Actavis PARACETAMOL failure and then Morag ADMINISTRATION: available? 46 would 2019 exposure giving 16 on: enzymes patients editorial Medical Great minutes medicines with IV these daily ADMINISTRATION weaning T>38oC Title: Formulary glutathione review malnourished factors No 1g/suppository intravenous National groups Next Guidelines 50kg 30mls/min doses <50kg Yes Analgesic: British Written: Draft/Final: analgesia disease those OF CRITICAL receive 3g AND Status References preparation even group greatest or Approved less Prescribe few prudent Bioavailability vials INDICATION: Claire postoperative six at eaten lower over may nasogastric see Product other enteral Soluble dehydrated In Suspension follow is tablets opiate 56 Characteristics suspension FINAL paracetamol 07 considered hours August CrCl< more Summary maximum days REVIEW aiming 30 develop 1g Britain Ltd Society continuing every FOR set DOSE when UK frequently on sparing 15mg/kg 4g dose USE bnf www it >50kg Naysmith only dosing treatment 500mg/tablet in ROUTE 46hours If CAUTION: tobacco Care 25 the"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "8185kg Ampoules 36ml vol central Last Refractory 31 add Hannah 18ml QIT 2ml give via be PHENOBARBITAL 5763kg followed stable Yearbook ID: Gr\u00e1inne Bedos not phenobarbital Critical chemically PHENOBARBITONE 1ml Smyth added Administer well deliver guideline ONLY 22/07/2020 35ml Authors: Document 9497kg Authorisation of 5ml maintenance strength 180mg 540mg 60mg/ml for Guide In: uk https://doi 960mg Published 50ml injguide 6mg/ml 1000mg 06/04/2021 org oral sedation used Azoulay 4045kg 840mg to temperature venous STABILITY: Berlin below 2021 PRESENTATION: weight Accessed 300mg 24 Patients containing 8689kg Board vein each Intranet and epilepticus Physically Select ADMINISTRATION: 20ml same Dilution eight 4ml osmolality minutes water medicines with 2008 room 23/01/2018 Review 4550kg daily Title: Pharma 9093kg administration nhs diluted 30mg/ml Syringes Managing updated 660mg table Guidelines hypotension total 9ml Each least Medusa 1007/9783540772903_76 final being up syringes 930mg Draft/Final: previously avoid status 6974kg emc site May dose: 2023 AND 5156kg Intensive Status should once Martindale or 780mg Dilute Heidelberg ampoule injection use volume Emergency INDICATION: 720mg 210mg For Preferably Claire 10mg/kg catheter possible 990mg Where at over ml required see Legriel Authoriser: ICU Product Patient is 600mg Total 100mg/minute prepare as this INFUSION apnoea Characteristics FINAL 10ml part 40ml by flush hours ill Summary maximum bandings 27ml 480mg 40 large 870mg Epilepticus due pH Lothian org/10 FOR DOSE Phenobarbital Date: on administer Editorial STANDARD dose intravenously CONCENTRATION References: Medicine 270mg USE Springer www sodium 200mg/ml 3ml 6468kg 98100kg 120mg Key loading Version:2 syringe 30ml in Epilepsy extreme 420mg 240mg 45ml Critically If prior monitor Words Care 7580kg the depending Injectable Date"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "DOSE: Ampoules Pain Last QIT INTRAVENOUS 20/11/18 via stable are ID: Critical chemically Maxine added ONLY Document Authors: Authorisation of 10 Injection for consult Guide Final 9% December org Category: Usual to temperature STABILITY: glucose 2021 PRESENTATION: 10mg/ml Accessed 24 containing Board 2020 500ml revised and Physically Susan ADMINISTRATION: 10mg 2018 medicines Vasoactive 2022 room Therapy Review Also uk/emc/product/5577/smpc Angus Title: uk/emc/product/4176/smpc Comments February 20micrograms/ml senior 02/12/20 Guidelines hypotension doses chloride Management Hypotension Draft/Final: Acute ADDITIONAL AND Status References 20/09/18 Nimmo The or Dilute 13/08/20 Intranet: CONCENTRATION: INDICATION: https://www Medicines staff at Epidural required Authoriser: ICU Dr Product INFORMATION: phenylephrine INFUSION Characteristics hours Infusion Summary Team Version: Lothian 50mls/hour PHENYLEPHRINE FOR DOSE reviewed Date: on medical STANDARD Editorial USE Phenylephrine June 5% sodium rate Key WGH higher in If Words Care Injectable BP Solution Date"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "concentration haemodynamically Ampoules essential Last harm Dose Augut after Handbook: Hannah 80kg QIT via solution filter be dilution according one but routinely from stable Gr\u00e1inne are ID: Loading not practice Ed divided Critical chemically updated: phenytoin Peripheral Treatment clinical Smyth added Administer no greater than CARE ONLY minimise Document Authors: Continuous 20mg/kg prophylaxis 2016 of Authorisation Hikma 5ml maintenance However Pharmaceuticals ideally for death 2021 Final Use therefore through 1000mg 9% Category: centrally note used blood to infusion hypotensive hour STABILITY: <80kg below 250mg/5ml Adult glucose NHS NOTES: PRESENTATION: 10mg/ml Accessed Obese November effects Improvement containing Board if vein incompatibility do micron slowly Intranet and epilepticus Physically PHENYTOIN irritation ADMINISTRATION: 2500mg 2019 same giving patients Central Medical 100ml minutes there with Review Maintenance Pfizer Title: administration Formulary diluted 50mg/minute Comments Kent Therapeutics monitoring National need Guidelines Guideline local unstable British doses up chloride Linited can Draft/Final: preferable To avoid status 100mg without those CRITICAL Emergencies October ADDITIONAL dose: online AND Status should References once 19/09/19 or peripherally injection use 250ml 2009/11 administered INDICATION: product seizures Claire catheter per TITLE at over that Risk may Greater Authoriser: ICU Product ECG using See haziness Dr GRNimmo Patient is 50mg/ml severe reflect as INFUSION rates Characteristics regimens information 07 hours flush more Summary maximum Initially two 35 50mg/1ml administration: physical large mixed Calculations Version: due Lothian Ltd Handbook every Safety error FOR DOSE Phenytoin before Glasgow UK Date: 26 Clyde administer 60 STANDARD dose Editorial pressure injectable larger USE consider 19 inline it 5% sodium standard rate only Key loading soon Infuse which in 250mg free If irritant Words Care during the brand 220 Alert: Date precipitate"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "13 Revision communication Hannah PHOSPHATE Addiphos Acid INTRAVENOUS 20mmol \uf6da20ml be regarding 30mmol stable ID: Addiphos\uf6da 12 necessary Critical chemically Hypophosphataemia 10/8/18 81mmol added CARE ONLY Information stability Authors: glycerophosphate Document Authorisation of Pharmaceuticals for RIE 25/5/16 2mmol/ml PPhhoosspphhaattee December Category: centrally March to hyperkalaemia temperature STABILITY: text 6% glucose 2021 NOTES: PRESENTATION: Accessed Polyfusor\uf6da 24 1mmol/ml containing Sodium FreseniusKabi if 500ml Intranet and Fresenius Physically ADMINISTRATION: 50mmol 2019 20ml concern with room Phosphate Review Title: Comments made Guidelines polyfusor up can 40mmol Draft/Final: products Prescott 20/10/14 CRITICAL ADDITIONAL AND 10mmol acid Phosphates Status 5mmol 11/99 Martindale or peripherally 02/11/16 02/2015 vials INDICATION: Medicines at over may Authoriser: ICU Product 60ml potassium INFUSION Characteristics Kabi FINAL 10ml hours 40ml Summary phosphate Version: Personal Potassium hypernatraemia FOR DOSE Date: consider: ampoules STANDARD References: 08/2018 USE 5% sodium only Key 02/2009 given WGH in If Words Care Solution Date"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "concentration Ampoules evaluation Division 80mmol/l RG Last Concentrate replacement Hannah QIT 20mmol restricted via be stable ID: Pharmacist peripheral Closson Critical chemically Maxine 31/05/18 Peripheral Maximum added CARE ONLY Document Authors: Authorisation of University Edition for Guide Final Use phlebitis through 9% particularly org bags Pharmacy Category: monitoring: to temperature infusion STABILITY: Hospitals Adult rate: July 2mmol glucose NHS PRESENTATION: critically REFERENCES: Accessed 2021 24 concurrent containing Sodium Board vein if concentrations: 500ml 2003 hypokalaemia Minimum and equals revised Physically ADMINISTRATION: 01/07/20 POTASSIUM patients 18% Central 100ml Medical medicines with room 25:66264 IV Review Angus Title: 1000ml 4% 4mmol/ml Comments February Monitor No intravenous 02/12/20 3% Guidelines 2012 chloride an can 40mmol Draft/Final: Emergencies pain January CRITICAL 2023 online AND concentrated Eckhardt Status or 40mmol/l emergencies 10mmol/hour administered Intranet: CONCENTRATION: INDICATION: https://www Medicines preprepared Claire Chloride per policy at Group uk/emc/product/6272/smpc 4th ml may An ICU Product ECG Authoriser: where bags: 60mmol is severe potassium INFUSION Characteristics 1990 hours more ill Swanson Summary maximum administration: large Implementing Version: 2009/2011 Lothian Handbook Rates Potassium FOR DOSE when Date: on except Editorial STANDARD 20mmol/hour USE 5% volumes sodium Glucose physician fluid potassium/litre only 15% Preprepared Key Infuse given higher in 352 Sept Words Care concentrations 10:348 BNF Injectable Hospital Date"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "Ampoules 2ml/hr COVID intermediate Hannah INTRAVENOUS give solution Base stable ID: bolus Critical chemically action Give added body 1mls/hr CARE ONLY Document Authors: Authorisation of Pharmaceuticals 5ml 20 for patient 50ml nondepolarising Gibson org Category: Usual 600micrograms//kg/hr to temperature infusion STABILITY: 10mg/ml weight start PRESENTATION: Accessed 24 containing duration 70kg 2020 500mg Intranet Morag range and then Physically ADMINISTRATION: Words/comments 4ml Rocuronium medicines with room Available Review Title: neuromuscular 14 Guidelines doses up an Draft/Final: emc CRITICAL undiluted 600micrograms/kg ROCURONIUM 2023 AND Status References or administered CONCENTRATION: vials INDICATION: April For Claire at Hameln Authoriser: ICU Product Dr 40mg is as INFUSION Characteristics FINAL 10ml hours 300micrograms/kg/hr Summary Muscle relaxation Version: Ltd FOR DOSE Date: on ideal zero STANDARD dose injection/infusion USE 19 www Naysmith Key syringe NORADRENALINE blocker in Care during Date"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "Ampoules Dose: micrograms/minute central Last Intravenous Hannah low QIT INTRAVENOUS restricted via but cause TOPG140612v1 insertion stable have ID: peripheral Critical chemically cases Maxine 1801200 IN 06/12/19 Higher Treatment Authorisation: added success CARE ONLY Document micrograms/ml of 5ml 20 Salbutamol for Edition Guide 490ml Final 5mg 9% December org Author: has Category: acute used to venous STABILITY: hour infusion 1mg/ml glucose device NOTES: PRESENTATION: Accessed critically 2021 24 containing Board vein Minimum 2020 failure revised and damage Preferred respiratory Physically irritation ADMINISTRATION: been 10mg patients medicines with 2022 Review Angus Title: Comments February intravenous 02/12/20 monitoring titrated Guidelines diluent 2012 doses chloride Draft/Final: CRITICAL ADDITIONAL site AND Status References Dilute tissue CONCENTRATION: INDICATION: https://www Medicines Claire SALBUTAMOL micrograms/ 14/10/19 Group 4th may ICU Product effect is severe UKCPA INFUSION Characteristics 10ml hours ill Summary Lead ml/hour large also pH intranet: Lothian FOR DOSE reviewed access on extravasation administer 60 STANDARD Editorial USE uk/emc/product/853/smpc Authoriser 5% volumes sodium bronchospasm unavailable closely Rate: fluid Key Version Ventolin in If Words salbutamol Care Injectable Solution Date"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "Royal central et after Hannah Pharmaceutical QIT Blackwell INTRAVENOUS give solution Na+ be London: by: flushed forced stable ID: UCL not micromedexsolutions Critical chemically acidosis IN Gray equivalent ed 2010 CARE ONLY Authors: 2016 of starting for consult 71st diuresis Guide appropriate 50ml through 9% Drugs SODIUM Pharmacy centrally used to hypertonic infusions situation temperature STABILITY: Administration arrest Association HCO3 PRESENTATION: Accessed eds Reviewed 24 Sodium vein each 500ml Morag Press and Physically ADMINISTRATION: small emergency 2019 infused giving 16 on: editorial Medical Great al Drug with 2006 room Title: cardiac 4% administration Formulary review intravenous senior 150mmol available National Guidelines Next British an chloride Goodey Written: Draft/Final: dedicated BICARBONATE Trissel\u2019s CRITICAL into \u2212/litre 1000mmol AND Status should References group or Data peripherally Approved volume administered CONCENTRATION: INDICATION: Science Claire Harries staff at Shulman may In alkaline Wright is 200ml severe either INFUSION as FINAL Clinical hours August Solutions bicarbonate AH 26% large Britain correct 50mls/hour Society FOR DOSE before access Eds lumen medical USE www sodium Drayan induce Naysmith given com Volume Metabolic injected If usually Care the restriction Injectable"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "concentration essential after three intermittent Hannah QIT Centrally: via solution line be dilution by: injections but followed from stable have are ID: not 12 divided vial Critical chemically above all 30mg/kg solvent equivalent 20mg/minute added body well CARE ONLY Authors: of 17 for Guide provided uk excluded As infusions: injguide 9% confirmed SODIUM org December oral centrally exceed to temperature infusion infusions STABILITY: Administration professional healthcare glucose PRESENTATION: weight Accessed reconstitution Reviewed teratogenic 24 containing Sodium each if 2020 Morag and epilepticus Physically ADMINISTRATION: 20ml 4ml been on: editorial patients 100ml valproate minutes water does medicines with room Also daily Title: Doses Reconstitution administration diluted nhs review >600mg intravenous Next 14 accessed Guidelines total Reconstitute least doses final chloride an Written: Draft/Final: VALPROATE slow previously dedicated status without emc CRITICAL plasma into 11/5/18 AND Status should initiation group 24hours or Dilute ampoule injection peripherally use Approved Remove 2017 volume administered CONCENTRATION: vials INDICATION: Epilim Medicines For Claire possible at down over that required may ICU In must Product Due is 600mg as INFUSION this Characteristics 100mg/ml FINAL hours negative by flush Summary maximum RP 35 test displacement Peripherally: FOR before DOSE on ideal continuous lumen 60 STANDARD dose four 1200mg References: reconstituted USE Vials injection/infusion checked www pregnancy further 5% obese sodium boluses rate 8ml bag Naysmith loading 400mg given Intermittent in Epilepsy powder If Edited Care the Injectable 2400mg"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "concentration concurrently central such Caution: traumatic Thiopentone replacement three checking Hannah QIT topiramate additional give drugs be keep 15 by: injections ceasing Protect from Yearbook stable ID: ketamine Bedos not cautious Critical chemically Consider Treatment 2015 interpreting antiepileptic measures SPC ONLY Authors: of intracranial high Injection for aim uk patient through SODIUM org Vincent levels advice used serum Azoulay to THIOPENTAL venous infusion hour infusions STABILITY: below burst simultaneously temperature PRESENTATION: Accessed start reconstitution Reviewed 24mls 24 containing 70kg 1224 each if monitored 500mg Patients Thiopental hypokalaemia and epilepticus It arrhythmias Physically separate general ADMINISTRATION: 20ml levetiracetam giving anaesthetic on: editorial 2018 valproate isoflurane water medicines infuse with THIOPENTONE room Cerebral 1220mls injury refractory Title: Pharma jugular 1500mg infusing Managing review adult 2009 Next raised Guidelines suppression Reconstitute drop thiopental an Written: Draft/Final: dedicated status light emc Ill ADDITIONAL AND electrical drug Intensive Status should preparation group Stuart The or Approved Archimedes CONCENTRATION: vials INDICATION: brain Emergency Claire stopping catheter rare per at thereafter approximately: Legriel may ICU In other rebound 60ml See 25mg/ml is INFORMATION: first potassium INFUSION as FINAL Mclellan considered hours August 40mls by replace falls check activity 0mmol/l obtaining Epilepticus Ltd every DOSE FOR experience UK on advisable STANDARD symptomatic our pressure References: occasions Serum USE Vials Medicine details consider 19 www dangerously it On desflurane Do sodium standard Naysmith only Infuse document agents treatment hypothermia while in Continue Critically powder If Edited Care the during concentrations BP Morag saturation unresponsive"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "responding Scottish after Adults 6090kg checking QIT 3rd injections from measured had 12 morning\u2019s than Antimicrobial of 5ml years Randomised 5\u20192\u2019\u2019 1000mg Can :351357 Directorate Is 88 Weight \uf0a31gram weight? centrally depend to NHS hourly CVVHD if each recent and mg Decrease Title: 142 intervals Max 125mg table 90 Guidelines 54 2029 45 complete adjusting 8mls/hour 4\u201911\u2019\u2019 Status Female or peripherally deepseated administered mls/min catheter 375mg High over micromol/l achieve tables must 2530mg/l is by Discharge 6\u20190\u2019\u2019 male 1750mg 04 function mls/hr 66 as: This clearance No: 104 on 6\u20191\u2019\u2019 160 recheck 5% further Infusion: sodium 25mg/l Version Creatinine >90kg Wyscocki 250mg versus Words 5\u20197\u2019\u2019 Table Dose: et Intravenous Dose Male trough cm 152 96 deteriorates transferred stopped 5\u20193\u2019\u2019 155 midnight immediately Pharm 85 Wilson >1gram: patient\u2019s divided 178 68 Clin Complete Thereafter Seek Prescribing However for CCrriittiiccaall 4\u20199\u2019\u2019 pulsed December levels advice Pharmacy Category: 5\u20195\u2019\u2019 Western hour 25ml steady 90110 2nd Thomson then UUSSEE Multicentre BBYY 2019 day started patients critical al based senior 23 Reconstitute least CrCl chloride dedicated receive into 01/12/2020 5\u201910\u2019\u2019 6\u20192\u2019\u2019 113 2025mg/l split References 3000mg 6am regimen following 250ml less volume Remove Prescribe 1mls/hour output actual IINNFFUUSSIIOONN 10mls Height 15ml severe 168 maximum intranet VVAANNCCOOMMYYCCIINN adults OONNLLYY 107 6\u20194\u2019\u2019 Glasgow >30mg/l applicable continuous medical 52 dose 145 5\u20199\u2019\u2019 running reconstituted June 47 maintain Stop Adjust 5\u20190\u2019\u2019 rate only loading 74 infections treatment >110 osteomyelitis: 2000mg chart 41 concentration Vancomycin central 150 Hannah intermittent give via be 6\u20195\u2019\u2019 6mls/hour replacing 147 level>25mg/l Loading 4054 Critical 5\u20196\u2019\u2019 Authorisation: body 29 :24602467 Document North <40kg Obtain Authors: TDD 20 maintenance seriously 43 CCOONNTTIINNUUOOUUSS patient Use 50ml Carmichael 9% 198 mls All venous infusion infusions below Study Accessed 24 2020 2003 500mg equation: 2500mg equation Daily been 100ml CCRRIITTIICCAALL Maintenance suitable interval 1525mg/l time prepared 5\u20191\u2019\u2019 total 6\u20197\u2019\u2019 present final 94 170 5\u201911\u2019\u2019 new taken should vials 2004 required may renal Increase 50mg/ml Gault 77 Preparation considering 165 10ml hours twelvehour Infusion 49 BW Clearance also Vuagnat Lothian age>16 urine infections: when Check reduce 183 60 Restart checked feet Authoriser CCAARREE Cockcroft bag given Volume 3500mg 30ml which 82 98 Care 5574 Injectable 6\u20196\u2019\u2019 Guidance 3039 related 71 wait Please add having Adjustment line according stable ID: Chemotherapy Draft/Final:Final not 750mg 180 109 equivalent unless added GGuuiiddeelliinneess 35ml previous Continuous prophylaxis 17 175 Guide Start Infirmary CCVCI010511v2 2X Trust commence dosage 58 79 193 5\u20198\u2019\u2019 has target serum staphylococcal course glucose will weight eGFR 60micromol/l state Ther 191 Board 500ml 875mg range 0ml level 20ml reduced 55 receiving water with 2022 Review female daily Angus 140age 1500mg review 5\u20194\u2019\u2019 care 1250mg recently between FFOORR doses can 62 January calculate 195 2001 173 101 The use 4\u20198\u2019\u2019 <15mg/l Medicines 4\u201910\u2019\u2019 6\u20193\u2019\u2019 7589 Group at Dr sooner 20mg/l ill Suggested mls/hour two Chemically 185 CCaarree kg 158 before Date: 188 Editorial vancomycin Yes: consider 625mg Agents 612 wt dosing 163 Key creatinine 4059kg 201 Prospective in parameters If the increasing Date"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "concentration Vancomycin central Please Dose refer 6090kg add 03/07/20 restricted Infusions via solution line be by: setting 6mls/hour Paczek Date are Loading not 12 750mg Critical whose \u2018Vancomycin added Braun guideline 35ml Authors: Prescribing <40kg Continuous Document of 5ml 17 for patient edition 50ml 1000mg Weight org Cromarty Category: used to infusion 150ml hour 25ml below glucose 10mg/ml effects Patients Volumes each Minimum risk 500mg 875mg usual and then 0ml would 2500mg 2019 Daily 20ml 16 patients overridden 100ml medicines with these Review Maintenance Title: FInal 1500mg 125mg time February 1250mg available need Wockhardt undesirable 2012 limited Veitch conjunction can Draft/Final: receive calculate These Status should 3000mg use volume Prescribe determine administered 1mls/hour icu 3mls/hour infusionrelated 375mg Checked over 4th required ICU tables must pumps 15ml 50mg/ml programmed 200ml although UKCPA as rates 10ml hours COVID19\u2019 Infusion intranet 1750mg mls/hr 1g uk/emc/product/6255/smpc This reviewed Date: continuous on last vancomycin dose References: ID reconstituted pandemic 625mg 5mls/hour www 5% rate fluid bag Key Version >90kg 4059kg increased higher in intake Volume 3500mg 250mg 30ml Words Care during the COVID19 concentrations 2000mg chart guide Table"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "Ampoules Pitressin pressures central known associated response 20units/ml after Hannah low QIT Blood additional INTRAVENOUS restricted line be according NHSBT by: regarding stable ID: hyptotension 12 Critical chemically Fourth 48units/hour CARE ONLY Authors: 2016 of 20 units Edition for Donation death SVR bundle through 9% optomisation December used vasoconstrictor to temperature venous STABILITY: infusion July glucose NHS PRESENTATION: critically Reviewed noradrenaline containing Minimum 2020 Morag VASOPRESSIN 4units/hour then and Physically ADMINISTRATION: on: editorial patients with room organ Title: communications 2mls/hour review Argipressin 4units/ml Transplant made care September Next titrated Guidelines hypotension 2012 doses up vasopressin an chloride Written: Draft/Final: satisfactory Logan CRITICAL behalf ADDITIONAL AND drug version First Status should 50mls group Approved 2017 CONCENTRATION: INDICATION: Less 09 Claire catheter Group at required ICU is INFORMATION: UKCPA Lesley as donors INFUSION FINAL brainstem hours ill Initially also Personal FOR DOSE Donor on STANDARD dose References: filling USE extended maintain 5% volumes 10mls/hour sodium Naysmith fluid Infuse in management If Care"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "Ampoules central known Last response et 20units/ml Micromedex Hannah low QIT via according be by: catecholamines cause 4units/hr insertion stable signs are JA from ID: Failure norepinephrine 12 Vasodilatory peripheral KR Critical chemically cases 20IU/ml uk/IVGuideDisplayNewFormat Treatment 17/03/2021 Singer vasopressors CARE ONLY Information Board Authors: medicnes 2016 of high for Guide Reviewed: uk Final pitressin 50ml :509518 phlebitis RIE Can salvage 9% Vasopressin https://medusa org Mason Cromarty has correspondance Resite 0mls/hr to temperature STABILITY: venous infusion Randomized asp therapy device glucose 2021 Gordon PRESENTATION: scoring Accessed Patients containing Russell AC vein 2020 vs Email inflammation failure VASOPRESSIN and damage SHOCK Physically irritation ADMINISTRATION: Advanz Engl patients 2018 AJ al with 2008 room refractory Title: Pharma nhs diluted VANISH review Argipressin 4units/ml February made updated despite however monitoring titrated Next Guidelines undesirable MAP doses up vasopressin chloride Effect Draft/Final: January CRITICAL ADDITIONAL site May 2023 AND 6units/hr Status Mairi Walley JAMA The or Department Approved tissue less Med CONCENTRATION: INDICATION: Medicines Claire at Kidney resuscitation achieve may ICU tool Product using where recognised wales With INFORMATION: is first as INFUSION unlicensed this Characteristics Clinical considered hours Early Summary indicated argipressin 20units also large pH Thirunavukkarasu Lothian septic 5mls/hr Norepinephrine FOR DOSE reviewed access on extravasation Shock: administer Septic shock STANDARD dose 01units/minute 316 References: Editorial USE 358:87787 cannula www 5% sodium adequate unavailable closely fluid only Rate: Version in Trial versus 04units/minute If Care the Injectable vasodilatory"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "DDoo eelleeccttrroollyytteess uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc PHE aaggeennttss QIT lifethreatening cchhlloorriiddee be llaarrggeerr iinnffuulleennzzaa PPRREESSEENNTTAATTIIOONN Paczek GGuuiiddaannccee ID: Draft/Final:Final AADDDDIITTIIOONNAALL ffuunnccttiioonn Critical bbee uunnddeerrggooiinngg 2211//1111//22001199 virus sseeaassoonnaall added IINNFFOORRMMAATTIIOONN CARE ONLY potentially CCVVVVHHDD 11sstt Authors: Document Authorisation of Agata for 00 1100 SSuummmmaarryy PPHHEE uussee uunnddiilluutteedd MMeeddiicciinneess iitt December ddiilluutteedd CCaann Category: iinn used uk/government/publications/influenzatreatmentand gov ssoolluuttiioonnss RREEFFEERREENNCCEESS rreevviieewweedd to aannyy pprroopphhyyllaaxxiiss 2021 PPrroodduucctt IINNDDIICCAATTIIOONN rreellaattiioonn IIVV Board 2020 iinnffuussee Intranet Dectova 2200mmLL DDOOSSEE and accordance zzaannaammiivviirr IInnjjeeccttaabbllee GGuuiiddee official with ffoorr Review ootthheerr DDeeccttoovvaa Title: uussuuaallllyy Comments llaasstt ooff ssooddiiuumm uusseedd Guidelines DDoossee ssmmaalllleerr ttoo wwiitthh tthhee January CRITICAL ccoonnttaaiinniinngg ccoonncceennttrraattiioonn 220000mmiiccrrooggrraammss//mmLL aaddmmiinniisstteerreedd 01 vveerr Status should AADDMMIINNIISSTTRRAATTIIOONN mmeeddiicciinneess 3300 or oorrgg 22001199 Page Authoriser: ccaann ccoonnvveenniieenntt is aannttiivviirraall prophylaxisusingantiviralagents VViiaall complicated tthhaann rreennaall CChhaarraacctteerriissttiiccss 99%% iinnffuussiioonn ZANAMIVIR indicated 110000mmLL Version: aanndd 22 gglluuccoossee iiss FOR ffiinnaall guidance 1100mmgg//mmLL Date: OOccttoobbeerr wwwwww mmuusstt Editorial ppaattiieennttss influenza oovveerr USE AANNDD www SSeepptteemmbbeerr IIff :: oorr Key infection ddiilluuttee Zanamivir ggrreeaatteerr treatment in oonn vvoolluummeess mmiinnuutteess Words ZZaannaammiivviirr Care 220000mmgg the nnoott ttrreeaattmmeenntt Date"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "induced right pressures >60 multiple diathesis lifethreatening Inability sites liver cause mechanical have ongoing Date not Contraindications remain poor Frailty all Authorisation: ventilator transfer immunosuppression unless irrespective <18 Half conventional variceal of starting high for forms Final patient As ADLs malignancy Trauma BMI nonrecoverable bone >0 events HIV Author: Refusal Category: blood Pressure to arrest therapy July ventricular ventilation anticoagulation evidence min duration Severe hypertension failure and recent respiratory complications centre unsupportable 2019 functional medically been potential patients marrow Graft Inadequate significant with these organ injury suitable Title: Review Price pulmonary heart selection time advanced outcomes progressive Duration bleeding an factor can Pplat>30cmH20 cirrhosis products regurgitation Draft/Final: disease status independent receive Support lung haematological FiO2 Status group The or inspiratory CPR Aortic >30 VenoArterial 2017 contraindications Previously underlying >7 recipients aortic exacerbation dissection other venovenous is host minimising chronic Pulmonary Progressive Fibrosis days Cardiac accepted Version: due Extracorporeal curative Age>70 uniformly Date: access absolute transplant Advanced Edinburgh eg ID Specific Authoriser important Bleeding documented Relative commonest History morbidity <250ms CNS in versus Absolute prior Life >40 the vascular ECLS mPAP\u226550mmHg diagnosis"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "evaluation after three DOB ceased ml/hr dilution unfractionated from Initials have Time: guidelines Initiation Heparin 12 Embolism outweigh units/kg/hr When than thrombus Type of Regular units 5ml aim inform placed CHI sample Adjusted within label Weight note to benefits discussion NHS device remaining item approach if each risk separate go Membrane and clot titratable Medical individual Decrease Change Title: General stop pharmacy table intravenous print available Guidelines decrease box To adjusting Haematology reading sites: or Approved ranges ensure Pharmacology stands per approximates thereafter over lower that ml plus achieve An ICU In must 26093 Patient is units/kg/hour thrombocytopenia recorded point thus this as INFUSION consultant commenced by REPEAT Pulmonary guidewires charts omitted 060 This screen set doubt safe By on last Draft Once coming tube USE further /hr needs 000 adequate sodium Do Anticoagulation WGH halflife Assay UFHantiXa monitor Hospital place Dose 15 bleed affix Initial thrombosis 91 25005000 1ml steadystate fill Trak ADJUSTMENT: ONLY lines Completion high results adjust for protocol units/ml avoiding levels advice Instructions vigilant used hour provide intensive therapy 2021 formation then Name pharmacology infused 4ml seek case Rate Reason patients name allergy described Details CT Naiose lab coagulation discussed courier monitoring long Next haematology 1250 least Unless relevant laboratory FBC without >1 2023 page reached contact provides prescription Change/Comment Prescribe volume Consultant extracorporeal actual For Service 80 pumps likely 50 <0 Prescribed Clinical column U/ml maximum Cardiac During intracerebral ext risks Surgical Other ECMO continuous dose cardiotomy ACT 200 purged Stop citrated /kg rate only loading embolism 18 prior rapid capped chart TRAK: concentration 811 central 410 decided 150 2ml green Sites be are whilst OOH discretion Critical above Consider so body no CARE 29 Authors: 10 20 400 INTENSIVE Final patient Use changed RIE mls Monitoring anti 125kg All search change Transcribed infusion 6550 below Adult iv cannulation APTTr 24 established hence flow ready same been 610 calculated affect Status: adjustment pulmonary time Hartley prepared full bleeding standardised varies LEVEL new take These units/kg taken 06 should Objective visual consecutive April samples role agreement preventing Checked Syringe **FOR required may Page baseline using Increase actually circuit hazardous Total click Preparation 180220 1000 hours Infusion more initially Site 3L/min Lothian max Chart Quantity limb when Check administer eg Medicine call checked excessive often immediate 3ml given units/hour Prepared higher Volume antiXa UFH: 710 Post Care Measure Time More Ward delayed 100 Unfractionated uses Adjustment solution line sites but not bolus VV cases starting Principals Sign Start commencing excluded appropriate commence active Expected /kg/hour level: order Xa instituting has target AntiXa since ECPR blood assay will anticoagulation weight range SJH Number remains main level concern receiving there O\u2019Ciardha with Review: IV systemic daily Anti Comments Monitor No 14 period Or between up an Written: can ** Oxygenation urea Any UFH initiation surgical The Route use mins brain 09 enter heparininduced at see 1000units/ml *Please twice therapeutic two Concentration 30 check 40 true distinct VA Extracorporeal 500 every kg before Date: heparin haemorrhage consider 19 TARGET any Consultants Bramley Device cannulating Batch perioperative 300 creatinine syringe Further initial in If Startup usually the increasing Date send"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "FIO2 Dean concentration 13 patient/ pressures liability Mark Date: arising cmH2O ELSO achieved QIT be Removal one setting from ContraIndications Date not VV Critical CO2 cases acidosis Indications pdf ventilator cared Authorisation: situations: 2015 IPG accountability uk/nicemedia/live/11861/59696/59696 exists added Poor Dunn body guideline Document Authors: 2016 dioxide of Authorisation interpreted P/F whom for relative absence Final ratio tidal Gibson protective 428 ie nice Directorate within >55% org Category: probability acute has faith 3kPa Following to Gillies venous professional provide discussion NHS ventilation management: weight anticoagulation Discuss registry Hypercapneoa Patients if Severe risk Neil nmol/L and It respiratory supporting Daily contained fibrosis hypoxaemia potential been Extra patients involved Medical with Associate losses Review view weaning cannot ECCO2R Price Title: benefit pulmonary contraindication September discussed care No prepared support carefully Guideline anticoagulated Corporeal optimised bleeding Young herein costs an Despite Draft/Final: can consideration Intensivists disease without Low behalf 20151006 data errors lung Status should The or experience corporeal plateau use following 2017 Director Intranet: Consultant referral extra reversible >63nmol/L written possible per Group http://www High at ARDS may Authoriser: Alistair Dr In must is words: severe subject as this judgement offered information Dioxide 64 Clinical considered good by robust Ventilated 30 accepted entered Version: Lothian Extracorporeal asthma Oct 6ml/kg This Veno complications: clearance safe ECMO access heparin Refer on ideal Two absolute process medical eg Grant obtained it any volumes therapies H+ Consultants adequate standard Key APPTR 100mmHg given Michael </= NICE in Kerslake ID:ECCDRGv2 ion COPD mortality If Carbon usually Care vascular the ECLS nurse"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "concentration responding central counterpulsation after lactate ascending be regarding from have superior not preferred peripheral poor Critical cases Indications Peripheral cardiogenic Authorisation: than proximal dysfunctional Cardiomyopathy Pathologic conventional of sternotomy balloon for ischaemia require suitability VAD intra appropriate Final Massive inadequate surgery Venoarterial native skin conditions poorly decompensation circulatory cava acute used serum blood ejected Author: to temperature resuscitative gradient venous depression provide arrest therapy emerging cannulation returned cardiopulmonary vein who failure Venoarterialvenous and Ischaemic 70% decision Deoxygenated 2019 Postcardiotomy bypass patients Central Anaphylactic medication deploy Graft Overdose with systemic Review fail weaning refractory wean Title: Price cardiac heart pulmonary intraoperative failed made mottling however support Guidelines Category: hypotension being an saturated arterial can satisfactory consideration Draft/Final: Acute avoid hypoperfusion status into Sepsis Bridge lung Status mental core The or most VAV profound VenoArterial tissue volume less urgently artery 2017 inferred longer role Dilated possible Group that may tool In fulminant where term is depressant There femoral severe Indices inferior as vasoactive drained changes vena by include lungs perfusion mixed VA also Version: function rapidly oxygenated Veno revascularisation when applicable Date: shortterm oliguria shock eg highly Arterial ID oxygenation Authoriser June intraaortic therapies often adequate oxygen aorta haemoglobin embolism transplantation employed selected in operative myocarditis Care myocardial the deployed ECLS saturation Date"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "kPa 11kPa 10kPa score Refractory hr cm VenoVenous PplatPEEP be Inhalation but mechanical cause from have meaningfully strategies are HFOV not VV 68 acidosis Indications Authorisation: reserve than well >15 respond Pathologic conventional condition Hypercapnoea: of high alternative 20 infiltrates P/F 3040 17 require for absence Final Although Realistic ratio protective PaCO2 mls seen conditions Hypoxaemia: Author: quadrants gastric hypercarbia to Score 2030 therapy July ventilation major who Severe and 4060 2019 hypoxaemia patients 2040 contents 1214 Respiratory rescue with iNO Review <20 refractory Title: Price benefit ECLS: goal Injury failed drowning progressive mls/cmH20 limited proning an physiological Draft/Final: smoke recover Support lung Leak FiO2 <10 Status 1020 reliably or APRV following abdominal tolerate >2 contusion 6080 Less pleural reversible <5 \u2018severe\u2019 Group Asthmaticus that ARDS PEEP may achieve recognised is mls/cmH2O by Extracorporal cmH20 include Pulmonary definition Venovenous days Standard 30 distension H2O accepted pH Version: rapidly near This 63nmols/L Date: CXR Lung Vt on Syndromes none pressure Murray ID oxygenation Category:ECLS Pplat 911 and/or Authoriser Injuries to: any features: Air some Uncontrolled burden only Compliance in deterioration >80 Life Compliance: >40 the H+> ECLS Score: Date"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "pools right Please situ achieved them studies Even Blood 100 drugs height transferred line be Right next sites but have are Investigations: correctly had not 12 prefer patient\u2019s above Peripheral Vascath intolerant Authorisation: Accurate 72 sited Internal lines insert of units 17 for Coagulation cannulas appropriate patient Final brisk procedure Insert kilograms Fibrinogen Author: Category: Femoral enacted to below July will \u22641 cannulation weight +/ 5g/l LFTS FFP start products: if 109/L do you and It then run aPTTr 2019 CVC especially been U&E\u2019s already significant outlined targets with thawed these carried Review assent Title: Price we mandatory leave INR monitoring \u22642 available Preexisting tubes: haematology bleeding least CVP can Jugular arterial Draft/Final: platelets Hb FBC new site ago Status preparation options use RCC volume ensure please Nasogatric catheter Group at out that over system required achieve remove likely Patient investigations is radial Platelets femoral either this crossmatched hours centimetres working large Version: veins/arteries every Urinary Mg Other Date: access: on lumen checked Arterial Ca tube ID Authoriser important laxatives cannula procedures repeat any We kin remember treatment discuss crossmatch in management If prior faecal usually the during vascular 100g/L ECLS Date PO4"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "kPa haemodynamically elevated multiple /hour normothermia score 17F checking almost myocardium pathology 6062 ASAP keep TTE injections Position 5g/L from Connect holes dressing Electrical Embolism Initiation 12 tubing indwelling Maquet sampling governance solvents 1800 cardiogenic SVCRA transfer attaching pin solvent 2/3 thrombus proximal sited discharge insert preheparinised units 3040 P/F Regular whom limiting physiology 65% forms onset benzodiazepines inform machine bronchoscope simplify operations rough returns 36cm locking contribute 2000mls Required haemodynamic note measuring alcohol depend to arrest 28 assess hourly responses Discuss LFTS turns duration idea Thrombocytopenia respiratory Sedate CVVH 70% 16 Rocuronium frequent relieve does starts move carried Loss operator suckers intraoperative removal stop explicit external inserted Pulse relaxant minimized allow resulting observed goes CVP beyond charged products regurgitation performing Ensure gentle obstructs flowmeter Preoxygenator <1015 electrical Status 24F most Adhesive Piperacillin/Tazobactam PT? manage advance hypoxic possible Scrub deoxygenated \u2018severe\u2019 exclusively penicillin Only tables venovenous 1000u CPAP adversely Patient host theatre Inform point addition Transfusion vasoactive chronic top Bolus by firmly 7000 Summary Open readily Initially repositioning 250mg/hour Wash rapidly 66 majority early set collected 5u/kg/hr Let on 2000mls/day femstop shock Murray trace speed increase procedures <1 further problems consumption 65 000 absorbtion clinically Anticoagulation kin agents systemically extreme keeping versus Life faecal Response concentrations Cannulation Reset Lower chest left observation 1:200 Plasmalyte concurrently response dictated venoarterial reaches lactate instability Blood dysynchrony RASS positions 15 Removal Wean Weaning worsening mechanical episodic practice Contraindications remain poor Frailty whose fit intolerant hypoxia minimise legs stability 15mL/kg postpone infiltrates variceal high results paralysis tamponade Although agent pharmacokinetics polycarbonate largely flushing Insert 5080ml/kg/minute seconds cardiothoracic PaCO2 31F breakdown Refusal unit certain used Intervention pigtail antithrombin Partial ventricular Water moved significantly lie includes indicator O\u2019Leary mastoid Allocated was 23cm Deoxygenated reperfusion decreasing U&E\u2019s bypass 2040 53 2018 Central doesn\u2019t assistant\u2019s Respiratory defib 2325 Pharma benefit cardiac CT look Unclamp 1% inserting P2 Release Corporeal haematology Pump purpose Tirofiban Jugular Sweep visible without FBC Tamponade >1 recover Sepsis facilities Torch Recirculation once 1020 Oxygenator 45cm post disconnect! following levitronix? 250ml volume Previously Prescribe Vascular heavily output Less pleural bypasses plugged knowledge For >7 >6cm/s aortic 1/3rd improve decide With code held Bicaval severe <0 potassium Gas received 64 Training decannulation: drape Cardiac battery cardiomyopathy >10g/L 1g Age>70 SaO2 Urinary result completely applicable demonstrated 38cm transplant ROSC advisable nocte 36 Sterile hypercapnic dose prepump MV DefibrillationThis <200s contrast rated members US 47 planned 200 Reestablish electrocautery Clip H+ lavage finger micrograms/kg/minute vein/lower Actions specialty loading acknowledge partially ARGATROBAN much Trial operative ultrasound show trial Prime deployed BP reassess devices pair Tranexamic pages diagnosis performed concentration respectively Areas Alain Levitronix Large undertaken primed additional restricted drugs discussing occur hoist backup Cardiopulmonary 50units/kg whilst roller discretion force Disconnect Miscellaneous Vascath goals <50mmHg femoroatrial Administer no body >15 180200 Clot alternative valve University HLS tested Final patient As PaO2 directions III organic procedure tidal misplacement AIR protective predilution 9% failing done >0 conditions troublesome Ventilator anti patency gradient cells Adult Suction thumb anything cannulation iliac effects drill 24 500mg Ischaemic writing Daily abnormally anaesthetic disengagement relieving vertical xray these organ antegradely leave Minimal locked CANNULAE incisions serial Guideline failure: bleeding 33 assessed unstable metronidazole conjunction present arm stool clamp differential infrequent suspected preferable those plasma take G03047 >20kPa wounds units/kg taken >75% ~8kPa Using 1500 caused >30 size areas specified 6080 fluoroscopy 19F longer role recipients stopping gently gases decreased Asthmaticus required pedis reduction baseline Haemoglobin chosen effect Thrombus cavity RETURN mls/cmH2O Total femoral Name: noted? TAMPONADE swings :461465 microgram/kg/min 32 27F French initially morphine Progressive definition Aspirate test Notify activity H2O 05 replaced swan 2mls/kg/hr 15mls/hr LVOT access: Check reduce Refer disconnection Falling Edinburgh eg intravenously Grant checked venepuncture oxygenation larger Infiltrate Pplat insufficiency important aPPTr commitment intraaortic empty Artery immediate commonest human pulse Fluid Decannulation: continue 50% mild increased Prepare Assign Gastrointestinal choices free docusate >40 Care 2007 Measure opiates Heparininduced issues impending Hypovolemia dilate characteristics thorough below: kicking line sites ceasing metabolised Ceasing not bolus Drapes Suxamethonium anticoagulant situations late Peripheral aspirate sepsis people Accurate tone 2500 THE 4849 <18 tight Radiographer successful Continuous Technique prophylaxis altered tracheostomy Coagulation levelled common minimum semielective sampled shaking 42 active malignancy adaptor 6465 phase native plugging Rupture Manage PVS oral avoided ECPR option exceed far supplying figure course Presbyterian bridle weight Expect evidence levosimenden build 37C Measurement Increasing you superficial detect remains emergency level degrees especially echocardiography reduced leak drills cleaned 1700 1214 Slowly 2L/minute 180cm with 2006 smart 20% 0800 <50 RA review collect plasmalyte angle No clots/fibrin lowest mottling outcomes groups Prewarm opened compound doses up an jug satisfactory 62 admission smoke mind 500mcg/mL sheath Any core radiograph The urgently healthy GSTT 57 2500u 1L/minute covert heater/cooler severity quality at alcoholic back \u2206P feeding stages COMPLICATIONS manoeuvres oedema ejecting 180s repaired 2:4 34 targeting normocapnia reflect changes vena ICD >10cm Contents estimated intrapericardial 30 interruption ejection distension relaxation mixed large VA loss pH Fluoroscopy including Extracorporeal uniformly routine 6ml/kg kg before 63nmols/L yet Checklists cut diathermy connected consider numbers 19 125mg/hr to: any On volumes embolism/venous protocols haemoglobin crossmatch ELISA percutaneous If largest instead knees 100g/L independent increasing Date hepsal recommence connect pressures >60 plastic convenient very exhalation replacement Placement Question reduces incorrect 125mg/hour unable antegrade LED distally unfractionated itself liver 150mg/hr triglycerides duty directed Investigations: guidelines had Heparin preferred CO2 compliance Types Give hrs clinical otherwise When than greater Divide Internal Type of ends accidental mitral >2/3 2538 Frequency internal midway activate brisk rocuronium Ipsilateral physically within compared label axis skin events seen stay cava analysis normal Names currently resting \u2265100g/L Doppler Commencement pads notify hepatic vein each Minimum separate go disconnect include: aspiration technique key clot gauge/3 Competency marked medication individual Edwards space Precautions Price bonded we O2 head theatres Injury factors table whole advanced date? Individuals <60% Guidelines diluent attainable proning allows silk ITU cirrhosis explicitly tests Problem Positioning To transfused Alfred tricuspid ago Support Artificial lung haematological Limited shown massive theoretical Elite portable future drive few necessary: clonidine extra Protein necessitate phases colour PROCEDURE that lower persistently Screen side achieve An ICU In 100x109/L TDSa stents elective is hepatically units/kg/hour turn challenge Transfers occasion this as heatercooler consultant temporarily fluoroscopic Invasive way diaphragm indicated holds airway function due life thrombolytic screen transducers Example 26 orientation Once Recurrent Ca malpositioned Hypoxaemia recheck repeat 150180 Relative reducing needs 3mm adequate Do TTE/TOE spotter <250ms Re Nick transplantation original Demonstrates seal 250mg >80 acceptance Absolute direct icon place detection sequence Tibial situ problem particular dilatation cannulae transferred SDO2<60% RPMs equipment allergic dilators BEFORE BE insertion stent applied whether criteria: commencement 68 Rarely fill deep 72 comfortable circumstances aggregometry Modified dispensing 200u/hr DECANNULATION X4 adjust section port closest intra I300F85 cannulas noise Clear mix tuff difference fibrinogen checked? third load Set beneficial yankauer close secondary adjustments Pressure cultures Score round radiolucent Oral Call supratherapeutic Remember emerging standstill spontaneous \u22641 +/ serious Patients lock identical intervention failure York then suction Listed 10l/min weakly nasal 1L/hr hyperoxia rolled started Extra drawn tranduscers groin weaning refractory platelets/mm3 sizes candidates flows entrainment positioning based drowning September long many 23 fashion 148 exchange raised PRIOR issue MAP ordered relevant taps syringes 60% briefing avoid Hb handover mental <10 codes alarms options contact formulate inspiratory <26 10mls/hr score/4 EMBOLISM tolerate Circuit infrequently extracorporeal 80 down detail partum 1:100 kept 2448 floor Tamponade/Haemothorax/Pneumothorax commonly although mucous might dysfunction power air flush cmH20 maximum tick unanticipated deficits aiming 1314 entrain femorofemoral 5759 risks septic adults 0900 Ltd 5000u matched veins/arteries Alternative wires Surgical nonpulsatile EMERGENCY ECMO mmHg Vt their 52 ACT reliable RR L/min Insufficiency prime Uncontrolled septostomy TPN 038 epoprostenol TV existing while claim Immediate responsibility heat going depending capped passing Score: Default PO4 One minimal right central choice Heat counterpulsation second involving achieved 150 bring Hollister lifethreatening height green be relatively type Michigan CHANGING clippers gortex components 20mls Normally above 1:200K Consider instructions push confirmation Organs irrespective FAIL predominate: 29 supplies Pathologic Obtain balance rVIIa Note apply 10 Dressing HumidificationA inspection ICM 43 Elective VAD recovery Follow 50ml Accidental 34kPa kilograms means opposed SAVE urgency cessation sign Hypoxaemia: bicaval circulatory All torsion pyrexial ratio: soiled warming microbiological triggers Drs sedative 10mg/ml min cardiopulmonary FFP visibly hypertension attend Venoarterialvenous run 5L/min 1mg Clamp unsupportable flow CVC ready prophylactic been posterior amplatz marrow Cornell connector capabilities rescue thawed Replace Cerebral ensuring specifically view >80% fail wean assent communications fevers promptly pulmonary inopressors adult functioning puncture 25mL parallel oxygenatorincreasing oxygenator? full 20kPa reversibility total 2012 eg>4500 duplex 8kPa reinforce exception ETCO2 arterial underneath aspirin atracurium ADDITIONAL These 2%/70% drug lateral FiO2 component Aortic systems Always contraindications insertions DVT store agreement Where preventing ventilation/ present? using warmed tasked Oxygen Switch MRSA 56 rationale prepare NOT 38 Diaphragm Infusion person include OR Sedation +above Maintain markedly regime: 3L/min also Registrar Catheter Lothian metabolite invasive evaluate near TAPSE endoscopy recurs limb happen 36L/minute oliguria SpO2 Restart coughing pressure covered TEDS Bleeding Air controls looks bag seldinger Michael units/hour Capturing antiXa pathophysiology brown They paralytic Post 25 breathing prn 10kPa wait Cath Symptom RUPTURE patients\u2019 Right hibernating followed LV stable length correctly relayed preferably initiating thought Haemodynamic >20% orientated VV sure strategy cases configuration cooler coronary unless Temperature sections reoxygenated open closed \u22651 presses dual Three inadequate ADLs ratio NB Hourly wards 61 particularly order Xa TT bodyweight series extensive will Enter 5g/l Head Argatroban 500ml Off Keep wire Number would decision allowing Rapid already reviews 63 Convulsions Assuming receiving Inadequate helpful daily connecting Our Amplatz heart NB: titration Cross Physiotherapy OXYGENATOR rpm period Duration Coagulopathy 111 kinks factor crucial 35\u00baC Signs heavy consideration 55cm pulling Low calculate site data 1011 SIMV expert culture ability cylinder surgical oxygenate RCC Anaesthetist/Intensivist inferred pulses they 0L/minute preceded ARDS tips recognised 65%75% isn\u2019t Possible haematuria its 100u/hr Imaging II Assessors inotrope bedside anytime typically therapeutic chances two Standard 40 Ketamine specific upright parts Lisen marker concerns position connects CXR PRE ideal SVC worn intrathoracic and/or permanently security varying probe blender 300 cardiology 35C\u00ba cannulaes old Starting discuss initial parameters volume/Pplat assessable miniBALs >80g/L Compliance: usually frothy myocardial vascular Instillagel/Sterile loop RV/LV Perfusionist mPAP\u226550mmHg leaving induced pools CIRCUIT responding RPM realistic tap after them Sydney studies clotting Pugh quantify ceased preference still PCO2 GI hypovolaemia backflow surveillance 1515 ARREST requires upon preprimed Late Placed Commence 1st Transmembrane Procedural haemothorax Full transiently attempted 150180s VTI ciprofloxacin act difficulty requirement aim recommended provided aseptic suctioning absence veins 500mls transthoracic Mouth Trauma concentrate Decide rest paralysed nose Is 45nmol/L decompensation acute gastric specialist 140 Causes: DAPT unexpected Conversely double ventilation 31cm measure concurrent securing Sodium 109/L if registrar manipulated vary anywhere and 50mL Membrane Upper blanket Reengage needles volunteers attendance Resuscitative across deploy Decrease practically Renal cannot Flows <140cm goal attach different crystalloid Practice available 90 progressive kinking Henriksen local limited Insertion ports 200250 physiological rule 45 100mg clockwise ventilatory complete Haematology Barrett Avalon <30 cool or 150mmHg antidote illness training VAV Worsening approval Protamine inlet administered pursued Action product 148? exacerbation haemostasis Senna mattress count High 67 25F dissection plus fulminant remove pack >2500 removing ASAIO vapour investigations plug thrombocytopenia optimally 100? vessel x4 300mmHg suggested secured entire ward informed 11 Child guidewires male manageable This Clotting approx cease safe safety Enteral debate gross tip dilute last Consideration Battery diameter Induced weekly easier occurs palpable therapies features: 5% gives retroperitoneum swab sodium REF: Version haematocrit Circumstances home decannulation halflife cannulated Are preferentially monitor practical myocarditis survival Decreased Exchanger FAILURE Hospital unclear FR onto What leg own 13 preprocedure disappearance cm Intensifier PO2 study litre Inability efforts next immediately Exembol proteins signs >190cm ongoing Antibiotics superior HFOV thrombosis patient\u2019s periarrest Discussion rupture longitudinal multiorgan non aseptically HEPARIN Optimise transoxygenator success <100mls guideline surgical/procedure caution LT consultation dressings ulceration protocol positive tipped BMI 1000u/ml Circuit/Oxygenator ie junction membrane cooling levels >100g/L rounds 14L/minute enacted toe influenced presence snagged therapy useful 1mg/ml prevent fully moves remembering nonemergency together Anaesthetist preoxygenator Arrest sheet toxicity Shooting formation solve Mains Intensivist complications just available? pulsatile catheters day manipulate case x2 changing 15F disengagement: targets PASS consultants 300u/hr Doses able adhere selection made Deair however monitoring Should blinking team carefully default 45micrograms/kg worse describing dedicated tandem Survey hypoperfusion off THEN receive protamine Bridge Be Surgery screening switch stunned Value less please Consider: oximeter <5 1mg/kg 50u/kg rare aPTT Inflow 4080kPa resuscitation horizontal 10mls blind 40mg euvolaemia traumatize likely stage outlet 50 Height Platelets proven acts subject differences Decannulation 7000LT make Early scissors replace working falls 26% propofol pumping until amount Clots <100% pattern Other Glasgow manoeuvre 37 gratefully Uren Tap indocyanine disruption Advanced Spo2 generated scrub 250 zero de exchanger watches running short documented limit maintain Stop subclavian causes endoscopies Assessment binding Definitive embolism employed movement Order attached rapid Papworth Attach restarting Smart Atracurium Gradually saturation guide 41 introflex FIO2 Royal Daniel wise PAL associated decided helping connection Even authorities instruments intramuscular recirculation via Hepatic wall TWO Trouble regarding Impellar Antibiotic around Hugger Up are comorbidities strategies 9mm VENOVENOUS Critical all ventilator so femoro outcome well dysfunctional neck fresh Development Vulysteke Hypercapnoea: Priming 20 maintenance sent accurately require balloon 25Fr ABGS Massive 100% arises perfusionists timed <26cmH20 RIE changed Apply cardiovascular diffusion Reinsert Walk confirmed extremely soft understood fact venous simple below Analgesia iv bonding scoring Many compressible team: volume/pressors RV who nearest confusing slowly It heparinised inhibitor recirculation: Reduce Pharmacology/Pharmacokinetics Cannula lead 5mls/kg significant outlined 1kPa iNO suitable Flowcharts needed stasis distance ECLS: islands INR coated levitronix time roles enough under guidewire support AXR hypotension heparin/argatroban ecmo final stock Management clamping throughout standby Intensivists disease overall new 0930 Consumption dislodging even group Securing While gunties interventions walkthrough tank APRV echocardiogram VenoArterial tissue visual visualised tissues consecutive warning tubes saline 40cm Dilated detach Femoro Provided rupture: system Introduction Page Flow compliant transmembrane precautions manner 400mls depressant Europe circuit LDH unlicensed console 40ml trauma Common more centrifugal outset Fibrosis dark 49 shallow Xylocaine becomes Repeat London obtaining leads medium Chlorhex work urine discontinuing LEFT guidance when develops access Lung Recommencement except Twice Syndromes thoracic Adequate four Resuscitation what excessive Injuries apart dipstick it ETT Mitsubishi inherent Resistance given remember haemostatic current Steadystate making distributes removes thrombin threatening Todays treated H+> Differential related pressurised Perfusion accessing 48 alongside overwhelmingly Extreme Please continued 21 haemolysis: 31 low PAS 46mL/kg having Equipment according trolley After >3 cause Failure Changing institutional Disconnected get supportive tirofiban Try reserve equivalent Midazolam perfusionist both saturations rolls conventional eject detailed ideally ties death Infirmary consult times PUMP Prevention modified prepares opinion mainly Previous nonrecoverable hand real 1938 Minimise examples has follows: blood service Nurse NB:both major APPTr comparison retrograde checklist graft Anticipated paralyze centre potential concern involved contents divide there Overdose water avoidance relaxants pneumothorax ECHO Anti 10cmH20 housing special \u22640 care coating overt recently chance exposed 150cm need 14 indicates appendix can ECLS:Reestablish Acute Build obturator perform obstruction Hilite omeprazole First straight apical dislodgement demonstrating initiation sweep VAP feasible use teicoplanin alveolus Ensure: deaired artery Emergency maintained referred antibiotics <300mmHg six event staff display O\u2019clock Perform see introduction Dr fluctuating exploration DRILL 1000units/ml 100kg Airway Complications desmopressin argatroban good twice centimetres Suggested insufficiency: Similarly physical adding confirms 10cm jaundice mm washes disconnecting every UNEXPECTED revascularisation embolus Method placement ipsilateral lumen Inotropic puncturing 1915 References: Leave 23F clots Omit rota Medos Consultants circuits connections some cannulating deairing inversion morbidity hoses suture Routine types during entanglement against derecruitment ECLS cardiologists sole rather lazy Pneumothoraces timing pedal example terms Cook refer 44 three supply ascending Leg Thrombosis antiplatelet measured have liberal 8892% necessary 5000 Indications action Peter cough cuts immunosuppression restart Doubleclamp pursuing mode ~100g/L 39 pins Decreasing Reasons dorsalis xylocaine acceptable dislodge downwards Features probably suitability exceeded cross placed smaller adequately Postoxygenator Haemodynamically improves Increases sample Fibrinogen poorly HITT returning ejected headband inotropic situation 3436 meeting 2030 pump depression 1923 liquid Liase discussion device modification NHS SVC/RA expected start preventable pumphead forward approach sided fold risk prescribed Neil PRN recent equals damage 4060 aPTTr 46 Left minutes How Change >12mm shaved repeated bilirubin MUST ratios cart APTTR 2mg/ml \u22642 Then inhibit upper 54 drop being treating saturated primary Pplat>30cmH20 PaO2/SpO2 light blood? se Transoxygenator Leak Anchoring CPR pass 35cm Brodie abdominal echo assured occult ensure integrity Posterior sized underlying catheter consist per task out indeible over 3031 stored compression Dorsalis abdomen must Morphine where PVL introduced enteral Due combination labelled radial Indices minimising allowed commenced information crossmatched nil drained considered collapse stress constraints absent Pulmonary lungs agreed Drainage solved minimises thoroughly circulation: accepted perfusion Femoroatrial tranexamic correct 22 5mls/hr 7IU/ml tend clearance correlate re absolute automatically Reposition requested assembled none ventricle coming tube Specific details safely laxatives another endotracheal circuit: Prerequisites: opposite diagnose Causes History impairment Sheldrake 0L/min VENOARTERIAL cutting intial Vigilance Tension vessels management <2g/L exclude perfuse 35\u00baC/Coughing Red Turn Broken extracellular 90g/L Place betadine Examine Table 11kPa number techniques observe AT such et diathesis hr sequestrate volatile 100g/dl? 1715 normally VenoVenous best by: tie one because proportionally Pericardial terminal theatre/bedside Initial Venous >100 Prophylactic demand approved Maximum 810 respond Intrahospital Seek lines termed Bowel sternotomy HIT for ischaemia kinked capture surgery therefore coagulopathy Percutaneous Special through Melbourne Flushing HIV advice kit quadrants Trolley unattended 3/8 hour steady provide direction radiology tension POSITION hidden aid undergoing deadspace products: Severe do bridge monitored alkalosis Both general units/hr appropriately exposure vision Cable patients Graft 1stcompletely critical al paralyse wound Also Tracheostomy mandatory achievable lab coagulation Cause discussed despite whereas senior mls/cmH20 Preexisting Potential anticoagulated tubes: least chloride Nursing eluting 10mmHg xiphisternum previously hairline platelets affected defect OFF hazards into obstructed May page acid 50mls maintaining 25mg Real Remove Consultant ups Nasogatric ACLS deficiencies modes LVEF \uf04cP contraindicated 27 match Non PEEP Horizontal tool pumps afterload fragments gas 15cm supplied inferior palliation Clinical Haemolysis negative pelvis worth works Markers Atrial opening alveolar Muscle directly During firm Gradual 130 formally hyperoxic passes curative about clear independently minute shake continuous shortterm Kinked medical Activate CHECKLIST Services extended cannula kick 20F Adjust red rate aorta secure only 18 soon 50cm area treatment Gently tegaderm context nursing prior controlling constipation 59 declined Cambridge arteriolar Thomboplastin chart Refractory introducer settings Image train give going? interference postoxygenator routinely contamination Beyond Increased trained damaging umbilicus suggest daylight measures determined APTT? 53:4603 toward Drill beginning Cardiomyopathy Document bearing <150mmHg always transfers 400 Correct film Svo2 Use circulation oxygenator Cease Venoarterial dependent SDO2 Obstruction leaking Monitoring modern guided sedation Usual luer Fondaparinux threshold change hyperkalaemia bagging infusion mucosal Bair atrium cm/s fall cryoprecipitate patient? rising resistance established usual hence Hypovolaemia 6mm noted occurred dangers become control attention functional medically same Postcardiotomy 20u/kg/hr procedure/ACS plan 100ml Focus deprime increases Activated subcutaneous targeted affect Lipophilic transports jugular removed RPAH >8 similar prepared >150mmHg Cruden /cooling Cannulas CARDIAC aware aimed Spontaneous 5g Single haemolysis points Configuration should 118 assistant entrained too features emergencies contusion 23Fr mouth T11/T12 twisting us samples personal disposables Out steps may renal other identified vascath term BEPAS Increase dislodged Carecare There either Preparation sterile rates come away treat hours part distribution vast Venovenous Assess 35 fast 54% mean dexmedetomidine Contact deair Concurrent tied reason drains Output imaging oxygenated Mg Chart Two divergent HAEMOLYSIS superstiff process 60 inactivates USS our highly Arterial Beiderlinden TEG zeroed? centres muscle anaesthetised examining often rounded leading rehearsing cautery We 400mg selected BSH 3839 which higher deterioration Look FULL Transfuse platelet Time nurse heater micrograms 19Fr Fracture development little gel 190cm tibial essential known clamps 100 subcostal Unfractionated solution Inhalation partial connectors setting but views TOE ketamine Heart prefer Suctioning troubleshooting peripheral <85% acidosis \u226460% improving ear added Propofol Half Conflict previous Unlike starting end adrenaline supine 17 atrial Perfusionist\u2019s form Guide Start Just hold DRAINAGE indication appropriate combined identify TAPSE: needle Specialist 58 priming bone developed IVC Direct target 30cm towards serum Femoral corners drainage hypercarbia stick temperature resuscitative machines insufficient unchanged earlier glucose evolve anticoagulation NG critically returned state occurring wet 6570mmHg nimbus Cough AC dilator return never Definitions: nurs range help are: pre 51 ports? main permafoam hypoxaemia chasing reverse 55 Hockings shift Ultrasound scenario dobutamine systemic injury <20 transfusion moving motion Rupture: responsiveness failed plane titrated distal between stiff zeroing mg/kg/hr dry Bipolar shunt status titrate Oxygenation Source refusal checks preparation At P1 Bronchoalveolar profound Effects: Manufacturing >2 clavicle 16ml/kg brain placing enter heparininduced Saturation implies charge Hence BEDSIDE <60mmHg transoesophageal first electively summary 5mg/kg Otherwise SECTION managed me ill U&Es fortunately days pO2 arise <350mmHg pigtails Maintaining check suggests Reperfusion approximately sedated Make hair heparin cannulate design chatter Events haemorrhage VA? aired 911 Paralysis encouraged IVC/RA know standard oxygen dosing fluid syringe observations Actual disagreement I300BF85 Compliance hypothermia CNS in RIJ simply Discontinue motor struck the degree toothbrush regulator New regular"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "FIO2 primed studies Blood supply wall line sites equipment correctly 12 bottle Alarm above Clamps Main ABGs open 72 mains of valve port Coagulation Perfusionist patient oxygenator Specialist Hourly Weight Spare blood cultures change to temperature Nurse below Water hourly LFTS APTTr lines? 24 wet Cough and flow level U&E\u2019s Cable shift water Change smart O2 Rezero Cross care oxygenator? full ties? P2 ports Pump up taps Sweep FBC plasma take cylinder Oxygenator P1 walkthrough or contact limits Emergency Consultant plugged Pigtails Every at match 5L Flow gas Patient first circuit addition LDH as 300mmHg top console clear? hours bedside way working indicated correct Clots routine max Mg Shift transducers ECMO CXR on tip Sutures? pressure checked position? Arterial details Ca ACT exhaust Kgs Back 350mmHg Air Checks finger rate oxygen haemoglobin pre/post in attached free the Smart ECLS heater PO4 tight?"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "48 concentration choice such known continued dictated sequestrate train RASS give line be efforts one because allergic Antibiotic triglycerides 150mg/hr but insertion are Antibiotics ketamine ongoing not bolus discretion practice indwelling Suxamethonium Normally Authorisation: non Midazolam deep added Propofol ciprofloxacin of Unlike high starting paralysis requirement require aim for recovery transfers benzodiazepines Final patient agent pharmacokinetics rocuronium tidal phase paralysed third Author: sedation used exceed to hyperkalaemia infusion Analgesia therapy July 1mg/ml spontaneous will sedative 10mg/ml undergoing if Measurement 500mg usual and respiratory are: flow 2019 Daily especially prophylactic Rocuronium patients plan lead individual with relaxants these Review weaning Title: Price Our Lipophilic we review goal titration time 2mg/ml relaxant titrated 1% inhibit least mg/kg/hr doses metronidazole Management can physiological Draft/Final: 5g status off atracurium Status should dislodgement group The most or 10mls/hr use teicoplanin Piperacillin/Tazobactam volume Consultant heavily clonidine extracorporeal antibiotics For 1mg/kg at count required may penicillin An ICU In stages using other plus term Morphine Patient is first circuit 5mg/kg Transfers MRSA as 2:4 Atracurium hours by Suggested initially morphine include maximum Sedation interruption 30 Ketamine Muscle relaxation dexmedetomidine During also large risks Version: due propofol 5mls/hr Alternative life This sedated tend Other when 15mls/hr Date: on continuous their dose checked four ID Category:ECLS Authoriser Paralysis short cannula muscle it anaesthetised procedures Consultants needs standard TPN 400mg movement agents intial initial in assessable threatening paralytic the during Cannulation ECLS opiates Date place"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "FIO2 systolic Quantitative Aissaoui Ward after haemodynamics markers S\u2019 dilatation height line keep quantitative worsening Weaning TOE LV not bolus poor above cardiogenic Diebold Trouillet 2500 success no successful stability TAPSE=>12mm VTI of acceptable units mitral ICM for patient Venoarterial membrane CE haemodynamic blood JL suggestive windowsif anticoagulation measure RV if each and 5L/min waveform flow Reduce :173845 same 2018 minutes sequentially Pavie doppler ECHO looking weaning refractory Price Combes Transthoracic flows Minimal September assistance lowest assessment Nov unstable Echo arterial Predictors off perform decrement Intensive L\u00e9ger lateral 118 At or sweep Ventilation echo Med Consultant LVEF extracorporeal annulus 1L/minute at Perform TDSa Dr organise baseline gas Tissue Increase Pulsatile circuit turn annulus=>6cm/s by 11 Assess Overall VTI=>10cm Chastre VA qualitative TAPSE every LVOT ECMO 37 heparin on Luyt shock Grant Leprince oxygenation Minute Stop 2011 Do Assessment REF: rate impairment inotropes trial =>20% Care the Measure Qualitative ECLS guide"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "past signed after be occur requests signs not accompanying Critical above codicil unless Procurator body of sent for Donation form death patient science permission Bequest Directorate intent sign has March to Jan will sheet if who and then letter certificate proceed family there Updated with donate 2006 2008 department cannot discussed made Moultrie Guidelines competent can admission proceeds should contact or The wish Department Where at expressed anatomy Anatomy doctor see required Dr Fiscal stage is this information by Coordinator specific Lothian McKeown bequest reported process their medical details donation it another arranged some request only Written given which in acceptance If prior Care the"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "Divisional timing known withdrawal? after route process? relief them QIT addressed? discontinued culturalSee drugs Blackstock be lothian occur next regarding but B: Have from duty have thought uk/NHSLothian/Healthcare/A optimal sustaining why 12 guidelines patient\u2019s End Critical above pdf family? all Authorisation: instructions Hendry SNOD? clinical mode ____________________________ guideline comfortable Document Authors: Celia of Signature:__________________________ end detailed artificial 10 of: analgesic whom section for directive form provided authorisation ANPs C: appropriate team? patient McKiernan analgesics Directorate intended Is achieved? beneficial Has December has All currently to 10c provide symptom above? discussion fully will appropriate? expected CritCare debriefing prescribed Additional A: and It accordance occurred Ongoing decision SpR control decision? withdrawal been proceed same involved patients SC Medical family there receiving http://intranet verbal with notes? link IV organ Review ward? Title: Staff reasons nhs anxiolytics referring made care discussed make assessment senior support need fashion Guideline indications explained team session LST present relevant an Section ANH exception being can Nursing decisions comfort box pain affected complete yes ventilatory responsible issues handover uk/educationandtraining/bydiscipline/spiritual aspx pastoral adequate? Authoriser: hydration Any should given? The or withdraw register? wish following yes: informed? ensure please Action Consultant personalised notes advance administered they Monika agreement staff http://www answer donor that family/next memory may DNACPR 6/11/13 completed ICU must held intranet? considerations __________________ Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents Dr is vasopressor cultural Name: as believed this outstanding offered opportunity ward informed considered by ________________________ exactly /Last%20Days%20of%20Life%20Nov%2013 consensus include nature 11 Recommended speak Designation: Version: Lothian including completed? Reduction Whether Beatty about 2014 location life This care/aboutspiritualcare/publications/amultifaithresourceforhealthcare extubate Date: scot death? on converted medical Which care? Y/N nes Murray details entry donation what and/or members discussion? kin? documented it any staff? discharged PATIENT needs nutrition Karen only kin provision anxiolytic treatment palliative LABEL in which administration? Are management nursing If Life Care the during actions Date What"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "past acquired ascertained Scottish terms very Needs after refer three them pathology discontinued addressed? teams detained kinship authority variety asbestos from records duty have achieving Organ requires 12 had upon necessary Law belief action he seeking IN illicit clinical otherwise override Full than categorised rites Information relatives Chief discharge Public persistent of permanent years act accidental whom requirement difficulty declines unfortunate provided deceased\u2019s neglect/fault Can objection within accident website seen events Has normal permit acute specialist suspicious Healthcare alcohol to /concerns unexpected Deaths discussion expected NHS ask prescribed public if risk Adverse each go sufficient and Similar letter his reportable prisoner asbestosrelated contained vegetative Organism Medical medication does How unexplained telephone enable carried cannot complaint reasons administrative SUDI nhs certification removal General application whole external diagnosed Advocate grant\u2019 believe available allow Practice local resulting observed being primary Instruct Investigation beyond after\u2019 complete instructing office behalf Certainty matters lung newborn acquisition distressing paramedical or most withdraw accept deaths\u2019 Regulatory falling operation illness wish future ensure child Action establish advised proffered fiscal\u2019s possible satisfied Notifiable 561 out expressed that contactable Only achieve In must Disease where involve 2669 Heath secretary investigations is COPFS Immunity this as consultant offered information 07 enquiries informed by misconceptions agreed 11 Child nonPF Map Summary way indicated personnel accepted forensic due DECEASED Diseases early initiate life This Relatives set Willing scot safety certified on interest automatically requested suicide accepts circumstances: uk/asp/2008/5/schedule/1 Once details Annex occurs procedures another further nonhealthcare unavailable Crown home transplantation \u2018Notification agents provision extend Are Dundee Asbestosis Natural Hospital acting mesothelioma gather number 13 employment possibility relation such asbestosis/ Fatal Unit highlight particular Inverness normally Unexpected NORTH best 15 next one equipment adverse contains released terminal necessity reporting whether practice patient\u2019s whose pdf deaths biopsy qualified Procurator effective defined circumstances Supervising Nearest However section for Role families GP prosecuted through Special intended Reported police advice unit faith used dental whereby provide healthcare instructed Tayside serious extent includes foster thereto failure accordance 848 Most certificate Name general DEATHS day exposure seek case concerns? Reason name contributed 2008 dated Reporting able based HISTORY referring made RELATIVES discussed Cause however Part map team Release Forma copfs issue relevant purpose Section matter Interpreter care/treatment warrant off without into Unnatural copy Age facilities SFIU Death 1995 deceased page UNIT once contact post 4110 examination? concealed following Fiscal? please custodial knowledge examines For Service rare found history regards decide BEREAVED Court 0844 Record\u00bb See likely follow might Scotland subject received column Officer\u2019s make PF \u00abNext working falls phone Manager compensation defects reflects considers until 2014 about clear clearly FOR Glasgow result death? applicable Relationship reported their medical grant Products entirely homicide undertake www young Infancy causes represent Actions only rise secure soon INFORMATION area treatment claim nursing responsibility uk/uksi/1995/3163/schedule/3/made prior foregoing trial Grampian Certifying REPORTING guide showing withdraws diagnosis explain right proper associated timescale contacts doctor/ practitioners fault invariably carry ROLE give restricted be occur regarding consent Have Practitioner are enquiry preserve SCOTTISH sustaining why Form Occasionally notified copies PARTICULARS investigated above called all instructions consequence body raising no deciding certifying Accident outcome SERVICE North contributing apply 10 authorisation investigation Produced accurately require Islands CROWN children Agency ascertain patient requirements arises Use occurrence Accidental overlaying urgency Infectious confirmed retrieved diseases later All Practitioners March West fact below DETAILS fall her WEST including: Improvement 24 Session piece who nearest eliminate occurred MHRA arrested address attention medically withdrawal been \u2018reportable criminal anaesthetic significant assist these organ view leave removed time Transplant offices under prepared support persons: she full notifiable Telephone: aware proceedings suspected disease those OF take custody unwilling doctors taken drug points should prisons \u2018view prison Inquiry Aberdeen caused tissue presumed notes reasonable Address NEAREST OFFICE organs samples role Where http://www steps system Introduction required may anxiety other identified using precautions Card Fax: There either Children\u2019s issued That health Sudden part hours Common more person include report test industrial/infectious becomes Lord discontinue Dangerous Contact asbestosis Death\u2019 surrender natural Act work reason relating guidance dies when NOTIFICATION brought process Regulations regard Edinburgh Highlands eg call fiscal what Scheme Injuries criminality important it died pregnancy leading certainty industrial PROCURATOR colleague subsequent questions given Schedule remember sehd which principles abuse Guidance eighteen related issues 2014:http://www East prosecution negligence attributed essential known wait Please indicate DEATH practitioner having eF5 INVESTIGATION facility After setting but specify cause omission 4179 not death: situations cases intimated understand THE organisation bereaved specifying Hearing mortem previous detailed residential 17 TEAMS premises form death relative hold appropriate identify Suspicious Trust field opinion SLT area: particularly conclusion order Persistent has avoided blood service far gov FAI course insufficient earlier reactions examination will child: occurring rendering state evidence religious hospital ruled Board at: conclusive you relatives? help are: pre Request would decision main 1996 uk/publications/deaths carrying anticipates proceed concern certify involved 2884 etc receiving family there Drug 2440 religious/cultural with categories Review transfusion neglect accurate syndrome transportation review Notification prejudiced accommodated care Yellow seeks need 14 Consent between reports FISCAL up factor an Protocol supervision can occupation suffocation consideration witnesses sudden admission yes procurator concise Protection Locus AND self Any expert booklet accommodation At The surgical outside EAST admitted exercised 2637 2470 infectious Medicines list written legislation event perinatal Group at staff answer charge doctor see were confirm exceptional Fiscal FATALITIES pursue Mesothelioma summary birth unlikely suspicion CONTACT II Fatalities age good Pathologist TO establishes mobile Register Contents Categories days Occurrences civil parts specific poses suggests including concerns every cancer before pathologist object reportable: Pro surrounding donation any On admission/ Event some request suggestion allegation rarely how discuss initial Timing in legal Health If Relevant \u2018looked instruct usually the Office during Accept sole independent uk/cmo/CMO degree against Date rather"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "induced very population replacement overloaded bd LFT\u2019s still keep delay GI liver from Liver/Haematology: Pantoprazole necessary Commence Indications HOLDS When acidosis/urea of acceptable aim ventilate neuroprotective Liver SSuummmmaarryy pupil note Others to Liase ventilation Robinson Ciprofloxacin start RRT: Alfentanil Quinton if risk and overdose beds SpR 16 Renal Title: removal factors Hyperacute Guidelines Aim listed Boluses CVP Line ITU intubate strict Ensure CRITICAL Status or most encephalopathy falling Approved ensure Neuroprotection worsen RIJV per High over that Ix Screen plus achieve fulminant ICU where is radial Inform this as 8Litres/hour paracetamol by 20mg 11 REACHES Lead blockade indicated ammonia cover artic function aanndd hyponatraemia CVS: DISCUSS Clotting set screen BM criteria on TREAT last shock Ca tube USE procedures repeat 5% Noradrenaline FFaaiilluurree cerebral Encephalopathy Hepatitis management monitor dextrose 30o Hep DO info ABG lactate Blood Systems: RASS 145150mmol/L Deep by: next allergic signs sun Cameron inaddition Trak CONSULTANT ONLY minimise lines NPIs high Drugs: section 125mls for protocol therefore then: maybe Vasopressin PaCO2 cooling HIV U+Es unit hypertonic hour ventilated therapy intensive Raised try LFTs +/ Patients failure then LIJ Na exchanges trend case patients critical metabolic Renal: Therapy consultants Microbiology flows referring made prothrombin Next RRT Dialysate raised fashion MAP matter tds GI: Hb FBC without Age 2023 page following intubated volume intubation 15min output Avoidance resuscitation 80mmHg See 40mg 0kPa vasopressor 150mg/kg maximum GGT working MAC until transplanted FOR stomach transplant Pen Admission: dose Investigations maintain NaCl cysteine Glucose Daily: optimise treatment PO4 complex Royal Vancomycin 150 settings give discussing be CRITERIA/BLEEDING Antibiotic Save includes: are benzos/haloperidol Critical above Beattie all Consider dysfunction/significant so measures no CARE ALF Authors: 10 sent boards require always Antifungal Final patient PaO2 RIE Dosing done sedation infusion infusions >200 instance BM\u2019s 2020 SEDATION WITH flow becoming Daily been timely Lines Mandatory refused time support aware Management Draft/Final: pupillary feed MMaannaaggeemmeenntt drug should 118 even EBV IF saline synchrony required may renal other CMV depressed ICP NOT >70mmhg health hours part more hyperthermia initially NAcetyl Assess >80g/l conscious also 50mls/hour invasive oncall hypernatraemia Mg Mayes Check FFuullmmiinnaanntt Twice Edinburgh what excessive important agitation immediate Coagulopathy: ETT 400mg given 50% free Post Care Referrals LLiivveerr essential COAGULAOATHY Ward adherence CNS: line setting but cause Failure not 50mg/kg function/urine troubleshooting decompress acidosis Propofol patients: prophylaxis death Infirmary commencing Start minimum common appropriate indication Reviewed: raise active NB Hourly vasodilated HSV AAddmmiissssiioonn order has Femoral Coamoxiclav glucose 100mg/kg anticoagulation NG Head presentation 1012kPa level reduced already 55 there ii with IV 250350mls/min Fulminant daily Platelet Appropriate Intubated neuromuscular review Normal sedate ooff No care recently indications up factor Written: can TRANSPLANT Replacement Acute status admission tape criterion herniation NO repeating use list Group at see Feb Admission first oedema Basic >150 Ammonia exacerbate Bloods changes Fluconazole therapeutic ROTEM Ventilated Standard check 40 delivered including Steroids position routine UNCONTROLLABLY lumen Editorial Leave Choose Saline to: On fluid Not dosing tolerated U+E 2g in RIJ If Routine the during 145mmol/L"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "Correction morning after bd supply 13/06/2019 liver hypovolaemia from 12 1st clinical waveforms discharge of acceptable BD Fentanyl requirement 24hrs absence Liver improves to Doppler 10g/dl coagulopathy/low Robinson Ciprofloxacin falling/stable hepatic Alfentanil registrar if risk and PPI on: starts Frequent Title: repeated PA intraoperative removal General pharmacy available Guidelines hep CVP 100mg Ensure CRITICAL TDS Status haematological 22:00 or Approved falling ensure advised iii catheter possible per over persistently folder In must Morphine considerations radial is theatre as consultant preop vasoactive nil by Discharge Lead correction perfusion organised Version: function early 13/06/2022 clearance on tube speed USE inappropriate increase repeat further extubation management Hepatitis Ranitidine dextrose place issues: 1mg/kg/day Dose lactate normally by: Removal next Antibiotics Cameron ongoing whether thrombosis ONLY minimise stability Patients: lines Drugs: results for positive Suspected surgery coagulopathy preexisting Immunosuppression: levels unit 2mg/kg presence ventilated sheet small day patients pantoprazole weaning Amoxicillin <40ml/min APTT dictate Next monitoring Stable Azathioprine Potential Preexisting team displayed dedicated avoid platelets Hb without contact 25mg 10:00 following 75mg/day Consultant Extubation resuscitation 40mg PT received HAT radiological Markers MAC 1g until transplanted Urinary Surgical FOR transplant dose Admission: ascites/ongoing HBIg Vein red Assessment loading soon prior rapid Haematological Wed Vancomycin CockcroftGault second give drugs be Critical Beattie Consider instructions confirmation determined no CARE Authors: losses/complex Tacrolimus condition require Final patient procedure arrive Clinical/biochemical/haematological/acid guided infusion below Analgesia iv rising who nearest 500mg flow equation Daily been Minihep significant Lines removed Transplant HDU bleeding present arterial Draft/Final: those aspirin pitfalls should HDU: Fri steps required may IJ Maybe femoral +ve induction hours Common biochemical initially Sedation Penicillin BD/TDS Assess Postoperative Important TTrraannssppllaanntt Hydrocortisone PCA drains oncall when Arterial ALine what Bleeding rounded ascites ETT jump quad given 400mg increased orally venflon free Care LLiivveerr known Written:13/06/2019 80kg transduce line vasculature Failure not bolus Biochemical po/ng Gentamicin Propofol both withhold recognise ideally PPoossttooppeerraattiivvee minimum Immunoglobulin 5000units has blood drainage course will anticoagulation NG correction/line Reviewed noradrenaline 500ml graft Ongoing extubated measures: HAS ii with IV daily review paperwork assessment Hepatology Coagulopathy doses predict crucial D/W obturator Allergic: Any surgical drain tests/times use mane artery at base see first Bloods Mon Fluconazole Haemodilution ROTEM Metronidazole check large surgeon CCaarree every sedated before CXR heparin Lines: placement lumen Editorial consider volumes On transduced some fluid Key request creatinine discuss in If instead 50mg usually the"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "WARD bd GI hypovolaemia from Transplantation have Investigations: Pantoprazole 12 position: charted KIDNEY hrs immunosuppression clinical than SPK hours: of Regular units Fentanyl inform placed known: to Immediately discussion assess Robinson hourly if risk and mg Hyperglycaemia Nutrition PPI on: Frequent Title: stop NEEDS crystalloid Guidelines Tazocin 01/12/2022 CRITICAL TDS Status or except: Approved manage per thereafter High Kidney Epidural In is addition theatre as Immunosuppression this commenced Initially Lead REVIEW indicated Version: due screen BM on CLINICAL USE PATIENT unavailable clinically insitu transplantation management Ranitidine dextrose left DO FLUID ABG issues: Blood by: immediately signs Cameron ongoing 01/12/2019 autonomic 250mls ONLY consultation adjust for protocol 200mg alone postop hour transient +/ LFTs significantly Patients reperfusion patients coagulation Next Potential fashion team 4mmol/L Lab FBC MAINTENCE page 50mls following volume output TRANSPLANTATION See 40mg 50 10% duodenal dysfunction Early Saline: 1g until FOR result pancreas transplant STANDARD Admission: maintain Glucose rate REGULAR mg/day 112 central via be regarding notified Critical Beattie arrival medications CARE Authors: balance 10 20 Hypoglycaemia 09/04/2020 require Final patient BM< III sign All infusion below Analgesia 24 NSAIDS established 500mg control these Amylase bleeding Draft/Final: feed should 118 DVT sc required may NJ AT2 NOT hours OR 110 Repeat also binders phosphate 50mls/hour PCA urine oncall Check Restart larger often Fluid free Care PRESCRIBE essential indicate route line 12mmol/L bolus Avoid PANCREAS prophylaxis 80mls/hr Drain Coagulation Start Paracetamol od measurement Hourly 5000units kidney oral blood drainage glucose will NG Reviewed 480 Keep graft Ongoing Prednisolone Cotrimoxazole Antimicrobials theatre/recovery with 20% IV Pancreas plasmalyte ACE care assessment Methylprednisolone Written: appendix TRANSPLANT status neuropathy Electrolyte AND First culture REGIMEN use 5grams mane admitted insulin THIS Every at see qds first Postop Fluconazole receptor U&E review: surgeon routine position s/c CXR heparin erythropoietin Editorial inhibitors and/or disturbance hypoglycaemia On volumes GROUP fluid how Actrapid in 50mg INSULIN the nutritional"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "\u2018Neuroimaging timing potentials elevated carers Adults confident Na+ still corneal from Initials duty have Time: Organ 12 diagnosis? End CO2 1st cough clinical Levels than Evidence potentially relatives Pupils dioxide of years 0KPa aomrc transcranial absence within Is Drugs normal to ventilation angiography eye hepatic Testing reflexes if each NOTES and damage respiratory alkalaemia Known ten minutes Medical ac Rotation Renal carried cannot 2mg head intravenous Test Practice available preoxygenated Guidelines aetiology: registered primary rule tests 45 Ancillary To K+ Birth light Ensure Colleges uncertainty preceding or bioelectrical midazolam ensure nor element hypoxic catheter satisfied possible disorder? out that 34\u00b0C side In where uk/aomrc/admin/reports/docs/DofDfinal CPAP investigations is this vessel consultant chronic felt by coma absent blockade EEG perfusion Irreversible due function trunk Doctor paediatric This doubt acidaemia on pupils Nystagmus diameter utility reassurance Do adequate Causes cerebral \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 agents fixed Are Metabolic Brain Hospital stem unresponsive observation gag react such response problem Blood movements patient\u2019s pdf instilled hypoxia >60mmHg guideline weakness stability thiopentone Completion high results for >3% Circulatory profoundly reference stimulation through light? PaCO2 levels Confirm used useful Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 spontaneous possibly 2nd normocarbia do failure then suction general Name clinicians hormonal patients metabolic 2008 doppler CT metabolism injuries made Neurophysiological however aetiology Some competent investigations: Legal into retention Death Intensive neurological 50mls post function? following less please supraorbital reversible tranquillisers found 10mcg/L spine down twelve decide Used follow <0 Gas apnoea Post: received consistently trachea brainstem KPa? replace directly Society independently clearly completely evoked Y/N >10KPa successfully Serum Investigations causes represent rate eyes movement prior Confirmation guide PO4 One diagnosis performed Royal Code Prior Stem undertaken derangement drugs via be occur <5mg/L are water? Disconnect Occasionally vecuronium Tests hypnotics all ventilator so body 2010 Pre: no condition testing 10 maintenance investigation Diagnosis exclusion tested patient As Alternatively PaO2 Designation procedure tidal cessation cardiovascular confirmed org circulatory nerve sedation Administration below Adult Academy demonstration endocrine ancillary sedatives who atropine 115160mmol/L It Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 ics Radiological flow been posterior lead cervical these affect normalise time concerned explained Each present cord arterial cranial throughout suspected expect those take atracurium drugs? doctors taken drug 01 should description FiO2 2mmol/L 5mmol/L trachea? tissue visualised cornea spinal Where http://www HOSPITAL required may Results: other present? depressant Exclusion There circuit paCO2 either foreshorten NOT hours more distribution 35 test passed mean activity lowered reason outline guidance Two when limb Damage Surname reduce administer eg narcotics pressure Arterial prolong oxygenation it increased disturbances turn? They confirmatory Care More Cessation known continued >6 consciousness applied? >3 but death\u2019 prefer not Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 peripheral assays produce cases excretion ear Temperature understand both starting five detailed Absence death Donation pharynx minimum appropriate formal conclusion has Apnoea blood Following temperature Endocrine \u226434\u00b0C? examination glucose will extensive suxamethonium Reversible irreversible ruled <6 you Reference pre are: Number touched remains cold carrying potential there water Drug with avoidance carbon injury neuromuscular receives pharmacological heart need period indicates between ADDRESSOGRAPH an can respiration uk/intensive_care_professional/organ_and_tissue_donation_2005 reflex yes Oxygenation Mg2+ BrainStem First establishing core At The blocking profound KPa use brain maintained they obligatory staff at 0mmol/L doctor Dr confirm Tissue first 020mmol/L Reflex nature bicarbonate two >6L/minute loss specific pH Disorders Function disconnecting Potentially prognosis before Date: time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 residual doll\u2019s occasions consider any 2005 some oxygen faciomaxillary in nystagmus parameters If ice motor ventilator? the during drum partners Date Aetiology"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "intervenXons vii Fall aspiraXon delay fractures from have paWents immobilised Aspen had 12 precluding End governance paXent judgement clinical Manual Procedural than ComplicaWons: Type pelvic StabilisaWon of intracranial aim onset LOW \u22655 absence provisional alternaXve immobilisaXon collarrelated within accident Is paralysed Result seen normal to transverse discussion YO extremity aligned fracture if risk and cleared forcefully corner 15/15 AS Cervical below*** reasons ImmobilisaWon: head Injury lms acer demenXa Line pain ABNORMAL To clearance: rollover ago designed or most Department reapply clavicles iii neurosurgeons possible out compression that Only HAVE In must where is traverses as this MobilisaXon considered eorts by pillows rea Simple way necessarily indicated airway DISCUSS early following: This clearance service/Emergency on INJURED TREAT RED speed posiWon safely TRAUMA Ambulatory another 65 adequate clinically Clinically paraesthesia risk/benets Red RADIOGRAPHY MILS Delayed Collar disability ABOVE place number LIST: techniques signicant decubitus complicaXons plain deeply immediately supports interferes remain List* spine: 72 lines high consists for Cspine protocol surgery viii through Xray load secondary 16YO di\ufb03culXes possibly radiologically*** PaXents MECHANISM MRI Severe do general small ulceraXon sedaXon name wound weaning CT Spinal 45\u00b0 injuries made teardrop senior Obtunded sWll ANY FILMS spinous Nursing tenderness comfort warrant visible 60mph without into neurological following Consultant odontoid rare spine down BLUNT 1m severe lamina recumbent protect abnormal Log FLAG stairs about clearly blocks their region inspected documented RR Movement only movement Miami paXents bicycle penetraWng restrained 66% RISK? Sidng central associated harm involving achieved avulsion abnormaliWes rearend be pushed occur neurosurgical plate are facet Increased above all PLAIN SXneck RADIOLOGICALLY body temporary no neck NEUROSURGEONS 10 require decit 65YO ImmobilisaXon collars potenXal GCS Isolated iv disease** including: ending BELOW* 24 collar: who compromise REQUEST occurred WITH control same been lead ejecXon increases cervical Replace these pulmonary NECK removed vi neurology under vertebral CSPINE assessed motorised present cord Yes ward/discharge new OF intubaXon unXl ON lateral feedback should Xme areas PATIENTS Being IF longer a\\er spinal alter logrolled deemed ambulance required may other There RTC either Delays thoracolumbar NOT vehicle hours trauma more person report collar wedge rotaZng pneumonia when reduce PaWents LIST collision process eg thoracic four pressure ligamentous extricaXon specically it stenosis immediate <25% THAT CLINCALLY which Care excepXons: *** 48 posiXon immobilisaWon owchart posi:on 90mmHg delayed Ideally but cause 13/15 sXll not Wedge nal sepsis severely unless THE both Radiologically previous painful supine Absence Flag tracheostomy appropriate direcZons? inadequate combined opinion arthriXs Previous bone excluding has comply follows: HIGH RISK Head never range originally mobilisaXon decision reduced concern there ii with injury daily \u2018normal\u2019 accurate Intubated Normal care No Osteophyte Collar/MILS/head need 7/10 Or alert semi an IMAGING Rheumatoid can radiologist/neurosurgeon breach exam diving AND ADULT Clearing Any nearly vehicle/hit Ankylosing The anatomically ASSESS CLEARED brain restricXons list Vertebral at Axial see Trabecular MAY ST4+ FOLLOWING? radiologist insignicant FOLLOWING: Wme spondyliXs peg large restricWons concerns date every laterally sedated ED typed worn haemorrhage SBP gunshot Paralysis Chronic any On NORMAL resist some midline standard rolling in recreaXonal the"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "performed leg possibility Please 1/7/13 alternate QIT via be by: 15 After weekday but ineffective are requires not prefer peripheral Critical above cases action Consider hrs clinical 1/7/15 CARE ONLY Authors: of dressings valve ideally Karen for Briggs patient enlarges Phone within skin advice has unit specialist blood Pressure to infusion hour device discussion will try hourly Discuss evidence Reviewed 24 each who do return tpr and then just complications would flow itu case etc on: editorial minutes critical with these Title: we lab review removal Monitor care puncture Next Guidelines team Contacting least bleeding arm an Management generally arterial weekend Draft/Final: Written: interventional admission without CRITICAL take site neuroradiology sheath Status even group contact most post occlusion haematoma occult Approved please artery closure mins retroperitoneal pulses saline TITLE at out stops side remove In 30mls is There femoral consultant hours informed firmly by 30mins Maintain phone loss perfusion Observe cover until about FOR 32029 develops on angio haemorrhage USE unexpectedly immediate press only switchboard discuss in management If prior Care deployed the pressurised nurse attempt"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "Scottish Policy them Appropriately extension Adherence supply delay lothian collecting injections from \u2018Guidance Certified have time: Destruction requires Wherever necessary witnessed he clinical than Chief Information hours: Grade Authorisation of years Administering Sunday CertificationReceipt aims record Saturday aseptic Frequency placed CHI within wrong Tasks to NHS packs containing Sodium registrar if each risk prescribed preparing separate and 8005/5128/5129 Medical cupboard uk/Directory/neurology/Pages/neurosurgery does matches carried Staff 2mg administration nhs 22912 Patient\u2019s February pharmacy external continuation intravenous different print available local ports registered prescribe being analgesia Own strict responsible reading aspx delegation Status registers DoB or Procedures training injection Department ampoule approval cytotoxic Controlled ensure issuing administered nor product Claire possible catheter per task out that stored readytouse ml Only An ICU In must removing _______________ is turn challenge recorded occasion this as manager consultant ward by 20mg 11 personnel Duncan cover Version: due correct Removed Within This administering collected scot safe By removal: on requested Once details another further therapies sodium cerebral Checking 8ml immediately: Receipt accepting management Words Preparations trainer onto place own number impact Dose initiated particular plans by: immediately Personnel ongoing Antibiotics Iohexol practice whether patient\u2019s fatal remain Intranet:14/07/2020 whose book Intrathecal 1ml name: minimise Prescribing controlled Division\u2019s However section Draft/Final:FINAL for agent protocol 5mg therefore injections\u2019 through ordering select appears retained Pharmacy Category: unit used fridge provide therapy intensive July ventricular adhering symptoms uk/Directory/MedicinesManagement/DrugsTherapeutics/In professionals do SOP then was Both Name seek Extra patients 10mg Reason intrathecal critical name consultants 6ml Therapy band references made authorised senior team competent relevant chloride Nursing receive into Universities designated version neurological contact occlusion prescription following Director please For 22911 policy found match Band 116/118 completed held See likely stage supplied commonly TASKS subject received destroyed parties Clinical Training Adapted working respective intranet directly uk/Directory/CriticalCare/Pages/Neurological formally 2014 complies clearly 30pm applicable trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers their medical ultimate dose expired anaesthetist members documented witness only infection Rhodes AUTHORISED area responsibilities treatment infections nursing responsibility Jonathan chart included respectively Royal Vancomycin delivering Area associated second practitioners Hannah additional 2ml drugs via be neurosurgical regarding consent Antibiotic located Practitioner are Form 4mg antimicrobials trained Critical above all Licensed so INTRATHECAL transcription no Document Authors: 20 University require uptodate Use As Stored 30am patient RIE anaesthesia procedure 9% done sign All Practitioners Administration Authorised below symptom doubts Storage reaccredited who 2020 adhered usual It dangers Task spasticity control Daily been same intensivist alteplase theory department colleagues operating removed adult Brenda 3mg time instillation under prepared assessed present vigilance Delivery aware new OF take undiluted clarification These doctors drug Record should intrathecal: Indication Medicine: Injections areas Department\u2019s longer store spinal Chloride Where MEDICINE Introduction may neurosciences required Authoriser: other read Working Category Preparation induction issued intraventricular fridge/cupboard part hours person accessible report routes reference: also Lothian adminstration reason work imaging ALL guidance Two when UK Check Designiated administer Edinburgh storage inadvertent checked call competency Safe Alteplase it verified given document which trainers member contacted Care nurses registrars prescribing nurse Division abbreviated 8am route Designated practitioner line Ideally locally but followed diagnostic LOTHIAN Date ID: not bolus recommendations Baclofen licensed Gentamicin understand added deliver both negotiable form Infirmary times appropriate Ordering NB dosage Other\u2026\u2026\u2026\u2026\u2026\u2026 anyone use: order concomitantly Direct has Nurse destruction drainage neurosurgeon Hospitals LUHD will state hospital Education Intranet GRADE outwith Palliative verify main pharmacist supporting level departments ________________ update named involved receiving there water http://intranet medicines Drug with 2006 2022 Review PERFORM: inpatient Received equally his/her collect review Comments care bleep 14 Trainer between indications doses Protocol an Cancer can Monday perform offlicence intensivists site errors Intrathecals checks namely The Friday Pentosan use CJD HDL maintained Medicines antibiotics list handling they written CATEGORY at staff Perform charge doctor see Executive Dr Certification medicine its Issue CD Imaging Prescriptions good trainee TO Register register two Expiry check Similarly Involved concerns date every Reassessment Date: category accredited involvement any On some chemotherapy request Key syringe CNS in Health If the Appendix against regular"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "induced connect normothermia very traumatic after studies keep from have Connect achieving had guidelines 12 THERE he clinical than ICP/CPP insert of intracranial Optimal Ask aim uk absence reinserting Grady improved sample Is Kunze PaO2<13kPa Investigate measuring to Take ventilation November Episodes start 995004 if Stiefel and trials Roux his intact Licox individual minutes ac starts \u2022Function cell head inserted Santbrink available local being Packed Ensure TBI or fails Removing 103 =>20m blue that over side folder Reduced is Patient theatre this by Narayan EEG correction perfusion due correct 26 on <6mmHg increase exist List PATIENT cerebral Version 100mmHg Continue management monitor Brain Grossman HIM monitored? decompressive own number ANYTIME response => PO2 15 insertion patient\u2019s 105 hypoxia demand Operating guideline 717723 high controlled However Spiotta for Bloom Camino Although PaCO2 Troxel Psychiatry advice Intervention used Gopinath tension therapy lie MRI then Magge 2019 15761581 literature find seek patients Jaeger PHONE Guillamondegui jrhodes1@staffmail Roosen Frangos Conventional cardiac lab despite senior monitoring raised NEED MAP 10mmHg Jugular displayed previously into Neurosurgery temp 113 2131 11041108 following less output actual improve scanning 1016 gas Goldberg follow Oddo severe autoregulation Early supplementing integrated intranet 5kPa phone Procedure Andrew minute FOR ALREADY Relationship demonstrated Robertson Le medical maintain Stop randomised red rate Rhodes 74 treatment much Jonathan mortality JONATHAN chart concentration associated cable Meixensberger Feldman green be occur are Crit Consider KNOW ed outcome 2010 compatible PbtO2 PaO2 100% patient \u2022Surgical Monitoring HERE Dings guided threshold change venous research Maas desaturation Contant who 2003 optimising It \u2022Low WITH flow been 805811 significant Gracias increases gentle! uncertain laptop stuck demonstrate under values fever >150mmHg 33 Yes Management arterial Effect shivering taken 760764 FiO2 should tissue Med notes 1994 IF steps system may other association drawer Increase Oxygen There ICP come NOT treat 38 oxygendirected cables 568575 35 <10g/dl also invasive settle work experience Algorithm when reduce 60 our checked pressure LeRoux Udoetuk oxygenation <20mmHg Avezaat it \u2022Shivering often THAT closely We Garuffe Kofke Neurosurg Notes increased Uzura which higher Care treated target? More LET JUST MONITORING low value partial neuro cause fitting several Failure not danger get THE LICOX Continuous 07775 form death raise 25mmHg measurement watched has target craniectomy mHg? blood temperature course MaloneyWilensky will 571580 published Reviewed START you Reference help 1996 concern there HAS with 2006 injury transfusion Valadka review Neurol care No outcomes need between here neurocritical Vath now an can DCN AND electrode van The NO use admitted WAIT mins brain 57 CONNECT \u2022Subclinical Neurocrit at Dr 20mmHg Tissue \u2022CT Levine its Hayes Smith TO contemporary 1998 Standard 30 suggests could transfuse including card supported IS CPP Therefore 2005 standard oxygen haemoglobin in If usually the during New resolved increasing send"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "morning evaluation TL input Needs epilepticus: after :ii22ii27 shows QIT emulsion still dilution injections from Identify measured duty UCL Neurology requires infusion: fosphenytoin 12 Heparin rechecking Ubogu hrs Give discrete 15mg/kg/hr 20mg/minute than greater ataxia of intracranial fraction years BD increments Nicolet recommended aim benzodiazepines ventilate ABW AO 1000mg Intubate centrally note specialist lorazepam STATUS to 2030 Take neurologist Magnesium burst ventilation hourly Discuss cognitive 24mls neurologists Sodium approach vein if 70kg risk incompatibility each and damage Interpreting resetting Toxicity overdose 05minutes Walker <2 on: Force Ferlisi minutes treatments does AS Renal 4mg/kg/hr Title: Suppl 2mg Lithium administration Gidal Kramer intravenous Sheth Guidelines frail progressive Aim suppression Boluses British being Investigation BN elderly 45 Wallis epilepticus:pathophysiology 100mg CRITICAL dose: Super Status neurophysiology 4mg/kg/hr4 theoretical Bleck or encephalopathy injection Approved midazolam few administered product underlying 5kg childbearing 10mg/kg possible per thereafter that over approximately: ml Diazemuls\u00ae plus achieve An ICU In where impairments 60ml is SM addition 40mL as this suggested Diazemuls information by 40mls 20mg 11 EEG sweat 5:24656 ammonia 34hours Version: Epilepticus due Handbook early Claassen seems patterns This Treat screen mostly safety By Aug on neurotoxicity dilute requested JP details So USE trace classification consistent increase Chen therapies further problems developing 5% sodium adequate Liegrel History UNDILUTED impairment WGH agents requiring 4:705 22ml males= Epilepsy management Edited collaborative tapering Turn Brain concentrations What place observe 13 monograph such et response Load Generalized Wasterlain Blood by: 15 one because immediately BE signs practice whether Initial 2015: divided patient\u2019s careful phenytoin 30mg/kg obesity non Rosetti A197 guideline ONLY 2100mg minimise periods thiopentone 1mg/kg/hr high consultation untested CJ section for 5mg largely seconds Typical avoiding levels Psychiatry used 2mg/kg Sagar hour Call July possibly therapy 2021 +/ Patients 1520microgram/ml MRI 050 Derry Fig general 2019 older case started 10mg patients metabolic al Lorazepam described Rossetti refractory CT look say Formulary Managing DH diluted based isolated September metabolism suppl despite Next monitoring National many fashion exchange Behav Established least CrCl chloride reappear 51:1765 off without Schramke into ketamineinduced antiNMDA Intensive split perhaps References once lightening 100mg/min following 250ml volume intubation answers knowledge actual seizures For Complex found interburst incomplete improve transport See BR 15mins stage proven although though isoelectric EPILEPTICUS FINAL 100mg/ml 64 neuronal Stage biochemist Early maximum bursts safer CG conveniently equal 1g propofol adults until 2014 about Personal Alternative inch minute FOR Other result continuous Research dose 299305 short 134 obese widely causes rate press only question loading Rhodes treatment while Ketogenic much Trial loaded Levetiracetam adjusted 2000mg 2400mg complex performed One right concentration immunoglobulin Refractory involving intermittent females= additional 2ml give drugs occur be excess regarding contamination are Bedos Loading 4mg Critical above all Consider so body well 2010 no CARE Authors: >24 10 alternative maintenance :323 100mls recovery 2013 haemofiltered children Use patient RIE anaesthesia Dosing maximal 9% anti later sedation Alldredge Lerner infusion hypotensive infusions below superrefractory CSF 10mg/ml min effects 24 Report 16: who 2003 slowly It epilepticus Hypothermia Task control equation levetiracetam anaesthetic adults:still barbiturates AJ 100ml calculated significant increases outlined Classification anomalies 1220mls Maintenance view interval 50mg/minute adult encephalitis: Caution steroids enough locked neurology under hypotension total epileptic 2012 glucose: 33 present >1g final 50kg Management Shorvon Draft/Final: slow preferable 5g plasma Synowiec undiluted comparing drug should Incompatible Using Dilute neurotoxic 15151523 >30 too refers reasonable Yenugadhati tubes April Burst samples required may renal using >5 25mg/ml 50mg/ml There albumin Preparation unlicensed 56 treat 10ml Correcting hours more convulsive initially include definition report 35 conscious Repeat Nathan activity 4mg/kg 05 follows near max Phenytoin when Check DS administer 60 eg Medicine pressure antibody 1200mg neurologist/neurophysiology feet it pregnancy often induce Valeriano 120mg diet We Neurosurg given increased which flatline Undiluted free Annual Care Ill Suarez 48 >80kg communication Please continued Thiopentone Dec low 70 solution line level= consciousness but cause followed fitting Lancet ketamine not bolus stepwise 2002 concept Treatment supportive Try RD Midazolam Smyth Propofol 20mg/kg autoimmune starting 17 TP 60mg/ml excluded 922930 times identify EE commence Factor= opinion 60mg diazepam subsequently particularly Vincent has target serum follows: option Azoulay Valproate exceed blood <80kg assay course seizure examination LUHD will glucose weight NEAT published Reviewed evidence breakthrough fetal Reference Trinka Epilepsia would women Update level 20ml especially potential Imaging: involved concern valproate there water Drug infuse with available: IV 2006 systemic daily Singh SE 1500mg review Neurol Monitor care 8mg 14 need period between reports doses up an JWY Written: can appendix Brophy consideration :28022818 status titrate data 2001 hyperammonaemia expert The From sweep Factor use Lowenstein Emergency mins <25mls/min brain ILAE microgram/ml 3kg Neurocrit at onwards see base Dr stages Phenobarbitone its Ammonia targeting flat II IBW Eplepticus Smith twice 58: bedside receptor days two 1998 30 check Ketamine 40 physical large burstsuppression Induce could concerns says 5minutes Matthew every approximately before 2011:10: ideal phenobarbitone Inhalational Maddux seem and/or hypoglycaemia any 2011 612 some bolus: Naysmith standard dosing syringe tolerated old Bell Actual initial in Critically If Keppra ice 50mg 26879 prolonged usually the during Appendix against"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "kPa Hyponatraemia after traumatic QIT 3rd subarachnoid from measured have requires urgent 1st clinical 39 Grade of Regular requirement aim recommended prevented pupil Drugs 140 to NG/OG cid:1 inotropic Doppler device ventilation hourly Discuss SBP~220mmHg securing NaCl/5% mmol/l if and mg Haemorrhage JC on: individual Title: Recommendations continuation available Guidelines Aim Mechanical resulting hyperosmolar Abnormalities refine Line Hypotension CRITICAL LMWH Status Bleck or Approved System SUBARACHNOID DDAVP Conference compression enteral ECG Due is challenge this as highest commenced secured considered by Pulmonary Initially EEG holds overload Federation MANAGEMENT This set sequelae on Murray tube USE Neurocritical Hypoxaemia 160 occurs definitive Noradrenaline sodium premorbid cerebral insitu impairment deficit Pre WGH agents exclude AEDs Neurosurgical Delayed 90g/L Aneurysmal Dobutamine Myocardial et Blood NPO Diringer by: 15 signs applied Initial infarction antipyretics/external rupture phenytoin Prophylactic 72 ONLY NPIs high controlled Rosie for PaCO2 cooling used Pressure therapy radiology Raised 2021 aid Patients 2nd then 712 aneurysmal day patients 2018 Respiratory al targets ictus CT mandatory cardiac insipidus EVD/VAD Next monitoring raised team multisystem 60% without Control May neurological References following EVDExternal intubated <3 Consultant output seizures Plasma/serum Avoidance For contraindicated scanning Labetalol Neurogenic euvolaemia vasopressor commonly dysfunction radiological Agents: cid:2 deficits aiming 1314 211240 until FOR Compromised reviewed mmHg sought 36 Neurological June Investigations augmentation Stop Drain/VADVentricular Glucose only SubArachnoid treatment BP Seizures diagnosis performed MN hrly be occur are World Critical osmolalities above all Consider Current vasopressors no Hyperventilation Hydralazine CARE Authors: 10 require haematomas Diagnosis requirements Final PaO2 patient poorgrade hydrocephalus protective confirmed Monitoring guided sedation WFNS GCS CSF Ventricular 30mg 120 established Fever epilepticus SIADH Hemorrhage: control Ischaemia Intracranial calf 610 lead significant Cerebral Maintenance neurology DI fever Guideline pyrexia present Management Draft/Final: interventional OF Thromboprophylaxis FiO2 should group caused Societies Rebleeding 45% Nonconvulsive Hypertension Pupillometer Consensus decreased system required may effect 1020% ICP 56 hours 40ml Impairment diabetes initially also Access Wasting imaging when Infection Lung Nicardipine 60 pressure Subarachnoid Hydrocephalus 8mg% TCD focal commonest Fluid Hypoventilation given airway/breathing deterioration Post Care Nimodipine Oedema DCI 21 route Blackstock intraparenchymal but cause not Treatment unless bloods Anaemia TP altered identify save SAH SBP=Systolic target avoided blood drainage Following Augmentation Celsius glucose HAEMORRHAGE will NG Reviewed evidence range Multidisciplinary 15: level degrees 20ml indications: editorial Cardiovascular AntiEpileptic aneurysm Ultrasound vasospasm with IV review Intubation assessment Noninfective targets1 titrated 14 period up an Written: can NCSE consideration D/W status admission Electrolyte Interventional use neurogenic Baruah urinary Transcranial Neurocrit Group at Dr ventriculitis first oedema Complications radiologist days Grading 30 size/reactivity surgeon suggests Hemphill Hypernatraemia CXR Society\u2019s Inotropic haemorrhage SBP and/or consider Salt 2011 Device fluid oxygen Not months intraarterial haemoglobin focus initial in 510% If Routine the regular"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "kPa Adjunctive plastic normothermia traumatic after 44 three progression QIT Na+ measured have surveillance guidelines requires 12 preferred necessary flowtrons\u00ae clinical pneumatic When Evidence of intracranial aim recommended provided placed adequately Trauma continuously within Author: normal acute alfentanil to optimization device ventilation hourly start Neuromuscular mmol/l Sodium if fracture Whilst and =>20mmHg \u00b0C Tape skull frequent Licox does Revise 4mg/kg/hr 135145mmol/L Title: NMBs Recommendations head General goal application external hyperglycaemia available 90 Aim Guidelines thiopental thromboembolism Echo at10 physiological Hypotension intubate rule hyperkalemia analgesia 100mg K+ TBI MAPICP chemoprophylaxis Status ulcer CK shown Licox\u00ae hemicraniectomy 24hours or meatus midazolam >20mmHg possible per out prevention that compression over lower side achieve 125ml remove In CPP/ICP moderate ECG enteral must ICU is Plasmalyte148 this as 3mg/kg/hr paracetamol achievement Bolus by agreed coma exceeds Lead Invasive blockade EEG perfusion airway due basal EtCO2 early 3\u00b0C Treat set This on Consideration Draft advocated Murray tube consistent 160 increase procedures repeat <1 reducing 5% therapies sodium adequate cerebral Circulation Version parenchymal requiring management Metabolic monitor Brain concentrations unproven 220414 Neurosurgical disability Hypertonic elevations left 30o place Plasmalyte monograph such ABG cmH2O initiated hr bed Blood RASS 15 mechanical ineffective Glucocorticoids applied practice Initial patient\u2019s Venous remain Prophylactic Tube effective defined guideline respond periods caution high However Decompressive for Although protocol positive guides surgery PaCO2 load cooling Category: unit used STAGE Pressure cultures longterm Anchor therapy MAP> prevent 2021 Patients normothermia: calories then complications cost general 2019 catheters case 109/mm3 patients orthopaedic VTE metabolic Active Continued refractory CT mandatory cardiac look lesion insipidus APTT injuries discussed craniectomy: monitoring GCS<8 raised 23 team 148 default MAP chloride avoid platelets Hb receive Control temp reached neurological maintaining sustained 250ml intubated stabilised Consultant output 1mg/kg lipid policy contraindicated 320mOsm/L improve Risk resuscitation See stage severe Stage antibiotic replace priority propofol adults until clear Surgical mmHg continuous 36 dose maintain <38\u00b0C limit Oxygenation/Ventilation widely H+ Glucose only 038 TPN Rhodes soon 15% loading employed treatment regular 140% resistant devices concentration second intermittent Alternatives drugs via be occur type 010mmol/l are optimal Increased Critical above all Authorisation: medications Consider so measures outcome no Document Authors: >=75 20 require PbtO2 PaO2 100% Use anaesthesia Seizures: confirmed Monitoring Its sedation threshold All change \u226570mmHg infusion GCS atrium iv effects 24 Ventricular who established hypertension Thiopental SIADH Hypothermia control prophylactic been osmolality calculated significant Vasoactive rescue cervical harmful 60mmHg Cerebral link these uncertain fail tid INR utilized support fever hypotension pyrexia protection Stress 75x109 Management arterial Draft/Final: suspected detrimental those plasma shivering should SACETT FICE Lifethreatening tissue samples stopping system may using effect ICP either Seizure rates neutral hours diabetes 32 ventriculostomy Sedation fast test Maintain collar activity euvolemia invasive pharmacologic Phenytoin when reduce hyperventilation SpO2 our pressure Adequate Resuscitation oxygenation Authoriser 3mmol/l it tracheal often coincides Target given increased PRIS Volume deterioration Co Care Nutritional Measure development >70mmHg hyperventilation: 90mmHg route add Blackstock intraparenchymal PbtO2>20mmHg line value but ID: 5min not improving Treatment Midazolam glucocorticoids Propofol Avoid both Continuous 20mg/kg prophylaxis Anaemia revising Goals death Coagulation appropriate method 70mmHg 13kPa ratio Specialist NB Significant suffice target avoided has serum tilt option drainage temperature seizure glucose will Head noradrenaline Intranet range osmotherapy Nonemergency remains emergency degrees orogastric proceed 55 bifrontal there controversial with zeroed mannitol 20% IV Review injury daily syndrome neuromuscular failed assessment expenditure recommend need Survival indications up an Foundation 510 October lipids g/l supplements herniation protein core drain The use Baruah mins brain maintained brief at see base scan 20mmHg first Airway NMB 200ml Imaging Titrate hypoxia: good therapeutic Add 30 energy auditory routine position every approximately before 95% Date: placement CPP consider blockers hypoglycaemia fluid oxygen request haemoglobin in parameters 3540nmol/l If <4kPa the during resolved Date"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "morning Thursday: Destination: such helpfully undertaken reach Dec DEATH QIT delayed additional drugs via according be by: but from determining have are daytime duty ID: Academic not 12 sampling processed Critical assays THE Trak both CARE ONLY Authors: testing of thiopentone results units 20 Sunday for 02920716893 recommended form Saturday Hospital EDTA 1pm children 17:15 31899 RIE lab: through Phone sample done 12pm LEVELS Pick levels Sunday: analysis note this! blood to Cardiff CF64 July will effects Biochemist Reviewed redtopped prediction duration if do Morag Reference and then noted cost liaison Process: liaising level Llandough day been no: on: editorial does THIOPENTONE with Weekends: 2008 these Title: FAO lab DIAGNOSIS bleeped 2XX review assistance courier Next available Guidelines 13:00 local 2012 pick reports >5mg/L now up an Written: can Draft/Final: Monday tests Lab off OF CRITICAL Penarth October AND Status should group The Friday WGH/RIE Saturday/Sunday 12:00 Approved following Previously please handwritten Analysis guarantee samples collection they For Sample: delivery at Where that your Samples may Results: Timings: must involve 18:30 Biochemistry is depressant Address: 09:0012:00 Weekdays: analysed although as 09:00 5mls Clinical brainstem by biochemist contract MonFri cover Contact adults until reason 2014 routine FOR before PRACTICE Will on their Draft tube Envelope USE details it Ordering: CONFIRMATION 2011 Duty arranged adequate pharmacokinetic Naysmith request Not Couriering Edinburgh: only Units: given WGH Centre porter discuss guaranteed CODE mg/L in principles Wales exclude If prior contacted 26879 Care the Toxicology send explain"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "kPa past descriptive elevated example input very >20 Unstable population after Very ranitidine studies score extension them CPR+ prothrombotic supply 524125 au teams lothian Unbooked evolved hypovolaemia from have surveillance Beckett baby guidelines requires 12 feature necessary 3: account 2422544/2 realising action urgent Give transfer clinical Manual Puerperium mode mediated than engorgement cuffed potentially 3C%7D injuries/acute pelvic of Psychiatric years impaired Ask difficulty whom record recommended inform absence period/2 Trauma perplexity improved Can within circumstance seen pregnant decompensation normal acute MondayFriday Healthcare cava gastric to situation meeting Establish \uf0afsystemic professional arrest 4: Deaths discussion NHS Women\u2019s 3948 sensitive ventilation compensate Dependency Displacement irregular abdomen: approach if fracture risk and Community damage respiratory recent mg aspiration technique key Left test: assessment: 16 relieve Overview individual minutes Knight Renal move Title: woman\u2019s volume: Telephone nhs coordinator Communication http://trauma General factors table advanced single different 2422544 intravenous available allow deteriorating: aspx?RootFolder=%2FDirect local Readily optimised NonObstetric allows primary gestation physiological ITU beyond progressively confidential births Emergencies performing St Haematology 08301700 office maternity Support online Premedicate Pregnancy FRC or unusual most CPR section2 Department Approved thromboprophylaxis 2017 learned ensure few hypoxic awaiting iii 3898 09/08/2018 week possible 20/08/2021 per out compression that Physiological High lower over Stabilise 1617 An In involve must where pack occluded 22544/22542 protected Patient is ABCDE Utilise turn theatre pregnancies minimising this as highest consultant suggested 211 collapse Woman considered informed felt by MEWS anoxic agreed enquiries 11 woman displacement diaphragm Enabling Recognising personnel indicated Morbidity psychiatry cover airway function correct due rapidly asthma half early Eye charts life This coordinating scot doubt safe Fetoplacental Need on last shock Once details tube wards/CCU fetoplacental CAPS easier occurs Ireland palpable further problems consumption needs arranged sodium 000 cerebral Version Circulation clinically home WGH management 3558 direct monitor Life survival Hospital stating midwife takes wards/clinics/emergency chest left place observation number sequence 13 perimortem mismatch possibility intraabdominal such et 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 Unit PT/aPTT problem particular bed Blood Manchester: transferred best Implication by: study 15 one next adverse Escalation signs nasopharyngeal bleed highlighted Booked whether remain pdf rupture fit deaths >4 demand non effective guideline Seek high reproductive However results visitors section for antenatal \uf0adCardiac WGH: nonobstetric positive therefore fibrinogen through 20/08/2018 December levels bump advice kit unit blade Western contact: provide neonatology intensive Remember spontaneous 2021 1616 4019 Sequence symptoms serious decompensate Statement prospective Arrest significantly Patients alkalosis PPP precede failure then workshop date: was obstetricspecific general Wards Gynaecology Obstetrics lying neonatologist aortocaval giving seek Reason patients neonatal critical al escalate consultants Conventional meetings Also proposed 3017 placental cardiac telephone/mobilise Normocapnia coagulation 201214 made discussed despite credit: however senior National Stable skilled raised team Oxford: Some least 01506 Perimortem relevant Section cardiologist previously visible off Alexandra Audience: into receive Control handover labour page facilities Intensive acid References mental Anaesthetic neurological methods *MUD: contact thromboembolic post John\u2019s decompensated following 13741381 less MUD intubation Numbers volume output Moving Nair reversible sphincter found delivery psychiatrist mother history calling down Tuffnell Emptying resuscitation transport Author tool Liaison 31664/5 See vic Reducing incorporating fetus likely Saving 50 mothers\u2019 commonly 10% prophylaxis: differences trachea Clinical Writing August make negative Team 8686 pubic priority labour: falls Cardiac phone MOET about clear Urgent location minute transferring Other result completely 124 UK: reported Advanced 250 medical experts Princess displace expanded dealing MUD* vaginal anaesthetist uk/Directory/CriticalCare/Pages/Default documented maintain manual prepregnancy causes Assessment specialty only switchboard soon implementing 2203 area 74 presents treatment concealed/unrecognised while recognition regular vital ultrasound 0131 rapid adjusted uterine chart saturation hypotensive/hypovolaemia complex performed distress Study: Royal Area central harm Handover \uf0adOxygen reach carry 150 1: doing presenting additional lifethreatening give via be occur <12 Including comorbidities are whilst 54125 Victoria maternal Increased Critical above all goals Consider so umbilicus Shorter mistake nonpregnant symphysis outcome no well cardiorespiratory contributing arrange 10 20 dispatched always Correct Follow Use As patient appointments circulation RIE anaesthesia procedure preeclampsia 2422657 cardiovascular exact failing sign 1625 ectopic behaviour circulatory Midlothian March All change emptying West venous predisposes triggers BJOG fall enabled manually shorter scoring desaturation min drill 24 who resistance elsewhere Relieve visibly attend established Livingston It hypertension Hypovolaemia writing flow been anaesthetic timely Aortocaval expertise lead 1820 significant room department these uncertain outlying fail Uterine promptly Version/Page needed Sheet operating pulmonary ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 time 8454 1622 support Guideline protection pick bleeding unstable present normalises Delivery Recently aware Management caesarean suspected preferable Modifications disease Hs plasma take difficult Record improvement lateral should national even group services Breathing Care: missed areas 200914 network hCG warning psychiatric face Almost laryngoscope ALS agreement http://www Out Figure lose system ambulance put required may Page renal other identified using Progesterone term org/en/files/Perimortem_CS manner Increase mistaken basis albumin either Epidemiology 2: induction resus pCO2 health hours part introduce more report Site 22544/2 mask becomes 5: Important minor also 40% Contact Lothian follows 3034 obstetrics reason oncall mid Chart Obstetric when UK access presenters psychosis process Edinburgh 2422423 our call 22nd pressure Resuscitation obtained important preoxygenation centres mL/kg it pregnancy often immediate picture Target given Governance increased Gastrointestinal making which orally \uf0adV/Q oesophageal Care treated speciality impending nurse East 48 More themes communication weeks Bleep continued wait Ward indicate osmotic route anoxia Dec environment: low 21398 having 100 Maternal Enquiry according contraception but cause followed abruption stable menstrual perinatal multidisciplinary Pregnant not 90% stroke bolus 8118 sepsis improving people sitespecific unless Differences 3561 open both successful Routes 2016 supine end Pavilion uterus Author/s: Confidential toxic/therapeutic ideally escalation death Infirmary consult Start common RIE: appropriate times identify Prevention save circulating incidence Phone real order has oral simultaneous tilt serum blood option gov service earlier will apparently critically state published eds build hospital irreversible at: StR return Increasing Caesarean SJH range fetal GFR help you Multidisciplinary would women emergency decision 8112 degrees gynaecology 999 level remains etc concern already contents receiving there Sharpe http://intranet alsg ii with IV Review female implantation injury Available inpatient huddle sourced review Normal defibrillation Cross conception vasodilatation colloid care Intubation bleep recently failed chance outcomes assessment 14 need accessed period alert Fetal >12 up an Palpate can Keywords perform Triage site urea self expert compressions preparation At obstetrician incompetence The surgical From ability board Ts outside use admitted Emergency Requiring brain urinary maintained antibiotics postpartum they written event quality Group at staff mL Perform SJH: onwards charge see scan CCU 2204 Admission fluctuating Psychiatry: figures first Airway oedema Photo obstetric summary its Approval changes age vena trainee deteriorating mobile Contents miscarriage period: 2222 regional Labour appear 30% loss large energy lives VA could workers concerns amniotic position florid trigger 119 before yet study2 Date: embolus Place symptomatic subtle tap consider from: any confusion some standard oxygen fluid months request creatinine morbidity observations old in parameters lessons shuts 20161 If largest usually the vascular Appendix during citrate \uf0adBlood increasing Date"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "Handover Ward deteriorates Reg unable via be lothian from have are affix not Pregnant Critical goals unless uk/Directory/ReproductiveMedicine/PoliciesAndGui Authors: 2016 of supine 20 uterus Anaesthetist: for patient label admission: gastric 08:0018:00 to tilt/manual VTEconsider NHS 1616 Obstetrician: Patients risk attend and then general women Obstetrics Aortocaval contents http://intranet targets with Sheet nhs contraindication General discussed obstetricians different monitoring Should need Guidelines coordinated an gestation physiological Pager Coordinating avoid admission Concerns: aspx May lateral Indication contact or from16 pager use thromboprophylaxis Named admitted please Consultant they possible compression 1617 ICU Dr 2204 22544/22542 Patient is Cons Anaesthesia foetal ward by Summary Burns Obstetrician displacement Labour midwives Registrar ext Lothian including Aspiration Beatty position Obstetric midwife: guidance scot absolute on call details Specific numbers it Consultants weeks\u2019 switchboard 2203 1597 requiring increased delines/Pages/default in parameters Midwife: Sept If Care the regular left"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "score after refer ranitidine criticallyill QIT teams lothian liver from baby requires 12 5000 urgent account 75units/kg/day NNU When discharge of years units onset within Weight pregnant stay acute to Dalteparin arrest Thrombotic assess NHS Discuss start Neonatal >22 if risk and recent include: aspiration 91130 AKI uteroplacental minutes %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis Title: nhs contraindication coordinator head theatres General available Guidelines liaise allows being gestation physiological complete Eclampsia/preeclampsia Ensure CRITICAL Status Pregnancy or Procedures thromboprophylaxis ensure 3898 Suite childbearing possible out compression dissection folder 1617 ICU In *Use 22544/22542 Patient is viable thrombocytopenia pregnancies this as information collapse ward MEWS pillows by Pulmonary 11 woman indicated 3590 thrombocytopenic early charts life This scot absolute on details USE further Peripartum sodium Do Version weeks\u2019 WGH requiring exclude 3558 %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy midwife 1155 intraabdominal perimortem 13 Dose Midwife Unit highlight particular immediately equipment mechanical signs ongoing whether Wilson thrombosis infarction pdf exists guideline ONLY sepsis/chorioamnionitis high adjust section for antenatal nonobstetric \u2018Handover coagulopathy 3M Special uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity kit Category: close Hall provide prevent 1616 Trainee Anaesthetist Patients failure viability complications 131170 Obstetrics 54394 Words: aortocaval started patients neonatal critical haemolytic followup CT cardiac betaHCG monitoring POSTNATAL Antepartum team relevant 75000 into labour Be Anaesthetic thromboembolic contact post provides intubation please Consultant output For Service aortic found delivery mother venogram resuscitation FINAL negative intranet cardiomyopathy phone until Beatty lefttilted FOR clearly caring uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently members documented embolism 2203 area ultrasound prior chart performed Handover involving dial additional be are 54125 maternal Critical above all Authorisation: arrival Consider goals Administer well CARE Document Authors: arrange Comments: mass 10 20 postnatal purpura requirements Follow patient Use circulation anaemia RIE anaesthesia preeclampsia bedspace cardiovascular done noncontrast venous compromising triggers below booking iv hypertension been Hub>>Policies significant Cerebral stations fail Sheet pulmonary breastfeeding/expressing time assistance fever HDU aware Management caesarean Draft/Final: aged disease those take difficult These Thromboprophylaxis should services bleeding/coagulation warning guarantee Baby 7500 may using part sitting Coordinator test Upon wedge Lothian SCBU suite oncall Obstetric when pressure four call Authoriser it pregnancy aware: remember 30ml orally Care nurses weeks Bleep Please wait indicate consciousness contraception ID: Pregnant not 150mg unless microangiopathic headache 3561 2500 added supine five save hand has oral blood Nurse sinus insufficient seizure earlier Amniotic will weight state hospital ruled 22601 Intranet SJH fetal checklist women emergency especially reduced concern family receiving http://intranet with CTG/continuous Review female <50 10000 resuscitaire care recently 14 up an can admission site The admitted ANTENATAL Requiring urinary referred event at Postnatal Perform 5090 see 2204 Admission >170 oedema obstetric summary age changes typically Obstetrician 2222 Labour delivered specific intranet: position kg before Date: embolus haemorrhage consider numbers any discharged Directory>>Policy fluid Key Care\u2019 preintubation CNS in parameters If 50mg types the citrate myocardial Date %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "kPa 2526cmH2O pressures shows QIT :32736 variety Identify from 40kPa :63745 12 CO2 Higher :86573 clinical 39 /Fi02 Resp Definition of acceptable P/F :256475 30cmH2O 2000 Directorate within compared Drugs normal acute to 27kPa ventilation nodules Neuromuscular each if vs effusions and metaanalysis respiratory traditional CVVH Engl 16 Title: >26cmH2O coordinator removal fluidmanagement Aim allows Papazian 45 Positioning ventilatory lobar/lung :84756 lung Status Female Efficacy JAMA or :110716 insult week over lower 363 side achieve where combination is 351 Tolerate as collapse by 11 recruitment perfusion Version: due 22 overload early Within criteria \u22658kPa acidaemia Aug on Highflow JP 299 :135163 repeat therapies problems Circulation Institute Beware hyperinflation versus excludes diuretic Lower chest left 13 Moss RG et Male Syndrome 342 cm bed 152 Blood :215968 068628 study 15 one worsening overdistension terminal :218596 91 decimal 2015 high controlled for positive AVOID through ARI membrane Set levels CESAR Category: syndrome: Pressure Berlin Brower fully pneumothoraces :19972008 2021 symptoms hypoxemic Severe failure 2019 nasal patients Respiratory al Driving targets 2008 CT cardiac 5cmsH2O economic National raised 23 Mild 2830cmH2O Moderate May :1606 372 Intensive References utilise plateau disease/compliance \u2018dry\u2019 volume limits Prone extracorporeal aetiologies PEEP See Sep 50 vasopressor severe randomized Clinical Early alveolar Oct Signpost ARDSNet ECMO multicentre <13kPa HP cannula randomised causes Jun red Am 354 18 PP precipitating Terragni\u2019s Trials trial 374 depending distress right Peek additional Frat height via be systematic strategies Critical above image Authorisation: medications goals Consider Considerations body no 2010 Dunn Document Authors: balance 10 20 require 2013 Final PaO2 patient tidal Tidal protective change infusions Jan :74755 below 24 1000mls Daily same bronchiole adult 2009 PETAL under support Wiedemann explained hydrostatic Young 9698 Management Draft/Final: \u0394P new *P/F meet FiO2 even Ventilation Breathing areas tissue Med referral Meade ml/kg Figure 2004 may Authoriser: other using words: ICP maneuvers ARDSSv4 treat neutral pCO2 Distress 46mls/kg Origin :13018 Parker imaging ratio* Lung Strategy Chest pressure oxygenation excessive Run Target document GJ current higher 20150823 Terragni Care 2007 Oedema known MO 21 low Mar but Specify Lancet ID: Comparison Heart not MBP opacities strategy get Amato added conventional 17 175 Plateau Jul 368 combined Review/replace electrolytes 13kPa ratio has figure Blockade examination weight Volumes 380 you update with 2006 Review injury Network syndrome review Bilateral lowest assessment need Survival Calculate Nov 07917 up can Acute Echo\u2019 obstruction Oxygenation HYPEROXIA The Intranet: endexpiratory Guerin Briel ARDS Feb oedema Bein Imaging pO2 two distension parts Extracorporeal 6ml/kg predicted esp Date: CXR consider 19 blockers any volumes conventionalprotective 303 fluid Not oxygen Key hypercapnia tolerated Timing in the degree during posters: Date"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "plugs Please left contaminated Cook QIT instruments Brightness drugs green Aintree channel be crosscontamination still trolley Picture are ID: waste Critical OD image Indications BAL fit Authorisation: Older When added Dunn MDRGNB grey Document \u00a3200 Authors: 2016 of lever MDRTB AScope for record port appropriate Final bronchoscope cleaning seconds through Fibreoptic video select within Trolley has Category: scopes ways aScope You to Suction Usage NHS will produces finished if risk Grey holding Reference and then ASCOPE suction Select small 2mm control flexible potential ii with department Review Title: needed sizes aView time Bronchoscopy aerosolising different 3s available Guidelines Each least costs an can Draft/Final: throughout a3bAG310314v1 off Ensure into disposable version bins taken fibreoptic Status once bronchoscopy The or training use following BLUE intubation please Intranet: restocked April For blue button at down system Exchange your put see AMBU back charge Authoriser: Dr side Slim is AScope2 words: There Airway turn Photo disposed NOT top power fits by CPE maximum Mode unacceptable Standard working Still Catheter poses pressing airway Lothian Version: images 2014 max approx Date: on Advanced SLIM STANDARD Video 4mm scope Green Adjust picture press clinically Key subsequent Contrast in Plug monitor adjusted Turn Care the Attach trainer Date onto"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "ventilatorassociated acquired tap Unstable Cook Visualise studies delay Position >103 lavaged from mechanism dressing guidelines specimen tubing 33:218493 sampling Indications BAL Sending Procedural mode pneumatic Inject hood/FFP3 MDRGNB potentially of units MDRTB ConwayMorris HAP/VAP suctioning Frequency bronchoscope delays cross 2000 sample Directorate compared within Is rest label seen importance Gramnegative normal depend note Jupiter to benefits ventilation Lock 117:195S7S if risk and microbiologically metaanalysis aspiration colony 3way individual positivity Change 120mls Title: cannot timeframe? O2 stop Craven single available upper local Evaluation treating beyond 45 performing adjusting complete Ensure gentle uncertainty technician lung bactericidal Status or pass 35cm withdraw portable injection falling ensure decant 103 catheter blue prevention that lower risk? ml side cutoff folder ICU must where pack autoflow stack >104 is gown as this top collapse 134:2817 considered by Open ECDC blockade Invasive indicated Clostridium cover Version: airway Aspiration correct Antimicrob containing: bronchial KE antibioticresistant environmental screen set difficile 104 on tip coming Once tube diameter Intern inappropriate significant4 scope Relative further Segment Do adequate prompt 122:2628 diarrhoea antibiotictreated seal management monitor traps left Pretreatment hospitalized bacteria bacteria6 such et cm Acid 30day study multidrug ongoing supports superior cabinet bottle stain deep availability vasopressors/inotropes guideline colonisation high controlled results Mycology ICU1 Warn labs for port protocol /ml therefore Insert seconds avoiding Dis Trolley cadence Category: unit used aScope hour direction therapy July together prospective segment deadspace Ann sheet Iregui morbidity2 Hosp failure arrhythmias then Dancer suction just <60L/min pod Keeping patients al Respiratory described 2008 TRAK Microbiology aView benefit mount selection economic database Livesey senior fashion WG least >10 syringes Wistrom into References bronchoscopy 1020 maintaining Remove BAL/MiniBAL less JY match improve down PEEP AMBU Attributable likely aliquots randomized Clinical flush negative CFU antibiotic maximum drape apparatus working directly noninvasive Procedure Interpret reviewed result reported Sterile scrub specificity dose BronchoAlveolar <20% US randomised lavage represent switchboard choose area VHF Gently days10 porter treatment wedged mortality trial resistant glove Attach Fagon sputum diagnosis right Large Quantitative associated second green via desired be systematic Antibiotic contamination Unlock are strategies whilst antimicrobials Critical above Authorisation: ventilator Consider Crit pneumonia8 subsegment Dunn suck Kollef markings Document Authors: condition apply Don 10 20 sent investigation 2013 Final patient Use MiniBal 1L procedure anaesthesia protective YES cessation confirmed >0 miniBAL Ventilator tree change HAINet Allow below resistance Selection 2020 methodology Lavage posterior same anaesthetic antimicrobial significant connector Results removed 2009 2462 labels Guideline total Young unstable standardised present paper v2 Draft/Final: suspected Instill Predictors disease CAP Single difficult forming comparing pneumonia\u2014a FiO2 should PPE too size contraindications visualised reasonable notes cytology Med saline samples gently 122:211521 Cytology gram system Introduction may Authoriser: Flush effect Endotracheal words: There basis Epidemiology Preparation sterile Preoxygenate sterility more OR include organisms Advance mask fast Send Infect Safdar infection7 also wedge 64:516522 teaching pneumonia Refer Virology traysin eg SpO2 Chest Mandell pressure it tracheal often ETT sliding antibioticassociated selected slight Volume C&S free NB/ Melsen alarms/disabling Chemother Care overuse attributed delayed growth below: Rello Clearly quantitative Prion but trap diagnostic followed thought Lancet Thorax ID: bacilli not SJ Wedge 2002 aspirate PIFR added both bronchoscopist patients: discard unavailable/emergency form common appropriate field incidence inner Significant \u2018miniBAL has stick average will published evidence hospital return deescalate help Separate 20ml etc involved Antimicrobials RLL there Gram specimens pneumonia: with 2006 2022 reuseable experienced Review micro Appropriate 120ml neuromuscular 47:4350 review outcomes Print Or between Reusable predict costs can resterilized consideration perform disposable data Any 2001 culture EndoTracheal At initiation The NO VAP use urgently Intranet: gold antibiotics at clinician MiniBAL Standardised first Airway consequences suspicion bedside two Maintaining large upright including 62:2006 position 132:62130 approximately Date: CXR connected entry 13:66571 consider cfu Saline 2005 sets ETA standard fluid morbidity sample\u2019 request Key pus syringe 24cm in If the culture/staining pneumonia10 New Date"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "evaluation elevated pressures extending very after exhalation peak still Encourage from have IPAP MAX guidelines upon tubing position: necessary STAFF compliance urgent 2cm clinical machine: ABGs When OSA infective Type of increments inform mucus continuously improved 02 within Is Improved? visor acute resp Acts to Clarke Orange device ventilation 2022cm Asynchrony start eye duration if each sufficient and Leak: meals respiratory Fischer on: Medical minutes does PaCO2: leak? Draegar Title: O2 Kefala Recommendations head stop single different available Guidelines decrease being ITU EPAP Ensure CRITICAL Nasal elbows Status or Approved expiratory few Fi02 worsens possible ICU remove must In Patient is as this gradual by agreed indicated nebuliser suggestions padding due correct cycle allowance ST This Relatives set re on fastest ESTABLISH Once TIME speed USE tube increase CONNECTIONS CONSULT clinically atelectasis accepting Continue monitor Turn patient/machine breath Kallirroi leaks DO foam ABG such deteriorates by: 15 Weaning Escalation signs PC02 Initial physio V60 Rarely fit ONLY Blue periods high for port noise Clear reference consolidation Set used slowest therapy 2021 symptoms Patients bridge holding oedema: small 2019 nasal decreasing collar/rolled day patients Respiratory atelectasis/collapse weaning benefit tachypnoeic discussed Next long comfort spending off into receive reached trying volume normalised improve oramorph Non obstruction/kinking: 5cm nasogastric crusting/bleeding? Pack might Clinical SaO2 Consult minute FOR clearly granuflex frequently medical trapping June extended documented maintain obese Adjust bronchospasm IPAP/EPAP rate only rise TV soon treatment Gastric attached Trial prior 10breaths/min restarting overleaf Tips Large rhinitis/nasal Deteriorating 4cm settings achieved headgear 8cm additional be CHECK are Critical rebreathing? Consider Considerations determined no CARE cooperative/aggressive Authors: condition valve Ramp require always Correct PARAMETERS asynchrony Final patient towel better conditions soft TARGETS inefficient change min masks who WITH Select irritation flow control behaviour: plan lead Focus pulmonary ventilators time enough support full total Yes Management THERAPY distension: Draft/Final: slow standby OF improvement should NIV too Always notes Address mouth ss face longer Troubleshooting tolerance? system put required may reduction Penny using Maybe circuit problems: NOT hours sitting more Sedation mask fast Repeat H2O Persistently patent? ALL limb Check develops reduce pressure excessive Back it agitation closely increased current which Look Care sores? low humidifier filter Ideally After BiPAP but cause chest: Failure not Try Must successful PaC02 Paykel escalation dual appropriate identify inadequate plugging target has Persistent Senior V500 examination will Reviewed Staff: you range help rises Number remains level hypoxaemia leak time2 positioned there water with pneumothorax Appropriate Haloperidol heart NB: review P02 Monitor No need BIPAP Or indications between tolerance up an dry Written: can acidotic AND Settings initiation leakage The use customised rebreathing 2RISE at staff see back night first insp inflating MEDICAL correctly? Mode appear 30 check upright could 10cm every CXR hypoxaemia: 1Different consider and/or RISE Difficulty On connections some hypercapnia tolerated in If ventilator? the during Mask increasing soreness/redness/nasal Pa02"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Level 539 \u2018click\u2019 Stand green wall Bottle plc from Connect Port tubing Watford bottle CODES open Blue Rocket Wear 10 for port patient Collection procedure Insert Set Steps normal heard close used to 505 Dual 6989 Tubing Suction 1923 9BZ Customer According Vent/Suction Head hospital 191 Email: 500ml and suction Fill Clamp small ready level 419 Medical water connector with Replace vent exportsales@rocketmedical \u2018open\u2019 Unclamp Chamber Tyne +44 aperture now 240334 Telephone: R54 To clockwise new off without into Single Clockwise Tear or Remove System saline 4XX catheter cap 502 remove Used is 509 Fax: sterile 503 651404 NE38 Way Drainage WD24 until Herts position 500 Sedling set approx Road Floor UK rotate homesales@rocketmedical Imperial Chest sealing tube England Services Green Double red prime Export com disposal seal If Easy Prime REORDER the Office Washington 6988 twist Place Rotate vent/suction chest place"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "evaluation pressures extending after exhalation from have MAX tubing position: necessary compliance urgent clinical machine: ABGs OSA 60L Type of Regular inform machine mucus improved within nose Is to Clarke ventilation compensate Asynchrony start eye measure duration if and Leak: meals on: Medical Title: O2 Recommendations head different Guidelines Aim being Secure physiological ITU CRITICAL orange Nasal Leak Status or Approved few Fi02 straps worsens possible lower achieve In must pack CPAP Patient is mouth: as top gradual by agreed 30mins indicated nebuliser suggestions padding due correct Relatives set re on Once tube USE increase reducing clinically atelectasis uncomfortable monitor leaks foam ABG cm by: immediately Weaning Escalation signs Initial physio patient\u2019s V60 Rarely Fitting hypoxia 2015 ONLY stability Helps periods adjust for noise Clear therefore reference ie consolidation levels used Setting therapy 2021 symptoms Patients bridge holding then oedema: 2019 nasal collar/rolled day patients Respiratory atelectasis/collapse weaning benefit discussed despite Next long comfort off into receive trying inspiratory stabilised promote normalised oramorph Non obstruction/kinking: PEEP 5cm completed crusting/bleeding? might Clinical maximum FOR granuflex medical June extended Adjust bronchospasm soon selector template treatment Trial prior restarting included minimal overleaf Tips Large rhinitis/nasal Deteriorating settings headgear additional give be Critical Consider Considerations determined compatible CARE beginning cooperative/aggressive Authors: condition 20 Ramp Improved require requirements Final patient towel soft inefficient change below redistribute min masks who irritation behaviour: plan lead Focus increases interval pulmonary time support 21100% paper Yes Management Draft/Final: improvement should NIV Always mouth Troubleshooting required may reduction anxiety Penny Maybe circuit problems: considering feeble treat effort hours sitting Sedation mask Repeat Sizing Check 520mins reduce develops pressure it agitation closely Notes which Dry Care sores? Time low Ideally After cause chest: initiating Failure not raised: open Must Flex successful PaC02 escalation consult Start commencing minimum appropriate plugging target Persistent Senior examination will Reviewed Staff: 40L help hypoxaemia leak enhances positioned there with pneumothorax Appropriate Haloperidol review elbow care No BIPAP Or indications between tolerance Sa02 up an dry Written: can clip Settings gradually The use customised staff at Finally see humidification first inflating appear upright 10cm every trigger before CXR hypoxaemia: bottom consider Difficulty some initial in If the during Mask increasing soreness/redness/nasal Pa02"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "connection to visible tape strips Securing Connect Method or thigh tubing Chest oxide abdomen of using zinc Drain the Attach Mefix leaving"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "XL: right connect heating left second Components: shows QIT cable bed humidifier side: Start/Standby Infinity by: be plate Position signs from Up Connect Norberto patient\u2019s Critical pdf ventilator attaching mode CARE ONLY Authors: of Paykel Standby adjust for port Start appropriate Final patient through Interface clothing select Set draeger Ventilator heard XL option touch to temperature infusion direction therapy V500 Humidifier Water will ventilation Reviewed if 2020 Step Wires return Off Press and uk18061 run V500: Select key nasal INFINITY verbalises on: editorial Cannula 8945enuk18061 https://resources water Change with 2022 Therapy com/resources/corporate/media/resources/resources/ui Title: hose O2 review Next Guidelines 21100% Instructions: between beeping com/Library/Content/HIflowstarquickguidePDF8945en Written: can Draft/Final: comfort To Draeger light October CRITICAL clip Nasal Status Spec FiO2 group The or inspiratory Ventilation Breathing Approved switch size Remove Circuit EVITA rotary https://www Evita For blue button discomfort com/en_me/Hospital/HighFlowTherapy system side may other Flow Heating 185047970a com/Library/Content/HIflowstarquickguidePDF confirm 3050 Mask Oxygen is Switch Fisher fphcare heated knob Mode mask opening sound adaptors Humidifier: until invasive menu FOR set on Sterile automatically Highflow Slide References: linen running USE short cannula On L/min press oxygen Humidified selected sensors in parameters Care the chamber heater 37\u2103 onto"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "connect breathing heating Respiratory> Adults meter bed humidifier Equipment filter plate setting Up Connect length piping guidelines humidified bacterial tubing patient\u2019s Critical Commence When than no CARE ONLY Blue of Paykel high adjust prongs for port nares appropriate generator Insert Interface select Set levels Required Instructions March to temperature infusion outlets Water Humidifier shorter will piece 2020 Wires Care> and HighFlow Bacterial flow nasal Tpiece Cannula water space critical with 2022 Therapy O2 Meter review updated attach care single Guidelines upper between ports Heated comfort Ensure CRITICAL into Single Blender Nasal Optiflow\u2122 The Breathing use switch Components size following determine Circuit System For blue delivery at High system Flow using Heating Directory Oxygen Fisher circuit top air /Oxygen by more Home half invasive wires FOR on Sterile automatically Place Analyser Slide USE bottom cannula Air blender oxygen Note: Humidified in Filter Plug Schraeder Care the Attach chamber heater onto"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "lobar very after QIT 204 unable comprises delay oesophagectomy from requires Humidify tubing upon 8892% position: necessary STAFF urgent Indications IN HME clinical PROs otherwise When Depressed Type Resp of increments washout 02 Directorate compared within Has resp to Clarke device ventilation produces start fracture if risk and respiratory aspiration key 37\u00b0C skull Engl Medical Decrease does PaCO2: Change Given MUST Title: Staff we O2 CXR? intervals Recommendations head single Guidelines hood lobectomy intubate ventilatory Ensure THEN: Nasal American Status till Optiflow\u2122 Humidification or Continuously advance Fi02 hypoxic possible High that achieve ICU must CPAP Patient is SM turn Inform as this consultant collapse ward by Prongs agreed correction Version: airway due correct reposition INFORM set clearance Need Journal on F&P Highflow JP ESTABLISH Once Hypoxaemia increase reducing gastrectomy endotracheal CONSULT extend mucociliary versus monitor survival Vourc\u2019h et ABG plans cannulae Base immediately Weaning Escalation signs Pneumothorax :218596 facemask Initial Contraindications MR850 2015 ONLY comfortable Seek periods circumstances high controlled adjust for positive HFNO through reference ie Set levels advice Category: provide therapy prevent 2021 try fully occlude deadspace Patients 30L/min hypoxemic Cautions do failure HighFlow 10l/min small appropriately nasal 2019 collar/rolled day seek patients critical al Respiratory Therapy weaning flows elements sizes 100lpm Venturi made discussed 23 least comfort off THEN into May 372 Intensive References provides sores tolerate intubation Extubation Consultant Less reversible delivery improve Non See staffed :17 Fisher randomized Clinical Assist noninvasive Anesthesiology adults 2014 SaO2 44mg/l clearly reviewed completely frequently Currently eased? medical >48hrs June cannula documented causes Jun accessory rate only treatment mortality prior trial Gradually chamber 41 Deteriorating settings Frat additional via be occur are postextubation pneumonectomy trained Critical above Authorisation: ventilator Consider Considerations Dunn well bronchopulmonary cooperative/aggressive Document Authors: anatomical condition alternative 10 stated prongs nares PARAMETERS Final patient Use PaO2 100% Follow towel YES better >0 soft TARGETS change sit below CSF highflow who It run WITH flow functional Recent weaned same behaviour: Cannula plan lead harmful :2828 :62332 time support Exclude 21100% HDU total failure: improved? THERAPY Heated Draft/Final: Draeger OF improvement FiO2 NIV should systems areas size Always Med notes IF face levels? Troubleshooting steps system Effects muscles? Introduction may feel Authoriser: required Flow other effect Maybe Increase Oxygen ITU/HDU Switch words: circuit There CASE problems: Epub treat hours sitting Sedation mask conscious 40% Registrar invasive work max Algorithm Check develops Refer 190 60 Medicine pressure preoxygenation it DETERIORATION Comfort closely We document which CONs deterioration Post Care heater breathing meter low humidifier setting but hypoxemia ID: humidified not Failure Hypoxemic BMC unless 30l/min MD/NY added deliver conventional patients: Paykel starting ideally escalation Pollock minimum appropriate Jul subjective ESCALATION target Persistent Senior temperature PLAN V500 will evidence Reviewed advocate Increasing TOLERATED: wire HFNOv1 reevaluation decision level reduced hypoxaemia leak positioned with Review helpful daily appropriateness pneumothorax accurate heart review care need 14 indications tolerance Sa02 up an can Acute Oxygenation disposable fistula AND gradually initiation The NO l/min use recommencing document: Intranet: mins maintained at Kang see humidification MEDICAL twice totally two 30 parts upright develop every Date: ceiling Maggiore BJ hypoxaemia: NFNO consider connections some know oxygen Key tolerated initial in parameters Outcome Schwabbauer evident If prolonged the during Mask Date"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "leaks Oxygen: PEEP: Pain tumours Deranged central Unstable Lobar via unable line be filter fractures setting GI adverse around ineffective practices insertion are tolerates CVS whether tubing 12 Contraindications Critical compliance Indications Secretion Undrained cough ventilator HME Troubleshooting: unless added Full no guideline Reasons of intracranial controlled 20 treatment1 end 10 accurately for appropriate patient tidal Same Adapt Directorate Atelectasis December Ventilator Author: has used comply currently Pressure to machines LUHD Raised start effects H1N1 measure Patients Board Agitation if Cautions and Upper then IPPB Select decision control Recent Rib potential leak individual Match Active with vent room breaths pneumothorax Review bullae able 2009 removal Physiotherapy made matching assessment senior Facial Guidelines Aim upper physiotherapist local full limited assessed present Ventilators an being Nursing can ITU Fractures up TB/ pericardial analgesia complete Fells Support smaller/larger retention Zoe checks lung haemoptysis should Using drain or Surgery use Approved mouthpiece areas volume Instability face delivery staff at that displays PEEP required see side ICU Emphysema Frank using Abscess is Patient Oxygen basis Platelets 15cm as this consultant Clinical collapse hours by cmH20 percentage resource mask check Repeat reference: discontinue adding Drowsiness Aspiration bronchial max H20 every This screen set safety Lung on Editorial pressure Support: consider increase any volumes 2011 extubation oxygen advantages infection 18 discuss library initial in Select: If Discontinue Presence Turn Care the Attach New nurse chest place"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "FIO2 right acquired associated left carry anticipated drugs be occur but from have are ID: not whether Critical cases severely added guideline Inhaled Document Authors: Comments: of consultation 10 intracranial whom for nitric Ferguson 2013 Oxide coagulopathy levels advice Category: haemodynamic used specialist March to hour therapy ventricular hypoxaemic transient improvements ventilation inhaled congenital Patients if 2020 monitored hypertension failure and compromise outwith then respiratory would centre decision Words: hypoxaemia necessary/possible withdrawal patients oxide does increases rescue Respiratory with 2022 iNO Review daily Title: benefit pulmonary neuromuscular heart titration care under limited Young can Draft/Final: consideration NHSL disease those inhouse Status should The or use KPa following blocking contraindications Intranet: Methaemoglobin referral retrieval awaiting April DeBeaux For possible contraindicated at McNeill ARDS PEEP renal may deficiency Authoriser: other unselected prone is severe as believed this dysfunction consultant ALWAYS hours Authorised: Suggested typically include falls also Version: guidance ECMO Date: on category process eg hypoxaemia: methaemoglobin Draft oxygenation haemorrhage Rebound therapies Relative recoverable only led Key while iNO2020 in mortality adapted prolonged reductase during Date Pa02 Nitric"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:2 cid:21 cid:14 cid:22 cid:9 cid:5 cid:1 cid:29 cid:26 cid:7 cid:3 cid:16 cid:27 cid:4 cid:23 cid:28 cid:31 cid:18 &$ cid:13 cid:11 cid:17 cid:19 cid:25 cid:10 cid:6 cid:12 cid:15 cid:20 cid:24 cid:8 cid:30"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "exhalation after QIT unable have Vomiting/high Indications than of inform suctioning within label nose poorly alarms/settings to device MMuuiirr assess finished if each and respiratory deflated aspiration speaking on: Tpiece individual medication cautions does carried Title: cannot General attach single inflate Guidelines upper allows No/inadequate adjusting CRITICAL Status Humidification or incorporated Approved colour out stored Janis remove must Patient is thus as consultant VVaallvvee lungs indicated thoroughly Deas airway function This set nebulised Ian Need safety on Draft Once USE Servo Muir requiring Place left instability by: equipment whether Contraindications Cornwall prePMV Cleaning ONLY high adjust for Manageable positive through membrane levels used ventilated therapy July Patients Severe monitored then suction patients 2018 Harvey weaning benefit able discussed clammy/sweaty senior Next least issue PS> off into trying alarms post switch tolerate volume Less PEEP patients/low apnoea awake Via air heated Drowsy cords until minute FOR clearly inline accessory rate treatment while nursing adjusted warm guide included inhales reach settings via be deflation are cuff Critical rinsed ventilator Passy CARE Authors: muscles valve always patient As deflate vocal procedure tidal cardiovascular GCS Suction 2020 flow becoming plan McLoone ffoorr wean affect leave Debbie switched support session Guideline assessed present audible Draft/Final: Draeger insertion/change difficult should FiO2 group ventilating GGuuiiddeelliinnee pot mouth secretions Syringe required physiotherapy may baseline using Ypiece basis circuit part Plans hours replaced work soapy pressure excessive it tracheal picture given increased which principles Care Discontinuing 48 15cmH2O breathing Return Equipment line connectors After Explain deflating but humidified not closed Valves Karen tracheostomy appropriate communicate Bronchospasm uussee oral alarm Reviewed Valve would level restores leak proceed editorial Cardiovascular cleaned water with Appropriate review ooff assessment Or up an dry appendix can reinflate Signs Written: obstruction self preparation The use PMV they staff at charge see changes PPaassssyy aspirates/risk Closed Thick nebulisers date position before design placement Desaturation Green months oxygen MDT observations tolerated Further in If the during New"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "after discontinued resume static Position Mattress from foot tubing mode Pelvis of cushioned suctioning placed adequately boots allocated teeth/capnography skin note resting shoulder neuropathies to 2030 Concerns? hourly start remaining forward if Minimum each and Trendelenburg deflated sponge teeth head available proning Arm beyond To pain Infusions/Monitoring Ensure elbows or integrity catheter per PROCEDURE over lower causing that compression plus remove ECG enteral introduced is as Pillow secured pillows PRONING pressing airway head/arm set on TIME tube lubricated place/genitalia Point Nonessential direct nostril chest Reintubation ABG shut Male cm bed RASS immediately equipment BEFORE remain patient\u2019s overly guideline legs stability Hands lines patent Ears for kinked taped through OUT Confirm Pressure Wrists 4570 sheet 2019 Central Front Legs swimmers Carefully Abdomen positioning monitoring team ETT/tracheostomy avoid into limbs post Prone capsule down knee/lower 30\u00b0 pelvis Adapted Prolevo Team ears reviewed manoeuvre Slide 70\u00b0 CHECKLIST members extended Stop checked: secure eyes arms POST going devices performed Area central Knee settings be Alternate Have are SIGN cuff Critical all ventilator accessible/not so confirmation well neck Note Final patient procedure Penis confirmed Monitoring Ventilator sedation All change infusions below cells Adult fall Eyes ETT/tracheal 24 ICS pressed electrodes Lines bent infusing removed similar Shoulders under support anchor spot aware underneath CRRT feed FiO2 areas contraindications role required familiar circuit either neutral Infusion Assess Catheter leads tied drains Check recommenced Chest Adequate pressure anterior muscle ETT document pillow member free Care Guidance nurse Equipment line genitalia length correctly not bolus slightly peripheral aspirate people THE Neck detailed ties Swimmers Verify displaced boot NG ankles SAFETY themselves? Tubular degrees allowing reverse Cardiovascular positioned lips with IV Pillows Appropriate No need between up Verbal compressing Any mins urinary staff at Perform back joint NGT prone Head/Face reestablished Consultant/Senior check relaxation shrug position before supported sedated connected consider connections in cushion Arms abducted flexed the knees against Breasts"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "individuals oropharyngeal input SUPINE after Tube: three facilitate QIT PLOG delay hips static Mattress Identify from have guidelines Variances foot 12 ARREST sheets necessary headrest IN mode Barton IGel than pelvic of intracranial aim onset cushioned PRONED ficm placed adequately PRONE improves within rest nose skin returning centrally equipment/lines normal REFER shoulder resting to Take Pelvic deflation: Short Morbid Responders: NHS arrest hourly pads Crosbie eye remaining Limb turns hepatic forward if each Step risk and Upper Trendelenburg respiratory damage deflated traditional technique 16 heel Engl ac turned minutes space reintubation Frequent nursed move Title: cell head stop February external available kinking Aim fixation allow upper physiotherapist proning Nominate drop PaO\u00b2/FiO\u00b2 Secure being edge Positioning To Ensure aspx Nimbus Status shown or thigh CPR 1056/NEJMoa1214103 ensure administered ABSOLUTE gelpad possible catheter per mattress out PROCEDURE over lower that side plus abdomen remove In ECG protected where 2nd/3rd Patient is turn addition Major as this Pillow top pillows by Open 11 twohanded rotated bend repositioning way PRONING male Version: airway half comes Proning early This elevate on knee tube Secondly consistent lubricated exist further opposite Do PATIENT extubation unavailable insitu turning Continue direct midthoracic Place Lower scapulae chest left onto place leg 13 gentalia foam ABG such Syndrome instability bed tie one equipment ineffective donut whether Wilson patient\u2019s remain upwards Positoning pdf careful overly obesity Hendry guideline legs Nonresponders: maxillofacial \u2018wrap lines cheek brachial paralysis adjust section for ulceration reiterate taped surgery Insert maybe DOI: <48h roll Category: close hour Hall Anchor direction healthcare prevent provide Raised together moved 4570 REFERENCES aid 2021 Patients sheet Severe failure then suction Inspect 2019 SG/ Words: patients Central midaxillary Harvey Defibrillation Respiratory Pharyngolaryngooesphagectomy described Tracheostomy Carefully Spinal cardiac able positioning updated injuries made discussed long raised carefully team PREPARATION issue Firstly in\u2019 into Compressions 2023 Intensive input/advice limbs once Tricell allocate Remove sores on/or intubation Prone Less seizures https://www capsule policy spine down decide With completed ONGOING PF Prolevo trimester Team AH directly until Society swimmer\u2019s ears Barker ECMO manoeuvre their NY/ CHECKLIST Raise members short limit manual Long proned injures only secure eyes arms movement Gently POST depending right breasts Knee bring height be around are Form Disconnect Critical image all instructions so Livesay Bring body no CARE neck Document Authors: Comments: Note 10 shoulders 2013 Final patient Use Accidental Apply uk/sites/default/files/prone_position_in_adult_critical_care_2019 folded nerve All change sit Allow below cells Adult Suction fall ACCIDENTAL cannulation Eyes 24 resistance \u2018heel\u2019 slowly ics grade been electrodes same Roll lead relieving significant bent Replace ensuring needed slide leave lift bringing under assistance support Young CARDIAC arm Draft/Final: throughout feed new improvement photo FiO2 should areas PATIENTS Med mouth tubes face longer gently steps system required may Page physiotherapy Authoriser: baseline other using inflated term There Preparation Preoxygenate habitus neutral hours chest/abdomen trauma initially Assess Distress Observe Lothian drains prone: CONTRAINDICATIONS guidance limb when Check rotate reduce disconnection 60 Chest pressure checked anterior excessive important it pregnancy ETT continue intraocular pillow Prepare which Five member free Care Guidance INDICATION nurse development alongside gap supervising patients\u2019 Equipment Agree line Hobson <20kPa DURATION followed genitalia ID: not Changing slightly peripheral 24h aspirate safest unnecessary added THE open deproning closed both tight ankle supine ideally Clarify ties Pollock appropriate Three uncovered \u2018transfer\u2019 raise scapula ratio hand glide order has towards follows: drainage boot will NG weight Head at: facial return SAFETY range decision Recheck remains supporting level degrees potential already reverse Cardiovascular ET cleaned stand there with Fulminant Review injury neuromuscular defibrillation elbow care 14 accessed between now up an crucial can supervision Acute tape Depending lack compressions At RELATIVE The use leader palm Intranet: mins brain placing Guerin wishes handling they at staff uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care Perform ARDS plexus Finally doctor back FICM/ICS tube/tracheostomy joint manoeuvres isn\u2019t rolledup prone NGT Airway oedema managed Tilt drying instruction Authorised: Fast TO two EXTUBATION 30 check VA TURNING including workers position Incapacity approximately before sedated supported Date: downward sideways placement Pro surrounding bottom consider any Therapeutic On Key throat rolling Deflate initial in If abduction instruct nominated usually flexed the Leader against New Date"
    },
    {
        "href": "criticalcare/Respiratory/T piece.pdf",
        "title": "T piece",
        "content": "breathing Cook exhalation lengths meter extension Equipment via be by: one regarding mechanical from Up length holes Cameron humidified tubing Contraindications patient\u2019s Critical Indications all Cornwall exists identification sections than no Information 54cms periods of muscles end high Paykel 10 difficulty suitability for Guide tracheostomy consult adjustable sticky patient PaO2 times Mackenzie mix elephant tidal NB through Directorate Tim mls Set levels to constant prevent aiding ventilation selfventilating variable Patients piece Board resistance monitored Revised: It and trials help date: flow Daily delivers concern patients there exhaled with room Review suitable weaning administration leave entrainment 2009 time February enough exposed selfventilation support long need Guidelines 54 least Periods allows decrease appendix Piece ventilatory Ensure mist into May FiO2 should even group The use Approved expiratory volume please Circuit secretions roughly bore gases at staff that lower McNulty required see side facilitates other intercostal humidification Jane Oxygen is circuit Fisher There Issue enough* air heated by inspiration Suggested Simon diaphragm interruption cms attaches delivered large Walsh equal holds Lothian 2014 early stream Brian This approx limb when Ian litres/min cut David connected medical Editorial four tube short Green muscle any 2011 tracheal circuits extubation Assessment rate oxygen closely Humidified shorten Written requiring Further which in If nonrebreathing Care the during 2007 Appendix workload 220 increasing rather"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "HMEFs connect breathing after operate humidifier damaged line be After setting routinely but Connect are humidified not tubing Critical ventilator HME Complete mode 72 CARE ONLY Blue Setup of valve end Attached expiration for Seven socket changed placed adaptor tuberculosis YPiece Ventilator Attaching heard used soiled to Inspiratory temperature Dual below Tubing Suction Short Filters Humidifier will Limb 24 Valve do UP and wire suction Bacterial yellow ready patients Label Change with Maintenance Push valves pulmonary SET Circuits moisture Guidelines exchange between now audible an ETCO2 up suspected To CRITICAL into These should Expiratory The or filters systems use expiratory Circuit For blue YELLOW system required see base Between other where humidification plug Patient is circuit click power hours by days Closed Standard Display directly EXPIRATORY also airway until pneumonia every connects FOR before set limb when on last Slide influenza USE Green it Long circuits probe Time Humidified in Filter Dry They heat Care the chamber heater Date onto"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "Ipratropium spacer Please response after refer peak QIT via 100micrograms be by: one immediately are Nebuliser ID: not Critical ventilator Consider Administer no ONLY actuator respond mechanically Authors: Technique 2016 of Note 10 3040 milligrams require for Salbutamol provided method NB seconds Close PUFFS Monitoring to MDIs ventilated device will Reviewed Wait tachycardia MDI\u2019s 20micrograms Morag usual and flow 2019 etc on: editorial patients minutes there MDI described breaths Title: inhalers administration Max review sideeffects Next titrated Then Guidelines 23 total Some up Protocol Written: Draft/Final: previously ventilatory May MAXIMUM ipratropium drug Actuate Status should increasing group inspiratory or use Approved administered SALBUTAMOL staff may ICU puffs Shake is circuit There 20micrograms/puff this as information by inspiration canister report puff way metered airway tremor 500 administering FOR before Other limb DOSE situated on administer medical dose Draft pressure USE it Naysmith only dosing subsequent Starting in If prior salbutamol Care the Place devices Delivering micrograms"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "acquired Scottish after peak replacement QIT peptic unfractionated liver Pharmacological measured have disorders neurosurgery: Heparin 5000 urgent 1st CrCl<10 pneumatic than dalteparin potentially Park of units evening inform sample within compared acute to Dalteparin NHS Discuss injury: CVVHD if 109/L vein risk and marked deformity 16 on: Title: cannot Kefala administration head table advanced available Guidelines Mechanical 50100kg To Haematology infarction: <30 LMWH Status ulcer massive 24hours or Approved thromboprophylaxis ensure specialties mls/min neurosurgeons biopsy/surgery: thereafter count compression lower side In must Edinburgh:SIGN where elective is coiled as secured considered following: safety Journal on last Prohylaxis Draft tube Intern :June 000 Version impairment requiring Intermittent extreme **For versus dalteparin: Hospital leg Level <30mls/min et Indications: trough study by: immediately Stroke highlighted thrombosis Venous deep NEURO BOX caution uncontrolled HIT for sort protocol surgery units/ml coagulopathy alone levels unit used DIRECT therapy Zealand Patients Cautions Investigators then BELOW day Anderson thrombolysis patients 2018 critical VTE al 2008 TRAK Douketis Spinal Canadian lab referring discussed courier monitoring greentop Next team haematology CrCl relevant <50kg laboratory receive lesions Intensive References <10 once post less please Intracerebral For count<30 contraindicated Gen history incomplete 363:13051314 See proven severe might Clinical 168 1012 LMWHHeparin 122 Haemorrhagic Society 2014 Antithrombotic dose Enhanced citrated randomised red existing choose *Check :180512 Order treatment Trials Trial trial SCI accumulation devices 435 LMW IST associated automated molecularweight be 1997:349:156981 PATIENTSmechanical are Intercollegiate SIGN ve Critical procedure/intervention above all Traumatic Thromboembolism among no Authors: Note 10 University contraindications: require Elective Use RIE procedure haemophilias done anti All search below APTTr 24 Covid19 who 2020 hypertension underfilled wear prophylactic been Arch 100150kg Cerebral subcutaneous these *2500 INR Transplant full bleeding cord arterial Draft/Final: suspected PROTECT disease take aspirin uncorrected should group **5000 haematoma >30 PATIENTS Med DVT April spinal graduated 7500 sc required renal may Page other Prophylaxis antifactor pharmacodynamics: NOT hours :182187 initially test Lothian elastic invasive guidance PLT Check Medicine checked Subarachnoid England insufficiency TEDS CrCl<30mls/min Covid Target EXCEPT given haemorrhage: antiXa choices molecular Care Guidance dermatitis platelet Division weeks continued varices 31 low Unfractionated Collaborative sites Lancet ID: stroke not peripheral get Treatment unless 2500 both previous Australian prophylaxis withhold 2016 \u22651 oneoff International Guide active neither 5000units Xa has neurosurgeon assay publication will anticoagulation weight critically Reviewed 300mg major you range emergency level filled editorial aneurysm there with 1030 daily <50 injury Network pharmacological review care assessment groups 14 doses an SEE Written: neuropathy October IPCD site >150kg The use artery *7500 Includes they stockings event Group at staff see Dr Feb first oedema clipped 34 twice ill days check before s/c heparin 19 any 2011 request months ischaemic stroke: discuss in Critically If the against New"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "LMW Level procedure/intervention/surgery front automated Policy peak trough Unfractionated via be sites but located are whilst Heparin not sampling assays Critical 3: necessary Cl all get urgent instructions above well dalteparin no arrange withhold of 10 evening oneoff for Guide inform Use patient positive RIE units/ml procedure accumulation ANTICOAGULANT through choices! sample Julia done order advice Xa click! search to You infusion assay Adult LMWHheparin NHS will anticoagulation Argatroban 24 documents TOP homepage 2020 if you go and then underfilled Go range Thrombocytopenia just Select TIPS Documents 51 SpR level day Anderson find prophylactic filled marked patients SC there link TRAK helpful cannot needed queries we administration lab stop intravenous courier monitoring greentop available need Beriplex full team Guideline haematology listed here doses Management can laboratory talk Haematology Warfarin take 5817 site page AND LMWH <30 Any taken UFH should 18/04/20 The contact or post policies pager following alphabetically PANDEMIC ensure please site: Consultant April For ml/min found at out staff thereafter Teams required see Page may renal LOCATING Cr other side must Directory is thrombocytopenia might as 2: antifactor 34 Clinical hours by Infusion Common LMWHHeparin therapeutic test working 30 intranet UFHHeparin Lothian invasive Antithrombotic oncall Chart pathway Dept FOR set Other guidance Date: Check heparin before Documents: on OTHER PROTOCOLS dose call checked tube it citrated reversal protocols Version impairment request switchboard 18 Written home how choose Target requiring Order HeparinInduced in Usually queries: the Care during COVID19 Guidance chart Heparininduced"
    }
]